"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Simple Family Members,Simple Family Member Jurisdictions,Extended Family Size,Extended Family Members,Extended Family Member Jurisdictions,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,B2,US 10653883 B2,185-754-452-969-825,2020-05-19,2020,US 201715721542 A,2017-09-29,US 201715721542 A;;US 35910409 A,2009-01-23,Implantable medical device for providing chronic condition therapy and acute condition therapy using vagus nerve stimulation,"Disclosed herein are methods, systems, and apparatus for treating a medical condition in a patient using an implantable medical device (IMD). The IMD is capable of generating a first electrical signal for treating a medical condition, for example epilepsy. The first electrical signal relates to a long term therapy during a first time period in which there is no indication that the patient's brain is in an stable state, the first electrical signal being a microburst stimulation signal. The implantable device is also capable of generating a second electrical signal for treating the medical condition. The second electrical signal relates to a short term therapy during a second time period, in response to an indication that the patient's brain is in an unstable state. The second electrical signal in one example, may be a conventional stimulation signal.",LIVANOVA USA INC,SCOTT TIMOTHY L,LIVANOVA USA INC (2017-06-30),https://lens.org/185-754-452-969-825,Granted Patent,yes,557,0,4,189-117-226-555-636;;185-754-452-969-825;;163-222-837-914-491;;055-675-337-627-329,WO;;US,4,163-222-837-914-491;;185-754-452-969-825;;055-675-337-627-329;;189-117-226-555-636,WO;;US,0,A61B5/4094;;A61N1/36082;;A61N1/36114;;A61B5/4047;;A61N1/361;;A61B5/369;;A61B5/4094;;A61N1/36082;;A61N1/36114;;A61B5/4047;;A61B5/372;;A61N1/361,A61N1/36;;A61B5/00;;A61B5/0476,,40,31,033-503-915-578-321;;022-135-781-119-799;;115-741-015-188-295;;133-410-771-910-294;;018-561-710-123-368;;003-939-398-464-949;;123-886-184-023-915;;067-481-428-794-501;;135-605-956-820-706;;046-397-703-096-430;;019-308-872-975-51X;;002-403-074-135-442;;017-495-188-561-656;;056-177-900-384-501;;070-039-192-994-908;;091-962-532-331-31X;;086-889-563-820-053;;103-040-249-541-832;;016-207-089-756-778;;015-820-060-894-869;;052-374-111-868-631;;014-013-359-446-529;;029-196-990-684-376;;119-424-987-704-131;;002-529-055-788-476;;003-290-790-587-579;;026-435-299-569-935;;123-619-185-160-560;;139-831-627-763-342;;023-093-432-161-773;;025-424-076-138-599,10.1016/0006-8993(77)90274-8;;406970;;10.1097/00004424-200108000-00006;;11500598;;11709644;;10.1097/00004691-200109000-00003;;10195186;;10.1038/4600;;9774527;;10.1006/nlme.1998.3863;;10.1002/cne.20240;;15300785;;10.1046/j.1528-1157.2001.0420081017.x;;11554887;;10.1006/ebeh.2000.0148;;12609181;;10.1523/jneurosci.20-21-08160.2000;;pmc6772743;;11050139;;10.1016/s0006-3223(99)00308-x;;10686263;;10.1016/0006-8993(77)90275-x;;195672;;10.1212/wnl.59.6_suppl_4.s3;;12270962;;9738678;;10.1111/j.1528-1157.1998.tb01448.x;;11709649;;10.1097/00004691-200109000-00008;;10.1016/j.seizure.2003.09.009;;15276142;;2226362;;10.1111/j.1528-1157.1990.tb05844.x;;11552020;;10.1212/wnl.57.5.879;;10.1088/2058-7058/15/7/27;;10.1103/physrevlett.88.218101;;12059504;;10.1016/s0140-6736(04)17594-6;;15610808;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;10.1109/10.704873;;9691579;;9670894;;10.1111/j.1528-1157.1998.tb01151.x;;10.1212/wnl.56.4.561;;11261422;;10214755;;10.1212/wnl.52.6.1267;;1705341;;10.1111/j.1540-8159.1991.tb04052.x;;10.1007/s00381-004-0947-x;;15083332;;10.1016/s0278-5846(01)00228-7;;11853100;;11709643;;10.1097/00004691-200109000-00002;;10.1111/j.1540-8159.1991.tb04053.x;;1705342;;10.1111/j.1528-1157.1992.tb01751.x;;1464256,"Bachman, D. S. et al, “Effects of Vagal Volleys and Serotonin on Units of Cingulate Cortex in Monkeys”, Brain Research, vol. 130. 1977. pp. 253-269.;;Bohning, D.E. et al, “Feasibility of Vagus Nerve Stimulation-Synchronized Blood Oxygenation Level-Dependent Functional MRI”, A journal of Clinical and Laboratory Research: Investigative Radiology; vol. 36, No. 8, Aug. 2001, pp. 470-479.;;Boon, Paul et al, “Programmed and Magnet-Induced Vagus Nerve Stimulation for Refractory Epilepsy”, Journal of Clinical Neurophysiology vol. 18 No. 5, 2001, pp. 402-407.;;Clark, K.B. et al, “Enhanced Recognition Memory Following Vagus Nerve Stimulation in Human Subjects”, Nature Neuroscience, vol. 2 No. 1, Jan. 1999, pp. 93-98.;;Clark, K.B. et al, “Posttraining Electrical Stimulation of Vagal Afferents with Concomitant Vagal Efferent Inactivation Enhances Memory Storage Processes in the Rat”, Neurobiology of Learning and Memory, vol. 70, 364-373, 1998, Art. No. NL983863.;;Craig, A.D. (BUD), “Distribution of Trigeminothalamic and Spinothalamic Lamina I Terminations in the Macaque Monkey”, The Journal of Comparative Neurology, vol. 477, pp. 119-148, 2004.;;DeGiorgo, Christopher M et al, “Vagus Nerve Stimulation: Analysis of Device Parameters in 154 Patients During the Long-Term XE5 Study”, Epilepsia, vol. 42 No. 8, 2001, pp. 1017-1020.;;Devous, Michael D et al, “Effects of Vagus Nerve Stimulation on Regional Cerebral Blood Flow in Treatment-Resistant Depression”, National Institute of Mental Health—42nd Annual NCDEU Meeting: Poster Session II; Poster Abstracts, Jun. 10-13, 2002, 1 page; http://www.numh.nih.gov/ncdeu/abstracts2002/ncdeu2019.cfm.;;Dodrill, Ph.D. et al, “Effects of Vagal Nerve Stimulation on Cognition and Quality of Life in Epilepsy”, Epilepsy and Behavior, vol. 2, 2001, pp. 46-53.;;Fanselow, E.E. et al, “Reduction of Pentylenetetrazole-Induced Seizure Activity in Awake Rats by seizure-Triggered Trigeminal Nerve Stimulation”, The journal of Neuroscience, vol. 20 No. 21, Nov. 2000, pp. 8160-8168.;;Fromes, G. et al, “Clinical Utility of On-Demand Magnet Use with Vagus Nerve Stimulation”, AES Proceedings, date unknown.;;George, M.S. et al, “Vagus Nerve Stimulation: A New Tool for Brain Research and Therapy”, Society of Biological Psychiatry vol. 47, 2000, pp. 287-295.;;George, M.S., et al, “Open Trial of VNS Therapy in Severe Anxiety Disorders”, 156th American Psychiatric Association Annual Meeting, May 17-22, 2003.;;Hallowitz, R.A. et al, “Effects of Vagal Volleys on Units of Intralaminar and Juxtalaminar Thalaminar Nuclei in Monkeys”, Brain Research, vol. 130, 1977, pp. 271-286.;;Harry, J.D. et al, “Balancing Act: Noise is the Key to Restoring the Body's Sense of Equilibrium”, IEEE Spectrum, Apr. 2005, pp. 37-41.;;Henry, MD, T.E., “Therapeutic Mechanisms of Vagus Nerve Stimulation” Neurology, vol. 59 Suppl. 4, Sep. 2002, pp. S3-S14.;;Henry, T.R., et al, “Brain Blood-Flow alterations Induced by Therapeutic Vagus Nerve Stimulation in Partial Epilepsy: I. Acute Effects at High and Low Levels of Stimulation”, Epilepsia vol. 39 No. 9, p. 984-990, 1998.;;International Search Report and Written Opinion for International Application No. PCT/US2010/021569, dated Apr. 26, 2010, 13 pages.;;King, M.D., “Effects of Short-Term Vagus Nerve Stimulation (VNS) on FOS Expression in Rat Brain Nuclei” 58th Annual Scientific Convention of the Society of Biological Psychiatry, May 2003.;;Klapper, M.D. et al, “VNS Therapy Shows Potential Benefit in Patients with Migraine and Chronic Daily Headache After 3 to 6 Months of Treatment )Preliminary Results)” 45th Annual Scientific Meeting of the American Headache Society, Jun. 2003.;;Koo, B., “EEG Changes with Vagus Nerve Stimulation” Journal of Clinical Neurophysiology, vol. 18 No. 5, Sep. 2001, pp. 434-441.;;Labar, D., “Vagus Nerve Stimulation for 1 Year in 269 patients on Unchanged Antiepileptic Drugs” Seizure vol. 13, 2004 pp. 392-398.;;Liebman, K.M. et al, “Improvement in Cognitive Function After Vagal Nerve Stimulator Implantation”, Epilepsia, vol. 39, Suppl. 6, 1998, 1 page.;;Lockard et al., “Feasibility and Safety of Vagal Stimulation in Monkey Model,” Epilepsia, vol. 31 (Supp. 2) 1990, pp. S20-S26.;;Malow, B.A. et al, “Vagus Nerve Stimulation Reduces Daytime Sleepiness in Epilepsy Patients” Neurology 57, 2001 ages 879-884.;;McClintock, P., “Can Noise Actually Boost Brain Power” Physics World Jul. 2002, pp. 20-21.;;Mori, T. et al, “Noise-Induced Entrainment and Stochastic Resonance in Human Brain Waves” Physical Review Letters vol. 88, No. 21 (May 2002), pp. 218101-1-218101-4.;;Rugg-Gunn, F.J. et al, “Cardiac Arrhythmias in Focal Epilepsy: a Prospective Long-Term Study” www.thelancet.com vol. 364, 2004, pp. 2212-2219.;;Rutecki, P. “Anatomical, Physiological, and Theoretical Basis for the Antiepileptic Effect of Vagus Nerve Stimulation” Epilepsia, vol. 31 Suppl. 2, S1-S6, 1990.;;Sahin, M et al, “Improved Nerve Cuff Electrode Recordings with Subthreshold Anodic Currents”, IEEE Transactions on Biomedical Engineering, vol. 45, No. 8, Aug. 1998, pp. 1044-1050.;;Schachter, S.C. et al, “Progress in Epilepsy Research: Vagus Nerve Stimulation”, Epilepsia, vol. 39, No. 7, 1998, pp. 677-686.;;Tatum, W.O. et al, “Vagus Nerve Stimulation and Drug Reduction” Neurology, vol. 56, No. 4, Feb. 2001, pp. 561-563.;;Tatum, W.O. et al, “Ventricular Asystole During Vagus Nerve Stimulation for Epilepsy in Humans” American Academy of Neurology, 1999, p. 1267-1269.;;Terry et al, “The Implantable Neurocybernetic Prosthesis System”, Pacing and Clinical Electrophysiology, vol. 14, No. 1, Jan. 1991, pp. 86-93.;;Tubbs, R.S. et al, “Left-Sided Vagus Nerve Stimulation Decreases Intracranial Pressure Without Resultant Bradycardia in the Pig: A Potential Therapeutic Modality for Humans” Child's nervous System Original Paper, Springer-Verlag 2004.;;Valdes-Cruz, A et al, “Chronic Stimulation of the Cat Vagus Nerve Effect on Sleep and Behavior” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 26, 2002, pp. 113-118.;;Vonck et al, “The Mechanism of Action of Vagus Nerve Stimulation for Refractory Epilepsy”, Journal of Clinical Neurophysiology, vol. 18(5), 2001, pp. 394-401.;;Ward, H., M.D. et al, “Treatment-Refractory Obsessive-Compulsive Disorder: Potential Benefit of VNS Therapy”, 23rd Annual Conference of the Anxiety Disorders Association of America, 2007.;;Woodbury, et al., “Vagal Stimulation Reduces the Severity of Maximal Electroshock Seizures in Intact Rats. Use of a Cuff Electrode for Stimulating and Recording”, Pacing and Clinical Electrophysiology, vol. 14, Jan. 1991, pp. 94-107.;;Zabara, J. “Inhibition of Experimental Seizures in Canines by Repetitive Vagal Stimulation”, Epilepsia vol. 22, No. 6, 1992, pp. 1005-1012.",ACTIVE
2,US,A1,US 2019/0255330 A1,007-884-010-648-638,2019-08-22,2019,US 201916400888 A,2019-05-01,US 201916400888 A;;US 201615134281 A;;US 201562150773 P,2015-04-21,EVALUATION OF EFFICACY OF EPILEPSY THERAPY,"A method of detecting an improvement in a seizure condition of a patient includes identifying a first EEG synchronization of the seizure condition of the patient; applying a therapy configured to improve the seizure condition of the patient; and identifying a second EEG synchronization of the seizure condition of the patient subsequent to application of the therapy, wherein an improvement of the seizure condition of the patient is demonstrated by a reduced EEG synchronization of the patient such that the second EEG synchronization is less than the first EEG synchronization.",LIVANOVA USA INC,SABESAN SHIVKUMAR,LIVANOVA USA INC (2016-08-26),https://lens.org/007-884-010-648-638,Patent Application,yes,0,0,7,073-334-930-168-220;;153-462-704-476-774;;162-069-306-844-813;;098-999-164-272-478;;009-920-343-125-112;;007-884-010-648-638;;130-835-733-603-60X,WO;;EP;;US,7,073-334-930-168-220;;153-462-704-476-774;;162-069-306-844-813;;098-999-164-272-478;;007-884-010-648-638;;009-920-343-125-112;;130-835-733-603-60X,WO;;EP;;US,0,A61B5/4094;;A61N1/36135;;A61B5/686;;A61B5/7203;;A61B5/7285;;A61B5/4848;;A61N1/36053;;A61N1/36064;;A61B5/374;;A61B5/318;;A61B5/024;;A61N1/36053;;A61N1/36064;;A61B5/4094;;A61B5/4848;;A61B5/686;;A61B5/7203;;A61B5/7285;;A61B2562/0209;;A61N1/36135;;A61B5/374;;A61B5/33,A61N1/36;;A61B5/00;;A61B5/024;;A61B5/374,,0,0,,,,ACTIVE
3,US,B2,US 11571573 B2,009-920-343-125-112,2023-02-07,2023,US 201916400888 A,2019-05-01,US 201916400888 A;;US 201615134281 A;;US 201562150773 P,2015-04-21,Evaluation of efficacy of epilepsy therapy,"A method of detecting an improvement in a seizure condition of a patient includes identifying a first EEG synchronization of the seizure condition of the patient; applying a therapy configured to improve the seizure condition of the patient; and identifying a second EEG synchronization of the seizure condition of the patient subsequent to application of the therapy, wherein an improvement of the seizure condition of the patient is demonstrated by a reduced EEG synchronization of the patient such that the second EEG synchronization is less than the first EEG synchronization.",LIVANOVA USA INC,SABESAN SHIVKUMAR,LIVANOVA USA INC (2016-08-26),https://lens.org/009-920-343-125-112,Granted Patent,yes,20,0,7,073-334-930-168-220;;153-462-704-476-774;;162-069-306-844-813;;098-999-164-272-478;;009-920-343-125-112;;007-884-010-648-638;;130-835-733-603-60X,WO;;EP;;US,7,073-334-930-168-220;;153-462-704-476-774;;162-069-306-844-813;;098-999-164-272-478;;007-884-010-648-638;;009-920-343-125-112;;130-835-733-603-60X,WO;;EP;;US,0,A61B5/4094;;A61N1/36135;;A61B5/686;;A61B5/7203;;A61B5/7285;;A61B5/4848;;A61N1/36053;;A61N1/36064;;A61B5/374;;A61B5/318;;A61B5/024;;A61N1/36053;;A61N1/36064;;A61B5/4094;;A61B5/4848;;A61B5/686;;A61B5/7203;;A61B5/7285;;A61B2562/0209;;A61N1/36135;;A61B5/374;;A61B5/33,A61B5/024;;A61B5/00;;A61B5/318;;A61B5/374;;A61N1/36,,10,7,024-615-933-308-472;;097-350-525-734-429;;056-177-900-384-501;;013-104-437-862-884;;064-177-146-301-54X;;051-738-650-682-981;;077-344-495-222-791,10.1016/j.neulet.2012.12.044;;23333601;;1464257;;10.1111/j.1528-1157.1992.tb01752.x;;11709649;;10.1097/00004691-200109000-00008;;10.1046/j.1528-1157.2002.08202.x;;12366734;;16055378;;10.1016/j.clinph.2005.06.015;;10.1109/ccdc.2013.6561869;;10.1016/j.seizure.2011.04.002;;21514181,"Fraschini, et al., VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy, Neuroscience Letters, vol. 536, Mar. 1, 2013, 5 pages.;;Hammond, et al., Electrophysiological studies of cervical vagus nerve stimulation in humans: I. EEG effects, Epilepsia, vol. 33, No. 6, Nov.-Dec. 1992, 8 pages.;;International Search Report for PCT Patent Application No. PCT/US2016/028489, dated Jul. 28, 2016, 7 pages.;;Koo, B., EEG changes with vagus nerve stimulation, Journal of Clinical Neurophysiology, vol. 18, No. 5, Sep. 2001, 8 pages.;;Kuba, et al., Effect or vagal nerve stimulation on interictal epileptiform discharges: a scalp EEG study, Epilepsia, vol. 43, No. 10, Oct. 2002, 8 pages.;;Marrosu, et al., Increase in 20-50 Hz (gamma frequencies) power spectrum and synchronization after chronic vagal nerve stimulation, Clinical Neurophysiology, vol. 116, No. 9, Sep. 2005, 11 pages.;;Shunan et al., A Novel Feature Extraction Method for Epilepsy EEG Signals Based on Robust Generalized Synchrony Analysis, Control and Decision Conference (CDCC), 2013 25th Chinese, IEEE, May 25, 2013, 4 pages.;;Vos, et al., Predicting success of vagus nerve stimulation (VNS) from interictal EEG, Seizure, vol. 20, No. 7, Sep. 2011, 5 pages.;;Office Action issued in EP 16720630.9 dated Nov. 9, 2021.;;EPO Examination Report issued on EP application No. 16720630.9 dated Oct. 27, 2020.",ACTIVE
4,US,A1,US 2020/0113473 A1,023-306-770-445-978,2020-04-16,2020,US 201916672177 A,2019-11-01,US 201916672177 A;;US 201514954250 A;;US 61678806 A,2006-12-27,LOW POWER DEVICE WITH CONTINGENT SCHEDULING,"Medical device systems and methods for operating medical device systems conserve energy by efficiently managing computational demands of the systems. A first analysis, having relatively lower computational processing demand than at least a second analysis, processes signals from a subject to determine a first estimate of a propensity for the subject to have a neurological event. If the first estimate meets a set of specified criteria, a second analysis is performed to determine a second estimate of the propensity for the subject to have a neurological event.",LIVANOVA USA INC,LEYDE KENT,,https://lens.org/023-306-770-445-978,Patent Application,yes,0,0,5,162-842-719-381-963;;121-065-581-346-274;;122-607-110-066-647;;171-739-665-854-198;;023-306-770-445-978,US,5,162-842-719-381-963;;121-065-581-346-274;;122-607-110-066-647;;171-739-665-854-198;;023-306-770-445-978,US,0,A61B5/0006;;A61B5/369;;A61B5/4094;;A61B5/7264;;A61B2560/0209;;G16H40/63;;A61B5/369;;A61B5/0006;;A61B5/024;;A61B5/4094;;A61B5/6814;;A61B5/7264;;A61B2560/0209;;G16H40/63,A61B5/0476;;A61B5/00;;A61B5/024;;G16H40/63,,0,0,,,,ACTIVE
5,US,B2,US 10406363 B2,130-835-733-603-60X,2019-09-10,2019,US 201615134281 A,2016-04-20,US 201615134281 A;;US 201562150773 P,2015-04-21,Evaluation of efficacy of epilepsy therapy,"A method of detecting an improvement in a seizure condition of a patient includes identifying a first EEG synchronization of the seizure condition of the patient; applying a therapy configured to improve the seizure condition of the patient; and identifying a second EEG synchronization of the seizure condition of the patient subsequent to application of the therapy, wherein an improvement of the seizure condition of the patient is demonstrated by a reduced EEG synchronization of the patient such that the second EEG synchronization is less than the first EEG synchronization.",LIVANOVA USA INC,SABESAN SHIVKUMAR,LIVANOVA USA INC (2016-08-26),https://lens.org/130-835-733-603-60X,Granted Patent,yes,20,0,7,073-334-930-168-220;;153-462-704-476-774;;162-069-306-844-813;;098-999-164-272-478;;009-920-343-125-112;;007-884-010-648-638;;130-835-733-603-60X,WO;;EP;;US,7,073-334-930-168-220;;153-462-704-476-774;;162-069-306-844-813;;098-999-164-272-478;;007-884-010-648-638;;009-920-343-125-112;;130-835-733-603-60X,WO;;EP;;US,0,A61B5/4094;;A61N1/36135;;A61B5/686;;A61B5/7203;;A61B5/7285;;A61B5/4848;;A61N1/36053;;A61N1/36064;;A61B5/374;;A61B5/318;;A61B5/024;;A61N1/36053;;A61N1/36064;;A61B5/4094;;A61B5/4848;;A61B5/686;;A61B5/7203;;A61B5/7285;;A61B2562/0209;;A61N1/36135;;A61B5/374;;A61B5/33,A61B5/024;;A61B5/00;;A61B5/374;;A61N1/36,,8,7,051-738-650-682-981;;024-615-933-308-472;;097-350-525-734-429;;056-177-900-384-501;;013-104-437-862-884;;064-177-146-301-54X;;077-344-495-222-791,10.1109/ccdc.2013.6561869;;10.1016/j.neulet.2012.12.044;;23333601;;1464257;;10.1111/j.1528-1157.1992.tb01752.x;;11709649;;10.1097/00004691-200109000-00008;;10.1046/j.1528-1157.2002.08202.x;;12366734;;16055378;;10.1016/j.clinph.2005.06.015;;10.1016/j.seizure.2011.04.002;;21514181,"International Search Report for PCT Patent Application No. PCT/US2016/028489, dated Jul. 28, 2016, 7 pages.;;Shunan et al., A Novel Feature Extraction Method for Epilepsy EEG Signals Based on Robust Generalized Synchrony Analysis, Control and Decision Conference (CDCC), 2013 25th Chinese, IEEE, May 25, 2013, 4 pages.;;Fraschini, et al., VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy, Neuroscience Letters, vol. 536, Mar. 1, 2013, 5 pages.;;Hammond, et al., Electrophysiological studies of cervical vagus nerve stimulation in humans: I. EEG effects, Epilepsia, vol. 33, No. 6, Nov.-Dec. 1992, 8 pages.;;Koo, B., EEG changes with vagus nerve stimulation, Journal of Clinical Neurophysiology, vol. 18, No. 5, Sep. 2001, 8 pages.;;Kuba, et al., Effect of vagal nerve stimulation on interictal epileptiform discharges: a scalp EEG study, Epilepsia, vol. 43, No. 10, Oct. 2002, 8 pages.;;Marrosu, et al., Increase in 20-50 Hz (gamma frequencies) power spectrum and synchronization after chronic vagal nerve stimulation, Clinical Neurophysiology, vol. 116, No. 9, Sep. 2005, 11 pages.;;Vos, et al., Predicting success of vagus nerve stimulation (VNS) from interictal EEG, Seizure, vol. 20, No. 7, Sep. 2011, 5 pages.",ACTIVE
6,US,B2,US 11033220 B2,093-115-552-108-356,2021-06-15,2021,US 201414561137 A,2014-12-04,US 201414561137 A;;US 201361912511 P,2013-12-05,Systems and methods of limb-based accelerometer assessments of neurological disorders,"A method of detecting a subject's physiological status, seizure state, or seizure type with limb-based accelerometers identifying a favored accelerometer or limb that provides a better sensitivity or false positive rate as compared to other accelerometers or limbs. The detection method may include determining whether the seizure conforms with an anticipated seizure type, and determining whether to base a seizure detection on data from the favored or un-favored accelerometers or limbs. The method may also include applying a weighing factor to base the detection on data obtained primarily from the favored accelerometer or limb or to not rely on data obtained primarily from un-favored accelerometers or limbs. The method may also include comparing data obtained from a favored accelerometer or limb with data obtained from other accelerometers or limbs or obtained from detection devices using ECG or EEG. An alert may be generated based on the detection of a seizure.",LIVANOVA USA INC,SABESAN SHIVKUMAR,LIVANOVA USA INC (2014-12-04),https://lens.org/093-115-552-108-356,Granted Patent,yes,12,0,3,184-705-906-138-325;;093-115-552-108-356;;084-085-493-319-581,US,3,184-705-906-138-325;;093-115-552-108-356;;084-085-493-319-581,US,0,A61B5/4094;;A61B5/11;;A61B5/349;;A61B5/369;;A61B5/6824;;A61B5/6828;;A61B5/7221;;A61B5/7246;;A61B5/7282;;A61B2562/04;;A61B5/4094;;A61B5/11;;A61B5/369;;A61B5/6824;;A61B5/6828;;A61B5/7221;;A61B5/7246;;A61B5/7282;;A61B2562/04,A61B5/11;;A61B5/00;;A61B5/369,,18,12,010-152-469-710-954;;008-341-744-900-471;;036-221-311-812-598;;025-843-710-923-305;;153-526-641-277-558;;032-350-916-556-967;;074-329-240-525-040;;138-427-422-383-935;;019-807-034-007-639;;022-864-484-490-620;;061-658-559-037-933;;116-755-726-919-406,10.1016/j.yebeh.2012.10.006;;23219410;;10.1111/j.1528-1167.2007.01215.x;;17651411;;10.1109/tbme.2007.890742;;17605368;;10.1007/s11517-010-0648-4;;20574724;;10.5220/0003742903420345;;10.1109/iembs.2009.5332557;;19963677;;10.1109/embc.2012.6346955;;23366916;;21220719;;10.1212/wnl.0b013e318206ca46;;10.1145/1921081.1921095;;22078524;;10.1016/j.yebeh.2011.09.012;;21458386;;10.1016/j.yebeh.2011.01.020;;10.1016/j.smrv.2007.01.001;;17379548,"Hildeman, Anders. “Classification of epileptic seizures using accelerometers.” (2011).;;Van de Vel, Anouk, et al. “Long-term home monitoring of hypermotor seizures by patient-worn accelerometers.” Epilepsy & Behavior 26.1 (2013): 118-125.;;Shiffman, Daniel. The Nature of the Code. D. Shiftman, 2012, web.archive.org/web/20121102061902/https://natureofcode.com/book/chapter-10-neural-networks/.;;Azar, et al., Postictal breathing pattern distinguishes epileptic from nonepileptic convulsive seizures, Epilepsia, Jan. 2008, vol. 49, No. 1, 6 pages.;;Bonnet, et al., A Magnetometer-Based Approach for Studying Human Movements, IEEE Transactions on Biomedical Engineering, Jul. 2007, vol. 54, No. 7, 3 pages.;;Chapman, et al., Sudden Unexpected Death in Epilepsy: continuing the global conversation, Epilepsy Australia, Epilepsy Bereaved & Sudep Aware, Camberwell, Australia, 2011, 87 pages.;;Cuppens, et al., Automatic video detection of body movement during sleep based on optical flow in pediatric patients with epilepsy, Medical & Biological Engineering & Computing, Sep. 2010, vol. 48, No. 9, 9 pages.;;Cuppens, et al., Automatic Video Detection of Nocturnal Epileptic Movement Based on Motion Tracks, Proceedings of the International Conference on Bio-inspired Systems and Signal Processing (Biosignals-2012), Feb. 2012, 4 pages.;;Cuppens, et al., Detection of Nocturnal Epileptic Seizures of Pediatric Patients Using Accelerometers: Preliminary Results, IEEE Benelux EMBS Symposium, Dec. 6-7, 2007, 4 pages.;;Cuppens, et al., Detection of nocturnal frontal lobe seizures in pediatric patients by means of accelerometers: a first study, 31st Annual International Conference of the IEEE EMBS, Sep. 2-6, 2009, Minneapolis, Minnesota, 4 pages.;;Cuppens, et al., Using Spatio-Temporal Interest Points (STIP) for myoclonic jerk detection in nocturnal video, 34th Annual International Conference of the IEEE EMBS, Aug. 28-Sep. 1, 2012, San Diego, CA, 4 pages.;;Decaigny, et al., Accelerometers used for the detection of nocturnal frontal lobe seizures in pediatric patients, Proceedings of the European Conference on the Use of Modern Information and Communications Technologies, Jan. 25, 2010, 12 pages.;;Loddenkemper, et al., Circadian patterns of pediatric seizures, Neurology, vol. 76, No. 2, Jan. 11, 2011, 9 pages.;;Masse, et al., Miniaturized Wireless ECG-Monitor for Real-Time Detection of Epileptic Seizures, Wireless Health 2010, ACM, Oct. 5-7, 2010, San Diego, CA, 7 pages.;;Osorio, et al., Extracerebral detection of seizures: A new era in epileptology?, Epilepsy & Behavior, Dec. 2011, vol. 22, 6 pages.;;Remi, et al., Quantitative movement analysis differentiates focal seizures characterized by automatisms, Epilepsy & Behavior, Apr. 2011, vol. 20, No. 4, 6 pages.;;Tinuper, et al., Movement disorders in sleep: Guidelines for differentiating epileptic from no-epileptic motor phenomena arising from sleep, Sleep Medicine Reviews, Aug. 2007, vol. 11, No. 4, 13 pages.;;Van Looy, et al., Detection of body movement using optical flow and clustering, Proceedings of the 2nd International Conference on Positioning and Context-Awareness, Mar. 2011, retrieved from the Internet at http://scholar.googleusercontent.com/scholar?q=cache:v7u2PnmRjxMJ:scholar.google.com/&hl=en&as_sdt=0,44 on Apr. 13, 2016, 10 pages.",ACTIVE
7,US,A1,US 2020/0113446 A1,128-542-947-899-134,2020-04-16,2020,US 201916656957 A,2019-10-18,US 201916656957 A;;US 201213453746 A,2012-04-23,"METHODS, SYSTEMS AND APPARATUSES FOR DETECTING INCREASED RISK OF SUDDEN DEATH","Methods, systems, and apparatuses for detecting seizure events are disclosed, including a system for identification of an increased risk of a severe neurological event. The system may include an electroencephalogram (“EEG”) monitoring unit configured to collect EEG data from the patient during at least a postictal phase or one or more seizures and a processing unit configured to receive the EEG data from the EEG monitoring unit. The processing unit is configured to detect postictal EEG suppression from the EEG data and to identify the increased risk of the severe neurological event based on the detected postictal EEG suppression. Other embodiments are described and claimed.",LIVANOVA USA INC,SABESAN SHIVKUMAR,,https://lens.org/128-542-947-899-134,Patent Application,yes,1,0,7,173-866-890-170-467;;172-252-762-979-488;;000-292-687-086-32X;;090-456-005-994-738;;128-542-947-899-134;;182-123-764-482-83X;;089-823-907-820-194,WO;;EP;;US,7,173-866-890-170-467;;172-252-762-979-488;;000-292-687-086-32X;;090-456-005-994-738;;128-542-947-899-134;;182-123-764-482-83X;;089-823-907-820-194,WO;;EP;;US,0,A61B5/0205;;A61B5/0816;;A61B5/1112;;A61B5/318;;A61B5/369;;A61B5/4094;;A61B5/7275;;A61B5/746;;A61B5/7465;;A61B2505/07;;G16H20/17;;G16H20/30;;G16H40/63;;G16H40/67;;G16H50/20;;A61B5/0205;;A61B5/0816;;A61B5/1112;;A61B5/33;;A61B5/372;;A61B5/4094;;A61B5/7275;;A61B5/746;;A61B5/7465;;A61B2505/07;;G16H20/17;;G16H20/30;;G16H40/63;;G16H40/67;;G16H50/20,A61B5/0205;;A61B5/00;;A61B5/0402;;A61B5/0476;;A61B5/08;;G16H20/17;;G16H20/30;;G16H40/63;;G16H40/67;;G16H50/20,,0,0,,,,ACTIVE
8,US,A1,US 2021/0298663 A1,084-085-493-319-581,2021-09-30,2021,US 202117346424 A,2021-06-14,US 202117346424 A;;US 201414561137 A;;US 201361912511 P,2013-12-05,SYSTEMS AND METHODS OF LIMB-BASED ACCELEROMETER ASSESSMENTS OF NEUROLOGICAL DISORDERS,"A method of detecting a seizure status of a subject includes collecting first data from a first accelerometer positioned on a first limb of the subject and a second data from a second accelerometer positioned on a torso of the subject, determining that one of the first accelerometer or the second accelerometer provides a better indication (e.g., greater level of sensitivity or a lesser level of a false positive rate) by comparing the first data and the second data, detecting an indication of the seizure status of the subject using at least one of the first data and the second data, and generating an alert in response to the detection of the indication of the seizure status of the subject.",LIVANOVA USA INC,SABESAN SHIVKUMAR,,https://lens.org/084-085-493-319-581,Patent Application,yes,5,0,3,184-705-906-138-325;;093-115-552-108-356;;084-085-493-319-581,US,3,184-705-906-138-325;;093-115-552-108-356;;084-085-493-319-581,US,0,A61B5/7282;;A61B2562/04;;A61B5/4094;;A61B5/11;;A61B5/7221;;A61B5/6824;;A61B5/6828;;A61B5/7246;;A61B5/349;;A61B5/369;;A61B5/4094;;A61B5/11;;A61B5/7221;;A61B5/6824;;A61B5/6828;;A61B5/7246;;A61B5/7282;;A61B2562/04;;A61B5/369,A61B5/00;;A61B5/11;;A61B5/369,,0,0,,,,PENDING
9,US,B2,US 11596314 B2,172-252-762-979-488,2023-03-07,2023,US 201916656957 A,2019-10-18,US 201916656957 A;;US 201213453746 A,2012-04-23,"Methods, systems and apparatuses for detecting increased risk of sudden death","Methods, systems, and apparatuses for detecting seizure events are disclosed, including a system for identification of an increased risk of a severe neurological event. The system may include an electroencephalogram (“EEG”) monitoring unit configured to collect EEG data from the patient during at least a postictal phase or one or more seizures and a processing unit configured to receive the EEG data from the EEG monitoring unit. The processing unit is configured to detect postictal EEG suppression from the EEG data and to identify the increased risk of the severe neurological event based on the detected postictal EEG suppression. Other embodiments are described and claimed.",LIVANOVA USA INC,SABESAN SHIVKUMAR,,https://lens.org/172-252-762-979-488,Granted Patent,yes,649,0,7,173-866-890-170-467;;172-252-762-979-488;;000-292-687-086-32X;;090-456-005-994-738;;128-542-947-899-134;;182-123-764-482-83X;;089-823-907-820-194,WO;;EP;;US,7,173-866-890-170-467;;172-252-762-979-488;;000-292-687-086-32X;;090-456-005-994-738;;128-542-947-899-134;;182-123-764-482-83X;;089-823-907-820-194,WO;;EP;;US,0,A61B5/0205;;A61B5/0816;;A61B5/1112;;A61B5/318;;A61B5/369;;A61B5/4094;;A61B5/7275;;A61B5/746;;A61B5/7465;;A61B2505/07;;G16H20/17;;G16H20/30;;G16H40/63;;G16H40/67;;G16H50/20;;A61B5/0205;;A61B5/0816;;A61B5/1112;;A61B5/33;;A61B5/372;;A61B5/4094;;A61B5/7275;;A61B5/746;;A61B5/7465;;A61B2505/07;;G16H20/17;;G16H20/30;;G16H40/63;;G16H40/67;;G16H50/20,A61B5/0205;;A61B5/00;;A61B5/08;;A61B5/11;;A61B5/318;;A61B5/369;;G16H20/17;;G16H20/30;;G16H40/63;;G16H40/67;;G16H50/20,,63,53,008-257-352-066-578;;033-503-915-578-321;;054-868-494-791-055;;019-411-892-837-769;;115-741-015-188-295;;052-630-116-618-842;;037-772-810-641-647;;145-702-660-075-441;;054-630-468-158-977;;018-561-710-123-368;;015-943-288-841-720;;048-642-493-280-14X;;046-397-703-096-430;;019-308-872-975-51X;;002-403-074-135-442;;112-897-527-124-30X;;005-812-068-829-241;;029-700-863-111-313;;035-904-149-105-698;;032-751-441-147-285;;046-621-728-923-715;;056-177-900-384-501;;098-586-850-446-33X;;066-328-676-515-762;;018-202-351-494-006;;029-031-434-346-661;;097-426-806-139-480;;072-028-517-836-043;;091-962-532-331-31X;;103-040-249-541-832;;016-207-089-756-778;;050-957-455-833-565;;011-498-617-423-119;;030-501-930-582-312;;013-993-295-891-841;;026-864-965-141-523;;019-773-125-379-283;;014-724-861-390-592;;015-820-060-894-869;;038-128-501-814-320;;112-318-944-745-749;;050-834-747-411-399;;025-424-076-138-599;;039-387-741-041-999;;088-853-742-205-302;;003-290-790-587-579;;026-435-299-569-935;;047-345-017-295-263;;022-966-379-058-403;;139-831-627-763-342;;024-644-707-340-274;;023-093-432-161-773;;079-757-926-093-134,10.1111/j.1542-474x.1996.tb00275.x;;10.1016/0006-8993(77)90274-8;;406970;;10.1023/a:1014866501535;;17446414;;10.1152/japplphysiol.00137.2007;;11709644;;10.1097/00004691-200109000-00003;;11974997;;10.1007/978-3-7091-6105-0_21;;10839541;;10.1038/35013070;;15109218;;10.1113/expphysiol.2003.002654;;17565508;;10.1142/s0129065707000993;;9774527;;10.1006/nlme.1998.3863;;10.1016/j.clinph.2003.12.016;;15066542;;10.1046/j.1528-1157.2001.0420081007.x;;11554886;;10.1016/s0006-3223(99)00308-x;;10686263;;10.1016/0006-8993(77)90275-x;;195672;;10.1212/wnl.59.6_suppl_4.s3;;12270962;;10.1109/tbme.2003.821013;;15000380;;12769431;;10.1109/tbme.2003.810705;;10.1046/j.1528-1157.2002.37801.x;;12181003;;2903494;;10.1111/j.1600-0773.1988.tb00913.x;;9684488;;10.1016/j.seizure.2007.11.004;;18096413;;11709649;;10.1097/00004691-200109000-00008;;9178333;;10.1097/00006842-199705000-00004;;10.1046/j.1528-1157.2003.34702.x;;12614390;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;10.1002/ana.22101;;20882604;;14662714;;10.1161/01.cir.0000105721.71640.da;;19047522;;10.1001/archpsyc.65.12.1358;;2226362;;10.1111/j.1528-1157.1990.tb05844.x;;10.1088/2058-7058/15/7/27;;10.1103/physrevlett.88.218101;;12059504;;17008335;;10.1093/brain/awl241;;10.1017/s0012162205000022;;15686283;;10.1097/00004691-200111000-00003;;11779966;;15668970;;10.1002/ana.20377;;10.1016/j.yebeh.2010.05.002;;20541980;;16051017;;10.1016/j.surneu.2004.11.026;;10.1007/s11062-006-0027-9;;10.1016/s0140-6736(04)17594-6;;15610808;;10.1016/j.ehj.2003.12.003;;15033247;;10413832;;10.1111/j.1528-1167.2012.03443.x;;22432911;;10.1111/j.1528-1157.1992.tb01751.x;;1464256;;10.1111/j.1528-1157.2000.tb00128.x;;11077466;;11684042;;10.1016/s0006-8993(01)02928-6;;1705341;;10.1111/j.1540-8159.1991.tb04052.x;;10.1007/s00381-004-0947-x;;15083332;;10.1016/s0735-1097(97)00554-8;;9502641;;16828317;;10.1016/j.seizure.2006.03.005;;11709643;;10.1097/00004691-200109000-00002;;16162428;;10.1111/j.1540-8159.1991.tb04053.x;;1705342;;10.1007/bf00928176;;4338867,"“Heart rate variability: Standards of measurement, physiological interpretation and clinical use”, Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, Circulation, Mar. 1993, vol. 93, Nos. pp. 1043-1065.;;Bachman, D. et al., “Effects of Vagal Volleys and Serotonin on Units of Cingulate Cortex in Monkeys”, Brain Research, vol. 130, 1977, pp. 253-269.;;Baevskii, R., “Analysis of Heart Rate Variability in Space Medicine”, Human Physiology, vol. 28, No. 2, 2002, pp. 202-213.;;Baevsky, R., “Autonomic cardiovascular and respiratory control during prolonged spaceflights aboard the International Space Station”, Journal of Applied Physiological, vol. 103, 2007, pp. 156-161.;;Boon, P. et al., “Programmed and Magnet-Induced Vagus Nerve Stimulation for Refractory Epilepsy”, Journal of Clinical Neurophysiology, vol. 18, No. 5, 2001, p. 402-407.;;Boon, P. et al., “Vagus Nerve Stimulation for Epilepsy, Clinical Efficacy of Programmed and Magnet Stimulation”, Acta Neurochirurgica Supplement, vol. 79, 2002, pp. 93-98.;;Borovikova, L. et al., “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin”, Letters to Nature, vol. 405, May 2000, pp. 458-462.;;Brack, K. et al., “Interaction Between Direct Sympathetic and Vagus Nerve Stimulation on Heart Rate in the Isolated Rabbit Heart”, Experimental Physiology, vol. 89, No. 1, 2004, pp. 128-139.;;Chakravarthy, N. et al., “Controlling Synchronization in a Neuron-Level Population Model”, International Journal of Neural Systems, vol. 17, No. 2, 2007, pp. 123-138.;;Clark, K. et al., “Posttraining Electrical Stimulation of Vagal Afferents with Concomitant Vagal Efferent Inactivation Enhances Memory Storage Processes in the Rat”, Neurobiology of Learning and Memory, vol. 70, Article No. NL983863, 1998, pp. 364-373.;;Digenarro, G. et al., “Ictal Heart rate Increase Precedes EEG Discharge in Drug-Resistant Mesial Temporal Lobe Seizures”, Clinical Neurophysiology, vol. 115, No. 5, May 2004, pp. 1169-1177.;;Frei, M. et al., “Left Vagus Nerve Stimulation with the Neurocybernetic Prosthesis has Complex Effects on Heart Rate and on its Variability in Humans”, Epilepsia, vol. 42, Nos. 2001, pp. 1007-1016.;;George, M. et al., “Vagus Nerve Stimulation: A New Tool for Brain Research and Therapy”, Society of Biological Psychiatry, vol. 47, 2000, pp. 287-295.;;Hallowitz, R. et al., “Effects of Vagal Volleys on Units of Intralaminar and Juxtalaminar Thalamic Nuclei in Monkeys”, Brain Research, vol. 130, No. 2, Jul. 1977, pp. 271-286.;;Henry, T., “Therapeutic Mechanisms of Vague Name Stimulation”, Neurology, vol. 59 (Supp. 4), Sep. 2002, pp. S3-S14.;;Iasemidis, L. et al., “Dynamical Resetting of the Human Brain at Epileptic: Application of Nonlinear Dynamics and Global Optimization Techniques”, IEEE Transactions on Biomedical Engineering, vol. 51, No. 3, Mar. 2004, pp. 493-508.;;Iasemidis, L. et al., “Spatiotemporal Transition to Epileptic Seizures: A Nonlinear Dynamical Analysis of Scalp and Intracranial EEG Recordings”, Spatiotemporal Models in Biological and Artificial Systems, IOS Press, 1997, pp. 81-88.;;Iasemidis, L., “Epileptic Seizure Prediction and Control”, IEEE Transactions on Biomedical Engineering, vol. 50, No. 5, May 2003, pp. 549-558.;;Zijlmans, M. et al., “Heart Rate Changes and ECG Abnormalities During Epileptic Seizures: Prevalence and Definition of an Objective Clinical Sign”, Epilepsia, vol. 43, Nos. 2002, pp. 847-854.;;International Search Report for PCT Patent Application No. PCT/US2013/037703, dated Aug. 23, 2013, 12 pages.;;Zabara, J., “Neuroinhibition of Xylaine Induced Emesis”, Pharmacology & Toxicology, vol. 63, Aug. 1988, pp. 70-74.;;Kautzner, J. et al., “Utility or Snort-Term Heart Rate Variability for Prediction of Sudden Cardiac Death After Acute Myocardial Infarction”, Acta Univ Palacki Olomuc Fac Med., vol. 141, 1998, pp. 69-73.;;Koenig, S. et al., “Vagus Nerve Stimulation Improves Severely Impaired Heart Rate Variability in a Patient with Lennox-Gastaut-Syndrome”, Seizure, vol. 17, Issue 5, Jul. 2008, pp. 469-472.;;Koo, B., “EEG Changes with Vagus Nerve Stimulation”, Journal of Clinical Neurophysiology, vol. 18, No. 5, Sep. 2001, pp. 434-441.;;Krittayaphong, M. et al., “Heart Rate Variability in Patients with Coronary Artery Disease: Differences in Patients with Higher and Lower Depression Scores”, Psychosomatic Medicine, vol. 59, 1997, pp. 231-235.;;Leutmezer, F. et al., “Electrocardiographic Changes at the Onset of Epileptic Seizures”, Epilepsia, vol. 44, No. 3, 2003, pp. 348-354.;;Lewis, M. et al., “Vagus Nerve Stimulation Decreases Left Ventricular Contractility in Vivo in the Human and Pig Heart”, The Journal of Physiology, vol. 534, No. 2, 2001, pp. 547-552.;;Lhatoo, Samden, D. et al., “An Electroclinical Case-Control Study Of Sudden Unexpected Death In Epilepsy,” Annals of Neurology, 68(6): 787-796, Dec. 29, 2010.;;Li, M. et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats”, Circulation, Jan. 2004, vol. 109, No. 1, pp. 120-124.;;Licht, C., “Association Between Major Depressive Disorder and Heart Rate Variability in the Netherlands Study of Depression and Anxiety (NESDA)”, Arch. Gen. Psychiatry, vol. 65, No. 12, Dec. 2008, pp. 1358-1367.;;Lockard, J. et al., “Feasibility and safety of vagal stimulation in monkey model”, Epilepsia, vol. 31 (Supp. 2), 1990, pp. S20-S26.;;Long, T. et al., “Effectiveness of Heart Rate Seizure Detection Compared to EEG in an Epilepsy Monitoring Unit (EMU)”, Abstract of AES Proceedings, Epilepsia, vol. 40, Supplement 7, 1999, p. 174.;;McClintock, P., Can Noise Actually Boost Brain Power, Physics World, Jul. 2002, vol. 15, pp. 20-21.;;Mori, T. et al., “Noise-Induced Entrainment and Stochastic Resonance in Human Brain Waves”, Physical Review Letters, vol. 88, No. 21, 2002, pp. 218101-1-2180101-4.;;Mormann, F. et al., “Seizure Prediction: The Long and Winding Road”, Brain, vol. 130, 2007, pp. 314-333.;;Nouri, M., “Epilepsy and the Autonomic Nervous System”, emedicine, Updated May 5, 2006, http://www.emedicine.com/neuro/toplo658.htm, pp. 1-14.;;O'Donovan, C. et al., “Computerized Seizure Detection Based on Heart Rate Changes”, Abstract of AES Proceedings, Epilepsia, vol. 36, Supplement 4, 1995, p. 7.;;O'Regan, M. et al., “Abnormalities in Cardiac and Respiratory Function Observed During Seizures in Childhood”, Developmental Medicine & Child Neurology, vol. 47, 2005, pp. 4-9.;;Osorio, I. et al., “An Introduction to contingent (Closed-Loop) Brain Electrical Stimulation for Seizure Blockage, to Ultra-Short-Term Clinical Trials, and to Multidimensional Statistical Analysis of Therapeutic Efficacy”, Journal of Clinical Neurophysiology, vol. 18, No. 6, 2001, pp. 533-544.;;Osorio, I. et al., “Automated Seizure Abatement in Humans Using Electrical Stimulation”, Annals of Neurology, vol. 57, No. 2, 2005, pp. 258-268.;;Osorio, I. et al., “Toward a Quantitative Multivariate Analysis of the Efficacy of Antiseizure Therapies”, Epilepsy & Behavior, vol. 18, No. 4, Aug. 2010, Academic Press, San Diego, CA, pp. 335-343.;;Pathwardhan, R. et al., “Control of Refractory Status Epilepticus Precipitated by Anticonvulsant Withdrawal Using Vagal Nerve Stimulation: A Case Report”, Surgical Neurology, Issue 64, Aug. 2005, pp. 170-173.;;PCT Search Report and Written Opinion for International application No. PCT/US2011/054287, dated Mar. 12, 2012, 18 pages.;;PCT Search Report and Written Opinion for International Application No. PCT/US2012/027639, dated Oct. 4, 2012, 22 pages.;;Poddubnaya, E., “Complex Estimation of Adaption Abilities of the Organism in Children Using the Indices of Responsiveness of the Cardiovascular System and Characteristics of EEG”, Neurophysiology, vol. 38, No. 1, 2006, pp. 63-74.;;Robinson, S. et al., Heart Rate Variability Changes as Predictor of Response to Vagal Nerve Stimulation Therapy for Epilepsy', Abstract of AES Proceedings, Epilepsia, vol. 40, Supplement 7, 1999, p. 147.;;Rugg-Gunn, F. et al., “Cardiac Arrhythmias in Focal Epilepsy: a Prospective Long-Term Study”, Lancet, vol. 364, Dec. 2004, pp. 2212-2219.;;Sajadieh, A. et al., “Increased Heart Rate and Reduced Heart-rate Variability and Associated with Subclinical Inflammation in Middle-Aged and Elderly Subjects with No Apparent Heart Disease”, European Heart Journal, vol. 25, 2004, pp. 363-370.;;Schernthaner, C. et al., “Autonomic Epilepsy—The Influence of Epileptic Discharges on Heart Rate and Rhythm”, The Middle European Journal of Medicine, vol. 111, No. 10, 1999, pp. 392-401.;;Seyal et al., “Postictal Generalized EEG Suppression Is Linked to Seizure-Associated Respiratory Dysfunction but not Postictal Apnea,” Epilepsia, 53(5): 825-831, Mar. 20, 2012.;;Zabara, J., “Inhibition of Experimental Seizures in Canines by Repetitive Vagal Stimulation”, Epilepsia, vol. 33, No. 6, 1992, pp. 1005-1012.;;Zabara, J., “Neural Control of Circulation I”, The Physiologist, vol. 28, No. 4, Aug. 1985, pp. 273-277.;;So, et al., “Postical Central Apnea as a Cause of SUDEP: Evidence From Near-SUDEP Incident,” Epilepsia, 41(11): 1494-1497, Nov. 1, 2000.;;Sunderam, S. et al., Vagal and Sciatic Nerve Stimulation Have Complex, Time-Dependent Effects on Chemically-Induced Seizures: A Controlled Study, Brain Research, vol. 918, 2001, pp. 60-66.;;Trry, R. et al., “The Implantaple Neurocybernetic Prostnesis System”, Pacing and Clinical Electrophysiology, vol. 14, No. 1, Jan. 1991, pp. 86-93.;;Tubbs, R. et al., “Left-Sided Vagus Nerve Stimulation Decreases Intracranial Pressure Without Resultant Bradycardia in the Pig: A Potential Therapeutic Modality for Humans”, Child's Nervous System, vol. 20, No. 5, May 2004, pp. 309-312.;;Umetani, M. et al., “Twenty-Four Hour Time Domain Heart Rate Variability and Heart Rate: Relations to Age and Gender Over Nine Decades”, JACC, vol. 31, No. 3, Mar. 1998, pp. 593-601.;;Van Elm Pt, W. et al., “A Model of Heart Rate Changes to Detect Seizures in Severe Epilepsy”, Seizure, vol. 15, 2006, pp. 366-375.;;Vonck, K. et al., “The Mechanism of Action of Vagus Nerve Stimulation for Refractory Epilepsy—The Current Status”, Journal of Neurophysiology, vol. 18, No. 5, 2001, pp. 394-401.;;Weil, S. et al., “Heart Rate Increase in Otherwise Subclinical Seizures is Different in Temporal Versus Extratemporal Seizure Onset: Support for Temporal Lobe Automatic Influence”, Epileptic Disord., vol. 7, Nos. Sep. 2005, pp. 199-204.;;Woodbury, J. et al., “Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording”, Pacing and Clinical Electrophysiology, vol. 14, Jan. 1991, pp. 94-107.;;Zabara, J. et al., “Neuroinhibition in the regulation of emesis”, Space Life Sciences, vol. 3, Issue 3, Jun. 1972, pp. 282-292.;;Office Action on EP Application No. 13721848.3 dated Aug. 13, 2020. 5 pages.",ACTIVE
10,US,B2,US 11529089 B2,171-739-665-854-198,2022-12-20,2022,US 201916672177 A,2019-11-01,US 201916672177 A;;US 201514954250 A;;US 61678806 A,2006-12-27,Low power device with contingent scheduling,"Medical device systems and methods for operating medical device systems conserve energy by efficiently managing computational demands of the systems. A first analysis, having relatively lower computational processing demand than at least a second analysis, processes signals from a subject to determine a first estimate of a propensity for the subject to have a neurological event. If the first estimate meets a set of specified criteria, a second analysis is performed to determine a second estimate of the propensity for the subject to have a neurological event.",LIVANOVA USA INC;;LIVANOVAUSA INC,LEYDE KENT,,https://lens.org/171-739-665-854-198,Granted Patent,yes,35,0,5,162-842-719-381-963;;121-065-581-346-274;;122-607-110-066-647;;171-739-665-854-198;;023-306-770-445-978,US,5,162-842-719-381-963;;121-065-581-346-274;;122-607-110-066-647;;171-739-665-854-198;;023-306-770-445-978,US,0,A61B5/0006;;A61B5/369;;A61B5/4094;;A61B5/7264;;A61B2560/0209;;G16H40/63;;A61B5/369;;A61B5/0006;;A61B5/024;;A61B5/4094;;A61B5/6814;;A61B5/7264;;A61B2560/0209;;G16H40/63,A61B5/369;;A61B5/00;;A61B5/024;;G16H40/63,,195,143,135-197-726-472-806;;043-209-732-625-194;;110-756-376-850-387;;022-986-350-191-09X;;099-738-184-995-471;;052-904-683-117-37X;;036-799-833-560-683;;165-272-421-305-535;;075-949-839-628-664;;091-489-529-599-197;;040-563-703-473-032;;010-542-698-038-106;;080-476-358-354-096;;010-031-887-527-334;;014-030-870-508-55X;;015-522-377-591-609;;053-176-049-549-89X;;134-256-610-404-255;;007-435-731-732-051;;017-658-731-501-924;;082-130-581-626-626;;023-267-619-814-161;;087-888-415-182-16X;;041-879-143-577-040;;038-812-576-998-057;;072-494-162-399-945;;036-765-169-783-989;;029-415-860-497-502;;011-439-172-416-329;;007-860-157-935-846;;021-927-186-932-311;;004-699-664-794-075;;030-983-039-493-075;;030-959-629-699-794;;034-726-247-442-625;;038-105-755-405-648;;058-354-881-914-817;;098-793-796-290-443;;008-217-796-572-141;;035-477-652-721-97X;;081-069-045-977-645;;021-357-805-075-514;;100-504-376-971-476;;009-408-154-386-927;;081-014-262-239-384;;037-270-502-089-758;;119-041-943-953-007;;035-591-284-396-294;;116-617-266-976-059;;007-102-427-091-207;;058-590-161-216-02X;;013-175-917-825-570;;035-202-529-233-089;;022-014-401-539-185;;047-917-227-447-051;;041-849-140-405-799;;015-010-310-018-059;;084-869-327-261-949;;164-068-260-839-362;;005-812-068-829-241;;102-065-286-791-958;;040-653-827-786-603;;079-496-522-034-098;;090-722-470-992-921;;077-437-257-509-116;;061-465-319-393-938;;071-794-997-821-559;;055-212-083-393-970;;027-951-309-891-088;;057-209-256-661-319;;021-904-530-539-008;;013-131-457-719-966;;022-340-064-605-885;;014-960-565-157-379;;004-744-607-902-199;;009-937-539-597-93X;;017-872-040-249-384;;047-557-590-620-81X;;001-684-727-218-323;;120-941-384-775-230;;038-895-519-332-589;;012-347-103-675-309;;129-688-805-152-535;;118-774-883-250-925;;056-713-840-473-145;;047-951-590-482-23X;;018-748-506-465-539;;099-242-910-542-727;;090-139-902-269-836;;023-634-408-186-013;;071-379-392-030-350;;067-202-305-611-192;;022-737-784-206-984;;008-683-222-517-061;;085-258-298-688-583;;025-462-190-148-245;;006-571-256-471-437;;008-525-576-094-074;;035-845-605-612-97X;;003-527-914-722-422;;029-826-474-472-813;;093-017-198-453-261;;085-287-764-394-56X;;050-957-455-833-565;;059-008-403-052-583;;024-400-776-056-719;;029-096-142-097-365;;079-621-744-256-569;;063-161-480-619-358;;143-398-932-451-548;;013-993-295-891-841;;026-040-501-717-238;;058-897-213-047-739;;058-699-127-035-371;;078-034-108-516-718;;094-833-913-753-979;;044-054-605-334-338;;109-633-160-417-984;;049-554-204-238-743;;010-447-571-408-178;;044-801-911-798-401;;026-161-434-624-269;;004-336-445-612-283;;059-721-223-992-598;;117-306-806-020-719;;046-394-936-902-110;;046-951-867-744-006;;029-313-181-841-642;;020-542-114-256-808;;014-590-560-212-185;;082-384-306-223-881;;066-581-502-575-086;;007-401-896-126-759;;042-683-317-156-433;;056-588-099-366-952;;081-339-542-705-015;;087-366-366-471-863;;127-486-336-288-668;;069-183-134-021-682;;060-719-041-136-865;;024-174-082-138-653;;108-365-920-087-726;;007-930-875-295-119,15133954;;15132516;;10.1109/tbme.2004.826642;;15689714;;10.1097/01.wnp.0000150880.19561.6f;;10.1615/jautomatinfscien.v36.i8.30;;14754292;;10.1103/physreve.68.066202;;10.1103/physreve.67.010901;;12636484;;10.1093/brain/awg265;;14506067;;16922871;;10.1111/j.1528-1167.2006.00616.x;;10.1016/s0022-2836(65)80093-6;;5859039;;10.1002/cplx.20065;;15365195;;10.1385/ni:2:3:333;;10.1385/1-59259-364-x:159;;12710673;;10.1016/s1388-2457(00)00543-5;;11165525;;11461312;;10.1103/physreve.64.012902;;10.1137/1.9781611972740.12;;10.1023/a:1009715923555;;15600505;;10.1103/physreve.70.046217;;12779843;;10.1063/1.166420;;10.1016/s0167-2789(96)00160-1;;10.1016/s0921-884x(96)95195-4;;9060860;;10.1007/s00422-004-0463-9;;15085343;;16919914;;10.1016/j.eplepsyres.2006.06.012;;15961284;;10.1016/j.eplepsyres.2005.03.009;;10.1016/s1388-2457(03)00194-9;;14499758;;10.1109/tbme.2003.810696;;12769433;;9475899;;10.1016/j.clinph.2004.11.014;;15721064;;12769436;;10.1109/tbme.2003.810706;;14597320;;10.1016/s0014-4886(03)00354-6;;15721062;;10.1016/j.clinph.2004.09.029;;8295931;;10.1152/physrev.1994.74.1.1;;10.1111/j.1528-1157.2000.tb01532.x;;11001334;;9749744;;10.1046/j.1460-9568.1998.00090.x;;10.1109/81.904882;;10.1016/j.clinph.2004.10.015;;pmc2941767;;15721065;;15897008;;10.1016/j.clinph.2005.03.006;;10.1016/0013-4694(88)90171-x;;2453336;;10.1016/s0165-0270(00)00188-6;;10837870;;10.1145/1068009.1068082;;10434388;;10.1007/s004220050540;;9775534;;10.1109/10.720198;;15325118;;10.1016/j.jneumeth.2004.03.016;;10.1016/j.clinph.2004.08.022;;15721066;;16252980;;10.1063/1.1935138;;10.1109/5254.708428;;10.1109/tbme.2003.810693;;12769434;;10.1016/s0375-9601(99)00342-4;;10.2172/814360;;10.1080/00029238.1980.11080015;;10.1109/tbme.2003.810689;;12769437;;15698148;;10.1103/physrevlett.94.019801;;10.1097/00004691-199609000-00041;;15721067;;10.1016/j.clinph.2004.10.013;;2116818;;10.1007/bf01140588;;10.1016/0013-4694(94)90046-9;;8174527;;10.1016/0920-1211(94)90081-7;;10.1016/0013-4694(90)91948-o;;10.1097/00004691-198810000-00042;;10.1097/00004691-199709000-00015;;12769431;;10.1109/tbme.2003.810705;;11528297;;10.1097/00004691-200105000-00005;;10.1016/j.clinph.2004.08.023;;15721068;;10.1016/j.clinph.2004.08.024;;15721069;;10.1016/s1388-2457(02)00344-9;;12705423;;10.1209/epl/i2004-10383-2;;1713830;;10.1016/0013-4694(91)90054-8;;10.1007/bf02345960;;15865133;;16337916;;10.1016/j.neuron.2005.09.026;;10.1016/j.crvi.2003.09.011;;14694754;;10.1103/physreve.69.061915;;15244625;;10.1002/(sici)1097-0193(1999)8:4<194::aid-hbm4>3.0.co;2-c;;10619414;;pmc6873296;;15446973;;10.1063/1.1777831;;12935113;;10.1103/physrevlett.91.068102;;10.1001/jama.291.5.605;;14762040;;12786206;;10.1103/physreve.67.052902;;10.1016/j.clinph.2004.10.014;;15721070;;10.1097/00004691-200105000-00002;;11528294;;12683064;;10.1109/memb.2003.1191451;;10.1016/j.clinph.2004.08.020;;15721063;;10.1016/s0167-8760(99)00043-4;;10555873;;10.1016/0013-4694(91)90201-e;;1718709;;10.1097/00001756-199907130-00028;;10424690;;10.1016/s0140-6736(03)12755-9;;10.1016/s0165-0270(01)00372-7;;11595276;;10.1016/s0167-2789(98)00258-9;;10.1016/j.crvi.2004.10.014;;15771005;;14618068;;10.1023/a:1027415927155;;10.1016/s0025-5564(03)00100-7;;14527747;;10.1088/1741-2560/2/2/002;;15928408;;10.1016/s1474-4422(02)00003-0;;12849542;;11923631;;10.1097/00019052-200204000-00008;;10.1016/j.physd.2004.02.013;;9771751;;10.1038/2667;;12769438;;10.1109/tbme.2003.810688;;12227632;;10.1007/bf02345078;;10.1007/978-3-540-30134-9_65;;10.1016/j.medengphy.2004.02.006;;15147746;;10.1016/s1350-4533(04)00031-1;;10.1016/s1388-2457(01)00712-x;;11801422;;12636720;;10.1103/physreve.67.021912;;12694925;;10.1016/s0920-1211(03)00002-0;;10.1016/s0167-2789(00)00087-7;;10.1016/j.clinph.2004.08.025;;15721071;;10.1097/01.wco.0000218237.52593.bc;;16538095;;17008335;;10.1093/brain/awl241;;11872619;;10.1093/brain/awf048;;15730536;;10.1111/j.0013-9580.2005.15504.x;;12723056;;10.1109/tbme.2003.809497;;14977058;;10.1179/016164104773026534;;12460255;;10.1046/j.1528-1157.2002.11102.x;;10.1111/j.1528-1157.1998.tb01430.x;;9637604;;15668970;;10.1002/ana.20377;;16177520;;10.1088/0031-9155/50/14/017;;10.1097/00004691-200105000-00003;;11528295;;10.1016/j.neuroimage.2005.11.021;;16413209;;15661120;;10.1016/j.clinph.2004.08.004;;10.1016/0013-4694(95)97919-r;;10.1142/9789812793782_0010;;10.1097/00004691-200612000-00003;;17143139;;10.1016/s0013-4694(97)86248-7;;10367436;;10.1007/bf02524422;;16269188;;10.1016/j.jneumeth.2005.09.001;;10.1063/1.2137623;;16599739;;10.1016/s1388-2457(02)00032-9;;11956006;;9579886;;10.1111/j.1528-1157.1997.tb01250.x;;12364503;;10.1152/jn.2002.88.4.1743;;10.1155/s1026022600000200;;15848265;;10.1016/j.cmpb.2004.10.009;;10.1073/pnas.75.9.4194;;pmc336078;;279908;;10.1103/physrevlett.81.3291;;10.1007/s00422-002-0368-4;;12567227;;10.1142/s0129065703001790;;15031857;;10.1016/0167-2789(92)90102-s;;14629902;;10.1016/s0887-8994(03)00145-0;;14701993;;10.1097/00004691-200309000-00004;;12724880;;10.1002/ana.10323;;12402252;;15987261;;10.1111/j.1528-1167.2005.01016.x;;15008506;;10415414;;10.1016/s0006-8993(99)01647-9;;12791335;;10.1016/s1525-5050(03)00105-7;;10.1152/jn.00190.2006;;pmc2230664;;17021032;;12423382;;10.1046/j.1528-1157.2002.15702.x;;10.1007/978-1-4613-0225-4_14,"Adjouadi, M. et al., “A New Mathematical Approach Based on Orthogonal Operators for the Detection of Interictal Spikes in Epileptogenic Data,” Presented at Rocky Mountain Bioengineering Symposium & International ISA Biomedical Sciences Instrumentation Symposium, 2004, pp. 175-180.;;Adjouadi, M. et al., “Interictal Spike Detection Using the Walsh Transform,” IEEE Transactions on Biomedical Engineering, May 2004, pp. 868-872, vol. 51, No. 5.;;Adjouadi, M. et al., “Detection of Interictal Spikes and Artifactual Data Through Orthogonal Transformations,” Journal of Clinical Neurophysiology, Feb. 2005, pp. 53-64, vol. 22, No. 1. (2005).;;Aksenova, T.I. et al., “Nonparametric On-Line Detection of Changes in Signal Spectral Characteristics for Early Prediction of Epilepsy Seizure Onset,” Journal of Automation and Information Sciences, 2004, pp. 35-45, vol. 36, No. 8.;;Aksenova, T.I. et al., “On-Line Disharmony Detection for Early Prediction of Epilepsy Seizure Onset,” 2003, 2 pages.;;Andrzejak, R.G. et al., “Bivariate Surrogate Techniques: Necessity, Strengths, and Caveats,” Physical Review, 2003, pp. 1-15, The American Physical Society, vol. 68, No. 066202.;;Andrzejak, R.G. et al., “Testing the Null Hypothesis of the Nonexistence of a Preseizure State,” Physical Review, 2003, pp. 1-4, The American Physical Society, vol. 67, No. 010901 (R).;;Aschenbrenner-Scheibe, R. et al., “How Well Can Epileptic Seizures be Predicted? An Evaluation of a Nonlinear Method,” Brain, Sep. 23, 2003, pp. 2616-2626, vol. 126.;;Avanzini, G., “Is Tolerance to Antiepileptic Drugs Clinically Relevant?” Epilepsia, 2006, pp. 1285-1287, vol. 47, No. 8, Blackwell Publishing, Inc.;;Bangham, A.D. et al., “Diffusion of Univalet Ions Across the Lamellae of Swollen Phospholipids,” J. Mol. Biol., 1965, pp. 238-252, vol. 13.;;Baruchi, I. et al., “Functional Holography of Complex Networks Activity—From Cultures to the Human Brain,” Complexity, 2005, pp. 38-51, vol. 10, No. 3, Wiley Periodicals, Inc.;;Baruchi, I. et al., “Functional Holography of Recorded Neuronal Networks Activity,” Neuroinformatics, 2004, pp. 333-352, vol. 4.;;Ben-Hur, A. et al., “Detecting Stable Clusters Using Principal Component Analysis,” in Methods in Molecular Biology, 2003 pp. 1-23.;;Bergey, G.K. et al., “Epileptic Seizures are Characterized by Changing Signal Complexity,” Clinical Neurophysiology, 2001, pp. 1-9, Elsevier.;;Betterton, P. et al., “Determining State of Consciousness from the Intracranial Electroencephalogram (IEEG) for Seizure Prediction,” Proceedings of the 22nd IASTED International Conference Modelling, Identification and Control, Feb. 10-13, 2003, Innsbruck, Austria, pp. 313-317.;;Bhattacharya, J. et al., “Enhanced Phase Synchrony in the Electroencephalography Band for Musicians While Listening to Music,” Physical Review, 2001, pp. 1-4, The American Physical Society, vol. 64, No. 012902.;;Boley, D. et al., “Training Support Vector Machine Using Adaptive Clustering,” Proceedings of the Fourth SIAM International Conference on Data Mining, 2004, 12 pages.;;Burges, C.J.C., “A Tutorial on Support Vector Machines for Pattern Recognition,” Data Mining and Knowledge Discovery, 1998, pp. 121-167, vol. 2, Kluwer Academic Publishers.;;Cao, Y. et al., “Detecting Dynamical Changes in Time Series Using the Permutation Entropy,” Physical Review, 2004, pp. 1-7, vol. 70, No. 046217.;;Carretero-Gonzalez, R. et al., “Scaling and Interleaving of Subsystem Lyapunov Exponents for Spatio-Temporal Systems,” Chaos, Jun. 1999, pp. 466-482, vol. 9, No. 2.;;Casdagli, M.C. et al., “Characterizing Nonlinearity in Invasive EEG Recordings from Temporal Lobe Epilepsy,” Physica D, Dec. 15, 1996, pp. 1-17, vol. 99, Issues 2-3.;;Casdagli, M.C. et al., “Nonlinear Analysis of Mesial Temporal Lobe Seizures Using a Surrogate Data Technique,” Epilepsia, Annual Meeting of the American Epilepsy Society, Baltimore, Maryland, Dec. 1-6, 1995, p. 142, vol. 36, Suppl. 4.;;Casdagli, M.C. et al., “Non-Linearity in Invasive EEG Recordings from Patients with Temporal Lobe Epilepsy,” Electroencephalography and Clinical Neurophysiology, Feb. 1997, pp. 1-10, vol. 102, Issue 2.;;Yatsenko, V. et al., “Geometric Models, Fiber Bundles and Biomedical Applications,” Proceedings of Institute of Mathematics of NAS of Ukraine, 2004, pp. 1518-1525, vol. 50, Part 3.;;Cerf, R. et al., “Criticality and Synchrony of Fluctuations in Rhythmical Brain Activity: Pretransitional Effects in Epileptic Patients,” Biological Cybernetics, Mar. 30, 2004, pp. 239-255, vol. 903.;;Chaovalitwongse, W. A. et al., “Reply to Comments on ‘Performance of a Seizure Warning Algorithm Based on the Dynamics of Intracranial EEG’ by Winterhalder, M., Schelter, B., Achulze-Bonhage, A., Timmer, J.,” Epilepsy Research, Jul. 31, 2006, pp. 82-84, vol. 72, Elsevier.;;Chaovalitwongse, W. et al., “Performance of a Seizure Warning Algorithm Based on the Dynamics of Intracranial EEG,” Epilepsy Research, 2005, pp. 1-46, vol. 64, Issue 3.;;Chaovalitwongse, W. et al., “EEG Classification in Epilepsy,” Jun. 30, 2004, Annals.tex, pp. 1-32, vol. 2, No. 37, Kluwer Academic Publishers, Netherlands.;;Zhang, X. et al., “High-Resolution EEG: Cortical Potential Imaging of Interictal Spikes,” Clinical Neurophysiology, 2003, pp. 1963-1973, vol. 114.;;Chavez, M. et al., “Spatio-Temporal Dynamics Prior to Neocortical Seizures: Amplitude Versus Phase Couplings,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 571-583, vol. 50 No.5.;;Chrichton, M., “The Terminal Man,” 1972, pp. 21-24, 32-33, 70-81, Alfred A. Knopf, New York.;;Curry, W.J. et al., “New Antiepileptic Drugs: Gabapentin, Lamotrigine, Felbamate, Topiramate and Fosphenytoin,” American Family Physician, Feb. 1, 1998, 9 pages, vol. 57, No. 3.;;D'Alessandro, M. et al., “A Multi-Feature and Multi-Channel Univariate Selection Process for Seizure Prediction,” Clinical Neurophysiology, 2005, pp. 506-516, vol. 116.;;D'Alessandro, M. et al., “Epileptic Seizure Prediction Using Hybrid Feature Selection Over Multiple Intracranial EEG Electrode Contacts: A Report of Four Patients,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 603-615, vol. 50, No. 5.;;Drury, I. et al., “Seizure Prediction Using Scalp Electroencephalogram,” Experimental Neurology, 2003, pp. S9-S18, vol. 184.;;Ebersole, J.S., “Functional Neuroimaging with EEG Source Models to Localize Epileptogenic Foci Noninvasively,” Neurology, Available at http://www.uchospitals.edu/pdf/uch.sub.--001471.pdf, Accessed Feb. 28, 2006, 3 pages.;;Ebersole, J.S., “In Search of Seizure Prediction: A Critique,” Clinical Neurophysiology, 2005, pp. 489-492, vol. 116.;;Elbert, T. et al., “Chaos and Physiology: Deterministic Chaos in Excitable Cell Assemblies,” Physiological Reviews, Jan. 1994, pp. 1-47, vol. 74, No. 1.;;Elger, C. E .et al., “Nonlinear EEG Analysis and Its Potential Role in Epileptology,” Epilepsia, 2000, pp. S34-S38, vol. 41, Suppl. 3.;;Elger, C.E. et al., “Short Communication—Seizure Prediction by Non-Linear Time Series Analysis of Brain Electrical Activity,” European Journal of Neuroscience, 1998, pp. 786-789, vol. 10.;;Esteller, R. et al., “A Comparison of Waveform Fractal Dimension Algorithms,” IEEE Transactions on Circuits and Systems 1: Fundamental Theory and Applications, Feb. 2001, pp. 177-183, vol. 48, No. 2.;;Esteller, R. et al., “Continuous Energy Variation During the Seizure Cycle: Towards an On-Line Accumulated Energy,” Clinical Neurophysiology, Jan. 22, 2005, pp. 517-526, vol. 116.;;Esteller, R. et al., “Feature Parameter Optimization for Seizure Detection/Prediction,” IntelliMedix, Inc., 2001, [online] [Retrieved on Oct. 31, 2005] Retrieved from the lnternet<URL:http://66.102.7.104/search?q=cache:4heOGuwtlacJ:icsl.m...re%2520Detection%2520Prediction.doc+intellimedix&hl=en>.;;Zhaveri, H.P. et al., “Time-Frequency Analyses of Non-Stationary Brain Signals,” Electroencephalography & Clinical Neurophysiology, Aug. 1991, pp. 28P-29P, vol. 79, No. 2.;;Faul, S. et al., “An Evaluation of Automated Neonatal Seizure Detection Methods,” Clinical Neurophysiology, 2005, pp. 1533-1541, vol. 116.;;Fein, G. et al., “Common Reference Coherence Data are Confounded by Power and Phase Effects,” Electroencephalography and Clinical Neurophysiology, 1988, pp. 581-584, vol. 69, Elsevier Scientific Publishers, Ireland, Ltd.;;Fell, J. et al., “Linear Inverse Filtering Improves Spatial Separation of Nonlinear Brain Dynamics: A Simulation Study,” Journal of Neuroscience Methods, 2000, pp. 49-56, vol. 98, Elsevier.;;Firpi, H. et al., “Epileptic Seizure Detection by Means of Genetically Programmed Artificial Features,” GECCO '05, Jun. 25-29, 2005, pp. 461-466.;;Fisher, R.S. “Reassessment: Vagus Nerve Stimulation for Epilepsy,” American Academy of Neurology, 1999, [online] [Retrieved on Apr. 14, 2006] Retrieved from the lnternet<URL:www.neurology.org>.;;Franaszczuk, P.J. et al., “An Autoregressive Method forthe Measurement of Synchronization of Interictal and Ictal EEG Signals,” Biological Cybernetics, 1999, pp. 3-9, vol. 81, Springer-Verlag.;;Gardner, A.B., “A Novelty Detection Approach to Seizure Analysis from Intracranial EEG,” Dissertation, Georgia Institute of Technology, Apr. 2004, pp. 1-146.;;Geva, A.B. et al., “Forecasting Generalized Epileptic Seizures from the EEG Signal by Wavelet Analysis and Dynamic Unsupervised Fuzzy Clustering,” IEEE Transactions on Biomedical Engineering, Oct. 1998, pp. 1205-1216, vol. 45, No. 10.;;Gigola, S. et al., “Prediction of Epileptic Seizures Using Accumulated Energy in a Multiresolution Framework,” Journal of Neuroscience Methods, 2004, pp. 107-111, vol. 138, Elsevier.;;Guyon, I. et al., “An Introduction to Variable and Feature Selection,” Journal of Machine Learning Research, Mar. 2003, pp. 1157-1182, vol. 3.;;Guyon, I. et al., “Multivariate Non-Linear Feature Selection with Kernel Multiplicative Updates and Gram-Schmidt Relief,” To appear in the proceedings of the BISC FLINT-CIBI 2003 workshop, Berkeley, Dec. 2003, pp. 1-11.;;Harrison, M.A. et al., “Accumulated Energy Revisited,” Clinical Neurophysiology, 2005, pp. 527-531, vol. 116, Elsevier.;;Harrison, M.A. F. et al., “Correlation Dimension and Integral Do Not Predict Epileptic Seizures,” Chaos, 2005, pp. 1-15, vol. 15, No. 033106, American Institute of Physics.;;Hearst, M.A., “Support Vector Machines,” IEEE Intelligent Systems, Jul./Aug. 1998, pp. 18-28.;;Hively, L.M. et al., “Channel-Consistent Forewarning of Epileptic Events from Scalp EEG,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 584-593, vol. 50, No. 5.;;Hively, L.M. et al., “Detecting Dynamical Change in Nonlinear Time Series,” Physics Letters A, Jul. 19, 1999, pp. 103-114, vol. 258, Elsevier.;;Hively, L.M. et al., “Epileptic Seizure Forewarning by Nonlinear Techniques,” Oak Ridge National Laboratory, Nov. 2000, 40 pages.;;Hjorth, B., “Source Derivation Simplifies Topographical EEG Interpretation,” Am.J. EEG Techol., 1980, pp. 121-132, vol. 20.;;Hsu, C-W. et al., “A Practical Guide to Support Vector Classification,” 2003, pp. 1-12.;;Huynh, J., “Evaluation of Gene Selection Using Support Vector Machine Recursive Feature Elimination,” Powerpoint Presentation, 2004, 41 pages.;;Huynh, J.A., “Evaluation of Gene Selection Using Support Vector Machine Recursive Feature Elimination,” Internship Report, May 26, 2004, pp. 1-25.;;Iasemidis, L.D. et al., “Adaptive Epileptic Seizure Prediction System,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 616-627, vol. 50, No. 5.;;Iasemidis, L.D. et al., “Automated Seizure Prediction Paradigm,” Epilepsia, Abstracts from the Annual Meeting of the American Epilepsy Society, San Diego, CA, Dec. 6-9, 1998, p. 207, vol. 39, Suppl. 6.;;Iasemidis, L.D. et al., “Chaos Theory and Epilepsy,” 1996, pp. 1-13.;;Iasemidis, L.D.et al., “Comment on ‘Inability of Lyapunov Exponents to Predict Epileptic Seizures,’” Physical Review Letters, Jan. 14, 2005, 1 page, PRL 94, 019801.;;Iasemidis, L.D. et al., “Detection of the Preictal Transition State in Scalp-Sphenoidal EEG Recordings: C206” Journal of Clinical Neurophysiology, Sep. 1996, pp. 443-444, vol. 13, No. 5.;;Iasemidis, L.D. et al., “Dynamical Interaction of the Epileptogenic Focus with Extrafocal Sites in Temporal Lobe Epilepsy,” Annals of Neurology, Sep. 1997, p. 429, vol. 42, No. 3.;;Iasemidis, L.D. et al., “Epileptogenic Focus Localization by Dynamic Analysis of Interictal Periods of EEG in Patients with Temporal Lobe Epilepsy,” Epilepsia, Abstracts from the Annual Meeting of the American Epilepsy Society, Boston, MA, Dec. 7-10, 1997, p. 213, vol. 38, Suppl. 8.;;Iasemidis, L.D. et al., “Long-Term Prospective On-Line Real-Time Seizure Prediction,” Clinical Neurophysiology, 2005, pp. 532-544, vol. 116.;;Iasemidis, L.D. et al., “Long-Time-Scale Temporo-Spatial Patterns of Entrainment of Preictal Electrocorticopraphic Data in Human Temporal Lobe Epilepsy,” Epilepsia, Sep./Oct. 1990, p. 621, vol. 31, No. 5.;;Iasemidis, L.D. et al., “Phase Space Topography and the Lyapunov Exponent of Electrocorticograms in Partial Seizures,” Brain Topography, Mar. 1990, pp. 187-201, vol. 2, No. 3.;;Iasemidis, L.D. et al., “Preictal Entrainment of a Critical Cortical Mass is a Necessary Condition for Seizure Occurrence,” Epilepsia, Abstracts from the Annual Meeting of the American Epilepsy Society, San Francisco, CA, Dec. 7-10, 1996, p. 90, vol. 37, Suppl. 5.;;Iasemidis, L.D. et al., “Quantification of Hidden Time Dependencies in the EEG within the Framework of Nonlinear Dynamics,” in Nonlinear Dynamical Analysis of the EEG, 1993, Eds. B.H. Jansen et al., pp. 30-47.;;Iasemidis, L.D. et al., “Spatiotemporal Dynamics of Human Epileptic Seizures,” in Proceedings of the 3rd Experimental Chaos Conference, 1996, R.G. Harrison et al. (Eds.), pp. 26-30.;;Iasemidis, L.D. et al., “Spatiotemporal Evolution of Dynamical Measures Precedes Onset of Mesial Temporal Lobe Seizures,” Epilepsia, Abstracts from the Annual Meeting of the American Epilepsy Society, New Orleans, LA, Dec. 2-8, 1994, p. 133, vol. 35, Suppl. 8.;;Iasemidis, L.D. et al., “Spatiotemporal Transition to Epileptic Seizures: A Nonlinear Dynamical Analysis of Scalp and Intracranial EEG Recordings,” Spatiotemporal Models in Biological and Artificial Systems, F.L. Silva et al. (Eds.), 1997, pp. 81-88, IOS Press.;;Iasemidis, L.D. et al., “The Evolution with Time of the Spatial Distribution of the Largest Lyapunov Exponent on the Human Epileptic Cortex,” in Measuring Chaos in the Human Brain, 1991, Eds. D. Duke et al., pp. 1-27.;;Iasemidis, L.D. et al., “The Use of Dynamical Analysis of EEG Frequency Content in Seizure Prediction,” Society Proceedings, American EEG Society, 1993 Annual Meeting, New Orleans, LA, Oct. 11-12, 1993, Electroencephalography and Clinical Neurophysiology, 1994, p. 39P, vol. 91.;;Iasemidis, L.D. et al., “Time Dependencies in Partial Epilepsy,” Epilepsia, Abstracts from the Annual Meeting of the American Epileptic Society, Miami, FL, Dec. 5-8, 1993, pp. 130-131, vol. 34, Suppl. 6.;;Iasemidis, L.D. et al., “Time Dependencies in the Occurrences of Epileptic Seizures,” Epilepsy Research, 1994, pp. 81-94, vol. 17, Elsevier.;;Iasemidis, L.D. et al., “Localizing Preictal Temporal Lobe Spike Foci Using Phase Space Analysis,” Abstracts of the XIIth International Congress of Electroencephalography and Clinical Neurophysiology, Rio de Janeiro, Brazil, Jan. 14-19, 1990, pp. S63-S64, vol. 75, No. 1, Elsevier Scientific Publishers Ireland, Ltd.;;Iasemidis, L.D. et al., “Measurement and Quantification of Spatio-Temporal Dynamics of Human Epileptic Seizures,” in Nonlinear Signal Processing in Medicine, M. Akay (Ed.), 1999, pp. 1-27, IEEE Press.;;Iasemidis, L.D. et al., “Modelling of EcoG in Temporal Lobe Epilepsy,” Proceedings of the 25th Rocky Mountain Bioengineering Symposium, Colorado Springs, CO, 1988, pp. 1-12.;;Iasemidis, L.D. et al., “Nonlinear Dynamics of Electrocorticographic Data in Temporal Lobe Epilepsy,” Journal of Clinical Neurophysiology, 1988, p. 339, vol. 5, No. 4, Raven Press.;;Iasemidis, L.D. et al., “Preictal-Postictal Versus Postictal Analysis for Epileptogenic Focus Localization,” J. Clin. Neurophysiology, 1997, p. 144, vol. 14.;;Iasemidis, L.D. et al., “Quadratic Binary Programming and Dynamical System Approach to Determine the Predictability of Epileptic Seizures,” Journal of Combinatorial Optimization, 2001, pp. 9-26, vol. 5, Kluwer Academic Publishers, Netherlands.;;Iasemidis, L.D., “Epileptic Seizure Prediction and Control,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 549-558, vol. 50, No. 5.;;Jerger, K.K. et al., “Early Seizure Detection,” Journal of Clinical Neurophysiology, 2001, pp. 259-268, vol. 18, No. 3.;;Jerger, K.K. et al., “Multivariate Linear Discrimination of Seizures,” Clinical Neurophysiology, 2005, pp. 545-551, vol. 116.;;Jouny, C.C. et al., “Signal Complexity and Synchrony of Epileptic Seizures: Is There an Identifiable Preictal Period?” Clinical Neurophysiology, 2005, pp. 552-558, vol. 116.;;Jouny, C.C. et al., “Characterization of Epileptic Seizure Dynamics Using Gabor Atom Density,” Clinical Neurophysiology, 2003, pp. 426-437, vol. 114.;;Kapiris, P.G. et al., “Similarities in Precursory Features in Seismic Shocks and Epileptic Seizures,” Europhysics Letters, Feb. 15, 2005, pp. 657-663, vol. 69, No. 4.;;Katz, A. et al., “Does Interictal Spiking Change Prior to Seizures?” Electroencephalography and Clinical Neurophysiology, 1991, pp. 153-156, vol. 79, Elsevier Scientific Publishers Ireland Ltd.;;Kerem, D.H. et al., “Forecasting Epilepsy from the Heart Rate Signal,” Medical & Biological Engineering & Computing, 2005, pp. 230-239, vol. 43.;;Khalilov, I. et al. “Epilptogenic Actions of GABA and Fast Oscillations in the Developing Hippocampus,” Neuron, Dec. 8, 2005, pp. 787-796, vol. 48, Elsevier Inc.;;Korn, H. et al., “Is there Chaos in the Brain? II. Experimental Evidence and Related Models,” C.R. Biologies, 2003, pp. 787-840, vol. 326.;;Kraskov, A., “Synchronization and Interdependence Measures and Their Applications to the Electroencephalogram of Epilepsy Patients and Clustering of Data,” Dissertation (PhD Thesis), Publication Series of the John von Neumann Institute for Computing (NIC), NIC Series, Feb. 2004, 106 pages, vol. 24.;;Kreuz, T. et al., “Measure Profile Surrogates: A Method to Validate the Performance of Epileptic Seizure Prediction Algorithms,” Jun. 15, 2004, Physical Review, pp. 1-9, vol. 69, No. 061915.;;Lachaux, J-P. et al., “Measuring Phase Synchrony in Brain Signals,” Human Brain Mapping, 1999, pp. 194-208, vol. 8.;;Lai, Y-C. et al., “Controlled Test for Predictive Power of Lyapunov Exponents: Their Inability to Predict Epileptic Seizures,” Chaos, Sep. 2004, pp. 630-642, vol. 14, No. 3.;;Lai, Y-C. et al., “Inability of Lyapunov Exponents to Predict Epileptic Seizures,” Physical Review Letters, Aug. 8, 2003, pp. 1-4, vol. 91, No. 6.;;Laroche, S.M. et al., “The New Antiepileptic Drugs,” Scientific Review, JAMA, Feb. 4, 2004, pp. 605-614, vol. 291, No. 5.;;Latka, M. et al., “Wavelet Analysis of Epileptic Spikes,” Dec. 22, 2002, pp. 1-6.;;Le Van Quyen, M. et al., “Preictal State Identification by Synchronization Changes in Long-Term Intracranial EEG Recordings,” Clinical Neurophysiology, 2005, pp. 559-568, vol. 116.;;Lehnertz, K. et al., “Nonlinear EEG Analysis in Epilepsy: Its Possible Use for Interictal Focus Localization, Seizure Anticipation, and Prevention,” Journal of Clinical Neurophysiology, 2001, pp. 209-222, vol. 18, No. 3.;;Lehnertz, K. et al., “Seizure Prediction by Nonlinear EEG Analysis,” IEEE Engineering in Medicine and Biology Magazine, Jan./Feb. 2003, pp. 57-63.;;Lehnertz, K. et al., “The First International Collaborative Workshop on Seizure Prediction: Summary and Data Description,” Clinical Neurophysiology, 2005, pp. 493-505, vol. 116, Elsevier.;;Lehnertz, K., “Non-Linear Time Series Analysis of Intracranial EEG Recordings in Patients with Epilepsy—An Overview,” International Journal of Psychophysiology, 1999, pp. 45-52, vol. 34, Elsevier.;;Lemos, M.S. et al., “The Weighted Average Reference Montage,” Electroencephalography and Clinical Neurophysiology, 1991, pp. 361-370, vol. 79, Elsevier Scientific Publishers Ireland, Ltd.;;Levan Quyen, M. et al., “Anticipating Epileptic Seizures in Real Time by a Non-Linear Analysis of Similarity Between EEG Recordings,” NeuroReport, Jul. 13, 1999, pp. 2149-2155, vol. 10, No. 10.;;Levan Quyen, M. et al., “Authors' Second Reply,” Correspondence, The Lancet, Mar. 15, 2003, p. 971, vol. 361.;;Levan Quyen, M. et al., “Comparison of Hilbert Transform and Wavelet Methods forthe Analysis of Neuronal Synchrony,” Journal of Neuroscience Methods, 2001, pp. 83-98, vol. 111, Elsevier.;;Levan Quyen, M. et al., “Nonlinear Analyses of Interictal EEG Map the Brain Interdependences in Human Focal Epilepsy,” Physica D, 1999, pp. 250-266, vol. 127, Elsevier.;;Levan Quyen, M., “Anticipating Epileptic Seizures: From Mathematics to Clinical Applications,” C.R. Biologies, 2004, pp. 1-12.;;Li, D. et al., “Linear and Nonlinear Measures and Seizure Anticipation in Temporal Lobe Epilepsy,” Journal of Computational Neuroscience, 2003, pp. 335-345, vol. 15, Kluwer Academic Publishers, Netherlands.;;Li, D. et al., “Non-Linear, Non-Invasive Method for Seizure Anticipation in Focal Epilepsy,” Mathematical Biosciences, 2003, pp. 63-77, vol. 186, Elsevier.;;Li, X. et al., “Fractal Spectral Analysis of Pre-Epileptic Seizures in Terms of Criticality,” Journal of Neural Engineering, Mar. 8, 2005, pp. 11-16, vol. 2.;;Litt, B. et al., “Prediction of Epileptic Seizures,” Neurology, The Lancet, May 2002, pp. 22-30, vol. 1, No. 1.;;Litt, B. et al., “Seizure Prediction and the Preseizure Period,” Current Opinion in Neurology, 2002 pp. 173-177, vol. 15.;;Maiwald, T. et al., “Comparison of Three Nonlinear Seizure Prediction Methods by Means of the Seizure Prediction Characteristic,” Physica D, 2004, pp. 357-368, vol. 194.;;Mangasarian, O.L. et al., “Lagrangian Support Vector Machines,” Mar. 9, 2006, pp. 1-22.;;Martinerie, J. et al., “Epileptic Seizures can be Anticipated by Non-Linear Analysis,” Nature Medicine, Oct. 1998, pp. 1173-1176, vol. 4, No. 10.;;McSharry, P.E. et al., “Comparison of Predictability of Epileptic Seizures by a Linear and a Nonlinear Method,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 628-633, vol. 50, No. 5.;;McSharry, P.E. et al., “Linear and Non-Linear Methods for Automatic Seizure Detection in Scalp Electro-Encephalogram Recordings,” Medical & Biological Engineering & Computing, 2002, pp. 447-461, vol. 40.;;McSharry, P.E., “Detection of Dynamical Transitions in Biomedical Signals Using Nonlinear Methods,” in Knowledge-Based Intelligent Information and Engineering Systems, 2004, pp. 483-490.;;Meng, L. et al., “Gaussian Mixture Models of EcoG Signal Features for Improved Detection of Epileptic Seizures,” Medical Engineering & Physics, 2004, pp. 379-393, vol. 26, Elsevier.;;Mizuno-Matsumoto, Y. et al., “Wavelet-Crosscorrelation Analysis Can Help Predict Whether Bursts of Pulse Stimulation Will Terminate Afterdischarges,” Clinical Neurophysiology, 2002, pp. 33-42, No. 113, Elsevier.;;Mormann, F. et al., “Automated Detection of a Preseizure State Based on a Decrease in Synchronization in Intracranial Electroencephalogram Recordings from Epilepsy Patients,” Physical Review, Feb. 26, 2003, vol. 67, No. 021912, The American Physical Society.;;Mormann, F. et al., “Epileptic Seizures are Preceded by a Decrease in Synchronization,” Epilepsy Research, 2003, pp. 173-185, vol. 53.;;Mormann, F. et al., “Mean Phase Coherence as a Measure for Phase Synchronization and its Application to the EEG of Epilepsy Patients,” Physica D, 2000, pp. 358-369, vol. 144, Elsevier.;;Mormann, F. et al., “On the Predictability of Epileptic Seizures,” Clinical Neurophysiology, 2005, pp. 569-587, vol. 116, Elsevier.;;Mormann, F. et al., “Seizure Anticipation: From Algorithms to Clinical Practice,” Current Opinion in Neurology, 2006, pp. 187-193, vol. 19, Lippincott Williams & Wilkins.;;Mormann, F. et al., “Seizure Prediction: The Long and Winding Road,” Brain, 2007, pp. 314-333, vol. 130.;;Navarro, V. et al., “Seizure Anticipation in Human Neocortical Partial Epilepsy,” Brain, 2002, pp. 640-655, vol. 125.;;Navarro, V. et al., “Seizure Anticipation: Do Mathematical Measures Correlate with Video—EEG Evaluation?” Epilepsia, 2005, pp. 385-396, vol. 46, No. 3.;;Niederhauser, J.J. et al., “Detection of Seizure Precursors from Depth—EEG Using a Sign Periodogram Transform,” IEEE Transactions on Biomedical Engineering, Apr. 2003, pp. 449-458, vol. 51, No. 4.;;Nigam, V. et al., “A Neural-Network-Based Detection of Epilepsy,” Neurological Research, Jan. 2004, pp. 55-60, vol. 26.;;Ochoa, J.G. et al., “Antiepileptic Drugs: An Overview,” eMedicine.com, WebMD, updated Sep. 26, 2006, 26 pages.;;Osorio, I. et al., “Performance Reassessment of a Real-Time Seizure-Detection Algorithm on Long ECoG Series,” Epilepsia, 2002, pp. 1522-1535, vol. 43, No. 12.;;Osorio, I. et al., “Real-Time Automated Detection and Quantitative Analysis of Seizures and Short-Term Prediction of Clinical Onset,” Epilepsia, 1998, pp. 615-627, vol. 39, No. 6.;;Osorio, I. et al., “Automated Seizure Abatement in Humans Using Electrical Stimulation,” Ann. Neurol., 2005, pp. 258-268, vol. 57, Wiley-Liss, Inc.;;Ossadtchi, A. et al., “Hidden Markov Modelling of Spike Propagation from Interictal MEG Data,” Physics in Medicine and Biology, Jul. 6, 2005, pp. 3447-3469, vol. 50, Institute of Physis Publishing.;;Pflieger, M.E. et al., “A Noninvasive Method for Analysis of Epileptogenic Brain Connectivity,” Presented at the American Epilepsy Society 2004 Annual Meeting, New Orleans, LA, Dec. 6, 2004, pp. 1-12.;;Pittman, V., “Flexible Drug Dosing Produces Less Side-Effects in People with Epilepsy,” Medical News Today Article, Dec. 29, 2005, [online] [Retrieved on Apr. 17, 2006] Retrieved from the lnternet< U RL: http://www.medicalnewstoday.com/printerfriend lynews.php?newsid=35478>.;;Platt, J.C. et al., “Large Margin DAGs for Multiclass Classification,” MIT Press, 2000, S.A. Solla et al. (Eds.), pp. 547-553.;;Platt, J.C., “Using Analytic QP and Sparseness to Speed Training of Support Vector Machines,” To Appear in Advances in Neural Information Processing Systems, M.S. Kearns et al. (Eds.), 1999, pp. 1-8, MIT Press.;;Protopopescu, V.A et al., “Epileptic Event Forewarning from Scalp EEG,” Journal of Clinical Neurophysiology, 2001, pp. 223-245, vol. 18, No. 3., Lippincott Williams & Wilkins, Inc.;;Rahimi, A. et al., “On the Effectiveness of Aluminum Foil Helmets: An Empirical Study,” Feb. 17, 2005, [online] [Retrieved on Dec. 13, 2005] Retrieved from the lnternetURL:http://people.csail.mitedu/rahimi/helmet/.;;Remington's, 18th Edition, A.R. Gennaro (Ed.), Pharmaceutical Sciences, 1990, 5 pages, Mack Publishing Company.;;Robinson, P.A. et al., “Steady States and Global Dynamics of Electrical Activity in the Cerebral Cortex,” Phys. Rev. E, Mar. 5, 1998, 13 pages, vol. 58, Issue 3.;;Rudrauf, D. et al., “Frequency Flows and the Time-Frequency Dynamics of Multivariate Phase Synchronization in Brain Signals,” NeuroImage, 2005, pp. 1-19.;;Saab, M.E. et al., “A System to Detect the Onset of Epileptic Seizures in Scalp EEG,” Clinical Neurophysiology, 2005, pp. 427-442, vol. 116, Elsevier.;;Sackellares, J.C. et al., “Computer-Assisted Seizure Detection Based on Quantitative Dynamical Measures,” Electroencephalography and Clinical Neurophysiology, 1995, p. 18P, vol. 95, No. 2.;;Sackellares, J.C. et al., “Dynamical Studies of Human Hippocampus in Limbic Epilepsy,” Neurology, Apr. 1995, p. A404-A405, vol. 45, Suppl. 4.;;Sackellares, J.C. et al., “Epilepsy—When Chaos Fails,” in Chaos in the Brain? K. Lehnertz et al. (Eds.), Jan. 3, 2000, pp. 1-22.;;Sackellares, J.C. et al., “Epileptic Seizures as Neural Resting Mechanisms,” Epilepsia, Abstracts from the 22nd International Epilepsy Congress, Dublin Ireland, Jun. 29-Jul. 4, 1997, 1 page, vol. 38, Suppl. 3, Lippincott-Raven Publishers.;;Sackellares, J.C. et al., “Measurement of Chaos to Localize Seizure Onset,” Epilepsia, Sep./Oct. 1989, p. 663, vol. 30, No. 5.;;Sackellares, J.C. et al., “Predictability Analysis for an Automated Seizure Prediction Algorithm,” Journal of Clinical Neurophysiology, Dec. 2006, pp. 509-520, vol. 23, No. 6.;;Sackellares, J.C. et al., “Relationship Between Hippocampal Atrophy and Dynamical Measures of EEG in Depth Electrode Recordings,” Electroencephalography and Clinical Neurophysiology, Jan. 1997, vol. 102, No. 1.;;Salant, Y., “Prediction of Epileptic Seizures from Two-Channel EEG,” Medical & Biological Engineering & Computing, Sep. 1998, pp. 549-556, vol. 36.;;Schelter, B. et al., “Testing for Directed Influences Among Neural Signals Using Partial Directed Coherence,” Journal of Neuroscience Methods, 2005, pp. 1-10, Elsevier.;;Schelter, B. et al., “Testing Statistical Significance of Multivariate Time Series Analysis Techniques for Epileptic Seizure Prediction,” Chaos, 2006, pp. 1-10, vol. 16, No. 013108.;;Schindler, K. et al., “EEG Analysis with Simulated Neuronal Cell Models Helps to Detect Pre-Seizure Changes,” Clinical Neurophysiology, 2002, pp. 604-614, vol. 113, Elsevier.;;Schwartzkroin, P.A., “Progress in Epilepsy Research—Origins of the Epileptic State,” Epilepsia, 1997, pp. 853-858, vol. 38, No. 8, Lippincott-Raven Publishers.;;Sheridan, T.B., “Humans and Automation: System Design and Research Issues,” HFES Issues in Human Factors and Ergomonics Series, 2002, 6 pages, vol. 3, John Wiley & Sons, Inc.;;Shoeb, A. et al., “Patient-Specific Seizure Detection,” MIT Computer Science and Artificial Intelligence Laboratory, Epilepsy & Behavior, 2004, pp. 193-194.;;Staba, R.J. et al., “Quantitative Analysis of High-Frequency Oscillations (80-500Hz) Recorded in Human Epileptic Hippocampus and Entorhinal Cortex,” J. Neurophysiology, 2002, pp. 1743-1752, vol. 88.;;Stefanski, A. et al., “Using Chaos Synchronization to Estimate the Largest Lyapunov Exponent of Nonsmooth Systems,” Discrete Dynamics in Nature and Society, 2000, pp. 207-215, vol. 4.;;Subasi, A. et al., “Classification of EEG Signals Using Neural Network and Logistic Regression,” Computer Methods and Programs in Biomedicine, 2005, pp. 87-99, vol. 78, Elsevier.;;Szoka, Jr., F. et al., “Procedure for Preparation of Liposomes with Large Internal Aqueous Space and High Capture by Reverse-Phase Evaporation,” Proc. Natl. Acad. Sci., Sep. 1978, pp. 4194-4198, vol. 75, No. 9.;;Tass, P. et al., “Detection of n:m Phase Locking from Noisy Data: Application to Magnetoencephalography,” Physical Review Letters, Oct. 12, 1998, pp. 3291-3294, vol. 81, No. 15.;;Terry, J.R. et al., “An Improved Algorithm forthe Detection of Dynamical Interdependence in Bivariate Time-Series,” Biol. Cybern., 2003, pp. 129-136, vol. 88.;;Tetzlaff, R. et al., “Cellular Neural Networks (CNN) with Linear Weight Functions for a Prediction of Epileptic Seizures,” International Journal of Neural Systems, 2003, pp. 489-498, vol. 13, No. 6, World Scientific Publishing Company.;;Theiler, J. et al., “Testing for Nonlinearity in Time Series: The Method of Surrogate Data,” Physica D, 1992, pp. 77-94, vol. 58.;;Tsakalis, K.S., “Prediction and Control of Epileptic Seizures: Coupled Oscillator Models,” Arizona State University, no date, 53 pages.;;Van Drongelen, W. et al., “Seizure Anticipation in Pediatric Epilepsy: Use of Kolmogorov Entropy,” Pediatric Neurology, 2003, pp. 207-213, vol. 29, No. 3.;;Vanputten, M.J.A.M., “Nearest Neighbor Phase Synchronization as a Measure to Detect Seizure Activity from Scalp EEG Recordings,” Journal of Clinical Neurophysiology, 2003, pp. 320-325, vol. 20, No. 5.;;Venugopal, R. et al., “A New Approach Towards Predictability of Epileptic Seizures: KLT Dimension,” ISA, 2003, Paper #2003-022, pp. 123-128. et al.",ACTIVE
11,US,B2,US 10463270 B2,121-065-581-346-274,2019-11-05,2019,US 201514954250 A,2015-11-30,US 201514954250 A;;US 61678806 A,2006-12-27,Low power device with contingent scheduling,"Medical device systems and methods for operating medical device systems conserve energy by efficiently managing computational demands of the systems. A first analysis, having relatively lower computational processing demand than at least a second analysis, processes signals from a subject to determine a first estimate of a propensity for the subject to have a neurological event. If the first estimate meets a set of specified criteria, a second analysis is performed to determine a second estimate of the propensity for the subject to have a neurological event.",CYBERONICS INC;;LIVANOVA USA INC,LEYDE KENT,LIVANOVA USA INC (2013-02-28),https://lens.org/121-065-581-346-274,Granted Patent,yes,35,12,5,162-842-719-381-963;;121-065-581-346-274;;122-607-110-066-647;;171-739-665-854-198;;023-306-770-445-978,US,5,162-842-719-381-963;;121-065-581-346-274;;122-607-110-066-647;;171-739-665-854-198;;023-306-770-445-978,US,0,A61B5/0006;;A61B5/369;;A61B5/4094;;A61B5/7264;;A61B2560/0209;;G16H40/63;;A61B5/369;;A61B5/0006;;A61B5/024;;A61B5/4094;;A61B5/6814;;A61B5/7264;;A61B2560/0209;;G16H40/63,A61B5/0476;;A61B5/00;;A61B5/024;;G16H40/63,,232,163,110-756-376-850-387;;080-476-358-354-096;;134-256-610-404-255;;007-435-731-732-051;;017-658-731-501-924;;023-267-619-814-161;;038-812-576-998-057;;036-765-169-783-989;;011-439-172-416-329;;030-959-629-699-794;;034-726-247-442-625;;038-105-755-405-648;;035-477-652-721-97X;;015-010-310-018-059;;084-869-327-261-949;;164-068-260-839-362;;047-917-227-447-051;;090-722-470-992-921;;009-937-539-597-93X;;085-287-764-394-56X;;013-993-295-891-841;;026-161-434-624-269;;059-721-223-992-598;;014-590-560-212-185;;127-486-336-288-668;;024-174-082-138-653;;041-879-143-577-040;;135-197-726-472-806;;043-209-732-625-194;;110-756-376-850-387;;022-986-350-191-09X;;052-904-683-117-37X;;099-738-184-995-471;;036-799-833-560-683;;165-272-421-305-535;;075-949-839-628-664;;040-563-703-473-032;;091-489-529-599-197;;010-542-698-038-106;;080-476-358-354-096;;010-031-887-527-334;;014-030-870-508-55X;;053-176-049-549-89X;;134-256-610-404-255;;007-435-731-732-051;;017-658-731-501-924;;082-130-581-626-626;;087-888-415-182-16X;;023-267-619-814-161;;038-812-576-998-057;;072-494-162-399-945;;036-765-169-783-989;;029-415-860-497-502;;007-860-157-935-846;;021-927-186-932-311;;004-699-664-794-075;;030-983-039-493-075;;034-726-247-442-625;;030-959-629-699-794;;038-105-755-405-648;;058-354-881-914-817;;098-793-796-290-443;;008-217-796-572-141;;035-477-652-721-97X;;081-069-045-977-645;;021-357-805-075-514;;100-504-376-971-476;;009-408-154-386-927;;081-014-262-239-384;;119-041-943-953-007;;035-591-284-396-294;;037-270-502-089-758;;116-617-266-976-059;;022-014-401-539-185;;015-010-310-018-059;;041-849-140-405-799;;013-175-917-825-570;;005-812-068-829-241;;007-102-427-091-207;;058-590-161-216-02X;;035-202-529-233-089;;102-065-286-791-958;;040-653-827-786-603;;090-722-470-992-921;;079-496-522-034-098;;077-437-257-509-116;;061-465-319-393-938;;071-794-997-821-559;;055-212-083-393-970;;027-951-309-891-088;;057-209-256-661-319;;021-904-530-539-008;;022-340-064-605-885;;013-131-457-719-966;;014-960-565-157-379;;004-744-607-902-199;;047-951-590-482-23X;;009-937-539-597-93X;;056-713-840-473-145;;012-347-103-675-309;;118-774-883-250-925;;129-688-805-152-535;;001-684-727-218-323;;120-941-384-775-230;;017-872-040-249-384;;047-557-590-620-81X;;038-895-519-332-589;;099-242-910-542-727;;018-748-506-465-539;;090-139-902-269-836;;023-634-408-186-013;;071-379-392-030-350;;067-202-305-611-192;;022-737-784-206-984;;025-462-190-148-245;;085-258-298-688-583;;008-683-222-517-061;;006-571-256-471-437;;008-525-576-094-074;;035-845-605-612-97X;;003-527-914-722-422;;093-017-198-453-261;;085-287-764-394-56X;;050-957-455-833-565;;029-826-474-472-813;;059-008-403-052-583;;024-400-776-056-719;;029-096-142-097-365;;079-621-744-256-569;;143-398-932-451-548;;063-161-480-619-358;;013-993-295-891-841;;026-040-501-717-238;;058-897-213-047-739;;078-034-108-516-718;;044-054-605-334-338;;094-833-913-753-979;;049-554-204-238-743;;109-633-160-417-984;;010-447-571-408-178;;044-801-911-798-401;;004-336-445-612-283;;059-721-223-992-598;;117-306-806-020-719;;046-394-936-902-110;;046-951-867-744-006;;029-313-181-841-642;;020-542-114-256-808;;014-590-560-212-185;;082-384-306-223-881;;066-581-502-575-086;;007-401-896-126-759;;042-683-317-156-433;;056-588-099-366-952;;081-339-542-705-015;;127-486-336-288-668;;087-366-366-471-863;;069-183-134-021-682;;060-719-041-136-865;;024-174-082-138-653;;108-365-920-087-726;;007-930-875-295-119;;041-879-143-577-040,15689714;;10.1097/01.wnp.0000150880.19561.6f;;10.1016/s1388-2457(00)00543-5;;11165525;;12779843;;10.1063/1.166420;;10.1016/s0167-2789(96)00160-1;;10.1016/s0921-884x(96)95195-4;;9060860;;16919914;;10.1016/j.eplepsyres.2006.06.012;;10.1109/tbme.2003.810696;;12769433;;10.1016/j.clinph.2004.11.014;;15721064;;14597320;;10.1016/s0014-4886(03)00354-6;;10.1109/81.904882;;10.1016/j.clinph.2004.10.015;;pmc2941767;;15721065;;15897008;;10.1016/j.clinph.2005.03.006;;10434388;;10.1007/s004220050540;;10.1016/0013-4694(90)91948-o;;10.1097/00004691-198810000-00042;;10.1097/00004691-199709000-00015;;10.1016/0013-4694(94)90046-9;;10.1016/s1388-2457(02)00344-9;;12705423;;10.1016/j.clinph.2004.10.014;;15721070;;10.1097/01.wco.0000218237.52593.bc;;16538095;;15668970;;10.1002/ana.20377;;10.1063/1.2137623;;16599739;;9579886;;10.1111/j.1528-1157.1997.tb01250.x;;10.1007/s00422-002-0368-4;;12567227;;15008506;;10.1152/jn.00190.2006;;pmc2230664;;17021032;;10.1016/s1388-2457(03)00194-9;;14499758;;15133954;;15132516;;10.1109/tbme.2004.826642;;15689714;;10.1097/01.wnp.0000150880.19561.6f;;10.1615/jautomatinfscien.v36.i8.30;;10.1103/physreve.67.010901;;12636484;;14754292;;10.1103/physreve.68.066202;;10.1093/brain/awg265;;14506067;;16922871;;10.1111/j.1528-1167.2006.00616.x;;10.1016/s0022-2836(65)80093-6;;5859039;;15365195;;10.1385/ni:2:3:333;;10.1002/cplx.20065;;10.1385/1-59259-364-x:159;;12710673;;10.1016/s1388-2457(00)00543-5;;11165525;;11461312;;10.1103/physreve.64.012902;;10.1137/1.9781611972740.12;;15600505;;10.1103/physreve.70.046217;;12779843;;10.1063/1.166420;;10.1016/s0167-2789(96)00160-1;;10.1016/s0921-884x(96)95195-4;;9060860;;10.1007/s00422-004-0463-9;;15085343;;15961284;;10.1016/j.eplepsyres.2005.03.009;;16919914;;10.1016/j.eplepsyres.2006.06.012;;10.1109/tbme.2003.810696;;12769433;;9475899;;10.1016/j.clinph.2004.11.014;;15721064;;12769436;;10.1109/tbme.2003.810706;;15721062;;10.1016/j.clinph.2004.09.029;;8295931;;10.1152/physrev.1994.74.1.1;;10.1111/j.1528-1157.2000.tb01532.x;;11001334;;9749744;;10.1046/j.1460-9568.1998.00090.x;;10.1016/j.clinph.2004.10.015;;pmc2941767;;15721065;;10.1109/81.904882;;15897008;;10.1016/j.clinph.2005.03.006;;10.1016/0013-4694(88)90171-x;;2453336;;10.1016/s0165-0270(00)00188-6;;10837870;;10.1145/1068009.1068082;;10434388;;10.1007/s004220050540;;9775534;;10.1109/10.720198;;15325118;;10.1016/j.jneumeth.2004.03.016;;10.1016/j.clinph.2004.08.022;;15721066;;16252980;;10.1063/1.1935138;;10.1109/5254.708428;;10.1016/s0375-9601(99)00342-4;;10.2172/814360;;10.1109/tbme.2003.810693;;12769434;;10.1080/00029238.1980.11080015;;2116818;;10.1007/bf01140588;;10.1016/0013-4694(90)91948-o;;8174527;;10.1016/0920-1211(94)90081-7;;10.1097/00004691-199609000-00041;;12769431;;10.1109/tbme.2003.810705;;10.1109/tbme.2003.810689;;12769437;;15698148;;10.1103/physrevlett.94.019801;;15721067;;10.1016/j.clinph.2004.10.013;;11528297;;10.1097/00004691-200105000-00005;;10.1016/j.clinph.2004.08.023;;15721068;;10.1016/s1388-2457(02)00344-9;;12705423;;10.1016/j.clinph.2004.08.024;;15721069;;10.1209/epl/i2004-10383-2;;1713830;;10.1016/0013-4694(91)90054-8;;10.1007/bf02345960;;15865133;;16337916;;10.1016/j.neuron.2005.09.026;;10.1016/j.crvi.2003.09.011;;14694754;;10.1103/physreve.69.061915;;15244625;;10.1002/(sici)1097-0193(1999)8:4<194::aid-hbm4>3.0.co;2-c;;10619414;;pmc6873296;;12935113;;10.1103/physrevlett.91.068102;;15446973;;10.1063/1.1777831;;10.1001/jama.291.5.605;;14762040;;12786206;;10.1103/physreve.67.052902;;10.1016/j.crvi.2004.10.014;;15771005;;10.1016/j.clinph.2004.10.014;;15721070;;10.1016/s0167-2789(98)00258-9;;10.1097/00001756-199907130-00028;;10424690;;10.1016/s0165-0270(01)00372-7;;11595276;;10.1016/s0140-6736(03)12755-9;;10.1016/j.clinph.2004.08.020;;15721063;;10.1016/s0167-8760(99)00043-4;;10555873;;10.1097/00004691-200105000-00002;;11528294;;12683064;;10.1109/memb.2003.1191451;;10.1016/0013-4694(91)90201-e;;1718709;;10.1016/s0025-5564(03)00100-7;;14527747;;14618068;;10.1023/a:1027415927155;;10.1088/1741-2560/2/2/002;;15928408;;10.1016/s1474-4422(02)00003-0;;12849542;;11923631;;10.1097/00019052-200204000-00008;;10.1016/j.physd.2004.02.013;;9771751;;10.1038/2667;;10.1007/978-3-540-30134-9_65;;12227632;;10.1007/bf02345078;;12769438;;10.1109/tbme.2003.810688;;10.1016/j.medengphy.2004.02.006;;15147746;;10.1016/s1350-4533(04)00031-1;;10.1016/s1388-2457(01)00712-x;;11801422;;12636720;;10.1103/physreve.67.021912;;12694925;;10.1016/s0920-1211(03)00002-0;;10.1016/j.clinph.2004.08.025;;15721071;;10.1097/01.wco.0000218237.52593.bc;;16538095;;17008335;;10.1093/brain/awl241;;10.1016/s0167-2789(00)00087-7;;11872619;;10.1093/brain/awf048;;15730536;;10.1111/j.0013-9580.2005.15504.x;;12723056;;10.1109/tbme.2003.809497;;14977058;;10.1179/016164104773026534;;10.1111/j.1528-1157.1998.tb01430.x;;9637604;;12460255;;10.1046/j.1528-1157.2002.11102.x;;15668970;;10.1002/ana.20377;;16177520;;10.1088/0031-9155/50/14/017;;10.1097/00004691-200105000-00003;;11528295;;15661120;;10.1016/j.clinph.2004.08.004;;10.1142/9789812793782_0010;;10.1016/0013-4694(95)97919-r;;10.1016/s0013-4694(97)86248-7;;10.1097/00004691-200612000-00003;;17143139;;10367436;;10.1007/bf02524422;;16269188;;10.1016/j.jneumeth.2005.09.001;;10.1016/s1388-2457(02)00032-9;;11956006;;9579886;;10.1111/j.1528-1157.1997.tb01250.x;;12364503;;10.1152/jn.2002.88.4.1743;;10.1155/s1026022600000200;;15848265;;10.1016/j.cmpb.2004.10.009;;10.1073/pnas.75.9.4194;;pmc336078;;279908;;10.1103/physrevlett.81.3291;;10.1007/s00422-002-0368-4;;12567227;;10.1142/s0129065703001790;;15031857;;10.1016/0167-2789(92)90102-s;;14629902;;10.1016/s0887-8994(03)00145-0;;14701993;;10.1097/00004691-200309000-00004;;12724880;;10.1002/ana.10323;;12402252;;15008506;;15987261;;10.1111/j.1528-1167.2005.01016.x;;10415414;;10.1016/s0006-8993(99)01647-9;;12791335;;10.1016/s1525-5050(03)00105-7;;10.1152/jn.00190.2006;;pmc2230664;;17021032;;12423382;;10.1046/j.1528-1157.2002.15702.x;;10.1007/978-1-4613-0225-4_14;;10.1016/s1388-2457(03)00194-9;;14499758,"Adjouadi, M. et al., “Detection of Interictal Spikes and Artifactual Data Through Orthogonal Transformations,” Journal of Clinical Neurophysiology, Feb. 2005, pp. 53-64, vol. 22, No. 1.;;Bergey, G.K. et al., “Epileptic Seizures are Characterized by Changing Signal Complexity,” Clinical Neurophysiology, 2001, pp. 1-9, Elsevier.;;Carretero-Gonzalez, R. et al., “Scaling and Interleaving of Subsystem Lyapunov Exponents for Spatio-Temporal Systems,” Chaos, Jun. 1999, pp. 466-482, vol. 9, No. 2.;;Casdagli, M.C. et al., “Characterizing Nonlinearity in Invasive EEG Recordings from Temporal Lobe Epilepsy,” Physica D, Dec. 15, 1996, pp. 1-17, vol. 99, Issues 2-3.;;Casdagli, M.C. et al., “Nonlinear Analysis of Mesial Temporal Lobe Seizures Using a Surrogate Data Technique,” Epilepsia, Annual Meeting of the American Epilepsy Society, Baltimore, Maryland, Dec. 1-6, 1995, p. 142, vol. 36, Suppl. 4.;;Casdagli, M.C. et al., “Non-Linearity in Invasive EEG Recordings from Patients with Temporal Lobe Epilepsy,” Electroencephalography and Clinical Neurophysiology, Feb. 1997, pp. 1-10, vol. 102, Issue 2.;;Chaovalitwongse, W. A. et al., “Reply to Comments on “Performance of a Seizure Warning Algorithm Based on the Dynamics of Intracranial EEG” by Winterhalder, M., Schelter, B., Achulze-Bonhage, A., Timmer, J.,” Epilepsy Research, Jul. 31, 2006, pp. 82-84, vol. 72, Elsevier.;;Chaovalitwongse, W. et al., “EEG Classification in Epilepsy,” Jun. 30, 2004, Annals.tex, pp. 1-32, vol. 2, No. 37, Kluwer Academic Publishers, Netherlands.;;Chavez, M. et al., “Spatio-Temporal Dynamics Prior to Neocortical Seizures: Amplitude Versus Phase Couplings,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 571-583, vol. 50 No. 5.;;D'Alessandro, M. et al., “A Multi-Feature and Multi-Channel Univariate Selection Process for Seizure Prediction,” Clinical Neurophysiology, 2005, pp. 506-516, vol. 116.;;Drury, I. et al., “Seizure Prediction Using Scalp Electroencephalogram,” Experimental Neurology, 2003, pp. S9-S18, vol. 184.;;Esteller, R. et al., “A Comparison of Waveform Fractal Dimension Algorithms,” IEEE Transactions on Circuits and Systems—I: Fundamental Theory and Applications, Feb. 2001, pp. 177-183, vol. 48, No. 2.;;Esteller, R. et al., “Continuous Energy Variation During the Seizure Cycle: Towards an On-Line Accumulated Energy,” Clinical Neurophysiology, Jan. 22, 2005, pp. 517-526, vol. 116.;;Esteller, R. et al., “Feature Parameter Optimization for Seizure Detection/Prediction,” IntelliMedix, Inc., [online] [Retrieved on Oct. 31, 2005] Retrieved from the Internet<URL:http://66.102.7.104/search?q=cache:4he0GuwtlacJ:icsl.m...re%2520Detection%2520Prediction.doc+intellimedix&h1=en>.;;Faul, S. et al., “An Evaluation of Automated Neonatal Seizure Detection Methods,” Clinical Neurophysiology, 2005, pp. 1533-1541, vol. 116.;;Franaszczuk, P.J. et al., “An Autoregressive Method for the Measurement of Synchronization of Interictal and Ictal EEG Signals,” Biological Cybernetics, 1999, pp. 3-9, vol. 81, Springer-Verlag.;;Iasemidis, L.D. et al., “Localizing Preictal Temporal Lobe Spike Foci Using Phase Space Analysis,” Abstracts of the XIIth International Congress of Electroencephalography and Clinical Neurophysiology, Rio de Janeiro, Brazil, Jan. 14-19, 1990, pp. S63-S64, vol. 75, No. 1, Elsevier Scientific Publishers Ireland, Ltd.;;Iasemidis, L.D. et al., “Measurement and Quantification of Spatio-Temporal Dynamics of Human Epileptic Seizures,” in Nonlinear Signal Processing in Medicine, M. Akay (Ed.), 1999, pp. 1-27, IEEE Press.;;Iasemidis, L.D. et al., “Modelling of EcoG in Temporal Lobe Epilepsy,” Proceedings of the 25th Rocky Mountain Bioengineering Symposium, Colorado Springs, CO, 1988, pp. 1-12.;;Iasemidis, L.D. et al., “Nonlinear Dynamics of Electrocorticographic Data in Temporal Lobe Epilepsy,” Journal of Clinical Neurophysiology, 1988, p. 339, vol. 5, No. 4, Raven Press.;;Iasemidis, L.D. et al., “Preictal-Postictal Versus Postictal Analysis for Epileptogenic Focus Localization,” J. Clin. Neurophysiol., 1997, p. 144, vol. 14.;;Iasemidis, L.D. et al., “Quadratic Binary Programming and Dynamical System Approach to Determine the Predictability of Epileptic Siezures,” Journal of Combinatorial Optimization, 2001, pp. 9-26, vol. 5, Kluwer Academic Publishers, Netherlands.;;Iasemidis, L.D. et al., “The Use of Dynamical Analysis of EEG Frequency Content in Seizure Prediction,” Society Proceedings, American EEG Society, 1993 Annual Meeting, New Orleans, LA, Oct. 11-12, 1993, Electroencephalography and Clinical Neurophysiology, 1994, p. 39P, vol. 91.;;Jouny, C.C. et al., “Characterization of Epileptic Seizure Dynamics Using Gabor Atom Density,” Clinical Neurophysiology, 2003, pp. 426-437, vol. 114.;;Le Van Quyen, M. et al., “Preictal State Identification by Synchronization Changes in Long-Term Intracranial EEG Recordings,” Clinical Neurophysiology, 2005, pp. 559-568, vol. 116.;;Mormann, F. et al., “Seizure Anticipation: From Algorithms to Clinical Pratice,” Current Opinion in Neurology, 2006, pp. 187-193, vol. 19, Lippincott Williams & Wilkins.;;Osorio, I. et al., “Automated Seizure Abatement in Humans Using Electrical Stimulation,” Ann. Neurol., 2005, pp. 258-268, vol. 57, Wiley-Liss, Inc.;;Rahimi, A. et al., “On the Effectiveness of Aluminum Foil Helmets: An Empirical Study,” Feb. 17, 2005, [online] [Retrieved on Dec. 13, 2005] Retrieved from the InternetURL:http://people.csail.mitedu/rahimi/helmet/.;;Robinson, P.A. et al., “Steady States and Global Dynamics of Electrical Activity in the Cerebral Cortex,” Phys. Rev. E, Mar. 5, 1998, 13 pages, vol. 58, Issue 3.;;Schelter, B. et al., “Testing Statistical Significance of Multivariate Time Series Analysis Techniques for Epileptic Seizure Prediction,” Chaos, 2006, pp. 1-10, vol. 16, No. 013108.;;Schwartzkroin, P.A., “Progres in Epilepsy Research—Origins of the Epileptic State,” Epilepsia, 1997, pp. 853-858, vol. 38, No. 8, Lippincott-Raven Publishers.;;Shoeb, A. et al., “Patient-Specific Seizure Detection,” MIT Computer Science and Artificial Intelligence Laboratory, Epilepsy & Behavior, 2004, pp. 193-194.;;Terry, J.R. et al., “An Improved Algorithm for the Detection of Dynamical Interdependence in Bivariate Time-Series,” Biol. Cybern., 2003, pp. 129-136, vol. 88.;;Tsakalis, K.S., “Prediction and Control of Epileptic Seizures: Coupled Oscillator Models,” Part 2, Arizona State University, no date, 28 pages.;;Vonck, K. et al., “Neurostimulation for Refractory Epilepsy,” Acta Neurol. Belg., 2003, pp. 213-217, vol. 103.;;Wells, R.B., “Spatio-Temporal Binding and Dynamic Cortical Organization: Research Issues,” Mar. 2005, pp. 1-68.;;Wong, S. et al., “A Stochastic Framework for Evaluationg Seizure Prediction Algorithms Using Hidden Markov Models,” J. Neurophysiol., Oct. 4, 2006, pp. 2525-2532, vol. 97.;;Zhang, X. et al., “High-Resolution EEG: Cortical Potential Imaging of Interictal Spikes,” Clinical Neurophysiology. 2003. DD. 1963-1973. vol. 114.;;Final Office Action dated Apr. 2, 2015 in U.S. Appl. No. 11/616,793, filed Dec. 27, 2006.;;Non-Final Office Action dated Jul. 17, 2014 in U.S. Appl. No. 11/616,793, filed Dec. 27, 2006.;;Adjouadi, M. et al., “A New Mathematical Approach Based on Orthogonal Operators for the Detection of Interictal Spikes in Epileptogenic Data,” Presented at Rocky Mountain Bioengineering Symposium & International ISA Biomedical Sciences Instrumentation Symposium, 2004, pp. 175-180.;;Adjouadi, M. et al., “Interictal Spike Detection Using the Walsh Transform,” IEEE Transactions on Biomedical Engineering, May 2004, pp. 868-872, vol. 51, No. 5.;;Adjouadi, M. et al., “Detection of Interictal Spikes and Artifactual Data Through Orthogonal Transformations,” Journal of Clinical Neurophysiolo˜JY. Feb. 2005, pp. 53-64, vol. 22, No. 1.;;Aksenova, T.I. et al., “On-Line Disharmony Detection for Early Prediction of Epilepsy Seizure Onset,” 2003, 2 pages.;;Aksenova, T.I. et al., “Nonparametric On-Line Detection of Changes in Signal Spectral Characteristics for Early Prediction of Epilepsy Seizure Onset,” Journal of Automation and Information Sciences, 2004, pp. 35-45, vol. 36, No. 8.;;Andrzejak, R.G. et al., “Testing the Null Hypothesis of the Nonexistence of a Preseizure State,” Physical Review, 2003, pp. 1-4, The American Physical Society, vol. 67, No. 010901(R).;;Andrzejak, R.G. et al., “Bivariate Surrogate Techniques: Necessity, Strengths, and Caveats,” Physical Review, 2003, pp. 1-15, The American Physical Society, vol. 68, No. 066202.;;Aschenbrenner-Scheibe, R. et al., “How Well Can Epileptic Seizures be Predicted? An Evaluation of a Nonlinear Method,” Brain, Sep. 23, 2003, pp. 2616-2626, vol. 126.;;Avanzin I, G., “Is Tolerance to Antiepileptic Drugs Clinically Relevant?” Epilepsia, 2006, pp. 1285-1287, vol. 47, No. 8, Blackwell Publishing, Inc.;;Bangham, A.D. et al., “Diffusion of Univalet Ions Across the Lamellae of Swollen Phospholipids,” J. Mol. Biol., 1965, pp. 238-252, vol. 13.;;Baruch I, I. et al., “Functional Holography of Recorded Neuronal Networks Activity,” Neuroinformatics, 2004, pp. 333-352, vol. 4.;;Baruch I, I. et al., Functional Holography of Complex Networks Activity—From Cultures to the Human Brain, Complexity, 2005, pp. 38-51, vol. 10, No. 3, Wiley Periodicals, Inc.;;Ben-Hur, A. et al., “Detecting Stable Clusters Using Principal Component Analysis,” in Methods in Molecular Biology, 2003 pp. 1-23.;;Bergey, G.K. et al., “Epileptic Seizures are Characterized by Changing Signal Complexity,” Clinical Neurophysioloqy, 2001, pp. 1-9, Elsevier.;;Betterton, P. et al., “Determining State of Consciousness from the Intracranial Electroencephalogram (IEEG) for Seizure Prediction,” Proceedings of the 22nd IASTED International Conference Modelling, Identification and Control, Feb. 10-13, 2003, Innsbruck, Austria, pp. 313-317.;;Bhattacharya, J. et al., “Enhanced Phase Synchrony in the Electroencephalography Band for Musicians While Listening to Music,” Physical Review, 2001, pp. 1-4, The American Physical Society, vol. 64, No. 012902.;;Boley, D. et al., “Training Support Vector Machine Using Adaptive Clustering,” Proceedigns of the Fourth SIAM International Conference on Data Mining, 2004,12 pages.;;Burges, C.J.C., “A Tutorial on Support Vector Machines for Pattern Recognition,” Data Mining and Knowledqe Discovery, 1998, pp. 121-167, vol. 2, Kluwer Academic Publishers.;;Cao, Y. et al., “Detecting Dynamical Changes in Time Series Using the Permutation Entropy,” Physical Review, 2004, pp. 1-7, vol. 70, No. 046217.;;Carretero-Gonzalez, R. et al., “Scaling and Interleaving of Subsystem Lyapunov Exponents for Spatia-Temporal Systems,” Chaos, Jun. 1999, pp. 466-482, vol. 9, No. 2.;;Casdagli, M.G. et al., “Nonlinear Analysis of Mesial Temporal Lobe Seizures Using a Surrogate Data Technique,” Epilepsia, Annual Meeting of the American Epilepsy Society, Baltimore, Maryland, Dec. 1-6, 1995, p. 142, vol. 36, Suppl. 4.;;Casdagli, M.G. et al., “Characterizing Nonlinearity in Invasive EEG Recordings from Temporal Lobe Epilepsy,” Physica D, Dec. 15, 1996, pp. 1-17, vol. 99, Issues 2-3.;;Casdagli, M.G. et al., “Non-Linearity in Invasive EEG Recordings from Patients with Temporal Lobe Epilepsy,” Electroencephalography and Clinical Neurophysiology, Feb. 1997, pp. 1-10, vol. 102, Issue 2.;;Cerf, R. et al., “Criticality and Synchrony of Fluctuations in Rhythmical Brain Activity: Pretransitional Effects in Epileptic Patients,” Bioloqical Cybernetics, Mar. 30, 2004, pp. 239-255, vol. 903.;;Chaovalitwongse, W. et al., “EEG Classification in Epilepsy,” Jun. 30, 2004, Annals. lex, pp. 1-32, vol. 2, No. 37, Kluwer Academic Publishers, Netherlands.;;Chaovalitwongse, W. et al., “Performance of a Seizure Warning Algorithm Based on the Dynamics of Intracranial EEG,” Epilepsy Research, 2003, pp. 1-46, vol. 64, Issue 3.;;Chaovalitwongse, W. A. et al., “Reply to Comments on “Performance of a Seizure Warning Algorithm Based on the Dynamics of Intracranial EEG” by Winterhalder, M., Scheller, B., Achulze-Bonhage, A., Timmer, J.,” Epilepsy Research, Jul. 31, 2006, pp. 82-84, vol. 72, Elsevier.;;Chávez, M. et al., “Spatia-Temporal Dynamics Prior to Neocortical Seizures: Amplitude Versus Phase Couplings,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 571-583, vol. 50 No. 5.;;Chrichton, M., “The Terminal Man,” 1972, pp. 21-24,32-33, 70-81, Alfred A. Knopf, New York.;;Curry, W.J. et al., “New Antiepileptic Drugs: Gabapentin, Lamotrigine, Felbamate, Topiramate and Fosphenytoin,” American Family Physician, Feb. 1, 1998, 9 pages, vol. 57, No. 3.;;D'Alessandro, M. et al., “A Multi-Feature and Multi-Channel Univariate Selection Process for Seizure Prediction,” Clinical Neurophysioloqy, 2005, pp. 506-516, vol. 116.;;D'Alessandro, M. et al., “Epileptic Seizure Prediction Using Hybrid Feature Selection Over Multiple Intracranial EEG Electrode Contacts: A Report of Four Patients,” IEEE Transactions on Biomedical Enqineerinq, May 2003, pp. 603-615, vol. 50, No. 5.;;Ebersole, J.S., “In Search of Seizure Prediction: A Critique,” Clinical Neurophysiology, 2005, pp. 489-492, vol. 116.;;Ebersole, J.S., “Functional Neuroimaging with EEG Source Models to Localize Epileptogenic Foci Noninvasively,” Neuorology, Available at http://www.uchospitals.edu/pdf/uch.sub.--001471.pdf, Accessed Feb. 28, 2006, 3 paqes.;;Elbert, T. et al., “Chaos and Physiology: Deterministic Chaos in Excitable Cell Assemblies,” Physiological Reviews, Jan. 1994, pp. 1-47, vol. 74, No. 1.;;Elger, C. E. et al., “Nonlinear EEG Analysis and Its Potential Role in Epileptology,” Epilepsia, 2000, pp. S34-S38, vol. 41, Suppl. 3.;;Elger, C.E. et al., “Short Communication—Seizure Prediction by Non-Linear Time Series Analysis of Brain Electrical Activity,” European Journal of Neuroscience, 1998, pp. 786-789, vol. 10.;;Esteller, R. et al., “Continuous Energy Variation During the Seizure Cycle: Towards an On-Line Accumulated Enerqy,” Clinical Neurophysioloqy, Jan. 22, 2005, pp. 517-526, vol. 116.;;Esteller, R. et al., “Feature Parameter Optimization for Seizure Detection/Prediction,” IntelliMedix, Inc., [online] [Retrieved on Oct. 31, 2005] Retrieved from the Internet<U RL: htlp://66.1 02.7 .1 04/search?q=cache:4heOGuwtlacJ :icsl.m...re%2520Detection%2520Prediction.doc+intellimedix&hl=en>.;;Esteller, R. et al., “A Comparison of Waveform Fractal Dimension Algorithms,” IEEE Transactions on Circuits and Systems—1: Fundamental Theory and Applications, Feb. 2001, pp. 177-183, vol. 48, No. 2.;;Faul, S. et al., “An Evaluation of Automated Neonatal Seizure Detection Methods,” Clinical Neurophysioloqy, 2005, pp. 1533-1541, vol. 116.;;Fein, G. et al., “Common Reference Coherence Data are Confounded by Power and Phase Effects,” Electroencephalography and Clinical Neurophysiology, 1988, pp. 581-584, vol. 69, Elsevier Scientific Publishers, Ireland, Ltd.;;Fell, J. et al., “Linear Inverse Filtering Improves Spatial Separation of Nonlinear Brain Dynamics: A Simulation Study,” Journal of Neuroscience Methods, 2000, pp. 49-56, vol. 98, Elsevier.;;Firpi, H. et al., “Epileptic Seizure Detection by Means of Genetically Programmed Artifical Features,” GECCO '05, Jun. 25-29, 2005, pp. 461-466.;;Fisher, R.S. “Reassessment: Vagus Nerve Stimulation for Epilepsy,” American Academy of Neurology, 1999, [online] [Retrieved on Apr. 14, 2006] Retrieved from the Internet<URL:www.neurology.org>.;;Franaszczuk, P.J. et al., “An Autoregressive Method for the Measurement of Synchronization of Interictal and Ictal EEG Siqnals,” Bioloqical Cybernetics, 1999, pp. 3-9, vol. 81, Sprinqer-Verlaq.;;Gardner, A.B., “A Novelty Detection Approach to Seizure Analysis from Intracranial EEG,” Dissertation, Georgia Institute of Technology, Apr. 2004, pp. 1-146.;;Geva, A.B. et al., “Forecasting Generalized Epileptic Seizures from the EEG Signal by Wavelet Analysis and Dynamic Unsupervised Fuzzy Clustering,” IEEE Transactions on Biomedical Engineering, Oct. 1998, pp. 1205-1216, vol. 45, No. 10.;;Gigola, S. et al., “Prediction of Epileptic Seizures Using Accumulated Energy in a Multiresolution Framework,” Journal of Neuroscience Methods, 2004, pp. 107-111, vol. 138, Elsevier.;;Guyon, I. et al., “Multivariate Non-Linear Feature Selection with Kernel Multiplicative Updates and Gram-Schmidt Relief,” To appear in the proceedings of the BISC FLINT-CIBI 2003 workshop, Berkeley, Dec. 2003, pp. 1-11.;;Guyon, I. et al., “An Introduction to Variable and Feature Selection,” Journal of Machine Learning Research, Mar. 2003, pp. 1157-1182, vol. 3.;;Harrison, M.A. et al., “Accumulated Energy Revisited,” Clinical Neurophysiology, 2005, pp. 527-531, vol. 116, Elsevier.;;Harrison, M.A. F. et al., “Correlation Dimension and Integral do not Predict Epileptic Seizures,” Chaos, 2005, pp. 1-15, vol. 15, No. 033106, American Institute of Physics.;;Hearst, M.A., “Support Vector Machines,” IEEE Intelligent Systems, Jul./Aug. 1998, pp. 18-28.;;Hively, L.M. et al., “Detecting Dynamical Change in Nonlinear Time Series,” Physics Letters A, Jul. 19, 1999, pp. 103-114, vol. 258, Elsevier.;;Hively, L.M. et al., “Epileptic Seizure Forewarning by Nonlinear Techniques,” Oak Ridge National Laboratory, Nov. 2000, 40 pages.;;Hively, L.M. et al., “Channel-Consistent Forewarning of Epileptic Events from Scalp EEG,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 584-593, vol. 50, No. 5.;;Hjorth, B., “Source Derivation Simplifies Topographical EEG Interpretation,” Am.J. EEG Techol., 1980, pp. 121-132, vol. 20.;;Hsu, C-W. et al., “A Practical Guide to Support Vector Classification,” 2003, pp. 1-12.;;Huynh, J.A., “Evaluation of Gene Selection Using Support Vector Machine Recursive Feature Elimination,” Internship Report, May 26, 2004, pp. 1-25.;;Huynh, J., “Evaluation of Gene Selection Using Support Vector Machine Recursive Feature Elimination,” Powerpoint Presentation, 2004, 41 pages.;;Iasemidis, L.D. et al., “Modelling of EcoG in Temporal Lobe Epilepsy,” Proceedings of the 251h Rocky Mountain Bioengineering Symposium, Colorado Springs, CO, 1988, pp. 1-12.;;Iasemidis, L.D. et al., “Phase Space Topography and the Lyapunov Exponent of Electrocorticograms in Partial Seizures,” Brain Topography, Mar. 1990, pp. 187-201, vol. 2, No. 3.;;Iasemidis, L.D. et al., “Localizing Preictal Temporal Lobe Spike Foci Using Phase Space Analysis,” Abstracts of the XIIth International Congress of Electroencephalography and Clinical Neurophysiology, Rio de Janeiro, Brazil, Jan. 14-19, 1990, pp. 863-864, vol. 75, No. 1, Elsevier Scientific Publishers Ireland, Ltd.;;Iasemidis, L.D. et al., “Long-Time-Scale Temporo-Spatial Patterns of Entrainment of Preictal Electrocorticopraphic Data in Human Temporal Lobe Epilepsy,” Epilepsia, Sep./Oct. 1990, p. 621, vol. 31, No. 5.;;Iasemidis, L.D. et al., “The Evolution with Time of the Spatial Distribution of the Largest Lyapunov Exponent on the Human Epileptic Cortex,” in Mearsuring Chaos in the Human Brain, 1991, Eds. D. Duke et al., pp. 1-27.;;Iasemidis, L.D. et al., “The Use of Dynamical Analysis of EEG Frequency Content in Seizure Prediction,” Society Proceedings, American EEG Society, 1993 Annual Meeting, New Orleans, LA, Oct. 11-12, 1993, Electroencephaloqraphy and Clinical Neurophysioloqy, 1994, p. 39P, vol. 91.;;Iasemidis, L.D. et al., “Quantification of Hidden Time Dependencies in the EEG within the Framework of Nonlinear Dynamics,” in Nonlinear Dynamical Analysis of the EEG, 1993, Eds. B.H. Jansen et al., pp. 30-47.;;Iasemidis, L.D. et al., “Time Dependencies in Partial Epilpesy,” Epilepsia, Abstracts from the Annual Meetinq of the American Epileptic Society, Miami, FL, Dec. 5-8, 1993, pp. 130-131, vol. 34, Suppl. 6.;;Iasemidis, L.D. et al., “Time Dependencies in the Occurrences of Epileptic Seizures,” Epilepsy Research, 1994, pp. 81-94, vol. 17, Elsevier.;;Iasemidis, L.D. et al., “Spatiotemporal Evolution of Dynamical Measures Precedes Onset of Mesial Temporal Lobe Seizures,” Epilepsia, Abstracts from the Annual Meeting of the American Epilepsy Society, New Orleans, LA, Dec. 2-8, 1994, p. 133, vol. 35, Suppl. 8.;;Iasemidis, L.D. et al., “Spatiotemporal Dynamics of Human Epileptic Seizures,” in Proceedings of the 3rd Experimental Chaos Conference, 1996, R.G. Harrison et al. (Eds. ), pp. 26-30.;;Iasemidis, L.D. et al., “Chaos Theory and Epilepsy,” 1996, pp. 1-13.;;Iasemidis, L.D. et al., “Detection of the Preictal Transition State in Scalp-Sphenoidal EEG Recordings,” Journal of Clinical Neurophysiology, Sep. 1996, pp. 443-444, vol. 13, No. 5.;;Iasemidis, L.D. et al., “Preictal Entrainment of a Critical Cortical Mass is a Necessary Condition for Seizure Occurrence,” Epilepsia, Abstracts from the Annual Meeting of the American Epilepsy Society, San Francisco, CA, Dec. 7-10, 1996, p. 90, vol. 37, Suppl. 5.;;Iasemidis, L.D. et al., “Spatiotemporal Transition to Epileptic Seizures: A Nonlinear Dynamical Analysis of Scalp and Intracranial EEG Recordings,” Spatiotemporal Models in Biological and Artificial Systems, F.L. Silva et al. (Eds.), 1997, pp. 81-88, IOS Press.;;Iasemidis, L.D. et al., “Epileptogenic Focus Localization by Dynamic Analysis of Interictal Periods of EEG in Patients with Temporal Lobe Epilepsy,” Epilepsia, Abstracts from the Annual Meeting of the American Epilepsy Society, Boston, MA, Dec. 7-10, 1997, p. 213, vol. 38, Suppl. 8.;;Iasemidis, L.D. et al., “Preictai-Postictal Versus Postictal Analysis for Epileptogenic Focus Localization,” J. Clin. Neurophysiol., 1997, p. 144, vol. 14.;;Iasemidis, L.D. et al., “Dynamical Interaction of the Epileptogenic Focus with Extrafocal Sites in Temporal Lobe Epilepsy,” Annals of Neurology, Sep. 1997, p. 429, vol. 42, No. 3.;;Iasemidis, L.D. et al., “Automated Seizure Prediction Paradigm,” Epilepsia, Abstracts from the Annual Meeting of the American Epilepsy Society, San Diego, CA, Dec. 6-9, 1998, p. 207, vol. 39, Suppl. 6.;;Iasemidis, L.D. et al., “Measurement and Quantification of Spatia-Temporal Dynamics of Human Epileptic Seizures,” in Nonlinear Signal Processing in Medicine, M. Akay (Ed.), 1999, pp. 1-27, IEEE Press.;;Iasemidis, L.D. et al., “Quadratic Binary Programming and Dynamical System Approach to Determine the Predictability of Epileptic Seizures,” Journal of Combinatorial Optimization, 2001, pp. 9-26, vol. 5, Kluwer Academic Publishers, Netherlands.;;Iasemidis, L.D., “Epileptic Seizure Prediction and Control,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 549-558, vol. 50, No. 5.;;Iasemidis, L.D. et al., “Adaptive Epileptic Seizure Prediction System,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 616-627, vol. 50, No. 5.;;Iasemidis, L.D. et al., “Comment on Inability of Lyapunov Exponents to Predict Epileptic Seizures,” Physical Review Letters, Jan. 14, 2005, 1 paqe, PRL 94, 019801.;;Iasemidis, L.D. et al., “Long-Term Prospective On-Line Real-Time Seizure Prediction,” Clinical Neurphysiology, 2005, pp. 532-544, vol. 116.;;Jerger, K.K. et al., “Early Seizure Detection,” Journal of Clinical Neurphysiology, 2001, pp. 259-268, vol. 18, No. 3.;;Jerger, K.K. et al., “Multivariate Linear Discrimination of Seizures,” Clinical Neurophysiology, 2005, pp. 545-551, vol. 116.;;Jouny, C. C. et al., “Characterization of Epileptic Seizure Dynamics Using Gabor Atom Density,” Clinical Neurophysioloqy, 2003, pp. 426-437, vol. 114.;;Jouny, C.C. et al., “Signal Complexity and Synchrony of Epileptic Seizures: Is There an Identifiable Preictal Period?” Clinical Neurophysiology, 2005, pp. 552-558, vol. 116.;;Kapiris, P.G. et al., “Similarities in Precursory Features in Seismic Shocks and Epileptic Seizures,” Europhysics Letters, Feb. 15, 2005, pp. 657-663, vol. 69, No. 4.;;Katz, A. et al., “Does Interictal Spiking Change Prior to Seizures?” Electroencephalography and Clinical Neurophysiology, 1991, pp. 153-156, vol. 79, Elsevier Scientific Publishers Ireland Ltd.;;Kerem, D.H. et al., “Forecasting Epilepsy from the Heart Rate Signal,” Medical & Biological Engineering & Computing, 2005, pp. 230-239, vol. 43.;;Khalilov, I. et al. “Epilptogenic Actions of GABA and Fast Oscillations in the Developing Hippocampus,” Neuron, Dec. 8, 2005, pp. 787-796, vol. 48, Elsevier Inc.;;Korn, H. et al., “Is there Chaos in the Brain? II. Experimental Evidence and Related Models,” C.R. Biologies, 2003, pp. 787-840, vol. 326.;;Kraskov, A., “Synchronization and Interdependence Measures and their Applications to the Electroencephalogram of Epilepsy Patients and Clustering of Data,” Dissertation (PhD Thesis), Publication Series of the John von Neumann Institute for Computing (NIC), NIC Series, Feb. 2004, 106 pages, vol. 24.;;Kreuz, T. et al., “Measure Profile Surrogates: A Method to Validate the Performance of Epileptic Seizure Prediction Algorithms,” Jun. 15, 2004, Physical Review, pp. 1-9, vol. 69, No. 061915.;;Lachaux, J-P. et al., “Measuring Phase Synchrony in Brain Signals,” Human Brain Mapping, 1999, pp. 194-208, vol. 8.;;Lai, Y-C. et al., “Inability of Lyapunov Exponents to Predict Epileptic Seizures,” Physical Review Letters, Aug. 8, 2003, pp. 1-4, vol. 91, No. 6.;;Lai, Y-C. et al., “Controlled Test for Predictive Power of Lyapunov Exponents: Their Inability to Predict Epileptic Seizures,” Chaos, Sep. 2004, pp. 630-642, vol. 14, No. 3.;;Laroche, S.M. et al., “The New Antiepileptic Drugs,” Scientific Review, JAMA, Feb. 4, 2004, pp. 605-614, vol. 291, No. 5.;;Latka, M. et al., “Wavelet Analysis of Epileptic Spikes,” Dec. 22, 2002, pp. 1-6.;;Levan Quyen, M., “Anticipating Epileptic Seizures: From Mathematics to Clinical Applications,” C.R. Biologies, 2004, pp. 1-12.;;Levan Quyen, M. et al., “Pre ictal State Identification by Synchronization Changes in Long-Term Intracranial EEG Recordings,” Clinical Neurophysioloqy, 2005, pp. 559-568, vol. 116.;;Levan Quyen, M. et al., “Nonlinear Analyses of Interictal EEG Map the Brain Interdependences in Human Focal Epilepsy,” Physica D, 1999, pp. 250-266, vol. 127, Elsevier.;;Levan Quyen, M. et al., “Anticipating Epileptic Seizures in Real Time by a Non-Linear Analysis of Similarity Between EEG Recordinqs,” NeuroReport, Jul. 13, 1999, pp. 2149-2155, vol. 10, No. 10.;;Levan Quyen, M. et al., “Comparison of Hilbert Transform and Wavelet Methods for the Analysis of Neuronal Synchrony,” Journal of Neuroscience Methods, 2001, pp. 83-98, vol. 111, Elsevier.;;Levan Quyen, M. et al., “Authors' Second Reply,” Correspondence, The Lancet, Mar. 15, 2003, p. 971, vol. 361.;;Lehnertz, K. et al., “The First International Collaborative Workshop on Seizure Prediction: Summary and Data Description,” Clinical Neurophysiology, 2005, pp. 493-505, vol. 116, Elsevier.;;Lehnertz, K., “Non-Linear Time Series Analysis of Intracranial EEG Recordings in Patients with Epilepsy—An Overview,” International Journal of Psychophysiology, 1999, pp. 45-52, vol. 34, Elsevier.;;Lehnertz, K. et al., “Nonlinear EEG Analysis in Epilepsy: Its Possible Use for Interictal Focus Localization, Seizure Anticipation, and Prevention,” Journal of Clinical Neurophysiology, 2001, pp. 209-222, vol. 18, No. 3.;;Lehnertz, K. et al., “Seizure Prediction by Nonlinear EEG Analysis,” IEEE Engineering in Medicine and Biology Magazine, Jan./Feb. 2003, pp. 57-63.;;Lemos, M.S. et al., “The Weighted Average Reference Montage,” Electroencephalography and Clinical Neurophysiology, 1991, pp. 361-370, vol. 79, Elsevier Scientific Publishers Ireland, Ltd.;;Li, D. et al., “Non-Linear, Non-Invasive Method for Seizure Anticipation in Focal Epilepsy,” Mathematical Biosciences, 2003, pp. 63-77, vol. 186, Elsevier.;;Li, D. et al, “Linear and Nonlinear Measures and Seizure Anticipation in Temporal Lobe Epilepsy,” Journal of Computational Neuroscience, 2003, pp. 335-345, vol. 15, Kluwer Academic Publishers, Netherlands.;;Li, X. et al, “Fractal Spectral Analysis of Pre-Epileptic Seizures in Terms of Criticality,” Journal of Neural Engineering, Mar. 8, 2005, pp. 11-16, vol. 2.;;Litt, B. et al., “Prediction of Epileptic Seizures,” Neurology, The Lancet, May 2002, pp. 22-30, vol. 1, No. 1.;;Litt, B. et al., “Seizure Prediction and the Preseizure Period,” Current Opinion in Neurology, 2002 pp. 173-177, vol. 15.;;Maiwald, T. et al., “Comparison of Three Nonlinear Seizure Prediction Methods by Means of the Seizure Prediction Characteristic,” Physica D, 2004, pp. 357-368, vol. 194.;;Mangasarian, O.L. et al., “Lagrangian Support Vector Machines,” Mar. 9, 2006, pp. 1-22.;;Martinerie, J. et al., “Epileptic Seizures can be Anticipated by Non-Linear Analysis,” Nature Medicine, Oct. 1998, pp. 1173-1176, vol. 4, No. 10.;;Mcsharry, P.E., “Detection of Dynamical Transitions in Biomedical Signals Using Nonlinear Methods,” in Knowledge-Based Intelligent Information and Engineering Systems, 2004, pp. 483-490.;;Mcsharry, P.E. et al., “Linear and Non-Linear Methods for Automatic Seizure Detection in Scalp Electro-Encephalogram Recordings,” Medical & Biological Engineering & Computing. 2002, pp. 447-461, vol. 40.;;Mcsharry, P.E. et al., “Comparison of Predictability of Epileptic Seizures by a Linear and a Nonlinear Method,” IEEE Transactions on Biomedical Engineering, May 2003, pp. 628-633, vol. 50, No. 5.;;Meng, L. et al., “Gaussian Mixture Models of EcoG Signal Features for Improved Detection of Epileptic Seizures,” Medical Engineering & Physics, 2004, pp. 379-393, vol. 26, Elsevier.;;Mizuno-Matsumoto, Y. et al., “Wavelet-Crosscorrelation Analysis Can Help Predict Whether Bursts of Pulse Stimulation Will Terminate Afterdischarges,” Clinical Neurophysiology, 2002, pp. 33-42, No. 113, Elsevier.;;Mormann, F. et al., “Automated Detection of a Preseizure State Based on a Decrease in Synchronization in Intracranial Electroencephalogram Recordings from Epilepsy Patients,” Physical Review, Feb. 26, 2003, vol. 67, No. 021912, The American Physical Society.;;Mormann, F. et al., “Epileptic Seizures are Preceded by a Decrease in Synchronization,” Epilepsy Research, 2003, pp. 173-185, vol. 53.;;Mormann, F. et al., “On the Predictability of Epileptic Seizures,” Clinical Neurophysiology, 2005, pp. 569-587, vol. 116, Elsevier.;;Mormann, F. et al., “Seizure Anticipation: From Algorithms to Clinical Practice,” Current Opinion in Neurology, 2006, pp. 187-193, vol. 19, Lippincott Williams & Wilkins.;;Mormann, F. et al., “Seizure Prediction: The Long and Winding Road,” Brain, 2007, pp. 314-333, vol. 130.;;Mormann, F. et al., “Mean Phase Coherence as a Measure for Phase Synchronization and its Application to the EEG of Epilepsy Patients,” Physica D, 2000, pp. 358-369, vol. 144, Elsevier.;;Navarro, V. et al., “Seizure Anticipation in Human Neocortical Partial Epilepsy,” Brain, 2002, pp. 640-655, vol. 125.;;Navarro, V. et al., “Seizure Anticipation: Do Mathematical Measures Correlate with Video-EEG Evaluation?” Epilepsia, 2005, pp. 385-396, vol. 46, No. 3.;;Niederhauser, J.J. et al., “Detection of Seizure Precursors from Depth-EEG Using a Sign Periodogram Transform,” IEEE Transactions on Biomedical Engineering, Apr. 2003, pp. 449-458, vol. 51, No. 4.;;Nigam, V. et al., “A Neural-Network-Based Detection of Epilepsy,” Neurological Research, Jan. 2004, pp. 55-60, vol. 26.;;Ochoa, J.G. et al., “Antiepileptic Drugs: An Overview,” eMedicine.com, WebMD, updated Sep. 26, 2006, 26 pages.;;Osorio, I. et al., “Real-Time Automated Detection and Quantitative Analysis of Seizures and Short-Term Prediction of Clinical Onset,” Epilepsia, 1998, pp. 615-627, vol. 39, No. 6.;;Osorio, I. et al., “Performance Reassessment of a Real-Time Seizure-Detection Algorithm on Long ECoG Series,” Epilepsia, 2002, pp. 1522-1535, vol. 43, No. 12.;;Osorio, I. et al., “Automated Seizure Abatement in Humans Using Electrical Stimulation,” Ann. Neural., 2005, pp. 258-268, vol. 57, Wiley-Liss, Inc.;;Ossadtchi, A. et al., “Hidden Markov Modelling of Spike Propagation from Interictal MEG Data,” Physics in Medicine and Biology, Jul. 6, 2005, pp. 3447-3469, vol. 50, Institute of Physis Publishing. et al.",ACTIVE
12,US,B2,US 10448839 B2,173-866-890-170-467,2019-10-22,2019,US 201213453746 A,2012-04-23,US 201213453746 A,2012-04-23,"Methods, systems and apparatuses for detecting increased risk of sudden death","Methods, systems, and apparatuses for detecting seizure events are disclosed, including a system for identification of an increased risk of a severe neurological event. The system may include an electroencephalogram (“EEG”) monitoring unit configured to collect EEG data from the patient during at least a postictal phase of one or more seizures and a processing unit configured to receive the EEG data from the EEG monitoring unit. The processing unit is configured to detect postictal EEG suppression from the EEG data and to identify the increased risk of the severe neurological event based on the detected postictal EEG suppression. Other embodiments are described and claimed.",SABESAN SHIVKUMAR;;LIVANOVA USA INC,SABESAN SHIVKUMAR,LIVANOVA USA INC (2012-04-23),https://lens.org/173-866-890-170-467,Granted Patent,yes,647,11,7,173-866-890-170-467;;172-252-762-979-488;;000-292-687-086-32X;;090-456-005-994-738;;128-542-947-899-134;;182-123-764-482-83X;;089-823-907-820-194,WO;;EP;;US,7,173-866-890-170-467;;172-252-762-979-488;;000-292-687-086-32X;;090-456-005-994-738;;128-542-947-899-134;;182-123-764-482-83X;;089-823-907-820-194,WO;;EP;;US,0,A61B5/0205;;A61B5/0816;;A61B5/1112;;A61B5/318;;A61B5/369;;A61B5/4094;;A61B5/7275;;A61B5/746;;A61B5/7465;;A61B2505/07;;G16H20/17;;G16H20/30;;G16H40/63;;G16H40/67;;G16H50/20;;A61B5/0205;;A61B5/0816;;A61B5/1112;;A61B5/33;;A61B5/372;;A61B5/4094;;A61B5/7275;;A61B5/746;;A61B5/7465;;A61B2505/07;;G16H20/17;;G16H20/30;;G16H40/63;;G16H40/67;;G16H50/20,A61B5/0476;;A61B5/00;;A61B5/0205;;A61B5/0402;;A61B5/08;;A61B5/11;;G16H20/17;;G16H20/30;;G16H40/63;;G16H40/67;;G16H50/20,,62,53,024-182-122-298-089;;033-503-915-578-321;;054-868-494-791-055;;019-411-892-837-769;;115-741-015-188-295;;052-630-116-618-842;;037-772-810-641-647;;145-702-660-075-441;;054-630-468-158-977;;018-561-710-123-368;;015-943-288-841-720;;022-966-379-058-403;;048-642-493-280-14X;;046-397-703-096-430;;019-308-872-975-51X;;002-403-074-135-442;;112-897-527-124-30X;;005-812-068-829-241;;032-751-441-147-285;;046-621-728-923-715;;056-177-900-384-501;;098-586-850-446-33X;;066-328-676-515-762;;018-202-351-494-006;;097-426-806-139-480;;072-028-517-836-043;;091-962-532-331-31X;;103-040-249-541-832;;016-207-089-756-778;;050-957-455-833-565;;011-498-617-423-119;;030-501-930-582-312;;013-993-295-891-841;;026-864-965-141-523;;019-773-125-379-283;;014-724-861-390-592;;015-820-060-894-869;;038-128-501-814-320;;112-318-944-745-749;;088-853-742-205-302;;003-290-790-587-579;;026-435-299-569-935;;047-345-017-295-263;;139-831-627-763-342;;024-644-707-340-274;;023-093-432-161-773;;079-757-926-093-134;;025-424-076-138-599;;035-904-149-105-698;;029-700-863-111-313;;029-031-434-346-661;;050-834-747-411-399;;039-387-741-041-999,10.1161/01.cir.93.5.1043;;8598068;;10.1016/0006-8993(77)90274-8;;406970;;10.1023/a:1014866501535;;17446414;;10.1152/japplphysiol.00137.2007;;11709644;;10.1097/00004691-200109000-00003;;11974997;;10.1007/978-3-7091-6105-0_21;;10839541;;10.1038/35013070;;15109218;;10.1113/expphysiol.2003.002654;;17565508;;10.1142/s0129065707000993;;9774527;;10.1006/nlme.1998.3863;;10.1016/j.clinph.2003.12.016;;15066542;;16828317;;10.1016/j.seizure.2006.03.005;;10.1046/j.1528-1157.2001.0420081007.x;;11554886;;10.1016/s0006-3223(99)00308-x;;10686263;;10.1016/0006-8993(77)90275-x;;195672;;10.1212/wnl.59.6_suppl_4.s3;;12270962;;10.1109/tbme.2003.821013;;15000380;;12769431;;10.1109/tbme.2003.810705;;9684488;;10.1016/j.seizure.2007.11.004;;18096413;;11709649;;10.1097/00004691-200109000-00008;;9178333;;10.1097/00006842-199705000-00004;;10.1046/j.1528-1157.2003.34702.x;;12614390;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;19047522;;10.1001/archpsyc.65.12.1358;;2226362;;10.1111/j.1528-1157.1990.tb05844.x;;10.1088/2058-7058/15/7/27;;10.1103/physrevlett.88.218101;;12059504;;17008335;;10.1093/brain/awl241;;10.1017/s0012162205000022;;15686283;;10.1097/00004691-200111000-00003;;11779966;;15668970;;10.1002/ana.20377;;10.1016/j.yebeh.2010.05.002;;20541980;;16051017;;10.1016/j.surneu.2004.11.026;;10.1007/s11062-006-0027-9;;10.1016/s0140-6736(04)17594-6;;15610808;;10.1016/j.ehj.2003.12.003;;15033247;;10413832;;11684042;;10.1016/s0006-8993(01)02928-6;;1705341;;10.1111/j.1540-8159.1991.tb04052.x;;10.1007/s00381-004-0947-x;;15083332;;10.1016/s0735-1097(97)00554-8;;9502641;;11709643;;10.1097/00004691-200109000-00002;;16162428;;10.1111/j.1540-8159.1991.tb04053.x;;1705342;;10.1007/bf00928176;;4338867;;10.1111/j.1528-1157.1992.tb01751.x;;1464256;;2903494;;10.1111/j.1600-0773.1988.tb00913.x;;10.1046/j.1528-1157.2002.37801.x;;12181003;;10.1002/ana.22101;;20882604;;10.1111/j.1528-1167.2012.03443.x;;22432911;;10.1111/j.1528-1157.2000.tb00128.x;;11077466,"“Heart rate variability: Standards of measurement, physiological interpretation and clinical use”, Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, Circulation, Mar. 1993, vol. 93, No. 5, pp. 1043-1065.;;Bachman, D. et al., “Effects of Vagal Volleys and Serotonin on Units of Cingulate Cortex in Monkeys”, Brain Research, vol. 130, 1977, pp. 253-269.;;Baevskii, R., “Analysis of Heart Rate Variability in Space Medicine”, Human Physiology, vol. 28, No. 2, 2002, pp. 202-213.;;Baevsky, R., “Autonomic cardiovascular and respiratory control during prolonged spaceflights aboard the International Space Station”, Journal of Applied Physiological, vol. 103, 2007, pp. 156-161.;;Boon, P. et al., “Programmed and Magnet-Induced Vagus Nerve Stimulation for Refractory Epilepsy”, Journal of Clinical Neurophysiology, vol. 18, No. 5, 2001, p. 402-407.;;Boon, P. et al., “Vagus Nerve Stimulation for Epilepsy, Clinical Efficacy of Programmed and Magnet Stimulation”, Acta Neurochirurgica Supplement, vol. 79, 2002, pp. 93-98.;;Borovikova, L. et al., “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin”, Letters to Nature, vol. 405, May 2000, pp. 458-462.;;Brack, K. et al., “Interaction Between Direct Sympathetic and Vagus Nerve Stimulation on Heart Rate in the Isolated Rabbit Heart”, Experimental Physiology, vol. 89, No. 1, 2004, pp. 128-139.;;Chakravarthy, N. et al., “Controlling Synchronization in a Neuron-Level Population Model”, International Journal of Neural Systems, vol. 17, No. 2, 2007, pp. 123-138.;;Clark, K. et al., “Posttraining Electrical Stimulation of Vagal Afferents with Concomitant Vagal Efferent Inactivation Enhances Memory Storage Processes in the Rat”, Neurobiology of Learning and Memory, vol. 70, Article No. NL983863, 1998, pp. 364-373.;;Digenarro, G. et al., “Ictal Heart rate Increase Precedes EEG Discharge in Drug-Resistant Mesial Temporal Lobe Seizures”, Clinical Neurophysiology, vol. 115, No. 5, May 2004, pp. 1169-1177.;;Van Elmpt, W. et al., “A Model of Heart Rate Changes to Detect Seizures in Severe Epilepsy”, Seizure, vol. 15, 2006, pp. 366-375.;;Frei, M. et al., “Left Vagus Nerve Stimulation with the Neurocybernetic Prosthesis has Complex Effects on Heart Rate and on its Variability in Humans”, Epilepsia, vol. 42, No. 8, 2001, pp. 1007-1016.;;George, M. et al., “Vagus Nerve Stimulation: A New Tool for Brain Research and Therapy”, Society of Biological Psychiatry, vol. 47, 2000, pp. 287-295.;;Hallowitz, R. et al., “Effects of Vagal Volleys on Units of Intralaminar and Juxtalaminar Thalamic Nuclei in Monkeys”, Brain Research, vol. 130, No. 2, Jul. 1977, pp. 271-286.;;Henry, T., “Therapeutic Mechanisms of Vague Name Stimulation”, Neurology, vol. 59 (Supp. 4), Sep. 2002, pp. S3-S14.;;Iasemidis, L. et al., “Dynamical Resetting of the Human Brain at Epileptic: Application of Nonlinear Dynamics and Global Optimization Techniques”, IEEE Transactions on Biomedical Engineering, vol. 51, No. 3, Mar. 2004, pp. 493-508.;;Iasemidis, L. et al., “Spatiotemporal Transition to Epileptic Seizures: A Nonlinear Dynamical Analysis of Scalp and Intracranial EEG Recordings”, Spatiotemporal Models in Biological and Artificial Systems, IOS Press, 1997, pp. 81-88.;;Iasemidis, L., “Epileptic Seizure Prediction and Control”, IEEE Transactions on Biomedical Engineering, vol. 50, No. 5, May 2003, pp. 549-558.;;Kautzner, J. et al., “Utility of Short-Term Heart Rate Variability for Prediction of Sudden Cardiac Death After Acute Myocardial Infarction”, Acta Univ Palacki Olomuc Fac Med., vol. 141, 1998, pp. 69-73.;;Koenig, S. et al., “Vagus Nerve Stimulation Improves Severely Impaired Heart Rate Variability in a Patient with Lennox-Gastaut-Syndrome”, Seizure, vol. 17, Issue 5, Jul. 2008, pp. 469-472.;;Koo, B., “EEG Changes with Vagus Nerve Stimulation”, Journal of Clinical Neurophysiology, vol. 18, No. 5, Sep. 2001, pp. 434-441.;;Krittayaphong, M. et al., “Heart Rate Variability in Patients with Coronary Artery Disease: Differences in Patients with Higher and Lower Depression Scores”, Psychosomatic Medicine, vol. 59, 1997, pp. 231-235.;;Leutmezer, F. et al., “Electrocardiographic Changes at the Onset of Epileptic Seizures”, Epilepsia, vol. 44, No. 3, 2003, pp. 348-354.;;Lewis, M. et al., “Vagus Nerve Stimulation Decreases Left Ventricular Contractility in Vivo in the Human and Pig Heart”, The Journal of Physiology, vol. 534, No. 2, 2001, pp. 547-552.;;Li, M. et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats”, Circulation, Jan. 2004, vol. 109, No. 1, pp. 120-124.;;Licht, C., “Association Between Major Depressive Disorder and Heart Rate Variability in the Netherlands Study of Depression and Anxiety (NESDA)”, Arch. Gen. Psychiatry, vol. 65, No. 12, Dec. 2008, pp. 1358-1367.;;Lockard, J. et al., “Feasibility and safety of vagal stimulation in monkey model”, Epilepsia, vol. 31 (Supp. 2), 1990, pp. S20-S26.;;Long, T. et al., “Effectiveness of Heart Rate Seizure Detection Compared to EEG in an Epilepsy Monitoring Unit (EMU)”, Abstract of AES Proceedings, Epilepsia, vol. 40, Supplement 7, 1999, p. 174.;;McClintock, P., “Can Noise Actually Boost Brain Power”, Physics World, Jul. 2002, vol. 15, pp. 20-21.;;Mori, T. et al., “Noise-Induced Entrainment and Stochastic Resonance in Human Brain Waves”, Physical Review Letters, vol. 88, No. 21, 2002, pp. 218101-1-2180101-4.;;Mormann, F. et al., “Seizure Prediction: The Long and Winding Road”, Brain, vol. 130, 2007, pp. 314-333.;;Nouri, M., “Epilepsy and the Autonomic Nervous System”, emedicine, Updated May 5, 2006, http://www.emedicine.com/neuro/toplo658.htm, pp. 1-14.;;O'Donovan, C. et al., “Computerized Seizure Detection Based on Heart Rate Changes”, Abstract of AES Proceedings, Epilepsia, vol. 36, Supplement 4, 1995, p. 7.;;O'Regan, M. et al., “Abnormalities in Cardiac and Respiratory Function Observed During Seizures in Childhood”, Developmental Medicine & Child Neurology, vol. 47, 2005, pp. 4-9.;;Osorio, I. et al., “An Introduction to Contingent (Closed-Loop) Brain Electrical Stimulation for Seizure Blockage, to Ultra-Short-Term Clinical Trials, and to Multidimensional Statistical Analysis of Therapeutic Efficacy”, Journal of Clinical Neurophysiology, vol. 18, No. 6, 2001, pp. 533-544.;;Osorio, I. et al., “Automated Seizure Abatement in Humans Using Electrical Stimulation”, Annals of Neurology, vol. 57, No. 2, 2005, pp. 258-268.;;Osorio, I. et al., “Toward a Quantitative Multivariate Analysis of the Efficacy of Antiseizure Therapies”, Epilepsy & Behavior, vol. 18, No. 4, Aug. 2010, Academic Press, San Diego, CA, pp. 335-343.;;Pathwardhan, R. et al., “Control of Refractory Status Epilepticus Precipitated by Anticonvulsant Withdrawal Using Vagal Nerve Stimulation: A Case Report”, Surgical Neurology, Issue 64, Aug. 2005, pp. 170-173.;;PCT Search Report and Written Opinion for International application No. PCT/US2011/054287, dated Mar. 12, 2012, 18 pages.;;PCT Search Report and Written Opinion for International Application No. PCT/US2012/027639, dated Oct. 4, 2012, 22 pages.;;Poddubnaya, E., “Complex Estimation of Adaption Abilities of the Organism in Children Using the Indices of Responsiveness of the Cardiovascular System and Characteristics of EEG”, Neurophysiology, vol. 38, No. 1, 2006, pp. 63-74.;;Robinson, S. et al., “Heart Rate Variability Changes as Predictor of Response to Vagal Nerve Stimulation Therapy for Epilepsy”, Abstract of AES Proceedings, Epilepsia, vol. 40, Supplement 7, 1999, p. 147.;;Rugg-Gunn, F. et al., “Cardiac Arrhythmias in Focal Epilepsy: a Prospective Long-Term Study”, Lancet, vol. 364, Dec. 2004, pp. 2212-2219.;;Sajadieh, A. et al., “Increased Heart Rate and Reduced Heart-rate Variability and Associated with Subclinical Inflammation in Middle-Aged and Elderly Subjects with No Apparent Heart Disease”, European Heart Journal, vol. 25, 2004, pp. 363-370.;;Schernthaner, C. et al., “Autonomic Epilepsy—The Influence of Epileptic Discharges on Heart Rate and Rhythm”, The Middle European Journal of Medicine, vol. 111, No. 10, 1999, pp. 392-401.;;Sunderam, S. et al., “Vagal and Sciatic Nerve Stimulation Have Complex, Time-Dependent Effects on Chemically-Induced Seizures: A Controlled Study”, Brain Research, vol. 918, 2001, pp. 60-66.;;Terry, R. et al., “The Implantable Neurocybernetic Prosthesis System”, Pacing and Clinical Electrophysiology, vol. 14, No. 1, Jan. 1991, pp. 86-93.;;Tubbs, R. et al., “Left-Sided Vagus Nerve Stimulation Decreases Intracranial Pressure Without Resultant Bradycardia in the Pig: A Potential Therapeutic Modality for Humans”, Child's Nervous System, vol. 20, No. 5, May 2004, pp. 309-312.;;Umetani, M. et al., “Twenty-Four Hour Time Domain Heart Rate Variability and Heart Rate: Relations to Age and Gender Over Nine Decades”, JACC, vol. 31, No. 3, Mar. 1998, pp. 593-601.;;Vonck, K. et al., “The Mechanism of Action of Vagus Nerve Stimulation for Refractory Epilepsy—The Current Status”, Journal of Neurophysiology, vol. 18, No. 5, 2001, pp. 394-401.;;Weil, S. et al., “Heart Rate Increase in Otherwise Subclinical Seizures is Different in Temporal Versus Extratemporal Seizure Onset: Support for Temporal Lobe Automatic Influence”, Epileptic Disord., vol. 7, No. 3, Sep. 2005, pp. 199-204.;;Woodbury, J. et al., “Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording”, Pacing and Clinical Electrophysiology, vol. 14, Jan. 1991, pp. 94-107.;;Zabara, J. et al., “Neuroinhibition in the regulation of emesis”, Space Life Sciences, vol. 3, Issue 3, Jun. 1972, pp. 282-292.;;Zabara, J., “Inhibition of Experimental Seizures in Canines by Repetitive Vagal Stimulation”, Epilepsia, vol. 33, No. 6, 1992, pp. 1005-1012.;;Zabara, J., “Neural Control of Circulation I”, The Physiologist, vol. 28, No. 4, Aug. 1985, pp. 273-277.;;Zabara, J., “Neuroinhibition of Xylaine Induced Emesis”, Pharmacology & Toxicology, vol. 63, Aug. 1988, pp. 70-74.;;Zijlmans, M. et al., “Heart Rate Changes and ECG Abnormalities During Epileptic Seizures: Prevalence and Definition of an Objective Clinical Sign”, Epilepsia, vol. 43, No. 8, 2002, pp. 847-854.;;International Search Report and Written Opinion for PCT Patent Application No. PCT/US2013/037703, dated Aug. 23 2013, 12 pages.;;Lhatoo, Samden, D. et al, “An Electroclinical Case-Control Study of Sudden Unexpected Death in Epilepsy,” Annals of Neurology, 68(6): 787-796, Dec. 29, 2010.;;Seyal et al., “Postictal Generalized EEG Suppression Is Linked to Seizure-Associated Respiratory Dysfunction But Not Postictal Apnea,” Epilepsia, 53(5): 825-831, Mar. 20, 2012.;;So, et al., “Postical Central Apnea As a Cause of SUDEP: Evidence From Near-SUDEP Incident,” Epilepsia, 41(11): 1494-1497, Nov. 1, 2000.",ACTIVE
13,WO,A1,WO 2023/038959 A1,071-844-336-054-607,2023-03-16,2023,US 2022/0042739 W,2022-09-07,US 202117471644 A,2021-09-10,AUTOMATIC GAIN CONTROL ALGORITHM FOR HEARTBEAT DETECTION,"An implantable medical device comprises a control circuit and a memory. The memory is operably coupled to the control circuit. The memory comprises instructions that, when executed by the control circuit, cause the control circuit to monitor an output of at least one comparator, the output of the at least one comparator being responsive to a cardiac signal of a patient. The instructions further cause the control circuit to automatically adjust a gain level applied to the cardiac signal over time based on the monitored output of the at least one comparator.",LIVANOVA USA INC,ADKINS ROBERT ALAN,,https://lens.org/071-844-336-054-607,Patent Application,yes,4,0,3,013-307-185-237-125;;071-844-336-054-607;;066-518-783-029-61X,WO;;EP;;US,3,013-307-185-237-125;;071-844-336-054-607;;066-518-783-029-61X,WO;;EP;;US,0,A61B5/0031;;A61B5/349;;A61B5/0245;;A61N1/025;;A61N1/36139,A61B5/00;;A61B5/0245;;A61B5/349,,0,0,,,,PENDING
14,US,A1,US 2023/0085110 A1,013-307-185-237-125,2023-03-16,2023,US 202117471644 A,2021-09-10,US 202117471644 A,2021-09-10,AUTOMATIC GAIN CONTROL ALGORITHM FOR HEARTBEAT DETECTION,"An implantable medical device comprises a control circuit and a memory. The memory is operably coupled to the control circuit. The memory comprises instructions that, when executed by the control circuit, cause the control circuit to monitor an output of at least one comparator, the output of the at least one comparator being responsive to a cardiac signal of a patient. The instructions further cause the control circuit to automatically adjust a gain level applied to the cardiac signal over time based on the monitored output of the at least one comparator.",LIVANOVA USA INC,ADKINS ROBERT ALAN,LIVANOVA USA INC (2022-04-06),https://lens.org/013-307-185-237-125,Patent Application,yes,4,0,3,013-307-185-237-125;;071-844-336-054-607;;066-518-783-029-61X,WO;;EP;;US,3,013-307-185-237-125;;071-844-336-054-607;;066-518-783-029-61X,WO;;EP;;US,0,A61B5/0031;;A61B5/349;;A61B5/0245;;A61N1/025;;A61N1/36139,A61N1/36;;A61N1/02,,0,0,,,,PENDING
15,US,A1,US 2019/0290901 A1,027-563-034-650-319,2019-09-26,2019,US 201916258214 A,2019-01-25,US 201916258214 A;;US 201113314119 A,2011-12-07,IMPLANTABLE DEVICE FOR PROVIDING ELECTRICAL STIMULATION OF CERVICAL VAGUS NERVES FOR TREATMENT OF CHRONIC CARDIAC DYSFUNCTION,"An implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction is provided. A stimulation therapy lead includes helical electrodes configured to conform to an outer diameter of a cervical vagus nerve sheath, and a set of connector pins electrically connected to the helical electrodes. A neurostimulator includes an electrical receptacle into which the connector pins are securely and electrically coupled. The neurostimulator also includes a pulse generator configured to therapeutically stimulate the vagus nerve through the helical electrodes in alternating cycles of stimuli application and stimuli inhibition that are tuned to both efferently activate the heart's intrinsic nervous system and afferently activate the patient's central reflexes by triggering bi-directional action potentials.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,,https://lens.org/027-563-034-650-319,Patent Application,yes,0,1,5,137-316-579-880-544;;027-563-034-650-319;;151-053-197-476-322;;151-255-709-204-255;;094-866-711-193-126,US,5,137-316-579-880-544;;027-563-034-650-319;;151-053-197-476-322;;151-255-709-204-255;;094-866-711-193-126,US,0,A61N1/0556;;A61N1/36053;;A61N1/36057;;A61N1/36114;;A61N1/36175;;A61N1/0556;;A61N1/36053;;A61N1/36057;;A61N1/36114;;A61N1/36175,A61N1/05;;A61N1/36,,0,0,,,,ACTIVE
16,US,B2,US 11013914 B2,137-316-579-880-544,2021-05-25,2021,US 201916258214 A,2019-01-25,US 201916258214 A;;US 201113314119 A,2011-12-07,Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction,"An implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction is provided. A stimulation therapy lead includes helical electrodes configured to conform to an outer diameter of a cervical vagus nerve sheath, and a set of connector pins electrically connected to the helical electrodes. A neurostimulator includes an electrical receptacle into which the connector pins are securely and electrically coupled. The neurostimulator also includes a pulse generator configured to therapeutically stimulate the vagus nerve through the helical electrodes in alternating cycles of stimuli application and stimuli inhibition that are tuned to both efferently activate the heart's intrinsic nervous system and afferently activate the patient's central reflexes by triggering bi-directional action potentials.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,,https://lens.org/137-316-579-880-544,Granted Patent,yes,237,3,5,137-316-579-880-544;;027-563-034-650-319;;151-053-197-476-322;;151-255-709-204-255;;094-866-711-193-126,US,5,137-316-579-880-544;;027-563-034-650-319;;151-053-197-476-322;;151-255-709-204-255;;094-866-711-193-126,US,0,A61N1/0556;;A61N1/36053;;A61N1/36057;;A61N1/36114;;A61N1/36175;;A61N1/0556;;A61N1/36053;;A61N1/36057;;A61N1/36114;;A61N1/36175,A61N1/05;;A61N1/36,,262,221,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;117-723-850-131-683;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;004-811-708-971-908;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10.1016/j.cardfail.2011.06.184;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;16387796;;10.1124/mol.105.020701;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning a new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., “Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure,” European Heart Journal, vol. 32, iss. 7, pp. 847-855 (Apr. 2011). Online publication date: Oct. 28, 2010. Available at: http://eurheartj.oxfordjournals.org/content/32/7/847.long.;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;European Office Action on Patent Application No. 12809005.7 dated Aug. 20, 2015. 7 pages.;;European Office Action on Patent Application No. 12809005.7 dated Feb. 7, 2018. 7 pages.;;European Office Action on Patent Application No. 12809005.7 dated Jan. 29, 2016. 7 pages.;;European Office Action on Patent Application No. 12809005.7 dated Jun. 2, 2017. 7 pages.;;European Office Action on Patent Application No. 12809005.7 dated Oct. 5, 2016. 7 pages.;;European Office Action on Patent Application No. 12809006.5 dated Mar. 16, 2017. 4 pages.;;European Search Report on Patent Application No. 16168072.3 dated Aug. 8, 2016. 5 pages.;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(1), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrioventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul lntegr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998). Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetid Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003. Available at: http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=14662714.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after 1 acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Presentation Abstract—Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm (2012). et al.",ACTIVE
17,US,B2,US 11129992 B2,125-572-218-104-66X,2021-09-28,2021,US 201815922863 A,2018-03-15,US 201815922863 A;;US 201414177542 A;;US 201213554656 A,2012-07-20,Implantable neurostimulator-implemented method for managing bradycardia through vagus nerve stimulation,"A method for managing bradycardia through vagus nerve stimulation is provided. An implantable neurostimulator configured to deliver electrical therapeutic stimulation in both afferent and efferent directions of a patient's cervical vagus nerve is provided. An operating mode is stored, which includes parametrically defining a maintenance dose of the electrical therapeutic stimulation tuned to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. The maintenance dose is delivered via a pulse generator through a pair of helical electrodes via an electrically coupled nerve stimulation therapy lead independent of cardiac cycle. The patient's physiology is monitored, and upon sensing a condition indicative of bradycardia, the delivery of the maintenance dose is suspended. A progressively increasing amount of time is spent waiting via a controller and, upon sensing a condition indicative of an absence or termination of the bradycardia, a progressively increasing partial maintenance dose is delivered via the pulse generator.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,LIVANOVA USA INC (2012-07-11),https://lens.org/125-572-218-104-66X,Granted Patent,yes,6,1,11,146-972-735-417-239;;079-327-493-833-298;;037-362-531-709-299;;046-093-444-342-656;;097-579-754-062-078;;040-699-578-169-041;;026-081-022-084-606;;025-465-856-592-769;;152-550-176-129-405;;125-572-218-104-66X;;023-211-254-163-526,ES;;WO;;EP;;US,11,146-972-735-417-239;;079-327-493-833-298;;046-093-444-342-656;;037-362-531-709-299;;040-699-578-169-041;;097-579-754-062-078;;026-081-022-084-606;;025-465-856-592-769;;152-550-176-129-405;;125-572-218-104-66X;;023-211-254-163-526,ES;;WO;;EP;;US,0,A61N1/36114;;A61B5/363;;A61N1/36139;;A61N1/36167;;A61N1/36171;;A61N1/36175;;A61N1/365;;A61B5/363;;A61N1/36114;;A61N1/36139;;A61N1/36167;;A61N1/36171;;A61N1/36175,A61N1/365;;A61B5/363;;A61N1/36,,2,0,,,"Office Action on European Patent Application No. 13741950.3 dated Apr. 17, 2018. 5 pages.;;International Search Report for PCT Application No. PCT/US2013/050390, dated Nov. 5, 2013, 6 pages.",ACTIVE
18,US,B2,US 11878159 B2,094-866-711-193-126,2024-01-23,2024,US 202117327926 A,2021-05-24,US 202117327926 A;;US 201916258214 A;;US 201113314119 A,2011-12-07,Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction,"An implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction is provided. A stimulation therapy lead includes helical electrodes configured to conform to an outer diameter of a cervical vagus nerve sheath, and a set of connector pins electrically connected to the helical electrodes. A neurostimulator includes an electrical receptacle into which the connector pins are securely and electrically coupled. The neurostimulator also includes a pulse generator configured to therapeutically stimulate the vagus nerve through the helical electrodes in alternating cycles of stimuli application and stimuli inhibition that are tuned to both efferently activate the heart's intrinsic nervous system and afferently activate the patient's central reflexes by triggering bi-directional action potentials.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,,https://lens.org/094-866-711-193-126,Granted Patent,yes,238,0,5,137-316-579-880-544;;027-563-034-650-319;;151-053-197-476-322;;151-255-709-204-255;;094-866-711-193-126,US,5,137-316-579-880-544;;027-563-034-650-319;;151-053-197-476-322;;151-255-709-204-255;;094-866-711-193-126,US,0,A61N1/0556;;A61N1/36053;;A61N1/36057;;A61N1/36114;;A61N1/36175;;A61N1/0556;;A61N1/36053;;A61N1/36057;;A61N1/36114;;A61N1/36175,A61N1/05;;A61N1/36,,262,219,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;106-931-623-348-337;;003-051-203-957-187;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;004-811-708-971-908;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;16387796;;10.1124/mol.105.020701;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of ADInstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30—Oct. 30, 15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., “Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure,” European Heart Journal, vol. 32, iss. 7, pp. 847-855 (Apr. 2011). Online publication date: Oct. 28, 2010. Available at: http://eurheartj.oxfordjournals.org/content/32/7/847.long.;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285¬2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;European Office Action on Patent Application No. 12809005.7 dated Aug. 20, 2015. 7 pages.;;European Office Action on Patent Application No. 12809005.7 dated Feb. 7, 2018. 7 pages.;;European Office Action on Patent Application No. 12809005.7 dated Jan. 29, 2016. 7 pages.;;European Office Action on Patent Application No. 12809005.7 dated Jun. 2, 2017. 7 pages.;;European Office Action on Patent Application No. 12809005.7 dated Oct. 5, 2016. 7 pages.;;European Office Action on Patent Application No. 12809006.5 dated Mar. 16, 2017. 4 pages.;;European Search Report on Patent Application No. 16168072.3 dated Aug. 8, 2016. 5 pages.;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of IMPROVE HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998). Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,”Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL- Induced NF-κB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetid Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003. Available at: http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=14662714.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after 1 acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK—Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-9A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Presentation Abstract—Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm (2012). et al.",ACTIVE
19,US,A1,US 2021/0275803 A1,151-053-197-476-322,2021-09-09,2021,US 202117327926 A,2021-05-24,US 202117327926 A;;US 201916258214 A;;US 201113314119 A,2011-12-07,IMPLANTABLE DEVICE FOR PROVIDING ELECTRICAL STIMULATION OF CERVICAL VAGUS NERVES FOR TREATMENT OF CHRONIC CARDIAC DYSFUNCTION,"An implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction is provided. A stimulation therapy lead includes helical electrodes configured to conform to an outer diameter of a cervical vagus nerve sheath, and a set of connector pins electrically connected to the helical electrodes. A neurostimulator includes an electrical receptacle into which the connector pins are securely and electrically coupled. The neurostimulator also includes a pulse generator configured to therapeutically stimulate the vagus nerve through the helical electrodes in alternating cycles of stimuli application and stimuli inhibition that are tuned to both efferently activate the heart's intrinsic nervous system and afferently activate the patient's central reflexes by triggering bi-directional action potentials.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,,https://lens.org/151-053-197-476-322,Patent Application,yes,1,0,5,137-316-579-880-544;;027-563-034-650-319;;151-053-197-476-322;;151-255-709-204-255;;094-866-711-193-126,US,5,137-316-579-880-544;;027-563-034-650-319;;151-053-197-476-322;;151-255-709-204-255;;094-866-711-193-126,US,0,A61N1/0556;;A61N1/36053;;A61N1/36057;;A61N1/36114;;A61N1/36175;;A61N1/0556;;A61N1/36053;;A61N1/36057;;A61N1/36114;;A61N1/36175,A61N1/05;;A61N1/36,,0,0,,,,ACTIVE
20,US,B2,US 10413732 B2,198-154-709-534-505,2019-09-17,2019,US 201816016422 A,2018-06-22,US 201816016422 A;;US 201715410316 A;;US 201615212744 A;;US 201414547342 A;;US 201213673811 A,2012-11-09,Implantable neurostimulator-implemented method for enhancing heart failure patient awakening through vagus nerve stimulation,"An implantable neurostimulator-implemented method for managing tachyarrhythmias upon a patient's awakening from sleep through vagus nerve stimulation is provided. An implantable neurostimulator, including a pulse generator, is configured to deliver electrical therapeutic stimulation in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers comprising the cervical vagus nerve of a patient. Operating modes of the pulse generator are stored. An enhanced dose of the electrical therapeutic stimulation is parametrically defined and tuned to prevent initiation of or disrupt tachyarrhythmia upon the patient's awakening from a sleep state through at least one of continuously-cycling, intermittent and periodic ON-OFF cycles of electrical pulses. Other operating modes, including a maintenance dose and a restorative dose are defined. The patient's physiological state is monitored via at least one sensor to detect that patient's awakening, which activates the delivery of the enhanced dose.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,LIVANOVA USA INC (2012-11-09),https://lens.org/198-154-709-534-505,Granted Patent,yes,265,0,9,030-173-579-038-01X;;147-631-833-891-293;;181-866-347-834-495;;005-285-710-989-946;;179-612-790-825-217;;044-223-582-207-639;;190-613-507-866-404;;039-753-691-537-116;;198-154-709-534-505,US,25,028-186-055-114-22X;;147-631-833-891-293;;064-349-732-670-59X;;044-856-202-788-292;;168-627-229-486-734;;051-334-838-825-269;;107-667-041-107-230;;190-979-166-662-310;;174-488-284-806-622;;092-057-191-349-867;;190-613-507-866-404;;198-154-709-534-505;;120-807-899-881-588;;005-285-710-989-946;;162-017-663-214-241;;122-277-305-760-015;;044-223-582-207-639;;082-373-411-720-544;;002-203-899-406-095;;181-866-347-834-495;;144-599-017-856-848;;179-612-790-825-217;;014-394-433-635-494;;039-753-691-537-116;;030-173-579-038-01X,WO;;EP;;US,0,A61N1/36114;;A61B5/0205;;A61B5/08;;A61B5/0816;;A61B5/1118;;A61B5/349;;A61B5/363;;A61B5/4809;;A61B5/4836;;A61B5/686;;A61N1/36053;;A61N1/36139;;A61N1/36157;;A61N1/3621;;A61N1/36114;;A61B5/0205;;A61B5/0245;;A61B5/08;;A61B5/0816;;A61B5/1118;;A61B5/349;;A61B5/363;;A61B5/4809;;A61B5/4812;;A61B5/4836;;A61B5/686;;A61N1/0551;;A61N1/36053;;A61N1/36057;;A61N1/36139;;A61N1/36157;;A61N1/36171;;A61N1/36175;;A61N1/3621,A61N1/36;;A61B5/00;;A61B5/0205;;A61B5/0245;;A61B5/08;;A61B5/11;;A61B5/363;;A61N1/05;;A61N1/362,,261,222,039-372-831-731-510;;114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;034-419-831-492-517;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;004-811-708-971-908;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599,10.1161/hypertensionaha.107.095216;;17846349;;10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;16387796;;10.1124/mol.105.020701;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zucker, et al., “Chronic Baroreceptor Activation Enhances Survival in Dogs with Pacing-Induced Heart Failure,” Journal of the American Heart Association, Hypertension (2007).;;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, Ja, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958¬2963 (1999).;;Bilgutay, et al., “Vagal Tuning a new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., “Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure,” European Heart Journal, vol. 32, iss. 7, pp. 847-855 (Apr. 2011). Online publication date: Oct. 28, 2010. Available at: http://eurheartj.oxfordjournals.org/content/32/7/847.long.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285¬2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of IMPROVE HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-κB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223¬231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425¬438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-84 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003. Available at: http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=14662714.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306¬311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/U52013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, International Preliminary Report on Patentability dated May 21, 2015, 9 pages.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Rhee, et al., “Presentation Abstract—Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm (2012). et al.",ACTIVE
21,US,A1,US 2019/0167999 A1,174-488-284-806-622,2019-06-06,2019,US 201916265770 A,2019-02-01,US 201916265770 A;;US 201715706946 A;;US 201615274919 A;;US 201213673766 A,2012-11-09,IMPLANTABLE NEUROSTIMULATOR-IMPLEMENTED METHOD FOR MANAGING TACHYARRHYTHMIA THROUGH VAGUS NERVE STIMULATION,"An implantable neurostimulator-implemented method for managing tachyarrhythmias through vagus nerve stimulation is provided. An implantable neurostimulator, including a pulse generator, is configured to deliver electrical therapeutic stimulation in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers of a patient's cervical vagus nerve. Operating modes of the pulse generator are stored. A maintenance dose of the electrical therapeutic stimulation is delivered to the vagus nerve via the pulse generator to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. A restorative dose of the electrical therapeutic stimulation is delivered to prevent initiation of or disrupt tachyarrhythmia through periodic electrical pulses delivered at higher intensity than the maintenance dose. The patient's normative physiology is monitored via a physiological sensor, and upon sensing a condition indicative of tachyarrhythmia, is switched to delivering the restorative dose to the vagus nerve.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,,https://lens.org/174-488-284-806-622,Patent Application,yes,0,0,9,002-203-899-406-095;;162-017-663-214-241;;107-667-041-107-230;;064-349-732-670-59X;;190-979-166-662-310;;082-373-411-720-544;;174-488-284-806-622;;168-627-229-486-734;;051-334-838-825-269,US,25,028-186-055-114-22X;;147-631-833-891-293;;064-349-732-670-59X;;044-856-202-788-292;;168-627-229-486-734;;051-334-838-825-269;;107-667-041-107-230;;190-979-166-662-310;;174-488-284-806-622;;092-057-191-349-867;;190-613-507-866-404;;198-154-709-534-505;;120-807-899-881-588;;005-285-710-989-946;;162-017-663-214-241;;122-277-305-760-015;;044-223-582-207-639;;082-373-411-720-544;;002-203-899-406-095;;181-866-347-834-495;;144-599-017-856-848;;179-612-790-825-217;;014-394-433-635-494;;039-753-691-537-116;;030-173-579-038-01X,WO;;EP;;US,0,A61N1/36114;;A61B5/0245;;A61B5/283;;A61B5/352;;A61B5/363;;A61B5/4836;;A61B5/686;;A61N1/36053;;A61N1/36139;;A61N1/3621;;A61N1/36114;;A61B5/0245;;A61B5/352;;A61B5/363;;A61B5/4836;;A61B5/686;;A61N1/36053;;A61N1/36139;;A61N1/3621,A61N1/36;;A61B5/00;;A61B5/0245;;A61B5/352;;A61B5/363,,0,0,,,,ACTIVE
22,US,A1,US 2022/0118250 A1,023-211-254-163-526,2022-04-21,2022,US 202117486188 A,2021-09-27,US 202117486188 A;;US 201815922863 A;;US 201414177542 A;;US 201213554656 A,2012-07-20,IMPLANTABLE NEUROSTIMULATOR-IMPLEMENTED METHOD FOR MANAGING BRADYCARDIA THROUGH VAGUS NERVE STIMULATION,"A method for managing bradycardia through vagus nerve stimulation is provided. An implantable neurostimulator configured to deliver electrical therapeutic stimulation in both afferent and efferent directions of a patient's cervical vagus nerve is provided. An operating mode is stored, which includes parametrically defining a maintenance dose of the electrical therapeutic stimulation tuned to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. The maintenance dose is delivered via a pulse generator through a pair of helical electrodes via an electrically coupled nerve stimulation therapy lead independent of cardiac cycle. The patient's physiology is monitored, and upon sensing a condition indicative of bradycardia, the delivery of the maintenance dose is suspended. A progressively increasing amount of time is spent waiting via a controller and, upon sensing a condition indicative of an absence or termination of the bradycardia, a progressively increasing partial maintenance dose is delivered via the pulse generator.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,,https://lens.org/023-211-254-163-526,Patent Application,yes,9,2,11,146-972-735-417-239;;079-327-493-833-298;;037-362-531-709-299;;046-093-444-342-656;;097-579-754-062-078;;040-699-578-169-041;;026-081-022-084-606;;025-465-856-592-769;;152-550-176-129-405;;125-572-218-104-66X;;023-211-254-163-526,ES;;WO;;EP;;US,11,146-972-735-417-239;;079-327-493-833-298;;046-093-444-342-656;;037-362-531-709-299;;040-699-578-169-041;;097-579-754-062-078;;026-081-022-084-606;;025-465-856-592-769;;152-550-176-129-405;;125-572-218-104-66X;;023-211-254-163-526,ES;;WO;;EP;;US,0,A61N1/36114;;A61N1/36139;;A61N1/36167;;A61N1/36171;;A61N1/36175;;A61B5/363;;A61N1/36114;;A61N1/36139;;A61N1/36167;;A61N1/36171;;A61N1/36175;;A61B5/363;;A61N1/365,A61N1/365;;A61B5/363;;A61N1/36,,0,0,,,,PENDING
23,US,B2,US 10449363 B2,189-894-155-417-880,2019-10-22,2019,US 201715585854 A,2017-05-03,US 201715585854 A;;US 201313828486 A,2013-03-14,Implantable neurostimulator-implemented method for managing tachyarrhythmic risk during sleep through vagus nerve stimulation,"A patient suffering from congestive heart failure is at increased risk of cardiac arrhythmogenesis during sleep, particularly if experiencing central sleep apnea as a co-morbidity. Low intensity peripheral neurostimulation therapies that target imbalance of the autonomic nervous system have been shown to improve clinical outcomes. Thus, bi-directional autonomic regulation therapy is delivered to the cervical vagus nerve at an intensity that is insufficient to elicit pathological or acute physiological side effects and without the requirement of an enabling physiological feature or triggering physiological marker. The patient's physiology is monitored to identify periods of sleep. In one embodiment, upon sensing a condition indicative of tachyarrhythmia following a period of bradycardia, as naturally occurs during sleep, an enhanced “boost” dose of bi-directional neural stimulation intended to “break” the tachyarrhythmic condition is delivered. In a further embodiment, the boost dose is delivered upon sensing a physiological pattern indicative of Cheyne-Stokes respiration.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,LIVANOVA USA INC (2013-03-13),https://lens.org/189-894-155-417-880,Granted Patent,yes,249,0,9,110-478-888-868-743;;189-894-155-417-880;;104-192-374-774-108;;150-410-011-870-425;;001-680-669-073-34X;;194-580-815-584-529;;098-778-003-239-58X;;109-246-684-681-516;;064-286-059-722-947,WO;;EP;;US,9,110-478-888-868-743;;189-894-155-417-880;;104-192-374-774-108;;150-410-011-870-425;;001-680-669-073-34X;;194-580-815-584-529;;098-778-003-239-58X;;109-246-684-681-516;;064-286-059-722-947,WO;;EP;;US,0,A61N1/3621;;A61B5/024;;A61B5/02405;;A61B5/1116;;A61B5/1118;;A61B5/363;;A61B5/4809;;A61B5/4836;;A61B5/686;;A61N1/36053;;A61N1/36114;;A61N1/36139;;A61N1/3621;;A61N1/36114,A61N1/362;;A61N1/36,,264,224,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;097-426-806-139-480;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;034-419-831-492-517;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;004-811-708-971-908;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;16387796;;10.1124/mol.105.020701;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at www.boddunan.com/education/20-medicine-a-surgery/12730-nerver-fiber- types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes-2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958¬2963 (1999).;;Bilgutay, et al., “Vagal Tuning a new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 2 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirecl.com/science/article/pii/SOO1448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., “Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure,” European Heart Journal, vol. 32, iss. 7, pp. 847-855 (Apr. 2011). Online publication date: Oct. 28, 2010. Available at: http://eurheartj.oxfordjournals.org/content/3217/847.long.;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285¬2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N. E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Health Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859¬866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL—Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223¬231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425¬438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” Plos One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003. Available at: http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=14662714.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Li, et al., “Vagal nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation, Journal of the American Heart Association, 109, pp. 120-124 (2004).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306¬311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-9 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Gire J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Olshansky, et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation, Journal of the American Heart Association, 118, pp. 863-871 (2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, International Preliminary Report on Patentability dated May 21, 2015, 9 pages.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, International Preliminary Report on Patentability dated Sep. 15, 2015, 11 pages.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-9A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Presentation Abstract—Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm (2012). et al.",ACTIVE
24,US,B2,US 11745015 B2,044-217-322-189-306,2023-09-05,2023,US 202117503094 A,2021-10-15,US 202117503094 A;;US 201816185838 A;;US 201615181177 A,2016-06-13,Neurostimulator with titration assist,"A method of neurostimulation titration. The method includes setting titration parameters for an electrical signal delivered by an implantable medical device, initiating titration with the titration parameters and an aggressiveness profile, performing titration by increasing at least one of a current amplitude, a frequency, a pulse width or a duty cycle of the electrical signal until a threshold is reached or a side effect is detected, pausing the titration while waiting for commands from the patient or caregiver, and resuming the titration in response to receiving authorization from an external device.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,,https://lens.org/044-217-322-189-306,Granted Patent,yes,35,0,23,112-143-765-299-577;;136-797-791-441-841;;086-606-908-249-76X;;132-903-207-905-071;;036-785-322-240-760;;071-007-421-711-263;;090-708-370-825-703;;138-075-625-160-831;;129-787-164-564-153;;176-787-590-328-430;;114-042-390-189-450;;024-654-621-020-375;;032-839-705-200-147;;018-124-493-379-467;;044-217-322-189-306;;022-897-998-007-537;;093-696-673-586-387;;117-307-554-078-600;;047-873-282-336-301;;145-867-134-623-052;;006-356-173-808-442;;115-325-010-119-896;;120-431-302-816-626,WO;;EP;;AU;;CN;;IL;;CA;;BR;;JP;;US,23,112-143-765-299-577;;136-797-791-441-841;;086-606-908-249-76X;;132-903-207-905-071;;036-785-322-240-760;;071-007-421-711-263;;090-708-370-825-703;;138-075-625-160-831;;129-787-164-564-153;;176-787-590-328-430;;114-042-390-189-450;;024-654-621-020-375;;032-839-705-200-147;;018-124-493-379-467;;044-217-322-189-306;;022-897-998-007-537;;093-696-673-586-387;;117-307-554-078-600;;145-867-134-623-052;;047-873-282-336-301;;006-356-173-808-442;;115-325-010-119-896;;120-431-302-816-626,WO;;EP;;AU;;CN;;IL;;CA;;BR;;JP;;US,0,A61N1/36114;;A61N1/36053;;A61N1/36139;;A61N1/36114;;A61N1/36053;;A61N1/05;;A61N1/32;;A61N1/36139;;A61N1/18;;A61N1/36114;;A61N1/36053;;A61N1/36139,A61N1/36,,16,0,,,"CN Office Action on CN Appl. Ser. No. 201780050108.3 dated Apr. 1, 2022, with translation (52 pages).;;JP Office Action on JP Appl. Ser. No. 2019-516926 dated Mar. 28, 2022 (13 pages).;;Extended European Search Report for EP 18821527.1 dated Dec. 22, 2020, 8 pages.;;Office Action issued in IL 263583 dated Oct. 18, 2021.;;Search Report on EP 17813868.1 dated Jan. 28, 2020.;;International Search Report and Written Opinion, PCT/IB/201854518, Cyberonics Inc., 9 pages (dated Oct. 18, 2018).;;International Search Report and Written Opinion, PCT/US2017/036990, Cyberonics, Inc., 6 pages (dated Aug. 22, 2017).;;Office Action issued in AU 2017284180 dated May 28, 2021.;;Office Action issued in CN 201780050108.3 dated May 6, 2021.;;Office Action issued in JP 2019-516926 dated May 31, 2021.;;Office action issued on CN 201780050108.3 dated Dec. 3, 2021.;;CA Office Action on CA Appl. Ser. No. 3,027,375 dated Jul. 20, 2022 (5 pages).;;CN Office Action on CN Appl. Ser. No. 201780050108 dated Aug. 11, 2022, no translation (19 pages).;;IL Office Action on IL Appl. Ser. No. 263583 dated Jul. 4, 2022 (4 pages).;;EP Office Action on EP Appl. Ser. No. 17 813 868.1 dated Nov. 30, 2022 (4 pages).;;EP Office Action on EP Appl. Ser. No. 18 821 527.1 dated May 17, 2023 (4 pages).",ACTIVE
25,US,A1,US 2022/0016428 A1,064-349-732-670-59X,2022-01-20,2022,US 202117388905 A,2021-07-29,US 202117388905 A;;US 201916265770 A;;US 201715706946 A;;US 201615274919 A;;US 201213673766 A,2012-11-09,IMPLANTABLE NEUROSTIMULATOR-IMPLEMENTED METHOD FOR MANAGING TACHYARRHYTHMIA THROUGH VAGUS NERVE STIMULATION,"An implantable neurostimulator-implemented method for managing tachyarrhythmias through vagus nerve stimulation is provided. An implantable neurostimulator, including a pulse generator, is configured to deliver electrical therapeutic stimulation in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers of a patient's cervical vagus nerve. Operating modes of the pulse generator are stored. A maintenance dose of the electrical therapeutic stimulation is delivered to the vagus nerve via the pulse generator to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. A restorative dose of the electrical therapeutic stimulation is delivered to prevent initiation of or disrupt tachyarrhythmia through periodic electrical pulses delivered at higher intensity than the maintenance dose. The patient's normative physiology is monitored via a physiological sensor, and upon sensing a condition indicative of tachyarrhythmia, is switched to delivering the restorative dose to the vagus nerve.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,,https://lens.org/064-349-732-670-59X,Patent Application,yes,3,0,9,002-203-899-406-095;;162-017-663-214-241;;107-667-041-107-230;;064-349-732-670-59X;;190-979-166-662-310;;082-373-411-720-544;;174-488-284-806-622;;168-627-229-486-734;;051-334-838-825-269,US,25,028-186-055-114-22X;;147-631-833-891-293;;064-349-732-670-59X;;044-856-202-788-292;;168-627-229-486-734;;051-334-838-825-269;;107-667-041-107-230;;190-979-166-662-310;;174-488-284-806-622;;092-057-191-349-867;;190-613-507-866-404;;198-154-709-534-505;;120-807-899-881-588;;005-285-710-989-946;;162-017-663-214-241;;122-277-305-760-015;;044-223-582-207-639;;082-373-411-720-544;;002-203-899-406-095;;181-866-347-834-495;;144-599-017-856-848;;179-612-790-825-217;;014-394-433-635-494;;039-753-691-537-116;;030-173-579-038-01X,WO;;EP;;US,0,A61N1/36114;;A61B5/0245;;A61B5/283;;A61B5/352;;A61B5/363;;A61B5/4836;;A61B5/686;;A61N1/36053;;A61N1/36139;;A61N1/3621;;A61N1/36114;;A61B5/0245;;A61B5/352;;A61B5/363;;A61B5/4836;;A61B5/686;;A61N1/36053;;A61N1/36139;;A61N1/3621,A61N1/36;;A61B5/00;;A61B5/0245;;A61B5/283;;A61B5/352;;A61B5/363,,0,0,,,,DISCONTINUED
26,US,B2,US 10384065 B2,044-856-202-788-292,2019-08-20,2019,US 201715585958 A,2017-05-03,US 201715585958 A;;US 201213673795 A,2012-11-09,Implantable neurostimulator—implemented method for enhancing post-exercise recovery through vagus nerve stimulation,"An implantable neurostimulator-implemented method for enhancing post-exercise recovery through vagus nerve stimulation is provided. An implantable neurostimulator, including a pulse generator configured to deliver electrical therapeutic stimulation in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers including a patient's cervical vagus nerve. An operating mode is stored in the pulse generator. An enhanced dose of the electrical therapeutic stimulation is parametrically defined and tuned to prevent or disrupt tachyarrhythmia through continuously-cycling, intermittent and periodic electrical pulses. The patient's physiological state is monitored during physical exercise via at least one sensor included in the implantable neurostimulator, and upon sensing a condition indicative of cessation of the physical exercise, the enhanced dose is delivered for a period of time the enhanced dose to the vagus nerve.",LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,LIVANOVA USA INC (2012-11-09),https://lens.org/044-856-202-788-292,Granted Patent,yes,262,0,4,014-394-433-635-494;;122-277-305-760-015;;044-856-202-788-292;;120-807-899-881-588,US,25,028-186-055-114-22X;;147-631-833-891-293;;064-349-732-670-59X;;044-856-202-788-292;;168-627-229-486-734;;051-334-838-825-269;;107-667-041-107-230;;190-979-166-662-310;;174-488-284-806-622;;092-057-191-349-867;;190-613-507-866-404;;198-154-709-534-505;;120-807-899-881-588;;005-285-710-989-946;;162-017-663-214-241;;122-277-305-760-015;;044-223-582-207-639;;082-373-411-720-544;;002-203-899-406-095;;181-866-347-834-495;;144-599-017-856-848;;179-612-790-825-217;;014-394-433-635-494;;039-753-691-537-116;;030-173-579-038-01X,WO;;EP;;US,0,A61N1/36114;;A61B5/1118;;A61B5/4836;;A61N1/36053;;A61N1/36139;;A61N1/3621;;A61N1/36114;;A61B5/1118;;A61B5/4836;;A61N1/36053;;A61N1/36139;;A61N1/3621,A61N1/36;;A61B5/00;;A61B5/11;;A61N1/362,,259,223,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;117-723-850-131-683;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;004-811-708-971-908;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10.1016/j.cardfail.2011.06.184;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;16387796;;10.1124/mol.105.020701;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul lntegr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning a new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., “Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure,” European Heart Journal, vol. 32, iss. 7, pp. 847-855 (Apr. 2011). Online publication date: Oct. 28, 2010. Available at: http://eurheartj.oxfordjournals.org/content/3217/847.long.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, val. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(1), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacal, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” the Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrioventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul lntegr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: the Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y—immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Crit Care Med, val 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: noninvasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL—Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 9293 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003. Available at: http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=14662714.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Gire J, 69, pp. 493-499 (2005).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky, et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation, Journal of the American Heart Association, 118, pp. 863-871 (2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” Pnas, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, International Preliminary Report on Patentability dated May 21, 2015, 9 pages.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-30 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Rhee, et al., “Presentation Abstract—Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996). et al.",ACTIVE
27,US,B2,US 10220212 B2,085-970-400-068-356,2019-03-05,2019,US 201615395872 A,2016-12-30,US 201615395872 A;;US 201414457807 A,2014-08-12,Neurostimulation titration process,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level. This titration process can minimize the amount of time required to complete titration so as to begin delivery of the stimulation at therapeutically desirable levels.,LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,LIVANOVA USA INC (2014-08-18),https://lens.org/085-970-400-068-356,Granted Patent,yes,232,3,13,083-099-283-788-583;;001-798-740-492-568;;085-970-400-068-356;;091-201-321-442-785;;013-289-519-104-925;;155-792-182-018-403;;126-699-603-179-961;;049-221-692-052-909;;111-318-125-117-291;;051-419-033-355-901;;197-594-477-147-858;;096-249-903-310-170;;032-101-503-149-151,WO;;EP;;US,13,083-099-283-788-583;;001-798-740-492-568;;085-970-400-068-356;;091-201-321-442-785;;013-289-519-104-925;;155-792-182-018-403;;126-699-603-179-961;;049-221-692-052-909;;111-318-125-117-291;;051-419-033-355-901;;197-594-477-147-858;;096-249-903-310-170;;032-101-503-149-151,WO;;EP;;US,0,A61B5/4836;;A61B5/02055;;A61B5/0245;;A61N1/36157;;A61N1/36139;;A61N1/36114;;A61N1/36171;;A61N1/36175;;A61N1/36157;;A61N1/36132;;A61N1/36139;;A61N1/36114;;A61N1/36171;;A61N1/36175;;A61B5/4836;;A61B5/02055;;A61B5/0245;;A61B5/0205,A61N1/36;;A61B5/00;;A61B5/0205;;A61B5/0245,,256,221,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;131-082-682-819-47X;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;117-723-850-131-683;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;051-782-858-038-376;;054-362-910-657-616;;003-971-372-447-956;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpheart.1997.273.2.h805;;9277498;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10.1016/j.cardfail.2011.06.184;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at www.boddunan.com/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzing, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 2 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirecl.com/science/article/pii/SOO1448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetyicholinesterase activity,” Am J Physiol Heart Circ Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(1), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutids, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrioventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Health Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;International Search Report for PCT Patent Application No. PCT/US2015/043878, dated Oct. 29, 2015, 6 pages.;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation protects cardiac injury by attenuating mitochondria) dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Lw, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,”Am. J. Physiol. 273 (Heart Circ. Physiol. 42), pp. H805-H816 (1997).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Gire J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky, et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation, Journal of the American Heart Association, 118, pp. 863-871 (2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/043878, Search Report and Written Opinion dated Oct. 20, 2015, 13 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-9A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 (2003).;;Ridker, et al., “Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First cardiovascular Events,” New England Journal of Medicine, vol. 347, No. 20, pp. 1557-1566 (Nov. 14, 2002). et al.",ACTIVE
28,US,A1,US 2023/0398358 A1,145-867-134-623-052,2023-12-14,2023,US 202318234186 A,2023-08-15,US 202318234186 A;;US 202117503094 A;;US 201816185838 A;;US 201615181177 A,2016-06-13,NEUROSTIMULATOR WITH TITRATION ASSIST,A method of neurostimulation titration includes titrating a neurostimulation signal from a first set of parameters toward a target set of parameters according to a titration aggressiveness profile having a titration hold point. The method further includes receiving a hold indicator indicating that the titration has reached the titration hold point. The method further includes initiating an intermediate hold of the titrating of the neurostimulation signal in response to receiving the hold indicator. The method further includes receiving an indication of a titration resumption that discontinues the intermediate hold.,LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,,https://lens.org/145-867-134-623-052,Patent Application,yes,2,0,23,112-143-765-299-577;;136-797-791-441-841;;086-606-908-249-76X;;132-903-207-905-071;;036-785-322-240-760;;071-007-421-711-263;;090-708-370-825-703;;138-075-625-160-831;;129-787-164-564-153;;176-787-590-328-430;;114-042-390-189-450;;024-654-621-020-375;;032-839-705-200-147;;018-124-493-379-467;;044-217-322-189-306;;022-897-998-007-537;;093-696-673-586-387;;117-307-554-078-600;;047-873-282-336-301;;145-867-134-623-052;;006-356-173-808-442;;115-325-010-119-896;;120-431-302-816-626,WO;;EP;;AU;;CN;;IL;;CA;;BR;;JP;;US,23,112-143-765-299-577;;136-797-791-441-841;;086-606-908-249-76X;;132-903-207-905-071;;036-785-322-240-760;;071-007-421-711-263;;090-708-370-825-703;;138-075-625-160-831;;129-787-164-564-153;;176-787-590-328-430;;114-042-390-189-450;;024-654-621-020-375;;032-839-705-200-147;;018-124-493-379-467;;044-217-322-189-306;;022-897-998-007-537;;093-696-673-586-387;;117-307-554-078-600;;145-867-134-623-052;;047-873-282-336-301;;006-356-173-808-442;;115-325-010-119-896;;120-431-302-816-626,WO;;EP;;AU;;CN;;IL;;CA;;BR;;JP;;US,0,A61N1/36114;;A61N1/36053;;A61N1/36139;;A61N1/36114;;A61N1/36053;;A61N1/05;;A61N1/32;;A61N1/36139;;A61N1/18;;A61N1/36114;;A61N1/36053;;A61N1/36139,A61N1/36,,0,0,,,,PENDING
29,US,A1,US 2023/0126576 A1,084-584-546-681-856,2023-04-27,2023,US 202117508539 A,2021-10-22,US 202117508539 A,2021-10-22,SYSTEMS AND METHODS FOR ACCELERATION-BASED SEIZURE DETECTION,"A seizure detection system comprises a sensor and a control system. The sensor is configured to detect acceleration data associated with a patient’s movements. The control system is programmed to monitor, via the sensor, the acceleration data to detect a seizure precursor event. The control system is further programmed to, upon detection of the seizure precursor event, perform a frequency analysis of the acceleration data to identify a frequency of the patient’s movements. The control system is further programmed to determine that the patient is experiencing a seizure event based on the frequency of the patient’s movements.",LIVANOVA USA INC,CARLSON GERRARD MERRILL,LIVANOVA USA INC (2022-03-22),https://lens.org/084-584-546-681-856,Patent Application,yes,2,0,3,084-584-546-681-856;;169-965-369-090-887;;151-853-644-394-384,WO;;EP;;US,3,084-584-546-681-856;;169-965-369-090-887;;151-853-644-394-384,WO;;EP;;US,0,G16H50/20;;G16H40/60;;G06F17/142;;A61N1/36031;;A61B2562/0219;;A61N1/36064;;A61N1/36135,A61N1/36,,5,3,099-811-247-000-717;;148-541-951-764-92X;;027-082-361-955-649,10.3389/fneur.2020.00701;;pmc7396638;;32849189;;10.1109/biocas.2011.6107722;;10.1145/199691.199815,"Kim T, Nguyen P, Pham N, Bui N, Truong H, Ha S, Vu T. Epileptic Seizure Detection and Experimental Treatment: A Review. Front Neurol. 2020 Jul 21;11:701. doi: 10.3389/fneur.2020.00701. PMID: 32849189; PMCID: PMC7396638. (Year: 2020);;Palmer, J. M. (2005, June 16). The hybrid architecture parallel fast Fourier transform (HAPFFT) (dissertation). The Hybrid Architecture Parallel Fast Fourier Transform (HAPFFT). Brigham Young University. Retrieved October 25, 2023, from https://scholarsarchive.byu.edu/etd/555/. (Year: 2005);;Ganganna, A. (2014). An Optimized Implementation of 128-Point FFT using Radix-4 Algorithm. International Journal of Scientific Engineering and Technology Research, 3(20), 4161–4165. (Year: 2014);;D. Chandler, J. Bisasky, J. L. V. M. Stanislaus and T. Mohsenin, ""Real-time multi-channel seizure detection and analysis hardware,"" 2011 IEEE Biomedical Circuits and Systems Conference (BioCAS), San Diego, CA, USA, 2011, pp. 41-44, doi: 10.1109/BioCAS.2011.6107722. (Year: 2011);;Eric S. Roberts. 1995. Loop exits and structured programming: reopening the debate. SIGCSE Bull. 27, 1 (March 1995), 268–272. https://doi.org/10.1145/199691.199815 (Year: 1995)",PENDING
30,US,A1,US 2024/0342479 A1,106-788-955-831-537,2024-10-17,2024,US 202318135325 A,2023-04-17,US 202318135325 A,2023-04-17,AUTOMATIC TITRATION WITH DEFIBRILLATION SENSITIVITY COMPENSATION,"A method of delivering neurostimulation therapy to a patient from an implantable medical device is provided. The method includes delivering, by the implantable medical device, the neurostimulation therapy to the patient. The method further includes determining, by the implantable medical device, that the patient has received a defibrillation shock from a defibrillation device. The method further includes adjusting, by the implantable medical device, the neurostimulation therapy based on determining that the patient has received the defibrillation shock.",LIVANOVA USA INC,LIBBUS IMAD;;STUBBS SCOTT;;KENKNIGHT BRUCE,LIVANOVA USA INC (2023-04-04),https://lens.org/106-788-955-831-537,Patent Application,yes,0,0,1,106-788-955-831-537,US,1,106-788-955-831-537,US,0,A61N1/36139;;A61N1/36114;;A61N1/36114;;A61B5/335;;A61N1/36139,A61N1/36;;A61B5/335,,0,0,,,,PENDING
31,US,A1,US 2022/0105347 A1,093-696-673-586-387,2022-04-07,2022,US 202117503094 A,2021-10-15,US 202117503094 A;;US 201816185838 A;;US 201615181177 A,2016-06-13,NEUROSTIMULATOR WITH TITRATION ASSIST,"A method of neurostimulation titration. The method includes setting titration parameters for an electrical signal delivered by an implantable medical device, initiating titration with the titration parameters and an aggressiveness profile, performing titration by increasing at least one of a current amplitude, a frequency, a pulse width or a duty cycle of the electrical signal until a threshold is reached or a side effect is detected, pausing the titration while waiting for commands from the patient or caregiver, and resuming the titration in response to receiving authorization from an external device.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,,https://lens.org/093-696-673-586-387,Patent Application,yes,0,0,23,112-143-765-299-577;;136-797-791-441-841;;086-606-908-249-76X;;132-903-207-905-071;;036-785-322-240-760;;071-007-421-711-263;;090-708-370-825-703;;138-075-625-160-831;;129-787-164-564-153;;176-787-590-328-430;;114-042-390-189-450;;024-654-621-020-375;;032-839-705-200-147;;018-124-493-379-467;;044-217-322-189-306;;022-897-998-007-537;;093-696-673-586-387;;117-307-554-078-600;;047-873-282-336-301;;145-867-134-623-052;;006-356-173-808-442;;115-325-010-119-896;;120-431-302-816-626,WO;;EP;;AU;;CN;;IL;;CA;;BR;;JP;;US,23,112-143-765-299-577;;136-797-791-441-841;;086-606-908-249-76X;;132-903-207-905-071;;036-785-322-240-760;;071-007-421-711-263;;090-708-370-825-703;;138-075-625-160-831;;129-787-164-564-153;;176-787-590-328-430;;114-042-390-189-450;;024-654-621-020-375;;032-839-705-200-147;;018-124-493-379-467;;044-217-322-189-306;;022-897-998-007-537;;093-696-673-586-387;;117-307-554-078-600;;145-867-134-623-052;;047-873-282-336-301;;006-356-173-808-442;;115-325-010-119-896;;120-431-302-816-626,WO;;EP;;AU;;CN;;IL;;CA;;BR;;JP;;US,0,A61N1/36114;;A61N1/36053;;A61N1/36139;;A61N1/36114;;A61N1/36053;;A61N1/05;;A61N1/32;;A61N1/36139;;A61N1/18;;A61N1/36114;;A61N1/36053;;A61N1/36139,A61N1/36,,0,0,,,,ACTIVE
32,US,B2,US 11185698 B2,111-318-125-117-291,2021-11-30,2021,US 201916290783 A,2019-03-01,US 201916290783 A;;US 201615395872 A;;US 201414457807 A,2014-08-12,Neurostimulation titration process,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level. This titration process can minimize the amount of time required to complete titration so as to begin delivery of the stimulation at therapeutically desirable levels.,LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,,https://lens.org/111-318-125-117-291,Granted Patent,yes,234,2,13,083-099-283-788-583;;001-798-740-492-568;;085-970-400-068-356;;091-201-321-442-785;;013-289-519-104-925;;155-792-182-018-403;;126-699-603-179-961;;049-221-692-052-909;;111-318-125-117-291;;051-419-033-355-901;;197-594-477-147-858;;096-249-903-310-170;;032-101-503-149-151,WO;;EP;;US,13,083-099-283-788-583;;001-798-740-492-568;;085-970-400-068-356;;091-201-321-442-785;;013-289-519-104-925;;155-792-182-018-403;;126-699-603-179-961;;049-221-692-052-909;;111-318-125-117-291;;051-419-033-355-901;;197-594-477-147-858;;096-249-903-310-170;;032-101-503-149-151,WO;;EP;;US,0,A61B5/4836;;A61B5/02055;;A61B5/0245;;A61N1/36157;;A61N1/36139;;A61N1/36114;;A61N1/36171;;A61N1/36175;;A61N1/36157;;A61N1/36132;;A61N1/36139;;A61N1/36114;;A61N1/36171;;A61N1/36175;;A61B5/4836;;A61B5/02055;;A61B5/0245;;A61B5/0205,A61N1/36;;A61B5/00;;A61B5/0205;;A61B5/0245,,256,219,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;131-082-682-819-47X;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;051-782-858-038-376;;054-362-910-657-616;;003-971-372-447-956;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpheart.1997.273.2.h805;;9277498;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of ADInstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration In Human Subjects and Verification In a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardiac agent, S 16257, on iconic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzing, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetyicholinesterase activity,” Am J Physiol Heart Circ Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” SLEEP, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 1-A, pp. E152-152 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of IMPROVE HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutids, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y—immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;International Search Report for PCT Patent Application No. PCT/US2015/043878, dated Oct. 29, 2015, 6 pages.;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL—Induced NF-κB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the Amercan Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-331 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Lw, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Circ. Physiol. 42), pp. H805-H816 (1997).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of lnterleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/043878, Search Report and Written Opinion dated Oct. 20, 2015, 13 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), p. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation or distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages. et al.",ACTIVE
33,EP,B1,EP 3468456 B1,138-075-625-160-831,2024-07-10,2024,EP 17813868 A,2017-06-12,US 201615181177 A;;US 2017/0036990 W,2016-06-13,NEUROSTIMULATOR WITH TITRATION ASSIST,,LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,,https://lens.org/138-075-625-160-831,Granted Patent,yes,7,0,23,112-143-765-299-577;;136-797-791-441-841;;086-606-908-249-76X;;132-903-207-905-071;;036-785-322-240-760;;071-007-421-711-263;;090-708-370-825-703;;138-075-625-160-831;;129-787-164-564-153;;176-787-590-328-430;;114-042-390-189-450;;024-654-621-020-375;;032-839-705-200-147;;018-124-493-379-467;;044-217-322-189-306;;022-897-998-007-537;;093-696-673-586-387;;117-307-554-078-600;;047-873-282-336-301;;145-867-134-623-052;;006-356-173-808-442;;115-325-010-119-896;;120-431-302-816-626,WO;;EP;;AU;;CN;;IL;;CA;;BR;;JP;;US,23,112-143-765-299-577;;136-797-791-441-841;;086-606-908-249-76X;;132-903-207-905-071;;036-785-322-240-760;;071-007-421-711-263;;090-708-370-825-703;;138-075-625-160-831;;129-787-164-564-153;;176-787-590-328-430;;114-042-390-189-450;;024-654-621-020-375;;032-839-705-200-147;;018-124-493-379-467;;044-217-322-189-306;;022-897-998-007-537;;093-696-673-586-387;;117-307-554-078-600;;145-867-134-623-052;;047-873-282-336-301;;006-356-173-808-442;;115-325-010-119-896;;120-431-302-816-626,WO;;EP;;AU;;CN;;IL;;CA;;BR;;JP;;US,0,A61N1/36114;;A61N1/36053;;A61N1/36139;;A61N1/36114;;A61N1/36053;;A61N1/05;;A61N1/32;;A61N1/36139;;A61N1/18;;A61N1/36114;;A61N1/36053;;A61N1/36139,A61N1/36,,0,0,,,,ACTIVE
34,US,A1,US 2019/0262615 A1,197-594-477-147-858,2019-08-29,2019,US 201916290783 A,2019-03-01,US 201916290783 A;;US 201615395872 A;;US 201414457807 A,2014-08-12,NEUROSTIMULATION TITRATION PROCESS,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level. This titration process can minimize the amount of time required to complete titration so as to begin delivery of the stimulation at therapeutically desirable levels.,LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,,https://lens.org/197-594-477-147-858,Patent Application,yes,0,0,13,083-099-283-788-583;;001-798-740-492-568;;085-970-400-068-356;;091-201-321-442-785;;013-289-519-104-925;;155-792-182-018-403;;126-699-603-179-961;;049-221-692-052-909;;111-318-125-117-291;;051-419-033-355-901;;197-594-477-147-858;;096-249-903-310-170;;032-101-503-149-151,WO;;EP;;US,13,083-099-283-788-583;;001-798-740-492-568;;085-970-400-068-356;;091-201-321-442-785;;013-289-519-104-925;;155-792-182-018-403;;126-699-603-179-961;;049-221-692-052-909;;111-318-125-117-291;;051-419-033-355-901;;197-594-477-147-858;;096-249-903-310-170;;032-101-503-149-151,WO;;EP;;US,0,A61B5/4836;;A61B5/02055;;A61B5/0245;;A61N1/36157;;A61N1/36139;;A61N1/36114;;A61N1/36171;;A61N1/36175;;A61N1/36157;;A61N1/36132;;A61N1/36139;;A61N1/36114;;A61N1/36171;;A61N1/36175;;A61B5/4836;;A61B5/02055;;A61B5/0245;;A61B5/0205,A61N1/36;;A61B5/00;;A61B5/0205;;A61B5/0245,,0,0,,,,ACTIVE
35,US,B2,US 11406317 B2,053-156-132-924-576,2022-08-09,2022,US 201514630867 A,2015-02-25,US 201514630867 A;;US 34337608 A;;US 1750107 P,2007-12-28,Method for detecting neurological and clinical manifestations of a seizure,Methods for detecting neurological and clinical manifestations of a seizure are provided. Systems are described including a monitoring device having a communication assembly for receiving neurological data transmitted external to a patient from a transmitter implanted in a patient; a processor that processes the neurological data to estimate the patient's brain state; and an assembly for automatically recording clinical manifestation data in response to a brain state estimate by the processor.,LIVANOVA USA INC,LEYDE KENT W;;BLAND MICHAEL,LIVANOVA USA INC (2013-02-28),https://lens.org/053-156-132-924-576,Granted Patent,yes,664,0,3,192-556-933-330-754;;053-156-132-924-576;;036-307-668-298-55X,US,3,192-556-933-330-754;;053-156-132-924-576;;036-307-668-298-55X,US,0,A61B5/4094;;A61B5/0031;;A61B5/374;;A61B5/7275;;A61N1/36082;;A61B5/4094;;A61B5/0031;;A61B5/11;;A61B5/291;;A61B5/316;;A61B5/374;;A61B5/7221;;A61B5/7246;;A61B5/7275;;A61N1/36082,A61B5/00;;A61B5/11;;A61B5/291;;A61B5/316;;A61B5/374;;A61N1/36,,202,150,024-162-606-052-378;;008-650-520-941-273;;064-762-265-649-431;;036-765-169-783-989;;063-161-480-619-358;;069-147-854-429-258;;135-197-726-472-806;;110-756-376-850-387;;043-209-732-625-194;;052-904-683-117-37X;;099-738-184-995-471;;036-799-833-560-683;;075-949-839-628-664;;091-489-529-599-197;;040-563-703-473-032;;010-542-698-038-106;;080-476-358-354-096;;010-031-887-527-334;;014-030-870-508-55X;;015-522-377-591-609;;053-176-049-549-89X;;134-256-610-404-255;;007-435-731-732-051;;017-658-731-501-924;;082-130-581-626-626;;016-009-427-904-052;;087-888-415-182-16X;;038-812-576-998-057;;036-765-169-783-989;;029-415-860-497-502;;011-439-172-416-329;;007-860-157-935-846;;021-927-186-932-311;;004-699-664-794-075;;030-983-039-493-075;;030-959-629-699-794;;034-726-247-442-625;;038-105-755-405-648;;058-354-881-914-817;;098-793-796-290-443;;008-217-796-572-141;;113-491-096-155-820;;035-477-652-721-97X;;081-069-045-977-645;;021-357-805-075-514;;100-504-376-971-476;;009-408-154-386-927;;081-014-262-239-384;;037-270-502-089-758;;119-041-943-953-007;;116-617-266-976-059;;007-102-427-091-207;;039-789-883-917-61X;;058-590-161-216-02X;;013-175-917-825-570;;015-010-310-018-059;;035-202-529-233-089;;054-838-485-144-772;;022-014-401-539-185;;164-068-260-839-362;;041-849-140-405-799;;005-812-068-829-241;;102-065-286-791-958;;040-653-827-786-603;;090-722-470-992-921;;079-496-522-034-098;;077-437-257-509-116;;061-465-319-393-938;;071-794-997-821-559;;055-212-083-393-970;;027-951-309-891-088;;057-209-256-661-319;;021-904-530-539-008;;013-131-457-719-966;;022-340-064-605-885;;004-744-607-902-199;;012-347-103-675-309;;129-688-805-152-535;;118-774-883-250-925;;056-713-840-473-145;;009-937-539-597-93X;;047-951-590-482-23X;;017-872-040-249-384;;047-557-590-620-81X;;001-684-727-218-323;;120-941-384-775-230;;038-895-519-332-589;;090-139-902-269-836;;018-748-506-465-539;;099-242-910-542-727;;023-634-408-186-013;;071-379-392-030-350;;067-202-305-611-192;;022-737-784-206-984;;008-683-222-517-061;;085-258-298-688-583;;025-462-190-148-245;;006-571-256-471-437;;008-525-576-094-074;;050-957-455-833-565;;035-845-605-612-97X;;003-527-914-722-422;;029-826-474-472-813;;093-017-198-453-261;;085-287-764-394-56X;;059-008-403-052-583;;024-400-776-056-719;;029-096-142-097-365;;079-621-744-256-569;;013-993-295-891-841;;063-161-480-619-358;;143-398-932-451-548;;026-040-501-717-238;;058-897-213-047-739;;078-127-184-717-119;;020-639-263-300-113;;058-699-127-035-371;;078-034-108-516-718;;109-633-160-417-984;;044-054-605-334-338;;010-447-571-408-178;;026-161-434-624-269;;044-801-911-798-401;;004-336-445-612-283;;059-721-223-992-598;;019-020-399-275-151;;117-306-806-020-719;;046-394-936-902-110;;046-951-867-744-006;;029-313-181-841-642;;020-542-114-256-808;;014-590-560-212-185;;082-384-306-223-881;;066-581-502-575-086;;007-401-896-126-759;;042-683-317-156-433;;056-588-099-366-952;;081-339-542-705-015;;087-366-366-471-863;;127-486-336-288-668;;065-998-894-428-372;;069-183-134-021-682;;060-719-041-136-865;;024-174-082-138-653;;129-492-350-975-572;;108-365-920-087-726;;041-879-143-577-040;;128-107-690-821-73X;;035-591-284-396-294;;045-181-901-588-859,10.1016/j.yebeh.2005.04.011;;15975855;;18018703;;10.1109/tbme.2007.895114;;10.1111/j.1528-1157.1986.tb05738.x;;3720711;;10.1016/j.clinph.2004.11.014;;15721064;;12460255;;10.1046/j.1528-1157.2002.11102.x;;14648153;;10.1007/s00415-003-0224-z;;15133954;;15689714;;10.1097/01.wnp.0000150880.19561.6f;;15132516;;10.1109/tbme.2004.826642;;10.1103/physreve.67.010901;;12636484;;14754292;;10.1103/physreve.68.066202;;10.1093/brain/awg265;;14506067;;10.1016/s0022-2836(65)80093-6;;5859039;;10.1002/cplx.20065;;15365195;;10.1385/ni:2:3:333;;10.1385/1-59259-364-x:159;;12710673;;10.1016/s1388-2457(00)00543-5;;11165525;;11461312;;10.1103/physreve.64.012902;;10.1137/1.9781611972740.12;;10.1023/a:1009715923555;;15600505;;10.1103/physreve.70.046217;;12779843;;10.1063/1.166420;;10.1016/s0167-2789(96)00160-1;;10.1016/s0921-884x(96)95195-4;;9060860;;10.1007/s00422-004-0463-9;;15085343;;10.1016/j.eplepsyres.2006.06.013;;15961284;;10.1016/j.eplepsyres.2005.03.009;;10.1109/tbme.2003.810696;;12769433;;10.1016/j.clinph.2004.11.014;;15721064;;12769436;;10.1109/tbme.2003.810706;;14597320;;10.1016/s0014-4886(03)00354-6;;15721062;;10.1016/j.clinph.2004.09.029;;8295931;;10.1152/physrev.1994.74.1.1;;10.1111/j.1528-1157.2000.tb01532.x;;11001334;;9749744;;10.1046/j.1460-9568.1998.00090.x;;10.1109/81.904882;;10.1016/j.clinph.2004.10.015;;pmc2941767;;15721065;;15897008;;10.1016/j.clinph.2005.03.006;;10.1016/0013-4694(88)90171-x;;2453336;;10.1016/s0165-0270(00)00188-6;;10837870;;10.1145/1068009.1068082;;10489023;;10.1212/wnl.53.4.666;;10434388;;10.1007/s004220050540;;9775534;;10.1109/10.720198;;15325118;;10.1016/j.jneumeth.2004.03.016;;10.1016/j.clinph.2004.08.022;;15721066;;16252980;;10.1063/1.1935138;;10.1109/5254.708428;;10.1109/tbme.2003.810693;;12769434;;10.1016/s0375-9601(99)00342-4;;10.1080/00029238.1980.11080015;;10.1109/tbme.2003.810689;;12769437;;10.1177/107385849600200213;;15698148;;10.1103/physrevlett.94.019801;;10.1097/00004691-199609000-00041;;10.1016/0013-4694(90)91948-o;;15721067;;10.1016/j.clinph.2004.10.013;;3378094;;2116818;;10.1007/bf01140588;;10.1097/00004691-199709000-00015;;8174527;;10.1016/0920-1211(94)90081-7;;12769431;;10.1109/tbme.2003.810705;;11528297;;10.1097/00004691-200105000-00005;;10.1016/j.clinph.2004.08.023;;15721068;;10.1016/s1388-2457(02)00344-9;;12705423;;10.1016/j.clinph.2004.08.024;;15721069;;10.1209/epl/i2004-10383-2;;1713830;;10.1016/0013-4694(91)90054-8;;10.1007/bf02345960;;15865133;;16337916;;10.1016/j.neuron.2005.09.026;;10.1016/j.crvi.2003.09.011;;14694754;;10.1103/physreve.69.061915;;15244625;;10.1002/(sici)1097-0193(1999)8:4<194::aid-hbm4>3.0.co;2-c;;10619414;;pmc6873296;;15446973;;10.1063/1.1777831;;12935113;;10.1103/physrevlett.91.068102;;12786206;;10.1103/physreve.67.052902;;10.1097/00001756-199907130-00028;;10424690;;10.1016/s0140-6736(03)12755-9;;10.1016/s0165-0270(01)00372-7;;11595276;;10.1016/s0167-2789(98)00258-9;;10.1016/j.clinph.2004.10.014;;15721070;;10.1016/j.crvi.2004.10.014;;15771005;;10.1097/00004691-200105000-00002;;11528294;;12683064;;10.1109/memb.2003.1191451;;10.1016/j.clinph.2004.08.020;;15721063;;10.1016/s0167-8760(99)00043-4;;10555873;;10.1016/0013-4694(91)90201-e;;1718709;;10.1088/1741-2560/2/2/002;;15928408;;14618068;;10.1023/a:1027415927155;;10.1016/s0025-5564(03)00100-7;;14527747;;10.1016/s1474-4422(02)00003-0;;12849542;;11923631;;10.1097/00019052-200204000-00008;;10.1016/j.physd.2004.02.013;;9771751;;10.1038/2667;;12769438;;10.1109/tbme.2003.810688;;12227632;;10.1007/bf02345078;;10.1007/978-3-540-30134-9_65;;10.1016/j.medengphy.2004.02.006;;15147746;;10.1016/s1350-4533(04)00031-1;;10.1016/s1388-2457(01)00712-x;;11801422;;17008335;;10.1093/brain/awl241;;12636720;;10.1103/physreve.67.021912;;12694925;;10.1016/s0920-1211(03)00002-0;;10.1016/s0167-2789(00)00087-7;;10.1016/j.clinph.2004.08.025;;15721071;;10.1097/01.wco.0000218237.52593.bc;;16538095;;11872619;;10.1093/brain/awf048;;15730536;;10.1111/j.0013-9580.2005.15504.x;;12723056;;10.1109/tbme.2003.809497;;14977058;;10.1179/016164104773026534;;15668970;;10.1002/ana.20377;;12460255;;10.1046/j.1528-1157.2002.11102.x;;10.1111/j.1528-1157.1998.tb01430.x;;9637604;;16177520;;10.1088/0031-9155/50/14/017;;10.1097/00004691-200105000-00003;;11528295;;10.1103/physreve.58.3557;;pmc321206;;10.1046/j.1535-7597.2003.03501.x;;15346164;;10.1016/j.neuroimage.2005.11.021;;16413209;;15661120;;10.1016/j.clinph.2004.08.004;;10.1097/00004691-200612000-00003;;17143139;;10.1142/9789812793782_0010;;10367436;;10.1007/bf02524422;;10.1063/1.2137623;;16599739;;16269188;;10.1016/j.jneumeth.2005.09.001;;10.1016/s1388-2457(02)00032-9;;11956006;;9579886;;10.1111/j.1528-1157.1997.tb01250.x;;18827312;;pmc2888045;;10.1088/1741-2560/5/4/004;;12364503;;10.1152/jn.2002.88.4.1743;;10.1155/s1026022600000200;;15848265;;10.1016/j.cmpb.2004.10.009;;10.1073/pnas.75.9.4194;;pmc336078;;279908;;10.1103/physrevlett.81.3291;;10.1007/s00422-002-0368-4;;12567227;;10.1142/s0129065703001790;;15031857;;10.1016/0167-2789(92)90102-s;;14629902;;10.1016/s0887-8994(03)00145-0;;14701993;;10.1097/00004691-200309000-00004;;12724880;;10.1002/ana.10323;;12402252;;15987261;;10.1111/j.1528-1167.2005.01016.x;;15008506;;10.2307/4010382;;10415414;;10.1016/s0006-8993(99)01647-9;;12791335;;10.1016/s1525-5050(03)00105-7;;10.1152/jn.00190.2006;;pmc2230664;;17021032;;10.1007/11430919_60;;12423382;;10.1046/j.1528-1157.2002.15702.x;;10.1016/s1388-2457(03)00194-9;;14499758;;10.1109/iembs.2001.1020546;;10.2172/814360;;10.1001/archneur.64.11.1595;;17998441,"Nijsen, T. M. E. et al; “The potential value of three-dimensional accelerometry for detection of motor seizures in severe epilepsy”; Epilepsy & Behavior 7 (2005) 74-84.;;Cuppens, K. et al; “Detection of nocturnal epileptic seizures of pediatric patients using accelerometers: preliminary results”; IEEE Benelux EMBS Symposium; Dec. 6-7, 2007; p. 1-4.;;Nijsen, T. M.; “Detection of Subtle Nocturnal Motor Activity From 3-D Accelerometery Recording in Epilepsy Patients”; IEEE Transactions on Biomedical Engineering; vol. 54; No. 11; Nov. 2007; p. 2073-2081. (Year: 2007).;;Quensey, L. F.; “Clinical and EEG features of Complex Partial Seizures of Temporal Lobe Origin”; Epilepsia, 27 (Suppl. 2):S27-S45, 1986. (Year: 1986).;;D'Alessandro, M. et al; “A multi-feature and multi-channel univariate selection process for seizure prediction”; Clinical Neurophysiology, vol. 116, Issue 3, 2005, pp. 506-516. (Year: 2005).;;Osorio, I. et al; (2002), “Performance Reassessment of a Real-time Seizure-detection Algorithm on Long ECoG Series”. Epilepsia, 43: 1522-1535. (Year: 2002).;;Reuber, Markus, et al. “Clinical significance of recurrent psychogenic nonepileptic seizure status.” Journal of Neurology 250.11 (2003): 1355-1362. (Year: 2003).;;Adjouadi, et al. A new mathematical approach based on orthogonal operators for the detection of interictal spikes in epileptogenic data. Biomed. Sci. Instrum. 2004; 40: 175-80.;;Adjouadi, et al. Detection of interictal spikes and artifactual data through orthogonal transformations. J. Clin. Neuorophysiol. 2005; 22(1):53-64.;;Adjouadi, et al. Interictal spike detection using the Walsh transform. IEEE Trans. Biomed. Eng. 2004; 51(5):868-72.;;Aksenova, et al. On-line disharmony detection for early prediction of epilepsy seizure onset. 5th International Workshop Neural Coding 2003. Aulla (Italy) Sep. 20-25, 2003. (Abstract).;;Aksevnova, et al. Nonparametric on-line detection of changes in signal spectral characteristics for early prediction of epilepsy seizure onset. J. Automation and Information Sciences. 2004; 36(8): 35-45.;;Andrzejak, et al. Testing the null hypothesis of the nonexistence of a preseizure state. Physical Review E. 2003; 67: 010901-1-010901-4.;;Andrzejak, et al. Bivariate surrogate techniques: necessity, strengths, and caveats. Physical Review E. 2003; 68: 066202-1-066202-15.;;Aschenbrenner-Scheibe, et al. How well can epileptic seizures be predicted? An evaluation of a nonlinear method. Brain. 2003; 126: 2616-26.;;Bangham et al. Diffusion of univalent ions across the lamellae of swollen phospholipids. 1965. J Mol. Biol. 13: 238-252.;;Baruchi, et al. Functional holography of complex networks activity—From cultures to the human brain. Complexity. 2005; 10(3): 38 R 51.;;Baruchi, et al. Functional holography of recorded neuronal networks activity. Neuroinformatics. 2004; 2(3): 333-51.;;Ben-Hur, et al. Detecting stable clusters using principal component analysis. Methods Mol. Biol. 2003; 224: 159-82.;;Bergey, et al. Epileptic seizures are characterized by changing signal complexity. Clin. Neurophysiol. 2001; 112(2): 241-9.;;Betterton, et al. Determining State of Consciousness from the Intracranial Electroencephalogram (IEEG) for Seizure Prediction. From Proceeding (377) Modeling, Identification, and Control. 2003; 377-201: 313-317.;;Bhattacharya, et al. Enhanced phase synchrony in the electroencephalograph gamma band for musicians while listing to music. Phys. Rev. E. 2001; 64:012902-1-4.;;Boley, et al. Training Support Vector Machine using Adaptive Clustering. 2004 SIAM International Conference on Data Mining, Apr. 22-Apr. 24, 2004. Lake Buena Vista, FL, USA. 12 pages.;;Burges, C. A Tutorial on Support Vector Machines for Pattern Recognition. Data Mining and Knowledge Discovery. 1998; 2: 121-167.;;Cao, et al. Detecting dynamical changes in time series using the permutation entropy. Physical Review E. 2004; 70:046217-1-046217-7.;;Carretero-Gonzalez, et al. Scaling and interleaving of subsystem Lyapunov exponents for spatio-temporal systems. Chaos. 1999; 9(2): 466-482.;;Casdagli, et al. Characterizing nonlinearity in invasive EEG recordings from temporal lobe epilepsy. Physica D. 1996; 99 (2/3): 381-399.;;Casdagli, et al. Nonlinear Analysis of Mesial Temporal Lobe Seizures Using a Surrogate Data Technique. Epilepsia. 1995; 36, suppl. 4, pp. 142.;;Casdagli, et al. Non-linearity in invasive EEG recordings from patients with temporary lobe epilepsy. Electroencephalogr. Clin Neurophysiol. 1997; 102(2): 98-105.;;Cerf, et al. Critically and synchrony of fluctuations in rhythmical brain activity: pretransitional effects in epileptic patients. Biol. Cybern. 2004; 90(4): 239-55.;;Chaovalitwongse et al.; Reply to comments on “Performance of a seizure warning based on the dynamics of intracranial EEG”; Epilepsy Research, Elsevier Science Publishers, Amsterdam, NL; vol. 72; No. 1; pp. 82-84; Nov. 1, 2006.;;Chaovalitwongse, et al. EEG Classification in Epilepsy. Annals. 2004; 2(37): 1-31.;;Chaovalitwongse, et al. Performance of a seizure warning algorithm based on the dynamics of intracranial EEG. Epilepsy Res. 2005; 64(3): 93-113.;;Chavez, et al. Spatio-temporal dynamics prior to neocortical seizures: amplitude versphase couplings. IEEE Trans. Biomed. Eng. 2003; 50(5):571-83.;;Crichton, Michael, “Terminal Man”, 1972, Ballantine Books, NY, NY, pp. 21-24, 32-33, 70-71, and 74-81.;;D'Alessandro, et al. A multi-feature and multi-channel univariate selection process for seizure prediction. Clin. Neurophysiol. 2005; 116(3): 506-16.;;D'Alessandro, et al. Epileptic seizure prediction using hybrid feature selection over multiple intracranial EEG electrode contacts: a report of four patients. IEEE Trans. Biomed. Eng. 2003; 50(5): 603-15.;;Drury, et al. Seizure prediction using scalp electroencephalogram. Exp. Neurol. 2003; 184 Suppl 1: S9-18.;;Ebersole, U.S. In search of seizure prediction: a critique. Clin. Neurophysiol. 2005; 116(3); 489-92.;;Elbert et al. Chaos and Physiology: Deterministic Chaos in Excitable Cell Assemblies. Physiological Reviews. 1994; 74(1):1-47.;;Elger, et al. Nonlinear EEG analysis and its potential role in epileptology. Epilepsia. 2000; 41 Suppl 3: S34-8.;;Elger, et al. Seizure prediction by non-linear time series analysis of brain electrical activity. Eur. J. Neurosci. 1998; 10(2): 786-789.;;Esteller, et al. A Comparison of Waveform Fractal Dimension Algorithms. IEEE Transactions on Circuits and Systems. 2001; vol. 48(2): 177-183.;;Esteller, et al. Continuoenergy variation during the seizure cycle: towards an on-line accumulated energy. Clin. Neurophysiol. 2005; 116(3): 517-26.;;Faul, et al. An evaluation of automated neonatal seizure detection methods. Clin. Neurophysiol. 2005; 116(7): 1533-41.;;Fein, et al. Common reference coherence data are confounded by power and phase effects. Electroencephalogr. Clin. Neurophysiol. 1988; 69:581-584.;;Fell, et al. Linear inverse filtering improves spatial separation of nonlinear brain dynamics: a simulation study. J. Neurosci. Methods. 2000; 98(1): 49-56.;;Firpi, et al. Epileptic seizure detection by means of genetically programmed artificial features. GECCO 2005: Proceedings of the 2005 conference on Genetic and evolutionary computation, vol. 1, pp. 461-466, Washington DC, USA, 2005. ACM Press.;;Fisher et al. 1999. Reassessment: Vagnerve stimulation for epilepsy, A report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology.53: 666-669.;;Franaszczuk et al.; An autoregressive method for the measurement of synchronization of interictal and ictal EEG signals; Biological Cybernetics, vol. 81; No. 1; pp. 3-9; 1999.;;Geva, et al. Forecasting generalized epileptic seizures from the EEG signal by wavelet analysis and dynamic unsupervised fuzzy clustering. IEEE Trans. Biomed. Eng. 1998; 45(10): 1205-16.;;Gigola, et al. Prediction of epileptic seizures using accumulated energy in a multiresolution framework. J. Neurosci. Methods. 2004; 138(1-2): 107-111.;;Guyon, I. An introduction to variable and feature selection. Journal of Machine Learning Research. 2003; 3:1157-1182.;;Guyon, I. Multivariate Non-Linear Feature Selection with Kernel Multiplicative Updates and Gram-Schmidt Relief. BISC FLINT-CIBI 2003 Workshop. Berkeley. 2003; p. 1-11.;;Harrison, et al. Accumulated energy revised. Clin. Neurophysiol. 2005; 116(3):527-31.;;Harrison, et al. Correlation dimension and integral do not predict epileptic seizures. Chaos. 2005; 15(3): 33106-1-15.;;Hearst M. Trends & Controversies: Support Vector Machines. IEEE Intelligent Systems. 1998; 13: 18-28.;;Hively, et al. Channel-consistent forewarning of epileptic events from scalp EEG. IEEE Trans. Biomed. Eng. 2003; 50(5): 584-93.;;Hively, et al. Detecting dynamical changes in nonlinear time series. Physics Letters A. 1999; 258: 103-114.;;Hjorth, B. Source derivation simplifies topographical EEG interpretation. Am. J. EEG Technol. 1980; 20:121-132.;;Huynh, J. A. Evaluation of Gene Selection Using Support Vector Machine Recursive Feature Elimination. Presentation slides. (41 pages) (May 26, 2004).;;Huynh, J. A. Evaluation of Gene Selection Using Support Vector Machine Recursive Feature Elimination. Arizona State University. May 26, 2004. (28 pages).;;Iasemidis, et al. Adaptive epileptic seizure prediction system. IEEE Trans. Biomed. Eng. 2003; 50(5):616-27.;;Iasemidis, et al. Automated Seizure Prediction Paradigm. Epilepsia. 1998; vol. 39, pp. 56.;;Iasemidis, et al. Chaos Theory and Epilepsy. The Neuroscientist. 1996; 2:118-126.;;Iasemidis, et al. Comment on “Inability of Lyapunov exponents to predict epileptic seizures.” Physical Review Letters. 2005; 94(1):019801-1.;;Iasemidis, et al. Detection of the Preictal Transition State in Scalp-Sphenoidal EEG Recordings. American Clinical Neurophysiology Society Annual Meeting, Sep. 1996. pp. C206.;;Iasemidis, et al. Dynamical Interaction of the Epileptogenic Focwith Extrafocal Sites in Temporal Lobe Epilepsy (TLE). Ann. Neurol. 1997; 42, pp. 429. pp. M146.;;Iasemidis, et al. Epileptogenic FocLocalization by Dynamical Analysis of Interictal Periods of EEG in Patients with Temporal Lobe Epilepsy. Epilepsia. 1997; 38, suppl. 8, pp. 213.;;Iasemidis, et al. Localizing Preictal Temporal Lobe Spike Foci Using Phase Space Analysis. Electroencephalography and Clinical Neurophysiology. 1990; 75, pp. S63-S64.;;Iasemidis, et al. Long-term prospective on-line real-time seizure prediction. Clin. Neurophysiol. 2005; 116(3): 532-44.;;Iasemidis, et al. Long-Time-Scale Temporo-spatial Patterns of Entertainment of Preictal Electrocorticographic Data in Human Temporal Lobe Epilepsy. Epilepsia. 1990; 31(5):621.;;Iasemidis, et al. Measurement and Quantification of Spatio-Temporal Dynamics of Human Epileptic Seizures. In: Nonlinear Signal Processing in Medicine, Ed. M. Akay, IEEE Press. 1999; pp. 1-27.;;Iasemidis, et al. Modelling of ECoG in temporal lobe epilepsy. Biomed. Sci. Instrum. 1988; 24: 187-93.;;Iasemidis, et al. Nonlinear Dynamics of EcoG Data in Temporal Lobe Epilepsy. Electroencephalography and Clinical Neurophysiology. 1998; 5, pp. 339.;;Iasemidis, et al. Phase space topography and the Lyapunov exponent of electrocorticograms in partial seizures. Brain Topogr. 1990; 2(3): 187-201.;;Iasemidis, et al. Preictal Entrainment of a Critical Cortical Mass is a Necessary Condition for Seizure Occurrence. Epilepsia. 1996; 37, suppl. 5. pp. 90.;;Iasemidis, et al. Preictal-Postictal Vers Postictal Analysis for Epileptogenic Foc Localization. J. Clin. Neurophysiol. 1997; 14, pp. 144.;;Iasemidis, et al. Quadratic binary programming and dynamic system approach to determine the predictability of epileptic seizures. Journal of Combinatorial Optimization. 2001; 5: 9-26.;;Iasemidis, et al. Quantification of Hidden Time Dependencies in the EEG within the Framework of Non-Linear Dynamics. World Scientific. 1993; pp. 30-47.;;Iasemidis, et al. Spatiotemporal dynamics of human epileptic seizures. World Scientific. 1996; pp. 26-30.;;Iasemidis, et al. Spatiotemporal Evolution of Dynamical Measures Precedes Onset of Mesial Temporal Lobe Seizures. Epilepsia. 1994; 358, pp. 133.;;Iasemidis, et al. Spatiotemporal Transition to Epileptic Seizures: A Nonlinear Dynamical Analysis of Scalp and Intracranial EEG Recordings. (In Silva, F.L. Spatiotemporal Models in Biological and Artificial Systems. Ohmsha IOS Press. 1997; 37, pp. 81-88.).;;Iasemidis, et al. The evolution with time of the spatial distribution of the largest Lyapunov exponent on the human epileptic cortex. World Scientific. 1991; pp. 49-82.;;Iasemidis, et al. Time Dependencies in Partial Epilepsy. 1993; 34, pp. 130-131.;;Iasemidis, et al. Time dependencies in the occurrences of epileptic seizures. Epilepsy Res. 1994; 17(1): 81-94.;;Iasemidis, L. D. Epileptic seizure prediction and control. IEEE Trans. Biomed. Eng. 2003; 50(5):549-58.;;Jerger, et al. Early seizure detection. Journal of Clin. Neurophysiol. 2001; 18(3):259-68.;;Jerger, et al. Multivariate linear discrimination of seizures. Clin. Neurophysiol. 2005; 116(3):545-51.;;Jouny, et al. Characterization of epileptic seizure dynamics using Gabor atom density. Clin. Neurophysiol. 2003; 114(3):426-37.;;Jouny, et al. Signal complexity and synchrony of epileptic seizures: is there an identifiable preictal period? Clin. Neurophysiol. 2005; 116(3):552-8.;;Kapiris, et al. Similarities in precursory features in seismic shocks and epileptic seizures. Europhys. Lett. 2005; 69(4);657-663.;;Katz, et al. Does interictal spiking change prior to seizures? Electroencephalogr. Clin. Neurophysiol. 1991; 79(2):153-6.;;Kerem, et al. Forecasting epilepsy from the heart rate signal. Med. Biol. Eng. Comput. 2005; 43(2):230-9.;;Khalilov, et al. Epileptogenic actions of GABA and fast oscillations in the developing hippocampus. Neuron. 2005; 48(5):787-96.;;Korn, et al. Is there chaos in the brain? II. Experimental evidence and related models. C. R. Biol. 2003; 326(9):787-840.;;Kreuz, et al. Measure profile surrogates: a method to validate the performance of epileptic seizure prediction algorithms. Phys. Rev. E. 2004; 69(6 Pt 1):061915-1-9.;;Lachaux, et al. Measuring phase synchrony in brain signals. Hum. Brain Mapp. 1999; 8(4):194-208.;;Lai, et al. Controlled test for predictive power of Lyapunov exponents: their inability to predict epileptic seizures. Chaos. 2004; 14(3):630-42.;;Lai, et al. Inability of Lyapunov exponents to predict epileptic seizures. Phys. Rev. Lett. 2003; 91(6):068102-1-4.;;Latka, et al. Wavelet analysis of epileptic spikes. Phys. Rev. E. 2003; 67(5 Pt 1):052902 (6 pages).;;Le Van Quyen, et al. Anticipating epileptic seizures in real time by a non-linear analysis of similarity between EEG recordings. Neuroreport. 1999; 10(10):2149-55.;;Le Van Quyen, et al. Author's second reply. The Lancet. 2003; 361:971.;;Le Van Quyen, et al. Comparison of Hilbert transform and wavelet methods for the analysis of neuronal synchrony. J. Neurosci. Methods. 2001; 111(2):83-98.;;Le Van Quyen, et al. Nonlinear analyses of interictal EEG map the brain interdependences in human focal epilepsy. Physicia D. 1999; 127:250-266.;;Le Van Quyen, et al. Preictal state identification by synchronization changes in long-term intracranial EEG recordings. Clin. Neurophysiol. 2005; 116(3):559-68.;;Le Van Quyen, M. Anticipating epileptic seizures: from mathematics to clinical applications. C. R. Biol. 2005; 328(2):187-98.;;Lehnertz, et al. Nonlinear EEG analysis in epilepsy: its possible use for interictal foe localization, seizure anticipation, and prevention. J. Clin. Neurophysiol. 2001; 18(3):209-22.;;Lehnertz, et al. Seizure prediction by nonlinear EEG analysis. IEEE Eng. Med. Biol. Mag. 2003; 22(1):57-63.;;Lehnertz, et al. The First International Collaborative Workshop on Seizure Prediction: summary and data description. Clin. Neurophysiol. 2005; 116(3):493-505.;;Lehnertz, K. Non-linear time series analysis of intracranial EEG recordings in patients with epilepsy—and overview. Int. J. Psychophysiol. 1999; 34(1):45-52.;;Lemos, et al. The weighted average reference montage. Electroencephalogr. Clin. Neurophysiol. 1991; 70(5):361-70.;;Li, et al. Fractal spectral analysis of pre-epileptic seizures in terms of critically. J. Neural Eng. 2005; 2(2):11-16.;;Li, et al. Linear and nonlinear measures and seizure anticipation in temporal lobe epilepsy. J. Comput. Neurosci. 2003; 15(3):335-45.;;Li, et al. Non-linear, non-invasive method for seizure anticipation in focal epilepsy. Math. Biosci. 2003; 186(1):63-77.;;Litt, et al. Prediction of epileptic seizures. Lancet Neurol. 2002; 1(1):22-30.;;Litt, et al. Seizure prediction and the preseizure period. Curr. Opin. Neurol. 2002; 15(2):173-7.;;Maiwald, et al. Comparison of three nonlinear seizure prediction methods by means of the seizure prediction characteristic. Physica D. 2004; 194:357-368.;;Mangasarian, et al. Lagrangian Support Vector Machines. Journal of Machine Learning Research. 2001; 1:161-177.;;Martinerie, et al. Epileptic seizures can be anticipated by non-linear analysis. Nat. Med. 1998; 4(10):1173-6.;;McSharry, et al. Comparison of predictability of epileptic seizures by linear and a nonlinear method. IEEE Trans. Biomed. Eng. 2003; 50(5):628.33.;;McSharry, et al. Linear and non-linear methods for automatic seizure detection in scalp electro-encephalogram recordings. Med. Biol. Eng. Comput. 2002; 40(4):447-61.;;McSharry, P. E. Detection of dynamical transitions in biomedical signals using nonlinear methods. Lecture Notes in Computer Science 2004; 3215:483-490.;;Meng, et al. Gaussian mixture models of ECoG signal features for improved detection of epileptic seizures. Med. Eng. Phys. 2004; 26(5):379-93.;;Mizuno-Matsumoto, et al. Wavelet-crosscorrelation analysis can help predict whether bursts of pulse stimulation will terminate after discharges. Clin. Neurophysiol. 2002; 113(1):33-42.;;Mormann et al.; Seizure prediction: the long and winding road; BRAIN; vol. 130; No. 2; pp. 314-333; Sep. 28, 2006.;;Mormann, et al. Automated detection of a preseizure based on a decrease in synchronization in intracranial electroencephalogram recordings from epilepsy patients. Phys. Rev. E. 2003; 67(2 Pt 1):021912-1-10.;;Mormann, et al. Epileptic seizures are preceded by a decrease in synchronization. Epilepsy Res. 2003; 53(3):173-85.;;Mormann, et al. Mean phase coherence as a measure for phase synchronization and its application to the EEG of epilepsy patients. Physica D. 2000; 144:358-369.;;Mormann, et al. On the predictability of epileptic seizures. Clin. Neurophysiol. 2005; 116(3):569-87.;;Mormann, et al. Seizure anticipation: from algorithms to clinical practice. Curr. Opin. Neurol. 2006; 19(2):187-93.;;Navarro, et al. Seizure anticipation in human neocortical partial epilepsy. Brain. 2002; 125:640-55.;;Navarro, et al. Seizure anticipation: do mathematical measures correlate with video-EEG evaluation? Epilepsia. 2005; 46(3):385-96.;;Niederhauser, et al. Detection of seizure precursors from depth-EEG using a sign periodogram transform. IEEE Trans. Biomed. Eng. 2003; 50(4):449-58.;;Nigam, et al. A neural-network-based detection of epilepsy. Neurological Research. 2004; 26(1):55-60.;;Osorio, et al. Automated seizure abatement in humans using electrical stimulation. Ann. Neurol. 2005; 57(2):258-68.;;Osorio, et al. Performance reassessment of a real-time seizure-detection algorithm on long ECoG series. Epilepsia. 2002; 43(12):1522-35.;;Osorio, et al. Real-time automated detection and quantitative analysis of seizures and short-term prediction of clinical onset. Epilepsia. 1998; 39(6):615-27.;;Ossadtchi, et al. Hidden Markov modeling of spike propagation from interictal MEG data. Phys. Med. Biol. 2005; 50(14):3447-69.;;Pflieger, et al. A noninvasive method for analysis of epileptogenic brain connectivity. Presented at the American Epilepsy Society 2004 Annual meeting, New Orleans. Dec. 6, 2004. Epilepsia. 2004; 45(Suppl. 7):70-71.;;Platt, et al. Large Margin DAGs for Multiclass Classification. S.A. Solla. T.K. Leen and K.R. Muller (eds.). 2000; pp. 547-553.;;Platt, J. C. Using Analytic QP and Sparseness to Speed Training of Support Vector Machines. Advances in Neural Information Processing Systems. 1999; 11:557-563.;;Protopopescu, et al. Epileptic event forewarning from scalp EEG. J. Clin. Neurophysiol. 2001; 18(3):223-45.;;Robinson, et al. Steady States and Global Dynamics of Electrical Activity in the Cerebral Coretex. Phys. Rev. E. 1998; (58):3557-3571.;;Rothman et al.; Local Cooling: a therapy for intractable neocortical epilepsy; Epilepsy Currents; vol. 3; No. 5; pp. 153-156; Sep./Oct. 2003.;;Rudrauf, et al. Frequency flows and the time-frequency dynamics of multivariate phase synchronization in brain signals. NeuroImage. 2005. (19 pages).;;Saab, et al. A system to detect the onset of epileptic seizures in scalp EEG. Clin. Neurophysiol. 2005; 116:427-442.;;Sackellares et al. Computer-Assisted Seizure Detection Based on Quantitative Dynamical Measures. American Electroencephalographic Society Annual Meeting, Sep. 1994.;;Sackellares et al. Dynamical Studies of Human Hippocampin Limbic Epilepsy. Neurology. 1995; 45, Suppl. 4, pp. A 404.;;Sackellares et al. Epileptic Seizures as Neural Resetting Mechanisms. Epilepsia. 1997; vol. 38, Sup. 3.;;Sackellares et al. Measurement of Chaos to Localize Seizure Onset. Epilepsia. 1989; 30(5):663.;;Sackellares et al. Predictability Analysis for an Automated Seizure Prediction algorrithim; Journal of Clinical Neurophysiology; vol. 23; No. 6; pp. 509-520; Dec. 2006.;;Sackellares et al. Relationship Between Hippocampal Atrophy and Dynamical Measures of EEG in Depth Electrode Recordings. American Electroencephalographic Society Annual Meeting, Sep. 1995. pp. A105.;;Sackellares, J. C. Epilepsy—when chaos fails. In: chaos in the brain? Eds. K. Lehnertz & C.E. Elger. World Scientific. 2000 (22 pages).;;Salant, et al. Prediction of epileptic seizures from two-channel EEG. Med. Biol. Eng. Comput. 1998; 36(5):549-56.;;Schelter et al.; Testing statistical significance of multivariate time series analysis techniques for epileptic seizure prediction; Chaos;: An Interdisciplinary Journal of Nonlinear Science; vol. 16; No. 013108; pp. 1-10; Jan. 2006.;;Schelter, et al. Testing for directed influences among neural signals using partial directed coherence. J. Neurosci. Methods. 2006; 152-(1-2):210-9.;;Schindler, et al. EEG analysis with simulated neuronal cell models helps to detect pre-seizure changes. Clin. Neurophysiol. 2002; 113(4):604-14.;;Schwartzkroin, P. Origins of the Epileptic State. Epilepsia. 1997; 38, supply. 8, pp. 853-858.;;Shoeb et al. Patient-specific seizure detection. MIT Computer Science and Artificial Intelligence Laboratory. 2004; pp. 193-194.;;Snyder et al.; The statistics of a practical seizure warning system; Journal of Neural Engineering; vol. 5; pp. 392-401; 2008.;;Staba, et al. Quantitative analysis of high-frequency oscillations (80-500 Hz) recorded in human epileptic hippocampand entorhinal cortex. J. Neurophysiol. 2002; 88(4): 1743-52.;;Stefanski, et al. Using chaos synchronization to estimate the largest Lyapunov exponent of nonsmooth systems, discrete Dynamics in Nature and Society. 2000; 4:207-215.;;Subasi, et al. Classification of EEG signals using neural network and logistic regression. Computer Methods Programs Biomed. 2005; 78(2):87-99.;;Szoka et al. Procedure for preparation of liposomes with large internal aqueospace and high capture volume by reverse phase evaporation. 1978 Proc. Natl Acad. Sci. USA. 75:4194-4198.;;Tass, et al. Detection of n: m Phase Locking from Noisy Data: Application to Magnetoencephalography. Physical Review Letters. 1998; 81(15):3291-3294.;;Terry, et al. An improved algorithm for the detection of dynamical interdependence in bivariate time-series. Biol. Cybern. 2003; 88(2):129-36.;;Tetzlaff, et al. Cellular neural networks (CNN) with linear weight functions for a prediction of epileptic seizures. Int'l. J. of Neural Systems. 2003; 13(6):489-498.;;Theiler, et al. Testing for non-linearity in time series: the method of surrogate data. Physica D. 1992; 58:77-94.;;Tsakalis, K. S. Prediction and control of epileptic seizures: Coupled oscillator models. Arizona State University. (Slide: 53 pages) (No date).;;Van Drongelen, et al. Seizure anticipation in pediatric epilepsy: use of Kolmogorov entropy. Pediatr. Neurol. 2003; 29(3): 207-13.;;Van Putten, M. Nearest neighbor phase synchronization as a measure to detect seizure activity from scalp EEG recordings. J. Clin. Neurophysiol. 2003; 20(5):320-5.;;Venugopal, et al. A new approach towards predictability of epileptic seizures: KLT dimension. Biomed Sci. Instrum. 2003; 39:123-8.;;Vonck, et al. Long-term amygdalohippocampal stimulation for refractory temporal lobe epilepsy. Ann. Neurol. 2002; 52(5):556-65.;;Vonck, et al. Long-term deep brain stimulation for refractory temporal lobe epilepsy. Epilepsia. 2005; 46 (Suppl 5):98-9.;;Vonck, et al. Neurostimulation for refractory epilepsy. Acta. Neurol. Belg. 2003; 103(4):213-7.;;Weiss, P. Seizure prelude found by chaos calculation. Science News. 1998; 153(20):326.;;Widman, et al. Reduced signal complexity of intracellular recordings: a precursor for epileptiform activity? Brain Res. 1999; 836(1-2):156-63.;;Winterhalder, et al. The seizure prediction characteristic: a general framework to assess and compare seizure prediction methods. Epilepsy Behav. 2003; 4(3):318-25.;;Wong et al.; A stochastic framework for evaluating seizure prediction algorithms using hidden markov models; Journal of Neurophysiology; vol. 97, No. 3; pp. 2525-2532; Oct. 4, 2006.;;Yang et al.; Testing whether a prediction scheme is better than guess; Ch. 14 in Quantitative Neuroscience: Models, Algorithms, Diagnostics, and Therapeutic Applications; pp. 252-262; 2004.;;Yang, et al. CLe Ver: A feature subset selection technique for multivariate time series. T.B. Ho, D. Cheung, and H. Liu (Eds.): PAKDD. 2005; LNAI 3518: 516-522.;;Yang, et al. Relation between Responsiveness to Neurotransmitters and Complexity of Epileptiform Activity in Rat Hippocampal CA1 Neurons. Epilepsia. 2002; 43(11):1330-1336.;;Yatsenko, et al. Geometric Models, Fiber Bundles, and Biomedical Applications. Proceedings of Institute of Mathematics of NAS of Ukraine. 2004; 50(Part 3):1518R1525.;;Zaveri et al. Time-Frequency Analyses of Nonstationary Brain Signals. Electroencephalography and Clinical Neurophysiology. 1991; 79, pp. 28P-29P).;;Zhang, et al. High-resolution EEG: cortical potential imaging of interictal spikes. Clin. Neurophysiol. 2003; 114(10):1963-73.;;Ebersole, J.S. Functional neuroimaging with EEG source models to localize epileptogenic foci noninvasively. 2006. 3 pages.;;Esteller, et al. Feature Parameter Optimization for Seizure Detection/Prediction. Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Istanbul, Turkey. Oct. 2001. 5 pages.;;Gardner, A.B. A Novelty Detection Approach to Seizure Analysis from Intracranial EEG. Georgia Institute of Technology. Apr. 2004. 160 pages.;;Hively, et al. Epileptic Seizure Forewarning by Nonlinear Techniques. ORNL/TM-2000/333 Oak Ridge National Laboratory. Nov. 2000. 41 pages.;;Hoppe et al.; Accuracy of Patient Seizure Counts; Arch Neurol.;vol. 64; No. 11: pp. 1595-1599; 2007.;;Hsu, et al. A practical guide to support vector classification. Technical report, Department of Computer Science and Information Technology, National Taiwan University, 2003. 12 pages.;;Iasemidis, et al. The Use of Dynamical Analysis of EEG Frequency content in Seizure Prediction. American Electroencephalographic Society Annual Meeting. Oct. 1993. 2 pages.;;Kraskov, A. Synchronization and Interdependence Measures and Their Applications to the Electroencephalogram of Epilepsy Patients and Clustering of Data. Feb. 2004. 106 pages.;;Pittman, V. Flexible Drug Dosing Procedures Less Side-effects in People With Epilepsy. Dec. 29, 2005. 3 pages.;;Rahimi, et al. On the Effectiveness of Aluminum Foil Helmets: An Empirical Study. Feb. 17, 2005. 5 pages.;;Remington, et al. Remington's Pharmaceutical Sciences, Mack Publishing co., Easton PA. 1990. pp. 674-677 and 1072-1081.;;Sheridan, T. Humans and Automation: System Design and Research Issues. NY: John Wiley. 2002. 144 pages.;;Wells, R. B. Spatio-Temporal Binding and Dynamic Cortical Organization: Research Issues. Mar. 2005. 68 pages.;;Winterhalder, et al. Sensitivity and specificity of coherence and phase synchronization analysis. 2006. 9 pages.;;Yang, et al. A supervised feature subset selection technique for multivariate time series. 2005. 10 pages.;;Tsakalis, K.S. Prediction and control of epileptic seizures: Coupled oscillator models. Arizona State University. (Slide: 53 pages) (2005).",ACTIVE
36,WO,A1,WO 2023/069540 A1,169-965-369-090-887,2023-04-27,2023,US 2022/0047160 W,2022-10-19,US 202117508539 A,2021-10-22,SYSTEMS AND METHODS FOR ACCELERATION-BASED SEIZURE DETECTION,"A seizure detection system comprises a sensor and a control system. The sensor is configured to detect acceleration data associated with a patient's movements. The control system is programmed to monitor, via the sensor, the acceleration data to detect a seizure precursor event. The control system is further programmed to, upon detection of the seizure precursor event, perform a frequency analysis of the acceleration data to identify a frequency of the patient's movements. The control system is further programmed to determine that the patient is experiencing a seizure event based on the frequency of the patient's movements.",LIVANOVA USA INC,CARLSON GERRARD MERRILL,,https://lens.org/169-965-369-090-887,Patent Application,yes,4,0,3,084-584-546-681-856;;169-965-369-090-887;;151-853-644-394-384,WO;;EP;;US,3,084-584-546-681-856;;169-965-369-090-887;;151-853-644-394-384,WO;;EP;;US,0,G16H50/20;;G16H40/60;;G06F17/142;;A61N1/36031;;A61B2562/0219;;A61N1/36064;;A61N1/36135,G16H40/60;;G06F17/14;;G16H50/20,,1,1,099-811-247-000-717,10.3389/fneur.2020.00701;;pmc7396638;;32849189,"KIM TAEHO ET AL: ""Epileptic Seizure Detection and Experimental Treatment: A Review"", FRONTIERS IN NEUROLOGY, vol. 11, 21 July 2020 (2020-07-21), XP093016370, DOI: 10.3389/fneur.2020.00701",PENDING
37,US,A1,US 2022/0080207 A1,091-201-321-442-785,2022-03-17,2022,US 202117537198 A,2021-11-29,US 202117537198 A;;US 201916290783 A;;US 201615395872 A;;US 201414457807 A,2014-08-12,NEUROSTIMULATION TITRATION PROCESS,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level. This titration process can minimize the amount of time required to complete titration so as to begin delivery of the stimulation at therapeutically desirable levels.,LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,LIVANOVA USA INC (2014-08-18),https://lens.org/091-201-321-442-785,Patent Application,yes,20,0,13,083-099-283-788-583;;001-798-740-492-568;;085-970-400-068-356;;091-201-321-442-785;;013-289-519-104-925;;155-792-182-018-403;;126-699-603-179-961;;049-221-692-052-909;;111-318-125-117-291;;051-419-033-355-901;;197-594-477-147-858;;096-249-903-310-170;;032-101-503-149-151,WO;;EP;;US,13,083-099-283-788-583;;001-798-740-492-568;;085-970-400-068-356;;091-201-321-442-785;;013-289-519-104-925;;155-792-182-018-403;;126-699-603-179-961;;049-221-692-052-909;;111-318-125-117-291;;051-419-033-355-901;;197-594-477-147-858;;096-249-903-310-170;;032-101-503-149-151,WO;;EP;;US,0,A61B5/4836;;A61B5/02055;;A61B5/0245;;A61N1/36157;;A61N1/36139;;A61N1/36114;;A61N1/36171;;A61N1/36175;;A61N1/36157;;A61N1/36132;;A61N1/36139;;A61N1/36114;;A61N1/36171;;A61N1/36175;;A61B5/4836;;A61B5/02055;;A61B5/0245;;A61B5/0205,A61N1/36;;A61B5/00;;A61B5/0205;;A61B5/0245,,0,0,,,,ACTIVE
38,US,B2,US 11918813 B2,051-419-033-355-901,2024-03-05,2024,US 202117537198 A,2021-11-29,US 202117537198 A;;US 201916290783 A;;US 201615395872 A;;US 201414457807 A,2014-08-12,Neurostimulation titration process,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level. This titration process can minimize the amount of time required to complete titration so as to begin delivery of the stimulation at therapeutically desirable levels.,LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,LIVANOVA USA INC (2014-08-18),https://lens.org/051-419-033-355-901,Granted Patent,yes,245,0,13,083-099-283-788-583;;001-798-740-492-568;;085-970-400-068-356;;091-201-321-442-785;;013-289-519-104-925;;155-792-182-018-403;;126-699-603-179-961;;049-221-692-052-909;;111-318-125-117-291;;051-419-033-355-901;;197-594-477-147-858;;096-249-903-310-170;;032-101-503-149-151,WO;;EP;;US,13,083-099-283-788-583;;001-798-740-492-568;;085-970-400-068-356;;091-201-321-442-785;;013-289-519-104-925;;155-792-182-018-403;;126-699-603-179-961;;049-221-692-052-909;;111-318-125-117-291;;051-419-033-355-901;;197-594-477-147-858;;096-249-903-310-170;;032-101-503-149-151,WO;;EP;;US,0,A61B5/4836;;A61B5/02055;;A61B5/0245;;A61N1/36157;;A61N1/36139;;A61N1/36114;;A61N1/36171;;A61N1/36175;;A61N1/36157;;A61N1/36132;;A61N1/36139;;A61N1/36114;;A61N1/36171;;A61N1/36175;;A61B5/4836;;A61B5/02055;;A61B5/0245;;A61B5/0205,A61N1/36;;A61B5/00;;A61B5/0205;;A61B5/0245,,258,219,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;131-082-682-819-47X;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-245-320-055-579;;061-418-436-648-248;;089-129-609-419-589;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;051-782-858-038-376;;054-362-910-657-616;;003-971-372-447-956;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpheart.1997.273.2.h805;;9277498;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;10733371;;10.1056/nejm200003233421202;;12432042;;10.1056/nejmoa021993;;9738637;;10.1161/01.cir.98.9.839;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;EP Extended Search Report on EP Appl. Ser. No. 21214800.1 dated Apr. 5, 2022 (5 pages).;;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration In Human Subjects and Verification In a Paced Canine Model Of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzing, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetyicholinesterase activity,” Am J Physiol Heart Circ Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of IMPROVE HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutids, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;International Search Report for PCT Patent Application No. PCT/US2015/043878, dated Oct. 29, 2015, 6 pages.;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Lw, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Circ. Physiol. 42), pp. H805-H816 (1997).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/043878, Search Report and Written Opinion dated Oct. 20, 2015, 13 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages. et al.",ACTIVE
39,US,B2,US 11147972 B2,114-042-390-189-450,2021-10-19,2021,US 201816185838 A,2018-11-09,US 201816185838 A;;US 201615181177 A,2016-06-13,Neurostimulator with titration assist,"A method of neurostimulation titration. The method includes setting titration parameters for an electrical signal delivered by an implantable medical device, initiating titration with the titration parameters and an aggressiveness profile, performing titration by increasing at least one of a current amplitude, a frequency, a pulse width or a duty cycle of the electrical signal until a threshold is reached or a side effect is detected, pausing the titration while waiting for commands from the patient or caregiver, and resuming the titration in response to receiving authorization from an external device.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,LIVANOVA USA INC (2017-02-01),https://lens.org/114-042-390-189-450,Granted Patent,yes,31,0,23,112-143-765-299-577;;136-797-791-441-841;;086-606-908-249-76X;;132-903-207-905-071;;036-785-322-240-760;;071-007-421-711-263;;090-708-370-825-703;;138-075-625-160-831;;129-787-164-564-153;;176-787-590-328-430;;114-042-390-189-450;;024-654-621-020-375;;032-839-705-200-147;;018-124-493-379-467;;044-217-322-189-306;;022-897-998-007-537;;093-696-673-586-387;;117-307-554-078-600;;047-873-282-336-301;;145-867-134-623-052;;006-356-173-808-442;;115-325-010-119-896;;120-431-302-816-626,WO;;EP;;AU;;CN;;IL;;CA;;BR;;JP;;US,23,112-143-765-299-577;;136-797-791-441-841;;086-606-908-249-76X;;132-903-207-905-071;;036-785-322-240-760;;071-007-421-711-263;;090-708-370-825-703;;138-075-625-160-831;;129-787-164-564-153;;176-787-590-328-430;;114-042-390-189-450;;024-654-621-020-375;;032-839-705-200-147;;018-124-493-379-467;;044-217-322-189-306;;022-897-998-007-537;;093-696-673-586-387;;117-307-554-078-600;;145-867-134-623-052;;047-873-282-336-301;;006-356-173-808-442;;115-325-010-119-896;;120-431-302-816-626,WO;;EP;;AU;;CN;;IL;;CA;;BR;;JP;;US,0,A61N1/36114;;A61N1/36053;;A61N1/36139;;A61N1/36114;;A61N1/36053;;A61N1/05;;A61N1/32;;A61N1/36139;;A61N1/18;;A61N1/36114;;A61N1/36053;;A61N1/36139,A61N1/36,,7,0,,,"International Search Report and Written Opinion, PCT/IB2018/54518, dated Oct. 18, 2018. 9 pages.;;International Search Report and Written Opinion, PCT/US2017/036990, dated Aug. 22, 2017. 11 pages.;;Search report on EP 17813868.1 dated Jan. 28, 2020.;;Extended European Search Report for EP 18821527.1 dated Dec. 22, 2020, 8 pages.;;Office Action issued in AU 2017284180 dated May 28, 2021.;;Office Action issued in CN 201780050108.3 dated May 6, 2021.;;Office Action issued in JP 2019-516926 dated May 31, 2021.",ACTIVE
40,US,A1,US 2024/0350097 A1,064-308-781-741-453,2024-10-24,2024,US 202418760951 A,2024-07-01,US 202418760951 A;;US 201715628287 A,2017-06-20,TITRATION ASSIST MANAGEMENT DASHBOARD,"Systems and methods of managing a plurality of patients undergoing titration using a management device. The method includes receiving titration parameters for a plurality of patients undergoing titration of neurostimulation delivered via implantable neurostimulators; determining a status of a progression of the titration of the neurostimulation for each patient based on the titration parameters, the status of the progression of the titration for each patient including a current stimulation parameter for the patient; determining a priority of each patient based on the status of the progression of the titration for the patient; generating a user interface visually indicating the priority and the current stimulation parameter of each patient; receiving an update of a selected stimulation parameter for a selected patient via an input received on the user interface; and transmitting the update of the selected stimulation parameter to the implantable neurostimulator of the selected patient.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,,https://lens.org/064-308-781-741-453,Patent Application,yes,0,0,6,112-598-744-138-847;;064-308-781-741-453;;187-340-746-287-128;;098-639-366-336-944;;053-550-863-558-341;;095-810-339-576-748,WO;;EP;;US,6,112-598-744-138-847;;064-308-781-741-453;;187-340-746-287-128;;098-639-366-336-944;;053-550-863-558-341;;095-810-339-576-748,WO;;EP;;US,0,A61B5/7475;;A61B5/0031;;A61B5/0245;;A61B5/4836;;A61N1/36114;;A61B2562/0219;;A61N1/37282;;G16H40/20;;G16H50/70;;G16H20/30;;G16H40/63;;A61N1/37247;;A61B5/024;;A61B5/349;;A61B5/7275;;G16H40/63;;A61B5/0031;;G16H50/70;;A61N1/37282;;A61B5/0245;;A61N1/36114;;A61B5/7475;;G16H40/20;;A61B5/4836;;A61B2562/0219;;G16H20/30;;A61B5/349,A61B5/00;;A61B5/0245;;A61B5/349;;A61N1/36;;A61N1/372;;G16H20/30;;G16H40/20;;G16H40/63;;G16H50/70,,0,0,,,,PENDING
41,US,A1,US 2024/0108901 A1,120-097-235-157-649,2024-04-04,2024,US 202318541938 A,2023-12-15,US 202318541938 A;;US 201916705043 A;;US 201615360188 A;;US 201414563181 A;;US 201462078600 P,2014-11-12,NEUROSTIMULATION TITRATION PROCESS VIA ADAPTIVE PARAMETRIC MODIFICATION,"Systems and methods are provided for delivering neurostimulation therapies to patients. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level. Between titration sessions one or more parameters, such as, for example, an acclimation interval, may be adjusted based on the patient's response to the stimulation. This personalized titration process can minimize the amount of time required to complete titration so as to begin delivery of the stimulation at therapeutically desirable levels.",LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI;;STUBBS SCOTT R,,https://lens.org/120-097-235-157-649,Patent Application,yes,2,0,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,0,A61N1/3702;;G16Z99/00;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/30;;A61B5/349;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/3702;;G16Z99/00;;G16H40/20;;G16H20/30;;A61B5/355;;A61B5/349;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/40,A61N1/36;;A61B5/349;;A61N1/05;;A61N1/37;;A61N1/372;;G16H20/30;;G16H20/40;;G16H40/20;;G16H40/63;;G16Z99/00,,0,0,,,,PENDING
42,US,A1,US 2020/0188671 A1,007-668-919-711-911,2020-06-18,2020,US 201916711309 A,2019-12-11,US 201916711309 A;;US 201862779344 P,2018-12-13,NEUROMODULATION THERAPY FOR AUTO-IMMUNE AND INFLAMMATORY DISORDERS,The present disclosure relates to a method for modulating the nervous system in order to reduce inflammation. The method includes delivering a vagus nerve stimulation (VNS) therapy to a vagus nerve of a patient for the treatment of inflammation according to a first set of parameters. The method further includes delivering a secondary nerve stimulation (SNS) therapy to a secondary nerve of the patient for the treatment of a sleep disorder according to a second set of parameters different from the first set of parameters.,LIVANOVA USA INC,LOVETT ERIC,LIVANOVA USA INC (2020-05-08),https://lens.org/007-668-919-711-911,Patent Application,yes,0,5,6,170-482-156-394-966;;079-591-993-595-751;;146-916-783-629-512;;007-668-919-711-911;;199-461-237-434-480;;147-444-582-760-446,WO;;EP;;US,6,170-482-156-394-966;;199-461-237-434-480;;146-916-783-629-512;;007-668-919-711-911;;079-591-993-595-751;;147-444-582-760-446,WO;;EP;;US,0,A61N1/3611;;A61N1/36139;;A61N1/36053;;A61N1/36078;;A61B5/4836;;A61B5/4812;;A61B5/0205;;A61B5/686;;A61N1/36053;;A61N1/36117;;A61N1/36139;;A61N1/36078;;A61N1/3606;;A61N1/3611,A61N1/36,,0,0,,,,ACTIVE
43,EP,B1,EP 3893988 B1,199-461-237-434-480,2025-03-12,2025,EP 19894543 A,2019-12-11,US 201862779344 P;;US 2019/0065792 W,2018-12-13,NEUROMODULATION SYSTEM FOR AUTO-IMMUNE AND INFLAMMATORY DISORDERS,,LIVANOVA USA INC,LOVETT ERIC,"LIVANOVA USA, INC. (2024-12-11)",https://lens.org/199-461-237-434-480,Granted Patent,yes,9,0,6,170-482-156-394-966;;079-591-993-595-751;;146-916-783-629-512;;007-668-919-711-911;;199-461-237-434-480;;147-444-582-760-446,WO;;EP;;US,6,170-482-156-394-966;;199-461-237-434-480;;146-916-783-629-512;;007-668-919-711-911;;079-591-993-595-751;;147-444-582-760-446,WO;;EP;;US,0,A61N1/3611;;A61N1/36139;;A61N1/36053;;A61N1/36078;;A61B5/4836;;A61B5/4812;;A61B5/0205;;A61B5/686;;A61N1/36053;;A61N1/36117;;A61N1/36139;;A61N1/36078;;A61N1/3606;;A61N1/3611,A61N1/36;;A61B5/00;;A61B5/0205;;A61N1/05;;A61N1/37;;A61N1/40,,0,0,,,,ACTIVE
44,US,A1,US 2020/0108256 A1,073-794-739-947-733,2020-04-09,2020,US 201916705043 A,2019-12-05,US 201916705043 A;;US 201615360188 A;;US 201414563181 A;;US 201462078600 P,2014-11-12,NEUROSTIMULATION TITRATION PROCESS VIA ADAPTIVE PARAMETRIC MODIFICATION,"Systems and methods are provided for delivering neurostimulation therapies to patients. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level. Between titration sessions one or more parameters, such as, for example, an acclimation interval, may be adjusted based on the patient's response to the stimulation. This personalized titration process can minimize the amount of time required to complete titration so as to begin delivery of the stimulation at therapeutically desirable levels.",LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI;;STUBBS SCOTT R,,https://lens.org/073-794-739-947-733,Patent Application,yes,0,0,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,0,A61N1/3702;;G16Z99/00;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/30;;A61B5/349;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/3702;;G16Z99/00;;G16H40/20;;G16H20/30;;A61B5/355;;A61B5/349;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/40,A61N1/36;;A61B5/0452;;A61N1/05;;A61N1/37;;A61N1/372;;G16H20/30;;G16H20/40;;G16H40/20;;G16H40/63;;G16Z99/00,,0,0,,,,ACTIVE
45,US,A1,US 2024/0245916 A1,117-514-853-968-824,2024-07-25,2024,US 202418423717 A,2024-01-26,US 202418423717 A;;US 202117144692 A;;US 201615285337 A;;US 201562237078 P,2015-10-05,STIMULATION SUSPENSION IN RESPONSE TO PATIENT DISCOMFORT OR STATE,"Systems and methods are provided for delivering neurostimulation therapies to patients. Stimulation from an implantable medical device (IMD) may be suspended in response to detecting a patient discomfort event, such as a cough, throat irritation, or voice alteration. The suspension period may be based on at least one of a severity level of the patient discomfort event and a patient physical state, such as being asleep or lying down. Detection of a patient discomfort event may be calibrated.",LIVANOVA USA INC,LIBBUS IMAD;;STUBBS SCOTT R;;KENKNIGHT BRUCE H,,https://lens.org/117-514-853-968-824,Patent Application,yes,0,0,7,145-158-920-258-759;;168-183-432-485-134;;110-378-002-453-162;;117-514-853-968-824;;130-767-094-738-433;;181-238-050-927-079;;012-260-058-023-245,WO;;EP;;US,7,145-158-920-258-759;;168-183-432-485-134;;110-378-002-453-162;;117-514-853-968-824;;181-238-050-927-079;;130-767-094-738-433;;012-260-058-023-245,WO;;EP;;US,0,A61B5/0823;;A61N1/36167;;A61B5/1135;;A61N1/36053;;A61N1/36114;;A61N1/36132;;A61N1/3614;;A61B5/086;;A61B5/0823;;A61N1/36167;;A61B5/1135;;A61N1/3614;;A61B5/086;;A61N1/36053;;A61N1/36114;;A61N1/36132;;A61N1/36139,A61N1/36;;A61B5/08;;A61B5/113,,0,0,,,,PENDING
46,US,B2,US 12029591 B2,112-598-744-138-847,2024-07-09,2024,US 201715628287 A,2017-06-20,US 201715628287 A,2017-06-20,Titration assist management dashboard,"Systems and methods of managing a plurality of patients undergoing titration using a management device. The method includes receiving, via a processor of a management device, a plurality of patient information from the plurality of patients, evaluating, via the processor of the management device, each patient based on patient information, determining, via the processor of the management device, a status of each patient, where the status is based on a progression of the titration based on titration assist parameters and determining, via the processor of the management device, a priority of each patient based on patient status. In some embodiments the method includes sorting that patients based on user input. In some embodiments, the plurality of patient information is received via remote communication with at least one of a programming device, an implantable medical device, or a home management device.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,LIVANOVA USA INC (2017-11-30),https://lens.org/112-598-744-138-847,Granted Patent,yes,36,0,6,112-598-744-138-847;;064-308-781-741-453;;187-340-746-287-128;;098-639-366-336-944;;053-550-863-558-341;;095-810-339-576-748,WO;;EP;;US,6,112-598-744-138-847;;064-308-781-741-453;;187-340-746-287-128;;098-639-366-336-944;;053-550-863-558-341;;095-810-339-576-748,WO;;EP;;US,0,A61B5/7475;;A61B5/0031;;A61B5/0245;;A61B5/4836;;A61N1/36114;;A61B2562/0219;;A61N1/37282;;G16H40/20;;G16H50/70;;G16H20/30;;G16H40/63;;A61N1/37247;;A61B5/024;;A61B5/349;;A61B5/7275;;G16H40/63;;A61B5/0031;;G16H50/70;;A61N1/37282;;A61B5/0245;;A61N1/36114;;A61B5/7475;;G16H40/20;;A61B5/4836;;A61B2562/0219;;G16H20/30;;A61B5/349,A61B5/00;;A61B5/0245;;A61B5/349;;A61N1/36;;A61N1/372;;G16H20/30;;G16H40/20;;G16H40/63;;G16H50/70,,16,0,,,"International Search Report and Written Opinion, PCT/IB/2018/54518, dated Oct. 18, 2018. 9 pages.;;International Search Report and Written Opinion, PCT/US2017/036990, Cyberonics, Inc., 6 pages (dated Aug. 22, 2017).;;Foreign Search Report on EP 17813868.1 dated Jan. 28, 2020.;;Extended European Search Report for EP 18821527.1 dated Dec. 22, 2020, 8 pages.;;Office Action issued in AU 2017284180 dated May 28, 2021.;;Office Action issued in CN 201780050108.3 dated May 6, 2021.;;Office Action issued in JP 2019-516926 dated May 31, 2021.;;Office Action issued in IL 263583 dated Oct. 18, 2021.;;Office action issued on CN 201780050108.3 dated Dec. 3, 2021.;;CA Office Action on CA Appl. Ser. No. 3,027,375 dated Jul. 20, 2022 (5 pages).;;CN Office Action on CN Appl. Ser. No. 201780050108 dated Aug. 11, 2022, no translation (19 pages).;;IL Office Action on IL Appl. Ser. No. 263583 dated Jul. 4, 2022 (4 pages).;;CN Office Action on CN Appl. Ser. No. 201780050108.3 dated Apr. 1, 2022, with translation (52 pages).;;JP Office Action on JP Appl. Ser. No. 2019-516926 dated Mar. 28, 2022 with translation (13 pages).;;EP Office Action on EP Appl. Ser. No. 17 813 868.1 dated Nov. 30, 2022 (4 pages).;;EP Office Action on EP Appl. Ser. No. 18 821 527.1 dated May 17, 2023 (4 pages).",ACTIVE
47,US,A1,US 2023/0146182 A1,106-282-597-216-367,2023-05-11,2023,US 202318092716 A,2023-01-03,US 202318092716 A;;US 201916422746 A;;US 201862676883 P,2018-05-25,EVALUATION OF VAGUS NERVE STIMULATION USING HEART RATE VARIABILITY ANALYSIS,"An implantable vagus nerve stimulation (VNS) system includes a sensor configured to measure ECG data for a patient, a stimulation subsystem configured to deliver VNS to the patient, and a control system configured to perform a heart rate variability analysis with the ECG data. In some aspects, performing the heart rate variability analysis includes measuring R-R intervals between successive R-waves for the ECG data measured during a stimulation period of VNS therapy and a baseline period of the VNS therapy, wherein the stimulation period comprises at least a portion of the ON period and the baseline period comprises at least a portion of the OFF period immediately preceding the ON period, and generating a plot of each R-R interval against an immediately successive R-R interval for each of the stimulation period and the baseline period configured to be displayed on a display.",LIVANOVA USA INC,LIBBUS IMAD;;NEARING BRUCE D;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;VERRIER RICHARD L,LIVANOVA USA INC (2020-09-23),https://lens.org/106-282-597-216-367,Patent Application,yes,8,0,5,167-858-741-250-319;;106-282-597-216-367;;171-227-471-534-074;;048-046-917-278-078;;015-568-530-804-206,US,5,048-046-917-278-078;;106-282-597-216-367;;171-227-471-534-074;;167-858-741-250-319;;015-568-530-804-206,US,0,A61B5/02405;;A61N1/36114;;A61N1/36139;;A61N1/3616;;A61N1/36175;;A61B5/4836;;A61N1/36171;;A61B5/366;;A61B5/352;;A61N1/36139;;A61B5/02405;;A61N1/36196;;A61N1/36114;;A61N1/3616;;A61N1/36175;;A61B5/352;;A61B5/366,A61N1/36;;A61B5/024,,0,0,,,,ACTIVE
48,US,A1,US 2024/0382755 A1,048-046-917-278-078,2024-11-21,2024,US 202418663956 A,2024-05-14,US 202418663956 A;;US 202318092716 A;;US 201916422746 A;;US 201862676883 P,2018-05-25,EVALUATION OF VAGUS NERVE STIMULATION USING HEART RATE VARIABILITY ANALYSIS,"An implantable vagus nerve stimulation (VNS) system includes a sensor configured to measure ECG data for a patient, a stimulation subsystem configured to deliver VNS to the patient, and a control system configured to perform a heart rate variability analysis with the ECG data. In some aspects, performing the heart rate variability analysis includes measuring R-R intervals between successive R-waves for the ECG data measured during a stimulation period of VNS therapy and a baseline period of the VNS therapy, wherein the stimulation period comprises at least a portion of the ON period and the baseline period comprises at least a portion of the OFF period immediately preceding the ON period, and generating a plot of each R-R interval against an immediately successive R-R interval for each of the stimulation period and the baseline period configured to be displayed on a display.",LIVANOVA USA INC,LIBBUS IMAD;;NEARING BRUCE D;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;VERRIER RICHARD L,,https://lens.org/048-046-917-278-078,Patent Application,yes,3,0,5,167-858-741-250-319;;106-282-597-216-367;;171-227-471-534-074;;048-046-917-278-078;;015-568-530-804-206,US,5,048-046-917-278-078;;106-282-597-216-367;;171-227-471-534-074;;167-858-741-250-319;;015-568-530-804-206,US,0,A61B5/02405;;A61N1/36114;;A61N1/36139;;A61N1/3616;;A61N1/36175;;A61B5/4836;;A61N1/36171;;A61B5/366;;A61B5/352;;A61N1/36139;;A61B5/02405;;A61N1/36196;;A61N1/36114;;A61N1/3616;;A61N1/36175;;A61B5/352;;A61B5/366,A61N1/36;;A61B5/024;;A61B5/352;;A61B5/366,,0,0,,,,PENDING
49,US,B2,US 11554263 B2,171-227-471-534-074,2023-01-17,2023,US 201916422746 A,2019-05-24,US 201916422746 A;;US 201862676883 P,2018-05-25,Evaluation of vagus nerve stimulation using heart rate variability analysis,"An implantable vagus nerve stimulation (VNS) system includes a sensor configured to measure ECG data for a patient, a stimulation subsystem configured to deliver VNS to the patient, and a control system configured to perform a heart rate variability analysis with the ECG data. In some aspects, performing the heart rate variability analysis includes measuring R-R intervals between successive R-waves for the ECG data measured during a stimulation period and a baseline period, plotting each R-R interval against an immediately preceding R-R interval for each of the stimulation period and the baseline period, and determining at least one of a standard deviation from an axis of a line perpendicular to an identity line for each of the stimulation period plot and the baseline period plot or a centroid of each of the stimulation period plot and the baseline period plot.",LIVANOVA USA INC,LIBBUS IMAD;;NEARING BRUCE D;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;VERRIER RICHARD L,LIVANOVA USA INC (2020-09-23),https://lens.org/171-227-471-534-074,Granted Patent,yes,8,2,5,167-858-741-250-319;;106-282-597-216-367;;171-227-471-534-074;;048-046-917-278-078;;015-568-530-804-206,US,5,048-046-917-278-078;;106-282-597-216-367;;171-227-471-534-074;;167-858-741-250-319;;015-568-530-804-206,US,0,A61B5/02405;;A61N1/36114;;A61N1/36139;;A61N1/3616;;A61N1/36175;;A61B5/4836;;A61N1/36171;;A61B5/366;;A61B5/352;;A61N1/36139;;A61B5/02405;;A61N1/36196;;A61N1/36114;;A61N1/3616;;A61N1/36175;;A61B5/352;;A61B5/366,A61N1/36;;A61B5/024;;A61B5/352;;A61B5/366,,1,1,036-246-033-697-323,28625397;;10.1016/j.jelectrocard.2017.06.007,"Libbus et al., “Quantitative Evaluation of Heartbeat Interval Time Series Using Poincar? Analysis Reveals Distinct Patterns of Heart Rate Dynamics During Cycles of Vagus Nerve Stimulation in Patients with Heart Failure,” 50 J. of Electrocardiology 898-903 (2017).",ACTIVE
50,US,B2,US 11865344 B2,140-020-919-801-976,2024-01-09,2024,US 201916705043 A,2019-12-05,US 201916705043 A;;US 201615360188 A;;US 201414563181 A;;US 201462078600 P,2014-11-12,Neurostimulation titration process via adaptive parametric modification,"Systems and methods are provided for delivering neurostimulation therapies to patients. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level. Between titration sessions one or more parameters, such as, for example, an acclimation interval, may be adjusted based on the patient's response to the stimulation. This personalized titration process can minimize the amount of time required to complete titration so as to begin delivery of the stimulation at therapeutically desirable levels.",LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI;;STUBBS SCOTT R,,https://lens.org/140-020-919-801-976,Granted Patent,yes,258,0,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,0,A61N1/3702;;G16Z99/00;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/30;;A61B5/349;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/3702;;G16Z99/00;;G16H40/20;;G16H20/30;;A61B5/355;;A61B5/349;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/40,A61N1/36;;A61B5/349;;A61N1/05;;A61N1/37;;A61N1/372;;G16H20/30;;G16H20/40;;G16H40/20;;G16H40/63;;G16Z99/00,,257,220,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,”J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration In Human Subjects and Verification In a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” SLEEP, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of IMPROVE HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y- immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;International Search Report for PCT Patent Application No. PCT/US2015/060200, dated Feb. 8, 2016, 14 pages.;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL—Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Future Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in Cibis II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCI/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/U.S. Pat. No. 20121068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages. et al.",ACTIVE
51,EP,B1,EP 3682798 B1,085-969-060-568-240,2024-02-21,2024,EP 19214855 A,2016-02-10,US 201562114480 P;;EP 16749776 A;;US 2016/0017275 W,2015-02-10,TITRATION OF HEART RATE TO IMPROVE STIMULATION THERAPY FOR HEART FAILURE PATIENTS,,LIVANOVA USA INC,CARLSON GERRARD MERRILL;;SABESAN SHIVKUMAR;;KENKNIGHT BRUCE H;;LIBBUS IMAD;;AMURTHUR BADRI,"LIVANOVA USA, INC. (2024-02-14)",https://lens.org/085-969-060-568-240,Granted Patent,yes,8,0,6,192-619-165-015-369;;009-637-188-674-651;;085-969-060-568-240;;061-047-852-440-200;;040-255-584-508-698;;097-648-398-802-522,WO;;EP,6,192-619-165-015-369;;009-637-188-674-651;;085-969-060-568-240;;061-047-852-440-200;;040-255-584-508-698;;097-648-398-802-522,WO;;EP,0,A61B5/02405;;A61N1/36053;;A61N1/36114;;A61N1/36139;;A61B5/7275;;A61B5/686;;A61B5/6877;;A61B5/0245;;A61B2505/09;;A61B5/4848;;A61B5/1118;;G16H40/63;;A61B5/363;;A61B5/352,A61B5/352,,0,0,,,,ACTIVE
52,US,A1,US 2021/0205620 A1,012-260-058-023-245,2021-07-08,2021,US 202117144692 A,2021-01-08,US 202117144692 A;;US 201615285337 A;;US 201562237078 P,2015-10-05,STIMULATION SUSPENSION IN RESPONSE TO PATIENT DISCOMFORT OR STATE,"Systems and methods are provided for delivering neurostimulation therapies to patients. Stimulation from an implantable medical device (IMD) may be suspended in response to detecting a patient discomfort event, such as a cough, throat irritation, or voice alteration. The suspension period may be based on at least one of a severity level of the patient discomfort event and a patient physical state, such as being asleep or lying down. Detection of a patient discomfort event may be calibrated.",LIVANOVA USA INC,LIBBUS IMAD;;STUBBS SCOTT R;;KENKNIGHT BRUCE H,,https://lens.org/012-260-058-023-245,Patent Application,yes,1,0,7,145-158-920-258-759;;168-183-432-485-134;;110-378-002-453-162;;117-514-853-968-824;;130-767-094-738-433;;181-238-050-927-079;;012-260-058-023-245,WO;;EP;;US,7,145-158-920-258-759;;168-183-432-485-134;;110-378-002-453-162;;117-514-853-968-824;;181-238-050-927-079;;130-767-094-738-433;;012-260-058-023-245,WO;;EP;;US,0,A61B5/0823;;A61N1/36167;;A61B5/1135;;A61N1/36053;;A61N1/36114;;A61N1/36132;;A61N1/3614;;A61B5/086;;A61B5/0823;;A61N1/36167;;A61B5/1135;;A61N1/3614;;A61B5/086;;A61N1/36053;;A61N1/36114;;A61N1/36132;;A61N1/36139,A61N1/36,,0,0,,,,DISCONTINUED
53,US,B2,US 12076566 B2,018-012-275-623-613,2024-09-03,2024,US 202017129467 A,2020-12-21,US 202017129467 A;;US 201816159415 A;;US 201514938641 A;;US 201462078600 P,2014-11-12,Neurostimulation titration utilizing T-wave alternans,Systems and methods are provided for delivering neurostimulation therapies to patients. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level until a target T-wave alternans change from a baseline T-wave alternans is achieved.,LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H,LIVANOVA USA INC (2018-08-24),https://lens.org/018-012-275-623-613,Granted Patent,yes,254,0,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,0,A61N1/3702;;G16Z99/00;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/30;;A61B5/349;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/3702;;G16Z99/00;;G16H40/20;;G16H20/30;;A61B5/355;;A61B5/349;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/40,A61N1/36;;A61B5/349;;A61N1/05;;A61N1/37;;A61N1/372;;G16H20/30;;G16H20/40;;G16H40/20;;G16H40/63;;G16Z99/00,,256,219,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration In Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept”, A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;International Search Report for PCT Patent Application No. PCT/US2015/060200, dated Feb. 8, 2016, 14 pages.;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-κB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLoS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., p. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PC1/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-9A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages. et al.",ACTIVE
54,US,A1,US 2019/0358456 A1,015-568-530-804-206,2019-11-28,2019,US 201916422746 A,2019-05-24,US 201916422746 A;;US 201862676883 P,2018-05-25,EVALUATION OF VAGUS NERVE STIMULATION USING HEART RATE VARIABILITY ANALYSIS,"An implantable vagus nerve stimulation (VNS) system includes a sensor configured to measure ECG data for a patient, a stimulation subsystem configured to deliver VNS to the patient, and a control system configured to perform a heart rate variability analysis with the ECG data. In some aspects, performing the heart rate variability analysis includes measuring R-R intervals between successive R-waves for the ECG data measured during a stimulation period and a baseline period, plotting each R-R interval against an immediately preceding R-R interval for each of the stimulation period and the baseline period, and determining at least one of a standard deviation from an axis of a line perpendicular to an identity line for each of the stimulation period plot and the baseline period plot or a centroid of each of the stimulation period plot and the baseline period plot.",LIVANOVA USA INC,LIBBUS IMAD;;NEARING BRUCE D;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;VERRIER RICHARD L,LIVANOVA USA INC (2020-09-23),https://lens.org/015-568-530-804-206,Patent Application,yes,0,3,5,167-858-741-250-319;;106-282-597-216-367;;171-227-471-534-074;;048-046-917-278-078;;015-568-530-804-206,US,5,048-046-917-278-078;;106-282-597-216-367;;171-227-471-534-074;;167-858-741-250-319;;015-568-530-804-206,US,0,A61B5/02405;;A61N1/36114;;A61N1/36139;;A61N1/3616;;A61N1/36175;;A61B5/4836;;A61N1/36171;;A61B5/366;;A61B5/352;;A61N1/36139;;A61B5/02405;;A61N1/36196;;A61N1/36114;;A61N1/3616;;A61N1/36175;;A61B5/352;;A61B5/366,A61N1/36;;A61B5/024,,0,0,,,,ACTIVE
55,US,B2,US 11433237 B2,079-591-993-595-751,2022-09-06,2022,US 201916711309 A,2019-12-11,US 201916711309 A;;US 201862779344 P,2018-12-13,Neuromodulation therapy for auto-immune and inflammatory disorders,The present disclosure relates to a method for modulating the nervous system in order to reduce inflammation. The method includes delivering a vagus nerve stimulation (VNS) therapy to a vagus nerve of a patient for the treatment of inflammation according to a first set of parameters. The method further includes delivering a secondary nerve stimulation (SNS) therapy to a secondary nerve of the patient for the treatment of a sleep disorder according to a second set of parameters different from the first set of parameters.,LIVANOVA USA INC,LOVETT ERIC,LIVANOVA USA INC (2020-05-08),https://lens.org/079-591-993-595-751,Granted Patent,yes,10,0,6,170-482-156-394-966;;079-591-993-595-751;;146-916-783-629-512;;007-668-919-711-911;;199-461-237-434-480;;147-444-582-760-446,WO;;EP;;US,6,170-482-156-394-966;;199-461-237-434-480;;146-916-783-629-512;;007-668-919-711-911;;079-591-993-595-751;;147-444-582-760-446,WO;;EP;;US,0,A61N1/3611;;A61N1/36139;;A61N1/36053;;A61N1/36078;;A61B5/4836;;A61B5/4812;;A61B5/0205;;A61B5/686;;A61N1/36053;;A61N1/36117;;A61N1/36139;;A61N1/36078;;A61N1/3606;;A61N1/3611,A61N1/36,,12,11,075-303-429-102-771;;009-839-134-167-633;;057-327-993-698-506;;106-325-447-723-504;;040-372-235-125-384;;032-478-178-751-914;;034-271-893-185-32X;;090-674-654-782-087;;000-567-741-850-801;;072-619-592-241-343;;004-403-319-404-499,10.1111/j.1365-2869.2003.00361.x;;14633242;;10.5664/jcsm.27284;;pmc2576315;;18853706;;10.5664/jcsm.5790;;26715401;;pmc4865552;;10.5664/jcsm.6908;;pmc5734887;;29198299;;10.3390/ijms20030459;;pmc6387387;;30678164;;pmc3995194;;24764789;;10.1164/ajrccm.164.7.2011030;;11673216;;12823576;;10.1046/j.1528-1157.2003.56202.x;;10.1183/13993003.00234-2016;;27587551;;28765254;;10.3899/jrheum.170460;;pmc5750105;;10.1111/epi.13252;;26589721,"International Search Report and Written Opinion on PCT/US2019/065792 dated Feb. 24, 2020. 13 pages.;;Alberti, Andrea et al., “Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study;” 2003, European Sleep Research Society; J. Sleep Res., 12, pp. 305-311.;;Ebben, Matthew et al., “Vagus Nerve Stimulation, Sleep Apnea, and CPAP Titration,” Journal of Clinical Sleep Medicine, vol. 4, No. 5, 2008, pp. 471-473.;;Egeberg, Alexander et al., “Psoriasis and Sleep Apnea: A Danish Nationwide Cohort Study,” Journal of Clinical Sleep Medicine, vol. 12, No. 5, 2016, pp. 663-671.;;Gabryelska, Agata et al., “Patients With Obstructive Sleep Apnea Are Over Four Times More Likely to Suffer From Psoriasis Than the General Population,” Journal of Clinical Sleep Medicine, vol. 14, No. 1, p. 153.;;Kheirandish-Gozal, Leila et al., “Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines,” International Journal of Molecular Sciences, 2019, vol. 20, No. 459, 19 pages.;;Kinnucan, Jami et al., “Sleep and Inflammatory Bowel Disease: Exploring the Relationship Between Sleep Disturbances and Inflammation,” Gastroenterology & Hepatology, vol. 9, Issue 11, Nov. 2013, pp. 718-727.;;Kuna, Samuel, “Effects of Pharyngeal Muscle Activation on Airway Size and Configuration,” Am J. Respir Crit Care Med, vol. 164, 2001, pp. 1236-1241.;;Marzec, Mary et al., “Effects of Vagus Nerve Stimulation on Sleep-Related Breathing in Epilepsy Patients,” Epilepsia, vol. 44, No. 7, 2003, pp. 930-935.;;Vicente, Eugenio et al., “Upper Airway and Systemic Inflammation in Obstructive Sleep Apnoea,” Eur Respir J., 2016, 48, pp. 1108-1117, DOI: 10.1183/13993003.00234-2016.;;Wilton, Katelynn et al., “Risk of Obstructive Sleep Apnea and its Association with Cardiovascular and Non-Cardiac Vascular Risk in Patients With Rheumatoid Arthritis: A Population-Based Study,” J. Rheumatol., Jan. 2018, vol. 45 No. 1, 15 pages, DOI: 10.3899/jrheum.170460.;;Zambrelli, Elena et al., “Laryngeal Motility Alteration: A Missing Link Between Sleep Apnea and Vagus Nerve Stimulation for Epilepsy,” Epilepsia, vol. 57, No. 1, pp. e-24-e-27, 2016, DOI: 10.1111/epi.13252.",ACTIVE
56,US,B2,US 11980758 B2,167-858-741-250-319,2024-05-14,2024,US 202318092716 A,2023-01-03,US 202318092716 A;;US 201916422746 A;;US 201862676883 P,2018-05-25,Evaluation of vagus nerve stimulation using heart rate variability analysis,"An implantable vagus nerve stimulation (VNS) system includes a sensor configured to measure ECG data for a patient, a stimulation subsystem configured to deliver VNS to the patient, and a control system configured to perform a heart rate variability analysis with the ECG data. In some aspects, performing the heart rate variability analysis includes measuring R-R intervals between successive R-waves for the ECG data measured during a stimulation period of VNS therapy and a baseline period of the VNS therapy, wherein the stimulation period comprises at least a portion of the ON period and the baseline period comprises at least a portion of the OFF period immediately preceding the ON period, and generating a plot of each R-R interval against an immediately successive R-R interval for each of the stimulation period and the baseline period configured to be displayed on a display.",LIVANOVA USA INC,LIBBUS IMAD;;NEARING BRUCE D;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;VERRIER RICHARD L,LIVANOVA USA INC (2020-09-23),https://lens.org/167-858-741-250-319,Granted Patent,yes,10,0,5,167-858-741-250-319;;106-282-597-216-367;;171-227-471-534-074;;048-046-917-278-078;;015-568-530-804-206,US,5,048-046-917-278-078;;106-282-597-216-367;;171-227-471-534-074;;167-858-741-250-319;;015-568-530-804-206,US,0,A61B5/02405;;A61N1/36114;;A61N1/36139;;A61N1/3616;;A61N1/36175;;A61B5/4836;;A61N1/36171;;A61B5/366;;A61B5/352;;A61N1/36139;;A61B5/02405;;A61N1/36196;;A61N1/36114;;A61N1/3616;;A61N1/36175;;A61B5/352;;A61B5/366,A61N1/36;;A61B5/024;;A61B5/352;;A61B5/366,,1,1,036-246-033-697-323,28625397;;10.1016/j.jelectrocard.2017.06.007,"Libbus et al., “Quantitative Evaluation of Heartbeat Interval Time Series Using Poincare Analysis Reveals Distinct Patterns of Heart Rate Dynamics During Cycles of Vagus Nerve Stimulation in Patients with Heart Failure,” Journal of Electrocardiology, vol. 50, 2017 (pp. 898-903).",ACTIVE
57,US,B2,US 10500398 B2,120-176-817-164-983,2019-12-10,2019,US 201615360188 A,2016-11-23,US 201615360188 A;;US 201414563181 A;;US 201462078600 P,2014-11-12,Neurostimulation titration process via adaptive parametric modification,"Systems and methods are provided for delivering neurostimulation therapies to patients. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level. Between titration sessions one or more parameters, such as, for example, an acclimation interval, may be adjusted based on the patient's response to the stimulation. This personalized titration process can minimize the amount of time required to complete titration so as to begin delivery of the stimulation at therapeutically desirable levels.",LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI;;STUBBS SCOTT R,LIVANOVA USA INC (2014-12-11),https://lens.org/120-176-817-164-983,Granted Patent,yes,257,2,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,0,A61N1/3702;;G16Z99/00;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/30;;A61B5/349;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/3702;;G16Z99/00;;G16H40/20;;G16H20/30;;A61B5/355;;A61B5/349;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/40,A61N1/36;;A61B5/0452;;A61N1/05;;A61N1/37;;A61N1/372;;G16H20/30;;G16H20/40;;G16H40/63;;G16Z99/00,,256,221,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;117-723-850-131-683;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510;;057-045-029-312-938,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10.1016/j.cardfail.2011.06.184;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349;;9482439;;10.1016/s0140-6736(97)11144-8,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb., 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at www.boddunan.com/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 2 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirecl.com/science/article/pii/SOO1448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari, et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(1), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of IMPROVE HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrioventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Health Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y- immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: noninvasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;International Search Report for PCT Patent Application No. PCT/US2015/060200, dated Feb. 8, 2016, 14 pages.;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Future Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation protects cardiac injury by attenuating mitochondria) dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure —Downregulation of Neuronal Nitric Oxide Synthase,” Gire J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK—Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky, et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation, Journal of the American Heart Association, 118, pp. 863-871 (2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US20121068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 (2003).;;Ridker, et al., “Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First cardiovascular Events,” New England Journal of Medicine, vol. 347, No. 20, pp. 1557-1566 (Nov. 14, 2002).;;Ridker, et al., “C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women,” The New England Journal of Medicine, vol. 342, No. 12, pp. 836-841 (Mar. 23, 2000). et al.",ACTIVE
58,WO,A1,WO 2020/123704 A1,147-444-582-760-446,2020-06-18,2020,US 2019/0065792 W,2019-12-11,US 201862779344 P,2018-12-13,NEUROMODULATION THERAPY FOR AUTO-IMMUNE AND INFLAMMATORY DISORDERS,The present disclosure relates to a method for modulating the nervous system in order to reduce inflammation. The method includes delivering a vagus nerve stimulation (VNS) therapy to a vagus nerve of a patient for the treatment of inflammation according to a first set of parameters. The method further includes delivering a secondary nerve stimulation (SNS) therapy to a secondary nerve of the patient for the treatment of a sleep disorder according to a second set of parameters different from the first set of parameters.,LIVANOVA USA INC,LOVETT ERIC,,https://lens.org/147-444-582-760-446,Patent Application,yes,7,0,6,170-482-156-394-966;;079-591-993-595-751;;146-916-783-629-512;;007-668-919-711-911;;199-461-237-434-480;;147-444-582-760-446,WO;;EP;;US,6,170-482-156-394-966;;199-461-237-434-480;;146-916-783-629-512;;007-668-919-711-911;;079-591-993-595-751;;147-444-582-760-446,WO;;EP;;US,0,A61N1/3611;;A61N1/36139;;A61N1/36053;;A61N1/36078;;A61B5/4836;;A61B5/4812;;A61B5/0205;;A61B5/686;;A61N1/36053;;A61N1/36117;;A61N1/36139;;A61N1/36078;;A61N1/3606;;A61N1/3611,A61N1/36;;A61B5/0476;;A61N1/05;;A61N1/37;;A61N1/40,,1,0,,,See also references of EP 3893988A4,PENDING
59,US,B2,US 11918812 B2,061-710-342-703-240,2024-03-05,2024,US 202016854054 A,2020-04-21,US 202016854054 A;;US 201715680139 A;;US 201414457754 A,2014-08-12,Vagus nerve and carotid baroreceptor stimulation system,"Systems and methods are provided for delivering vagus nerve stimulation and carotid baroreceptor stimulation to patients for treating chronic heart failure and hypertension. The vagus nerve stimulation and carotid baroreceptor stimulation therapies may be provided using a single implantable pulse generator, which can coordinate delivery of the therapies.",LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,LIVANOVA USA INC (2014-08-18),https://lens.org/061-710-342-703-240,Granted Patent,yes,256,0,10,130-936-599-485-78X;;159-305-919-121-136;;102-447-152-298-360;;018-511-036-251-302;;070-200-308-937-832;;041-369-578-015-813;;175-188-516-858-993;;061-710-342-703-240;;130-386-978-968-382;;105-213-225-815-419,WO;;EP;;US,10,130-936-599-485-78X;;159-305-919-121-136;;102-447-152-298-360;;018-511-036-251-302;;070-200-308-937-832;;041-369-578-015-813;;175-188-516-858-993;;061-710-342-703-240;;130-386-978-968-382;;105-213-225-815-419,WO;;EP;;US,0,A61N1/0551;;A61N1/36114;;A61N1/0556;;A61N1/36117;;A61N1/36053;;A61N1/36146;;A61N1/0556;;A61N1/36117;;A61N1/36053;;A61N1/36057;;A61N1/36139;;A61N1/0551;;A61N1/36114,A61N1/36;;A61N1/05,,261,224,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;097-426-806-139-480;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;117-723-850-131-683;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;004-811-708-971-908;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10.1016/j.cardfail.2011.06.184;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;16387796;;10.1124/mol.105.020701;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, p. 511-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration In Human Subjects and Verification In a Paced Canine Model Of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4): 1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirect.com/science/article/pii/S001448861000347X.;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 2 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirecl. com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;International Search Report for PCT Patent Application No. PCT/US2015/043827, dated Nov. 11 2015, 6 pages.;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003. Available at: http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=14662714.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), p. 642 (2011).;;Li, et al., “Vagal nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation, Journal of the American Heart Association, 109, pp. 120-124 (2004).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihet, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;PCT Application No. PCT/US2015/043827, Search Report and Written Opinion dated Nov. 5, 2015, 14 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), p. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012). et al.",ACTIVE
60,US,A1,US 2021/0205630 A1,127-432-511-724-161,2021-07-08,2021,US 202117149395 A,2021-01-14,US 202117149395 A;;US 201715714769 A;;US 201414457843 A,2014-08-12,VAGUS NERVE STIMULATION AND SUBCUTANEOUS DEFIBRILLATION SYSTEM,"Systems and methods are provided for delivering vagus nerve stimulation and cardioversion/defibrillation therapies to patients for treating chronic heart failure. The vagus nerve stimulation and cardioversion/defibrillation therapies may be provided using a single implantable pulse generator, which can coordinate delivery of the therapies to provide an acute vagus nerve stimulation therapy in advance of delivering cardioversion-defibrillation energy.",LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI;;STUBBS SCOTT R,,https://lens.org/127-432-511-724-161,Patent Application,yes,2,0,7,183-297-703-096-747;;005-259-507-390-402;;127-432-511-724-161;;180-013-345-040-527;;111-131-571-661-908;;130-638-235-719-244;;053-312-266-709-769,WO;;EP;;US,7,183-297-703-096-747;;005-259-507-390-402;;127-432-511-724-161;;180-013-345-040-527;;053-312-266-709-769;;130-638-235-719-244;;111-131-571-661-908,WO;;EP;;US,0,A61N1/3962;;A61N1/0504;;A61N1/0556;;A61N1/0587;;A61N1/36053;;A61N1/36114;;A61N1/3615;;A61N1/3627;;A61N1/3756;;A61N1/39622;;A61N1/3962;;A61N1/0504;;A61N1/0556;;A61N1/0587;;A61N1/36053;;A61N1/36114;;A61N1/36135;;A61N1/36139;;A61N1/3615;;A61N1/3627;;A61N1/3756;;A61N1/39622;;A61N1/3987,A61N1/39;;A61N1/36,,0,0,,,,DISCONTINUED
61,US,B2,US 11167142 B2,114-851-423-522-29X,2021-11-09,2021,US 201816130799 A,2018-09-13,US 201816130799 A;;US 201762558817 P,2017-09-14,Customizable titration for an implantable neurostimulator,"Systems and methods for customizable titration of an implantable neurostimulator are provided. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator includes delivering a first neurostimulation signal with a first set of parameters, increasing a first value of the first neurostimulation signal at a first rate for a first period of time while delivering the first neurostimulation signal, ceasing delivery of the first neurostimulation signal when the first value reaches a first target value, delivering a second neurostimulation signal with a second set of parameters, and increasing the second neurostimulation signal at a second rate for a second period of time while delivering the second neurostimulation signal.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE;;AMURTHUR BADRI,LIVANOVA USA INC (2019-07-30),https://lens.org/114-851-423-522-29X,Granted Patent,yes,51,0,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,0,G16H20/30;;A61N1/37247;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;G16H40/63;;A61N1/36171;;A61N1/36157;;A61N1/37235;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;A61N1/365;;G16H40/63;;A61N1/37223;;A61N1/36171;;A61N1/36157;;A61N1/37235;;G16H20/30;;A61N1/37247,A61N1/36;;A61N1/365;;A61N1/372;;G16H20/30;;G16H40/63,,1,0,,,"International Search Report and Written Opinion for International Application No. PCT/US18/50930, dated Dec. 21, 2018, 19 pages.",ACTIVE
62,US,B2,US 10870005 B2,081-875-674-187-554,2020-12-22,2020,US 201816159415 A,2018-10-12,US 201816159415 A;;US 201514938641 A;;US 201462078600 P,2014-11-12,Neurostimulation titration utilizing T-wave alternans,Systems and methods are provided for delivering neurostimulation therapies to patients. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level until a target T-wave alternans change from a baseline T-wave alternans is achieved.,LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H,LIVANOVA USA INC (2018-08-24),https://lens.org/081-875-674-187-554,Granted Patent,yes,254,0,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,0,A61N1/3702;;G16Z99/00;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/30;;A61B5/349;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/3702;;G16Z99/00;;G16H40/20;;G16H20/30;;A61B5/355;;A61B5/349;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/40,A61N1/36;;A61B5/0452;;A61N1/05;;A61N1/37;;A61N1/372;;G16H20/30;;G16H20/40;;G16H40/20;;G16H40/63;;G16Z99/00,,256,221,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;039-372-831-731-510;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;117-723-850-131-683;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/hypertensionaha.107.095216;;17846349;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10.1016/j.cardfail.2011.06.184;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning a new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Zucker, et al., “Chronic Baroreceptor Activation Enhances Survival in Dogs with Pacing-Induced Heart Failure,” Journal of the American Heart Association, Hypertension (2007).;;International Search Report for PCT Patent Application No. PCT/US2015/060200, dated Feb. 8, 2016, 14 pages.;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaelmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages. et al.",ACTIVE
63,US,A1,US 2024/0416130 A1,190-825-607-793-999,2024-12-19,2024,US 202418821703 A,2024-08-30,US 202418821703 A;;US 202017129467 A;;US 201816159415 A;;US 201514938641 A;;US 201462078600 P,2014-11-12,NEUROSTIMULATION TITRATION UTILIZING T-WAVE ALTERNANS,Systems and methods are provided for delivering neurostimulation therapies to patients. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level until a target T-wave alternans change from a baseline T-wave alternans is achieved.,LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H,,https://lens.org/190-825-607-793-999,Patent Application,yes,0,0,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,0,A61N1/3702;;G16Z99/00;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/30;;A61B5/349;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/3702;;G16Z99/00;;G16H40/20;;G16H20/30;;A61B5/355;;A61B5/349;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/40,A61N1/36;;A61B5/349;;A61B5/355;;A61N1/05;;A61N1/37;;A61N1/372;;G16H20/30;;G16H20/40;;G16H40/20;;G16H40/63;;G16Z99/00,,0,0,,,,PENDING
64,US,A1,US 2020/0246623 A1,130-936-599-485-78X,2020-08-06,2020,US 202016854054 A,2020-04-21,US 202016854054 A;;US 201715680139 A;;US 201414457754 A,2014-08-12,VAGUS NERVE AND CAROTID BARORECEPTOR STIMULATION SYSTEM,"Systems and methods are provided for delivering vagus nerve stimulation and carotid baroreceptor stimulation to patients for treating chronic heart failure and hypertension. The vagus nerve stimulation and carotid baroreceptor stimulation therapies may be provided using a single implantable pulse generator, which can coordinate delivery of the therapies.",LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,LIVANOVA USA INC (2014-08-18),https://lens.org/130-936-599-485-78X,Patent Application,yes,2,2,10,130-936-599-485-78X;;159-305-919-121-136;;102-447-152-298-360;;018-511-036-251-302;;070-200-308-937-832;;041-369-578-015-813;;175-188-516-858-993;;061-710-342-703-240;;130-386-978-968-382;;105-213-225-815-419,WO;;EP;;US,10,130-936-599-485-78X;;159-305-919-121-136;;102-447-152-298-360;;018-511-036-251-302;;070-200-308-937-832;;041-369-578-015-813;;175-188-516-858-993;;061-710-342-703-240;;130-386-978-968-382;;105-213-225-815-419,WO;;EP;;US,0,A61N1/0551;;A61N1/36114;;A61N1/0556;;A61N1/36117;;A61N1/36053;;A61N1/36146;;A61N1/0556;;A61N1/36117;;A61N1/36053;;A61N1/36057;;A61N1/36139;;A61N1/0551;;A61N1/36114,A61N1/36,,0,0,,,,ACTIVE
65,US,A1,US 2020/0108255 A1,188-187-393-279-234,2020-04-09,2020,US 201916693005 A,2019-11-22,US 201916693005 A;;US 2018/0050930 W;;US 201762558817 P,2017-09-14,CUSTOMIZABLE TITRATION FOR AN IMPLANTABLE NEUROSTIMULATOR,"Systems and methods for customizable titration of an implantable neurostimulator are provided. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator includes delivering a first neurostimulation signal with a first set of parameters, increasing a first value of the first neurostimulation signal at a first rate for a first period of time while delivering the first neurostimulation signal, ceasing delivery of the first neurostimulation signal when the first value reaches a first target value, delivering a second neurostimulation signal with a second set of parameters, and increasing the second neurostimulation signal at a second rate for a second period of time while delivering the second neurostimulation signal.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,LIVANOVA USA INC (2020-02-25),https://lens.org/188-187-393-279-234,Patent Application,yes,11,0,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,0,G16H20/30;;A61N1/37247;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;G16H40/63;;A61N1/36171;;A61N1/36157;;A61N1/37235;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;A61N1/365;;G16H40/63;;A61N1/37223;;A61N1/36171;;A61N1/36157;;A61N1/37235;;G16H20/30;;A61N1/37247,A61N1/36,,0,0,,,,ACTIVE
66,US,A1,US 2021/0178163 A1,092-151-533-009-506,2021-06-17,2021,US 202017129467 A,2020-12-21,US 202017129467 A;;US 201816159415 A;;US 201514938641 A;;US 201462078600 P,2014-11-12,NEUROSTIMULATION TITRATION UTILIZING T-WAVE ALTERNANS,Systems and methods are provided for delivering neurostimulation therapies to patients. A titration process is used to gradually increase the stimulation intensity to a desired therapeutic level until a target T-wave alternans change from a baseline T-wave alternans is achieved.,LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H,LIVANOVA USA INC (2018-08-24),https://lens.org/092-151-533-009-506,Patent Application,yes,1,0,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,18,140-020-919-801-976;;089-000-164-654-959;;146-493-080-868-267;;092-151-533-009-506;;120-176-817-164-983;;040-468-818-508-324;;018-012-275-623-613;;138-485-792-876-441;;114-263-774-201-155;;074-813-390-868-473;;073-794-739-947-733;;086-321-160-545-032;;117-433-214-234-07X;;027-121-086-774-614;;032-085-803-444-884;;081-875-674-187-554;;120-097-235-157-649;;190-825-607-793-999,ES;;WO;;EP;;US,0,A61N1/3702;;G16Z99/00;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/30;;A61B5/349;;A61N1/36139;;A61N1/0551;;A61N1/36114;;G16H40/63;;A61N1/3702;;G16Z99/00;;G16H40/20;;G16H20/30;;A61B5/355;;A61B5/349;;A61N1/36132;;A61N1/3615;;A61N1/36167;;A61N1/37223;;A61N1/37235;;G16H20/40,A61N1/36;;A61B5/349;;A61N1/05;;A61N1/37;;A61N1/372;;G16H20/30;;G16H20/40;;G16H40/20;;G16H40/63;;G16Z99/00,,0,0,,,,ACTIVE
67,US,A1,US 2022/0062641 A1,008-315-569-372-042,2022-03-03,2022,US 202117521496 A,2021-11-08,US 202117521496 A;;US 201816130799 A;;US 201762558817 P,2017-09-14,CUSTOMIZABLE TITRATION FOR AN IMPLANTABLE NEUROSTIMULATOR,"Systems and methods for customizable titration of an implantable neurostimulator are provided. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator includes delivering a first neurostimulation signal with a first set of parameters, increasing a first value of the first neurostimulation signal at a first rate for a first period of time while delivering the first neurostimulation signal, ceasing delivery of the first neurostimulation signal when the first value reaches a first target value, delivering a second neurostimulation signal with a second set of parameters, and increasing the second neurostimulation signal at a second rate for a second period of time while delivering the second neurostimulation signal.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE;;AMURTHUR BADRI,,https://lens.org/008-315-569-372-042,Patent Application,yes,3,0,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,0,G16H20/30;;A61N1/37247;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;G16H40/63;;A61N1/36171;;A61N1/36157;;A61N1/37235;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;A61N1/365;;G16H40/63;;A61N1/37223;;A61N1/36171;;A61N1/36157;;A61N1/37235;;G16H20/30;;A61N1/37247,A61N1/36;;A61N1/372;;G16H20/30,,0,0,,,,ACTIVE
68,US,B2,US 10646716 B2,175-188-516-858-993,2020-05-12,2020,US 201715680139 A,2017-08-17,US 201715680139 A;;US 201414457754 A,2014-08-12,Vagus nerve and carotid baroreceptor stimulation system,"Systems and methods are provided for delivering vagus nerve stimulation and carotid baroreceptor stimulation to patients for treating chronic heart failure and hypertension. The vagus nerve stimulation and carotid baroreceptor stimulation therapies may be provided using a single implantable pulse generator, which can coordinate delivery of the therapies.",LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,LIVANOVA USA INC (2014-08-18),https://lens.org/175-188-516-858-993,Granted Patent,yes,252,0,10,130-936-599-485-78X;;159-305-919-121-136;;102-447-152-298-360;;018-511-036-251-302;;070-200-308-937-832;;041-369-578-015-813;;175-188-516-858-993;;061-710-342-703-240;;130-386-978-968-382;;105-213-225-815-419,WO;;EP;;US,10,130-936-599-485-78X;;159-305-919-121-136;;102-447-152-298-360;;018-511-036-251-302;;070-200-308-937-832;;041-369-578-015-813;;175-188-516-858-993;;061-710-342-703-240;;130-386-978-968-382;;105-213-225-815-419,WO;;EP;;US,0,A61N1/0551;;A61N1/36114;;A61N1/0556;;A61N1/36117;;A61N1/36053;;A61N1/36146;;A61N1/0556;;A61N1/36117;;A61N1/36053;;A61N1/36057;;A61N1/36139;;A61N1/0551;;A61N1/36114,A61N1/36;;A61N1/05,,261,225,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;097-426-806-139-480;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;034-419-831-492-517;;117-723-850-131-683;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;004-811-708-971-908;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;10.1016/j.cardfail.2011.06.184;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;16387796;;10.1124/mol.105.020701;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul lntegr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at www.boddunan.com/education/20-medicine-a-surgery/12730-nerver-fiber- types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. 511-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 2 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirecl.com/science/article/pii/SOO1448861000347X.;;Castoro et al.,“Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 2 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirecl. com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” SLEEP, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(1), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrioventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Health Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;International Search Report for PCT Patent Application No. PCT/US2015/043827, dated Nov. 11, 2015, 6 pages.;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” Plos One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003. Available at: http://circ.aha.journals.org/cgi/pmidlookup?view=long&pmid=14662714.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of Iosartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Li, et al., “Vagal nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation, Journal of the American Heart Association, 109, pp. 120-124 (2004).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Gire J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky, et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation, Journal of the American Heart Association, 118, pp. 863-871 (2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;PCT Application No. PCT/US2015/043827, Search Report and Written Opinion dated Nov. 5, 2015, 14 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012). et al.",ACTIVE
69,US,A1,US 2024/0399153 A1,114-978-927-032-890,2024-12-05,2024,US 202418731997 A,2024-06-03,US 202418731997 A;;US 202117521496 A;;US 201816130799 A;;US 201762558817 P,2017-09-14,CUSTOMIZABLE TITRATION FOR AN IMPLANTABLE NEUROSTIMULATOR,"Systems and methods for customizable titration of an implantable neurostimulator are provided. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator includes delivering a first neurostimulation signal with a first set of parameters, increasing a first value of the first neurostimulation signal at a first rate for a first period of time while delivering the first neurostimulation signal, ceasing delivery of the first neurostimulation signal when the first value reaches a first target value, delivering a second neurostimulation signal with a second set of parameters, and increasing the second neurostimulation signal at a second rate for a second period of time while delivering the second neurostimulation signal.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE;;AMURTHUR BADRI,,https://lens.org/114-978-927-032-890,Patent Application,yes,0,0,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,0,G16H20/30;;A61N1/37247;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;G16H40/63;;A61N1/36171;;A61N1/36157;;A61N1/37235;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;A61N1/365;;G16H40/63;;A61N1/37223;;A61N1/36171;;A61N1/36157;;A61N1/37235;;G16H20/30;;A61N1/37247,A61N1/36;;A61N1/365;;A61N1/372;;G16H20/30;;G16H40/63,,0,0,,,,PENDING
70,US,B2,US 11998747 B2,119-898-557-909-65X,2024-06-04,2024,US 202117521496 A,2021-11-08,US 202117521496 A;;US 201816130799 A;;US 201762558817 P,2017-09-14,Customizable titration for an implantable neurostimulator,"A programmer configured to collect data from an implantable pulse generator about ongoing neurostimulation being applied during a stimulation titration process by the implantable pulse generator while in communication with the communication circuitry; display, via a user interface, an indication relating to a timing of neurostimulation bursts applied by the implantable pulse generator while in communication with the communication circuitry based on the collected data, the indication being displayed according to a time delay that accounts for a transport delay between the implantable pulse generator and the programmer such that the indication displayed coincides with an actual application of each stimulation burst by the implantable pulse generator; and adjust at least one stimulation parameter applied during the stimulation titration process by the implantable pulse generator.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE;;AMURTHUR BADRI,,https://lens.org/119-898-557-909-65X,Granted Patent,yes,55,0,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,0,G16H20/30;;A61N1/37247;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;G16H40/63;;A61N1/36171;;A61N1/36157;;A61N1/37235;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;A61N1/365;;G16H40/63;;A61N1/37223;;A61N1/36171;;A61N1/36157;;A61N1/37235;;G16H20/30;;A61N1/37247,A61N1/36;;A61N1/365;;A61N1/372;;G16H20/30;;G16H40/63,,5,0,,,"CN Office Action on CN Appl. Ser No. 201880073480.0 dated Feb. 27, 2023 (8 pages).;;JP Office Action on JP Appl. Ser. No. 2020-515167 dated Sep. 1, 2022, with translation (12 pages).;;International Search Report and Written Opinion for International Application No. PCT/US18/50930, dated Dec. 21, 2018, 19 pages.;;CN Office Action for CN Appl. Ser. No. 201880073480.0 dated Sep. 26, 2023 (5 pages).;;CN Office Action for CN Appl. Ser. No. 201880073480.0 dated Jan. 12, 2024 (56 pages).",ACTIVE
71,US,B2,US 10967185 B2,044-630-552-533-503,2021-04-06,2021,US 201916693005 A,2019-11-22,US 201916693005 A;;US 2018/0050930 W;;US 201762558817 P,2017-09-14,Customizable titration for an implantable neurostimulator,"Systems and methods for customizable titration of an implantable neurostimulator are provided. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator includes delivering a first neurostimulation signal with a first set of parameters, increasing a first value of the first neurostimulation signal at a first rate for a first period of time while delivering the first neurostimulation signal, ceasing delivery of the first neurostimulation signal when the first value reaches a first target value, delivering a second neurostimulation signal with a second set of parameters, and increasing the second neurostimulation signal at a second rate for a second period of time while delivering the second neurostimulation signal.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;KENKNIGHT BRUCE H;;AMURTHUR BADRI,LIVANOVA USA INC (2020-02-25),https://lens.org/044-630-552-533-503,Granted Patent,yes,50,0,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,13,008-315-569-372-042;;150-863-683-197-896;;114-978-927-032-890;;066-527-159-306-294;;098-489-077-670-419;;186-713-758-096-196;;046-714-234-611-837;;114-851-423-522-29X;;044-630-552-533-503;;191-503-802-676-119;;188-187-393-279-234;;119-898-557-909-65X;;132-555-042-755-512,WO;;CN;;JP;;US,0,G16H20/30;;A61N1/37247;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;G16H40/63;;A61N1/36171;;A61N1/36157;;A61N1/37235;;A61N1/36139;;A61N1/36114;;A61N1/36132;;A61N1/36175;;A61N1/365;;G16H40/63;;A61N1/37223;;A61N1/36171;;A61N1/36157;;A61N1/37235;;G16H20/30;;A61N1/37247,A61N1/36;;A61N1/365;;A61N1/372;;G16H20/30;;G16H40/63,,1,0,,,"International Search Report and Written Opinion for International Application No. PCT/US18/50930, dated Dec. 21, 2018, 19 pages.",ACTIVE
72,US,B2,US 11097106 B2,002-203-899-406-095,2021-08-24,2021,US 201916265770 A,2019-02-01,US 201916265770 A;;US 201715706946 A;;US 201615274919 A;;US 201213673766 A,2012-11-09,Implantable neurostimulator-implemented method for managing tachyarrhythmia through vagus nerve stimulation,"An implantable neurostimulator-implemented method for managing tachyarrhythmias through vagus nerve stimulation is provided. An implantable neurostimulator, including a pulse generator, is configured to deliver electrical therapeutic stimulation in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers of a patient's cervical vagus nerve. Operating modes of the pulse generator are stored. A maintenance dose of the electrical therapeutic stimulation is delivered to the vagus nerve via the pulse generator to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. A restorative dose of the electrical therapeutic stimulation is delivered to prevent initiation of or disrupt tachyarrhythmia through periodic electrical pulses delivered at higher intensity than the maintenance dose. The patient's normative physiology is monitored via a physiological sensor, and upon sensing a condition indicative of tachyarrhythmia, is switched to delivering the restorative dose to the vagus nerve.",LIVANOVA USA INC;;LIVANOVAUSA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,,https://lens.org/002-203-899-406-095,Granted Patent,yes,267,0,9,002-203-899-406-095;;162-017-663-214-241;;107-667-041-107-230;;064-349-732-670-59X;;190-979-166-662-310;;082-373-411-720-544;;174-488-284-806-622;;168-627-229-486-734;;051-334-838-825-269,US,25,028-186-055-114-22X;;147-631-833-891-293;;064-349-732-670-59X;;044-856-202-788-292;;168-627-229-486-734;;051-334-838-825-269;;107-667-041-107-230;;190-979-166-662-310;;174-488-284-806-622;;092-057-191-349-867;;190-613-507-866-404;;198-154-709-534-505;;120-807-899-881-588;;005-285-710-989-946;;162-017-663-214-241;;122-277-305-760-015;;044-223-582-207-639;;082-373-411-720-544;;002-203-899-406-095;;181-866-347-834-495;;144-599-017-856-848;;179-612-790-825-217;;014-394-433-635-494;;039-753-691-537-116;;030-173-579-038-01X,WO;;EP;;US,0,A61N1/36114;;A61B5/0245;;A61B5/283;;A61B5/352;;A61B5/363;;A61B5/4836;;A61B5/686;;A61N1/36053;;A61N1/36139;;A61N1/3621;;A61N1/36114;;A61B5/0245;;A61B5/352;;A61B5/363;;A61B5/4836;;A61B5/686;;A61N1/36053;;A61N1/36139;;A61N1/3621,A61N1/36;;A61B5/00;;A61B5/0245;;A61B5/283;;A61B5/352;;A61B5/363;;A61N1/362,,259,224,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;117-723-850-131-683;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;004-811-708-971-908;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10.1016/j.cardfail.2011.06.184;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;16387796;;10.1124/mol.105.020701;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in me Amygdala Following Myocardial Intarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958¬2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285¬2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, val. 6, No. 8, pp. 844-852 (Aug. 2005).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardia neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859¬866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AJA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223¬231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425¬438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003. Available at: http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=14662714.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306¬311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Non-Final Office Action dated Mar. 20, 2015 in U.S. Appl. No. 14/271,714, filed May 7, 2014.;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996). et al.",ACTIVE
73,US,B2,US 11666760 B2,025-665-567-448-337,2023-06-06,2023,US 202117216251 A,2021-03-29,US 202117216251 A;;US 201816184789 A;;US 201414316258 A;;US 201361840461 P;;US 201361888303 P,2013-06-28,Cranial nerve stimulation to treat seizure disorders,"A method includes applying, by an implantable medical device (IMD), stimulation to a cranial nerve of a patient responsive to a determination that a level of synchrony between neural activity of one or more regions of an autonomic nervous system of the patient and one or more regions of a central nervous system of the patient falls below a first threshold and discontinuing the application of stimulation by the IMD when the level of synchrony exceeds a second threshold.",LIVANOVA USA INC,SABESAN SHIVKUMAR;;MASCHINO STEVEN E,LIVANOVA USA INC (2014-06-25),https://lens.org/025-665-567-448-337,Granted Patent,yes,10,0,5,025-665-567-448-337;;011-703-367-960-172;;124-803-962-154-533;;090-219-842-772-578;;057-981-760-479-464,US,5,025-665-567-448-337;;011-703-367-960-172;;124-803-962-154-533;;090-219-842-772-578;;057-981-760-479-464,US,0,A61N1/36064;;A61N1/36053;;A61N1/36139;;A61N1/36178;;A61N1/36064;;A61N1/36053;;A61N1/36139;;A61N1/36178,A61N1/36,,1,1,041-708-426-262-034,10.1016/j.jsmc.2012.02.001,"Grigg-Damberger et al., “Sleep-Related Epilepsy and Electroencephalography”, Sleep Medicine, Mar. 2012, vol. 7, No. 1, pp. 46-48 (Year: 2012).",ACTIVE
74,US,A1,US 2021/0213289 A1,124-803-962-154-533,2021-07-15,2021,US 202117216251 A,2021-03-29,US 202117216251 A;;US 201816184789 A;;US 201414316258 A;;US 201361840461 P;;US 201361888303 P,2013-06-28,CRANIAL NERVE STIMULATION TO TREAT SEIZURE DISORDERS,"A method includes applying, by an implantable medical device (IMD), stimulation to a cranial nerve of a patient responsive to a determination that a level of synchrony between neural activity of one or more regions of an autonomic nervous system of the patient and one or more regions of a central nervous system of the patient falls below a first threshold and discontinuing the application of stimulation by the IMD when the level of synchrony exceeds a second threshold.",LIVANOVA USA INC,SABESAN SHIVKUMAR;;MASCHINO STEVEN E,LIVANOVA USA INC (2014-06-25),https://lens.org/124-803-962-154-533,Patent Application,yes,2,0,5,025-665-567-448-337;;011-703-367-960-172;;124-803-962-154-533;;090-219-842-772-578;;057-981-760-479-464,US,5,025-665-567-448-337;;011-703-367-960-172;;124-803-962-154-533;;090-219-842-772-578;;057-981-760-479-464,US,0,A61N1/36064;;A61N1/36053;;A61N1/36139;;A61N1/36178;;A61N1/36064;;A61N1/36053;;A61N1/36139;;A61N1/36178,A61N1/36,,1,1,041-708-426-262-034,10.1016/j.jsmc.2012.02.001,"Grigg-Damberger et al., ""Sleep-Related Epilepsy and Electroencephalography’”, Sleep Medicine, March 2012, Vol. 7, Number 1, pp46-48 (Year: 2012)",ACTIVE
75,WO,A1,WO 2019/195320 A1,128-876-051-014-137,2019-10-10,2019,US 2019/0025427 W,2019-04-02,US 201862652147 P,2018-04-03,USER INTERFACE FOR TITRATION ASSIST,"Systems and methods for a user interface for titration of an implantable neurostimulator are provided. A method of managing titration using a management device for a patient implanted with a neurostimulator includes receiving, from the neurostimulator, data for the patient relating to stimulation being provided to the patient by the neurostimulator while the neurostimulator is in communication with the management device, displaying a user interface on a display of the management device, the user interface including at least a portion of the data displayed within a graph, the user interface allowing a user to modify a parameter of the titration, receiving a selection of the parameter, based on the selection, determining a titration schedule for the patient, and transmitting the titration schedule to the neurostimulator.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,,https://lens.org/128-876-051-014-137,Patent Application,yes,2,3,6,164-956-180-651-912;;128-876-051-014-137;;188-913-624-385-59X;;140-207-995-630-179;;117-273-011-194-960;;034-120-916-805-053,WO;;EP;;US,6,164-956-180-651-912;;128-876-051-014-137;;188-913-624-385-59X;;140-207-995-630-179;;034-120-916-805-053;;117-273-011-194-960,WO;;EP;;US,0,A61N1/37247;;A61N1/36167;;A61N1/36114;;G16H40/63;;G16H20/30;;G16H20/40;;A61N1/36167;;A61N1/37247,A61N1/36,,1,0,,,See also references of EP 3773882A4,PENDING
76,EP,B1,EP 3773882 B1,034-120-916-805-053,2024-11-20,2024,EP 19781090 A,2019-04-02,US 2019/0025427 W;;US 201862652147 P,2018-04-03,USER INTERFACE FOR TITRATION ASSIST,,LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,"LIVANOVA USA, INC., HOUSTON, US (2024-11-19);;LIVANOVA USA, INC. (2024-12-11)",https://lens.org/034-120-916-805-053,Granted Patent,yes,6,0,6,164-956-180-651-912;;128-876-051-014-137;;188-913-624-385-59X;;140-207-995-630-179;;117-273-011-194-960;;034-120-916-805-053,WO;;EP;;US,6,164-956-180-651-912;;128-876-051-014-137;;188-913-624-385-59X;;140-207-995-630-179;;034-120-916-805-053;;117-273-011-194-960,WO;;EP;;US,0,A61N1/37247;;A61N1/36167;;A61N1/36114;;G16H40/63;;G16H20/30;;G16H20/40;;A61N1/36167;;A61N1/37247,A61N1/372;;A61N1/36;;G16H20/30;;G16H40/63,,0,0,,,,ACTIVE
77,US,A1,US 2021/0038899 A1,140-207-995-630-179,2021-02-11,2021,US 201917044711 A,2019-04-02,US 201917044711 A;;US 201862652147 P;;US 2019/0025427 W,2018-04-03,USER INTERFACE FOR TITRATION ASSIST,"Systems and methods for a user interface for titration of an implantable neurostimulator are provided. A method of managing titration using a management device for a patient implanted with a neurostimulator includes receiving, from the neurostimulator, data for the patient relating to stimulation being provided to the patient by the neurostimulator while the neurostimulator is in communication with the management device, displaying a user interface on a display of the management device, the user interface including at least a portion of the data displayed within a graph, the user interface allowing a user to modify a parameter of the titration, receiving a selection of the parameter, based on the selection, determining a titration schedule for the patient, and transmitting the titration schedule to the neurostimulator.",LIVANOVA USA INC,STUBBS SCOTT;;LIBBUS IMAD;;MAZAR SCOTT;;AMURTHUR BADRI;;KENKNIGHT BRUCE H,LIVANOVA USA INC (2020-10-02),https://lens.org/140-207-995-630-179,Patent Application,yes,8,1,6,164-956-180-651-912;;128-876-051-014-137;;188-913-624-385-59X;;140-207-995-630-179;;117-273-011-194-960;;034-120-916-805-053,WO;;EP;;US,6,164-956-180-651-912;;128-876-051-014-137;;188-913-624-385-59X;;140-207-995-630-179;;034-120-916-805-053;;117-273-011-194-960,WO;;EP;;US,0,A61N1/37247;;A61N1/36167;;A61N1/36114;;G16H40/63;;G16H20/30;;G16H20/40;;A61N1/36167;;A61N1/37247,A61N1/36;;A61N1/372;;G16H20/40,,0,0,,,,PENDING
78,US,A1,US 2025/0032793 A1,077-970-841-848-569,2025-01-30,2025,US 202418914756 A,2024-10-14,US 202418914756 A;;US 202117386970 A;;US 201916288238 A;;US 201313746478 A,2013-01-22,METHODS AND SYSTEMS TO DIAGNOSE DEPRESSION,"A system includes one or more memory devices having instructions stored thereon that, when executed by one or more processors, cause the one or more processors to perform operations including calculating a depression detection value based in part on a first depression-indicative value based on a first body parameter value, a second depression-indicative value based on a second body parameter value, and a weighting applied to at least one of the first depression-indicative value and the second depression-indicative value, comparing the depression detection value to a first threshold and a second threshold that is different from the first threshold to detect an onset of a depression episode, and initiating neurostimulation therapy by one or more electrodes responsive to detecting the onset of the depression episode.",LIVANOVA USA INC,LIAO WANGCAI,,https://lens.org/077-970-841-848-569,Patent Application,yes,0,0,7,085-926-432-381-525;;183-930-199-757-737;;183-843-259-992-865;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,7,085-926-432-381-525;;183-843-259-992-865;;183-930-199-757-737;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,0,A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61N1/36096;;A61B5/4836;;A61B5/24;;A61N1/36096;;A61B5/4836;;A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61B5/24,A61N1/36;;A61B5/00;;A61B5/01;;A61B5/0205;;A61B5/16;;A61B5/24;;A61N1/05;;G16H20/70;;G16H50/20,,0,0,,,,PENDING
79,US,B2,US 10716938 B2,038-482-359-301-699,2020-07-21,2020,US 201815920247 A,2018-03-13,US 201815920247 A;;US 201514694848 A,2015-04-23,Lead engagement devices and methods for electrical stimulation and/or monitoring systems,"According to aspects of the present disclosure, an implantable pulse generator includes a housing, a header, and a retainer device. The housing includes circuitry and a battery. The header is coupled to the housing and includes a bore configured to receive an end of a lead, and a passage disposed transverse to the bore and extending between an exterior surface of the header and an anchor cavity that extends into the header from the bore. The header supports at least one electrical contact within the bore coupled to the circuitry. The retainer device includes a looped member arranged within the bore, a proximal end extending at least partially into the passage, and anchored at a distal end by the anchor cavity. The looped member has a first position defining a first loop diameter that permits egress of the lead into the bore and a second position defining a second loop diameter that occludes at least a portion of the bore and is configured to engage at least two opposing sides of the lead sufficiently to prevent egress of the lead from the bore. The first loop diameter is greater than the second loop diameter.",LIVANOVA USA INC,RAMESH RAJESH;;THOMPSON DAVID L;;ALLIS STEVEN W,LIVANOVA USA INC (2017-06-30),https://lens.org/038-482-359-301-699,Granted Patent,yes,73,0,7,126-666-747-207-406;;038-482-359-301-699;;092-085-889-134-292;;057-106-413-415-022;;194-587-126-687-444;;004-155-170-451-261;;132-786-584-856-033,WO;;EP;;US,7,126-666-747-207-406;;038-482-359-301-699;;092-085-889-134-292;;057-106-413-415-022;;194-587-126-687-444;;004-155-170-451-261;;132-786-584-856-033,WO;;EP;;US,0,A61N1/3752;;A61N1/3752;;A61N1/36,A61N1/36;;A61N1/375,,1,0,,,"International Search Report and Written Opinion for Patent Application No. PCT/US2016/028491, dated Jul. 22, 2016, 11 pages.",ACTIVE
80,US,A1,US 2021/0353947 A1,055-458-164-846-820,2021-11-18,2021,US 202117386970 A,2021-07-28,US 202117386970 A;;US 201916288238 A;;US 201313746478 A,2013-01-22,METHODS AND SYSTEMS TO DIAGNOSE DEPRESSION,"A system includes one or more memory devices having instructions stored thereon that, when executed by one or more processors, cause the one or more processors to perform operations including calculating a depression detection value based in part on a first depression-indicative value based on a first body parameter value, a second depression-indicative value based on a second body parameter value, and a weighting applied to at least one of the first depression-indicative value and the second depression-indicative value, comparing the depression detection value to a first threshold and a second threshold that is different from the first threshold to detect an onset of a depression episode, and initiating neurostimulation therapy by one or more electrodes responsive to detecting the onset of the depression episode.",LIVANOVA USA INC,LIAO WANGCAI,,https://lens.org/055-458-164-846-820,Patent Application,yes,2,0,7,085-926-432-381-525;;183-930-199-757-737;;183-843-259-992-865;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,7,085-926-432-381-525;;183-843-259-992-865;;183-930-199-757-737;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,0,A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61N1/36096;;A61B5/4836;;A61B5/24;;A61N1/36096;;A61B5/4836;;A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61B5/24,A61N1/36;;A61B5/00;;A61B5/16;;A61N1/05;;G16H20/70;;G16H50/20,,0,0,,,,ACTIVE
81,US,B2,US 12144992 B2,010-269-063-908-10X,2024-11-19,2024,US 202117386970 A,2021-07-28,US 202117386970 A;;US 201916288238 A;;US 201313746478 A,2013-01-22,Methods and systems to diagnose depression,"A system includes one or more memory devices having instructions stored thereon that, when executed by one or more processors, cause the one or more processors to perform operations including calculating a depression detection value based in part on a first depression-indicative value based on a first body parameter value, a second depression-indicative value based on a second body parameter value, and a weighting applied to at least one of the first depression-indicative value and the second depression-indicative value, comparing the depression detection value to a first threshold and a second threshold that is different from the first threshold to detect an onset of a depression episode, and initiating neurostimulation therapy by one or more electrodes responsive to detecting the onset of the depression episode.",LIVANOVA USA INC,LIAO WANGCAI,,https://lens.org/010-269-063-908-10X,Granted Patent,yes,600,0,7,085-926-432-381-525;;183-930-199-757-737;;183-843-259-992-865;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,7,085-926-432-381-525;;183-843-259-992-865;;183-930-199-757-737;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,0,A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61N1/36096;;A61B5/4836;;A61B5/24;;A61N1/36096;;A61B5/4836;;A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61B5/24,A61N1/36;;A61B5/00;;A61B5/01;;A61B5/0205;;A61B5/16;;A61B5/24;;A61N1/05;;G16H20/70;;G16H50/20,,65,51,046-503-391-804-165;;019-411-892-837-769;;052-630-116-618-842;;115-741-015-188-295;;037-772-810-641-647;;145-702-660-075-441;;054-630-468-158-977;;018-561-710-123-368;;032-676-139-657-586;;015-943-288-841-720;;022-966-379-058-403;;048-642-493-280-14X;;046-397-703-096-430;;019-308-872-975-51X;;002-403-074-135-442;;005-812-068-829-241;;112-897-527-124-30X;;032-751-441-147-285;;046-621-728-923-715;;056-177-900-384-501;;098-586-850-446-33X;;066-328-676-515-762;;018-202-351-494-006;;097-426-806-139-480;;072-028-517-836-043;;091-962-532-331-31X;;103-040-249-541-832;;016-207-089-756-778;;050-957-455-833-565;;011-498-617-423-119;;030-501-930-582-312;;013-993-295-891-841;;019-773-125-379-283;;014-724-861-390-592;;015-820-060-894-869;;038-128-501-814-320;;013-620-213-165-976;;112-318-944-745-749;;088-853-742-205-302;;003-290-790-587-579;;026-435-299-569-935;;047-345-017-295-263;;033-503-915-578-321;;139-831-627-763-342;;024-644-707-340-274;;023-093-432-161-773;;025-424-076-138-599;;079-757-926-093-134;;035-904-149-105-698;;029-700-863-111-313;;054-868-494-791-055,10.1016/s0273-1177(98)80014-8;;11541400;;17446414;;10.1152/japplphysiol.00137.2007;;11974997;;10.1007/978-3-7091-6105-0_21;;11709644;;10.1097/00004691-200109000-00003;;10839541;;10.1038/35013070;;15109218;;10.1113/expphysiol.2003.002654;;17565508;;10.1142/s0129065707000993;;9774527;;10.1006/nlme.1998.3863;;10.1111/j.1528-1167.2006.00594.x;;16886985;;10.1016/j.clinph.2003.12.016;;15066542;;16828317;;10.1016/j.seizure.2006.03.005;;10.1046/j.1528-1157.2001.0420081007.x;;11554886;;10.1016/s0006-3223(99)00308-x;;10686263;;10.1016/0006-8993(77)90275-x;;195672;;10.1212/wnl.59.6_suppl_4.s3;;12270962;;12769431;;10.1109/tbme.2003.810705;;10.1109/tbme.2003.821013;;15000380;;9684488;;10.1016/j.seizure.2007.11.004;;18096413;;11709649;;10.1097/00004691-200109000-00008;;9178333;;10.1097/00006842-199705000-00004;;10.1046/j.1528-1157.2003.34702.x;;12614390;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;19047522;;10.1001/archpsyc.65.12.1358;;2226362;;10.1111/j.1528-1157.1990.tb05844.x;;10.1088/2058-7058/15/7/27;;10.1103/physrevlett.88.218101;;12059504;;17008335;;10.1093/brain/awl241;;10.1017/s0012162205000022;;15686283;;10.1097/00004691-200111000-00003;;11779966;;15668970;;10.1002/ana.20377;;16051017;;10.1016/j.surneu.2004.11.026;;10.1007/s11062-006-0027-9;;10.1016/s0140-6736(04)17594-6;;15610808;;10.1016/j.ehj.2003.12.003;;15033247;;15741842;;10.1249/01.mss.0000155388.39002.9d;;10413832;;11684042;;10.1016/s0006-8993(01)02928-6;;1705341;;10.1111/j.1540-8159.1991.tb04052.x;;10.1007/s00381-004-0947-x;;15083332;;10.1016/s0735-1097(97)00554-8;;9502641;;10.1016/0006-8993(77)90274-8;;406970;;11709643;;10.1097/00004691-200109000-00002;;16162428;;10.1111/j.1540-8159.1991.tb04053.x;;1705342;;10.1111/j.1528-1157.1992.tb01751.x;;1464256;;10.1007/bf00928176;;4338867;;2903494;;10.1111/j.1600-0773.1988.tb00913.x;;10.1046/j.1528-1157.2002.37801.x;;12181003;;10.1023/a:1014866501535,"Baevsky, R.M. et al., “Regulation Of Autonomic Nervous System In Space And Magnetic Storms”, Adv. Space Res., vol. 22, No. 2., pp. 227-234; 1998.;;Baevsky, R.M., et al.; “Autonomic Cardiovascular and Respiratory Control During Prolonged Spaceflights Aboard the International Space Station;” J. Applied Physiological, vol. 103, (2007) pp. 156-161.;;Boon, P., et al.; “Vagus Nerve Stimulation for Epilepsy, Clinical Efficacy of Programmed and Magnet Stimulation;” (2001); pp. 93-98.;;Boon, Paul, et al.; “Programmed and Magnet-Induced Vagus Nerve Stimulation for Refractory Epilepsy;” Journal of Clinical Neurophysiology vol. 18 No. 5; (2001); pp. 402-407.;;Borovikova, L.V., et al.; “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin;” Letters to Nature; vol. 405; (May 2000); pp. 458-462.;;Brack, Kieran E., et al.; “Interaction Between Direct Sympathetic and Vagus Nerve Stimulation on Heart Rate in the Isolated Rabbit Heart;” Experimental Physiology vol. 89, No. 1; pp. 128-139, 2004.;;Chakravarthy, N., et al.; “Controlling Synchronization in a Neuron-Leve/ Population Model;” International Journal of Neural Systems, vol. 17, No. 2 (2007) pp. 123-138.;;Apmkorea, “Leading PhotoPlethysmoGraphy Sensor Technology, Transmissive SpO2 PPG Sensor,” found at: http://www.apmkr.com/spo2_oximeter_blood_sensor.htm.;;Clark, K.B. et al, “Posttraining Electrical Stimulation of Vagal Afferents with Concomitant Vagal Efferent Inactivation Enhances Memory Storage Processes in the Rat”, Neurobiology of Learning and Memory, vol. 70, 364-373, 1998, Art. No. NL983863.;;clinicaltrials.gov, “Exploring Biomarkers for Depression,” found at: http://clinicaltrials.gov/ct2/show/ NCT01424111.;;Degiorgio et al., “Pilot Study Of Trigeminal Nerve Stimulation (TNS) for Epilepsy: A Proof-of-Concept Trial,” Epilepsia, 47(7):1213-1215, 2006.;;Digenarro, Giancarlo et al., “Ictal Heart Rate Increase Precedes EEG Discharge In Drug-Resistant Mesial Temporal Lobe Seizures,” Clinical Neurophysioloqv, No. 115, 2004, pp. 1169-1177.;;“Heart Rate Variability—Standards of Measurement, Physiological Interpretation, and Clinical Use” Circulation—Electrophysiology vol. 93, No. 5; http://circ.ahajournals.org/cgi/content-nw/full/93/5/1043/F3, printed on Sep. 10, 2013.;;Elmpt, W.J.C., et al.; “A Model of Heart Rate Changes to Detect Seizures in Severe Epilepsy” Seizure vol. 15, (2006) pp. 366-375.;;Frei, M.G., et al.; “Left Vagus Nerve Stimulation with the Neurocybernetic Prosthesis Has Complex Effects on Heart Rate and on Its Variability in Humans:” Epilepsia, vol. 42, No. 8 (2001); pp. 1007-1016.;;George, M.S., et al.; “Vagus Nerve Stimulation: A New Tool for Brain Research and Therapy;” Society of Biological Psychiatry vol. 47 (2000) pp. 287-295.;;Hallowitz et al., “Effects Of Vagal Volleys On Units Of Intralaminar and Juxta/aminar Tha/amic Nuclei in Monkeys;” Brain Research, vol. 130 (1977), pp. 271-286.;;Henry, Thomas R.; “Therapeutic Mechanisms Of Vague Name Stimulation;”. Neurology, vol. 59 (Supp 4) (Sep. 2002), pp. S3-S14.;;Iasemidis, L.D.; “Epileptic Seizure Prediction and Control” IEEE Transactions on Biomedical Engineering, vol. 50, No. 5 (May 2003); pp. 549-558.;;Iasemidis; L.D., et al.; “Dynamical Resetting of the Human Brain at Epilepctic Seizures: Application of Nonlinear Dynamics and Global Optimization Techniques;” IEEE Transactions on Biomedical Engineering, vol. 51, No. 3 (Mar. 2004); pp. 493-506.;;Iasemidis; L.D., et al.; “Spatiotemporal Transition to Epileptic Seizures: A Nonlinear Dynamical Analysis of Scalp and Intracranial EEG Recordings;” Spatiotemporal Models in Biological and Artificial Systems; F.L. Silva et al. (Eds.) IOS Press, 1997; pp. 81-88.;;Kautzner, J., et al.; “Utility of Short-Term Heart Rate Variability for Prediction of Sudden Cardiac Death After Acute Myocardial Infarction” Acta Univ. Palacki. Olomuc., Fae. Med., vol. 141 (1998) pp. 69-73.;;Koenig, S.A., et al.; “Vagus Nerve Stimulation Improves Severely Impaired Heart Rate Variability in a Patient with Lennox-Gastaut-Syndrome” Seizure (2007) Article in Press—YSEIZ-1305; pp. 1-4.;;Koo, B., “EEG Changes With Vagus Nerve Stimulation” Journal of Clinical Neurophysiology, vol. 18 No. 5 (Sep. 2001); pp. 434-441.;;Krittayaphong, M.D., et al.; “Heart Rate Variability in Patients with Coronary Artery Disease: Differences in Patients with Higher and Lower Depression Scores” Psychosomatic Medicine vol. 59 (1997) pp. 231-235.;;Leutmezer, F., et al.; “Electrocardiogramges at the Onset of Epileptic Seizures;” Epilepsia, vol. 44, No. 3; (2003); pp. 348-354.;;Lewis, M.E., et al.; “Vagus Nerve Stimulation Decreases Left Ventricular Contractility in Vivo in the Human and Pig Heart” The Journal of Physiology vol. 534, No. 2, (2001) pp. 547-552.;;Li, M., et al.; “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats;” Circulation (Jan. 2004) pp. 120-124.;;Licht, C.M.M.; Association Between Major Depressive Disorder and Heart Rate Variability in the Netherlands Study of Depression and Anxiety (NESDA); Arch. Gen Psychiatry, vol. 65, No. 12 (Dec. 2008); pp. 1358-1367.;;Lockard et al., “Feasibility and Safety of Vagal Stimulation in Monkey Model,” Epilepsia, vol. 31 (Supp. 2) 1990, pp. S20-S26.;;Long, Teresa J. et al., “Effectiveness Of Heart Rate Seizure Detection Compared To EEG In An Epilepsy MoitoringUnit (EMU),” abstract of AES Proceedin s, Epilepsia, vol. 40, Suppl. 7, 1999, p. 174.;;McClintock, P., “Can Noise Actually Boost Brain Power” Physics World Jul. 2002; pp. 20-21.;;Method of Evaluation of the Functional State Regulatory Body of Biological Object; Russia Patent Application No. RU 2103911, published Nov. 8, 1993 to Baevsky et al.;;Mori, T., et al.; “Noise-Induced Entrainment and Stochastic Resonance in Human Brain Waves” Physical Review Letters vol. 88, No. 21 (2002); pp. 218101-1-218101-4.;;Mormann, F., “Seizure prediction: the long and winding road,” Brain 130 (2007), 314-333.;;Mousavi et al., Effects of Selected Aerobic Exercises on the Depression and Concentrations of Plasma Serotonin in the Depressed Female, Research Gate, Jan. 2012.;;Neurosigma, “Trigeminal Nerve Stimulation (TNS),” found at: http://www.neurosigma.com/tns.html.;;Nouri, M.D.; “Epilepsy and the Autonomic Nervous System” emedicine (updated May 5, 2006); pp. 1-14; http://www.emedicine.com/neuro/topic658.htm.;;O'Donovan, Cormac A. et al., “Computerized Seizure Detection Based On Heart Rate Changes,” abstract of AES Proceedings, Epilepsia, vol. 36, Suppl. 4, 1995, p. 7.;;O'Regan, M.E., et al.; “Abnormalities in Cardiac and Respiratory Function Observed During Seizures in Childhood” Developmental Medicine & Child Neurlogy, vol. 47 (2005) pp. 4-9.;;Osorio, Ivan et al., “An Introduction To Contingent (Closed-Loop) Brain Electrical Stimulation For Seizure Blockage, To Ultra-Short-Term Clinical Trials, And To Multidimensional Statistical Analysis Of Therapeutic Efficacy,” Journal Of Clinical Neurophysioloqv, vol. 18, No. 6, pp. 533-544, 2001.;;Osorio, Ivan et al., “Automated Seizure Abatement In Humans Using Electrical Stimulation,” Annals Of Neurology, vol. 57, No. 2, pp. 258-268, 2005.;;Pathwardhan, R.V., et al., Control of Refractory status epilepticus precipitated by anticonvulasnt withdrawal using left vagal nerve stimulation: a case report, Surgical Neurology 64 (2005) 170-73.;;Poddubnaya, E.P., “Complex Estimation of Adaptation Abilities of the Organism in Children Using the Indices of Responsiveness of the Cardiovascular System and Characteristics of EEG” Neurophysiology vol. 38, No. 1 (2006); pp. 63-74.;;PR Newswire, “NeuroSigma at the 2011 American Epilepsy Society Annual Meeting and Introduce External Trigeminal Nerve Stimulation-the USB Port to le Brain,” Nov. 29, 2011, found at: http://www.prnewswire.com/ news-releases/neurosigma-to-exhibit-at-the-2011-american-epilepsy-society-annual-meeting.;;Robinson, Stephen E et al., “Heart Rate Variability Changes As Predictor Of Response To Vagal Nerve Stimulation Therapy For Epilepsy,” abstract of AES Proceedings,Epilepsia, vol. 40, Suppl. 7, 1999, p. 147.;;Rugg-Gunn, F.J., et al.; “Cardiac Arrhythmias in Focal Epilepsy: a Prospective Long-Term Study” www.thelancet.com vol. 364 (2004) pp. 2212-2219.;;Sajadieh, A., et al.; “Increased Heart Rate and Reduced Heart-Rte Variability are Associated with Subclinical Inflammation in Middle-Aged and Elderly Subjects with No Apparent Heart Disease” European Heart Journal vol. 25, (2004); pp. 363-370.;;Sandercock et al., Effect of Exercise on Heart Rate Variability: inferences from Meta-Analysis, Med Sci Sports Exerc., p. 433-439,2005.;;Schernthaner, C., et al.; “Autonomic Epilepsy—The Influence of Epileptic Discharges on Heart Rate and Rhythm” The Middle European Journal of Medicine vol. 111, No. 10 (1999) pp. 392-401.;;Sunderam, Sridhar et al., “Vagal And Sciatic Nerve Stimulation Have Complex, Time-Dependent Effects On Chemically-Induced Seizures: A Controlled Study,” Brain Research, vol. 918, pp. 60-66, 2001.;;Terry et al.; The Implantable Neurocybernetic Prosthesis System, Pacing and Clinical Electrophysiology, vol. 14, No. 1 (Jan. 1991), pp. 86-93.;;Tubbs, R.S., et al.; “Left-Sided Vagus Nerve Stimulation Decreases Intracranial Pressure Without Resultant Bradycardia in the Pig: A Potential Therapeutic Modality for Humans” Child's Nervous System Original Paper; Springer-Verlag 2004.;;Umetani, M.D., et al.; “Twenty-Four Hour Time Domain Heart Rate Variability and Heart Rate: Relations to Age and Gender Over Nince Decades” JACC vol. 31, No. 3; (Mar. 1998); pp. 593-601.;;Bachman, D., S. et al.; “Effects Of Vagal Volleys And Serotonin On Units Of Cingulate Cortex in Monkeys;” Brain Research , vol. 130 (1977). pp 253-269.;;Vonck, K., et al. “The Mechanism of Action Of Vagus Nerve Stimulation For Refractory Epilepsy—The Current Status”, Journal of Neurophysiology, vol. 18 No. 5 (2001), pp. 394-401.;;Weil, Sabine et al, “Heart Rate Increase In Otherwise Subclinical Seizures Is Different In Temporal Versus Extratemporal Seizure Onset: Support For Temporal Lobe Automatic Influence,” Epileptic Disord., vol. 7, No. 3, Sep. 2005, pp. 199-204.;;Wikipedia, “Photoplethysmogram,” found at: http://en.wikipedia.org/wiki/Photoplethysmogram.;;Woodbury, et al., “Vagal Stimulation Reduces the Severity Of Maximal Electroshock Seizures in Intact Rats. Use ofa Cuff Electrode for Stimulating And Recording”; Pacing and Clinical Electrophysiology, vol. 14 (Jan. 1991), pp. 94-107.;;Zabara, J. “Inhibition of Experimental Seizures in Canines by Repetivie Vagal Stimulation” Epilepsia vol. 33, No. 6 (1992); pp. 1005-1012.;;Zabara, J., et al.; “Neural Control of Circulation /” The Physiologist, vol. 28 No. 4 (1985); 1 page.;;Zabara, J., et al.; “Neuroinhibition in the Regulation of Emesis” Space Life Sciences, vol. 3 (1972) pp. 282-292.;;Zabara, J.; “Neuroinhibition ofXylaine Induced Emesis” Pharmacology & Toxicology, vol. 63 (1988) pp. 70-74.;;Zijlmans, Maeike et al., “Heart Rate Changes And ECG Abnormalities During Epileptic Seizures: Prevalence And Definition Of An Objective Clinical Siqn,” Epilepsia, vol. 43, No. 8, 2002, oas. 847-854.;;Baevskii, R.M. “Analysis of Heart Rate Variability in Space Medicine;” Human Physiology, vol. 28, No. 2, (2002); pp. 202-213.",ACTIVE
82,US,B2,US 11103707 B2,147-392-582-829-739,2021-08-31,2021,US 201916288238 A,2019-02-28,US 201916288238 A;;US 201313746478 A,2013-01-22,Methods and systems to diagnose depression,"A method includes receiving sensor data at a processor from sensors of an external medical device. The sensor data corresponds to at least a first body parameter value for a patient and a second body parameter value for the patient. The method includes determining a first depression-indicative value based on the first body parameter value, a second depression-indicative value based on the second body parameter value, a depression detection value as a function of a first weight applied to the first depression-indicative value and a second weight applied to the second depression-indicative value, and a depression state based at least in part on a comparison of the depression detection value to one or more threshold values.",LIVANOVA USA INC,LIAO WANGCAI,,https://lens.org/147-392-582-829-739,Granted Patent,yes,599,2,7,085-926-432-381-525;;183-930-199-757-737;;183-843-259-992-865;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,7,085-926-432-381-525;;183-843-259-992-865;;183-930-199-757-737;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,0,A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61N1/36096;;A61B5/4836;;A61B5/24;;A61N1/36096;;A61B5/4836;;A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61B5/24,A61N1/36;;A61B5/00;;A61B5/01;;A61B5/0205;;A61B5/16;;A61B5/24;;A61N1/05;;G16H20/70;;G16H50/20,,65,51,054-868-494-791-055;;046-503-391-804-165;;019-411-892-837-769;;052-630-116-618-842;;115-741-015-188-295;;037-772-810-641-647;;145-702-660-075-441;;054-630-468-158-977;;018-561-710-123-368;;032-676-139-657-586;;015-943-288-841-720;;022-966-379-058-403;;048-642-493-280-14X;;046-397-703-096-430;;019-308-872-975-51X;;002-403-074-135-442;;005-812-068-829-241;;112-897-527-124-30X;;032-751-441-147-285;;046-621-728-923-715;;056-177-900-384-501;;098-586-850-446-33X;;066-328-676-515-762;;018-202-351-494-006;;097-426-806-139-480;;072-028-517-836-043;;091-962-532-331-31X;;103-040-249-541-832;;016-207-089-756-778;;050-957-455-833-565;;011-498-617-423-119;;030-501-930-582-312;;013-993-295-891-841;;019-773-125-379-283;;014-724-861-390-592;;015-820-060-894-869;;038-128-501-814-320;;013-620-213-165-976;;112-318-944-745-749;;088-853-742-205-302;;003-290-790-587-579;;026-435-299-569-935;;047-345-017-295-263;;033-503-915-578-321;;139-831-627-763-342;;024-644-707-340-274;;023-093-432-161-773;;025-424-076-138-599;;079-757-926-093-134;;035-904-149-105-698;;029-700-863-111-313,10.1023/a:1014866501535;;10.1016/s0273-1177(98)80014-8;;11541400;;17446414;;10.1152/japplphysiol.00137.2007;;11974997;;10.1007/978-3-7091-6105-0_21;;11709644;;10.1097/00004691-200109000-00003;;10839541;;10.1038/35013070;;15109218;;10.1113/expphysiol.2003.002654;;17565508;;10.1142/s0129065707000993;;9774527;;10.1006/nlme.1998.3863;;10.1111/j.1528-1167.2006.00594.x;;16886985;;10.1016/j.clinph.2003.12.016;;15066542;;16828317;;10.1016/j.seizure.2006.03.005;;10.1046/j.1528-1157.2001.0420081007.x;;11554886;;10.1016/s0006-3223(99)00308-x;;10686263;;10.1016/0006-8993(77)90275-x;;195672;;10.1212/wnl.59.6_suppl_4.s3;;12270962;;12769431;;10.1109/tbme.2003.810705;;10.1109/tbme.2003.821013;;15000380;;9684488;;10.1016/j.seizure.2007.11.004;;18096413;;11709649;;10.1097/00004691-200109000-00008;;9178333;;10.1097/00006842-199705000-00004;;10.1046/j.1528-1157.2003.34702.x;;12614390;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;19047522;;10.1001/archpsyc.65.12.1358;;2226362;;10.1111/j.1528-1157.1990.tb05844.x;;10.1088/2058-7058/15/7/27;;10.1103/physrevlett.88.218101;;12059504;;17008335;;10.1093/brain/awl241;;10.1017/s0012162205000022;;15686283;;10.1097/00004691-200111000-00003;;11779966;;15668970;;10.1002/ana.20377;;16051017;;10.1016/j.surneu.2004.11.026;;10.1007/s11062-006-0027-9;;10.1016/s0140-6736(04)17594-6;;15610808;;10.1016/j.ehj.2003.12.003;;15033247;;15741842;;10.1249/01.mss.0000155388.39002.9d;;10413832;;11684042;;10.1016/s0006-8993(01)02928-6;;1705341;;10.1111/j.1540-8159.1991.tb04052.x;;10.1007/s00381-004-0947-x;;15083332;;10.1016/s0735-1097(97)00554-8;;9502641;;10.1016/0006-8993(77)90274-8;;406970;;11709643;;10.1097/00004691-200109000-00002;;16162428;;10.1111/j.1540-8159.1991.tb04053.x;;1705342;;10.1111/j.1528-1157.1992.tb01751.x;;1464256;;10.1007/bf00928176;;4338867;;2903494;;10.1111/j.1600-0773.1988.tb00913.x;;10.1046/j.1528-1157.2002.37801.x;;12181003,"Baevskii, R.M. “Analysis of Heart Rate Variability in Space Medicine,” Human Physiology, vol. 28, No. 2, (2002); pp. 202-213.;;Baevsky, R.M. et al., “Regulation of Autonomic Nervous System in Space and Magnetic Storms”, Adv. Space Res., vol. 22, No. 2., pp. 227-234; 1998.;;Baevsky, R.M., et al.; “Autonomic Cardiovascular and Respiratory Control During Prolonged Spaceflights Aboard the International Space Station,” J. Applied Physiological, vol. 103, (2007) pp. 156-161.;;Boon, P., et al.; “Vagus Nerve Stimulation for Epilepsy, Clinical Efficacy of Programmed and Magnet Stimulation,” (2001); pp. 93-98.;;Boon, Paul, et al.; “Programmed and Magnet-Induced Vagus Nerve Stimulation for Refractory Epilepsy,” Journal of Clinical Neurophysiology vol. 18 No. 5; (2001); pp. 402-407.;;Borovikova, L.V., et al.; “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin,” Letters to Nature; vol. 405; (May 2000); pp. 458-462.;;Brack, Kieran E., et al.; “Interaction Between Direct Sympathetic and Vagus Nerve Stimulation on Heart Rate in the Isolated Rabbit Heart,” Experimental Physiology vol. 89, No. 1; pp. 128-139, 2004.;;Chakravarthy, N., et al.; “Controlling Synchronization in a Neuron-Leve/ Population Model;” International Journal of Neural Systems, vol. 17, No. 2 (2007) pp. 123-138.;;Apmkorea, “Leading PhotoPlethysmoGraphy Sensor Technology, Transmissive SpO2 PPG Sensor,” found at: http://www.apmkr.com/spo2_oximeter_b1ood_sensor.htm.;;Clark, K.B. et al, “Posttraining Electrical Stimulation of Vagal Afferents with Concomitant Vagal Efferent Inactivation Enhances Memory Storage Processes in the Rat”, Neurobiology of Learning and Memory, vol. 70, 364-373, 1998.;;Clinicaltrials.gov, “Exploring Biomarkers for Depression,” found at: http://clinicaltrials.gov/ct2/show/ NCT01424111.;;DeGiorgio et al., “Pilot Study of Trigeminal Nerve Stimulation (TNS) for Epilepsy: A Proof-of-Concept Trial,” Epilepsia, 47(7):1213-1215, 2006.;;DiGenarro, Giancarlo et al., “Ictal Heart Rate Increase Precedes EEG Discharge in Drug-Resistant Mesial Temporal Lobe Seizures,” Clinical Neurophysioloqv, No. 115, 2004, pp. 1169-1177.;;“Heart Rate Variability—Standards of Measurement, Physiological Interpretation, and Clinical Use” Circulation-Electrophysiology vol. 93, No. 5; http://circ.ahajournals.org/cgi/content-nw/full/93/5/1043/F3, printed on Sep. 10, 2013.;;Elmpt, W.J.C., et al.; “A Model of Heart Rate Changes to Detect Seizures in Severe Epilepsy” Seizure vol. 15, (2006) pp. 366-375.;;Frei, M.G., et al.; “Left Vagus Nerve Stimulation with the Neurocybernetic Prosthesis Has Complex Effects on Heart Rate and on Its Variability in Humans:” Epilepsia, vol. 42, No. 8 (2001); pp. 1007-1016.;;George, M.S., et al.; “Vagus Nerve Stimulation: A New Tool for Brain Research and Therapy,” Society of Biological Psychiatry vol. 47 (2000) pp. 287-295.;;Hallowitz et al., “Effects of Vagal Volleys on Units of Intralaminar and Juxta/aminar Tha/amic Nuclei in Monkeys,” Brain Research, vol. 130 (1977), pp. 271-286.;;Henry, Thomas R.; “Therapeutic Mechanisms of Vague Name Stimulation;”. Neurology, vol. 59 (Supp 4) (Sep. 2002), pp. S3-S14.;;Iasemidis, L.D.; “Epileptic Seizure Prediction and Control” IEEE Transactions on Biomedical Engineering, vol. 50, No. 5 (May 2003); pp. 549-558.;;Iasemidis; L.D., et al.; “Dynamical Resetting of the Human Brain at Epilepctic Seizures: Application of Nonlinear Dynamics and Global Optimization Techniques,” IEEE Transactions on Biomedical Engineering, vol. 51, No. 3 (Mar. 2004); pp. 493-506.;;Iasemidis; L.D., et al.; “Spatiotemporal Transition to Epileptic Seizures: A Nonlinear Dynamical Analysis of Scalp and Intracranial EEG Recordings,” Spatiotemporal Models in Biological and Artificial Systems; F.L. Silva et al. (Eds.) IOS Press, 1997; pp. 81-88.;;Kautzner, J., et al.; “Utility of Short-Term Heart Rate Variability for Prediction of Sudden Cardiac Death After Acute Myocardial Infarction” Acta Univ. Palacki. Olomuc., Fae. Med., vol. 141 (1998) pp. 69-73.;;Koenig, S.A., et al.; “Vagus Nerve Stimulation Improves Severely Impaired Heart Rate Variability in a Patient with Lennox-Gastaut-Syndrome” Seizure (2007) Article in Press—YSEIZ-1305; pp. 1-4.;;Koo, B., “EEG Changes With Vagus Nerve Stimulation” Journal of Clinical Neurophysiology, vol. 18 No. 5 (Sep. 2001); pp. 434-441.;;Krittayaphong, M.D., et al.; “Heart Rate Variability in Patients with Coronary Artery Disease: Differences in Patients with Higher and Lower Depression Scores” Psychosomatic Medicine vol. 59 (1997) pp. 231-235.;;Leutmezer, F., et al.; “Electrocardiographic Changes at the Onset of Epileptic Seizures,” Epilepsia, vol. 44, No. 3; (2003); pp. 348-354.;;Lewis, M.E., et al.; “Vagus Nerve Stimulation Decreases Left Ventricular Contractility in Vivo in the Human and Pig Heart” The Journal of Physiology vol. 534, No. 2, (2001) pp. 547-552.;;Li, M., et al.; “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation (Jan. 2004) pp. 120-124.;;Licht, C.M.M.; Association Between Major Depressive Disorder and Heart Rate Variability in the Netherlands Study of Depression and Anxiety (NESDA); Arch. Gen Psychiatry, vol. 65, No. 12 (Dec. 2008); pp. 1358-1367.;;Lockard et al., “Feasibility and Safety of Vagal Stimulation in Monkey Model,” Epilepsia, vol. 31 (Supp. 2) 1990, pp. S20-S26.;;Long, Teresa J. et al., “Effectiveness of Heart Rate Seizure Detection Compared to EEG in an Epilepsy MoitoringUnit (EMU),” abstract of AES Proceedin s, Epilepsia, vol. 40, Suppl. 7, 1999, p . 174.;;McClintock, P., “Can Noise Actually Boost Brain Power” Physics World Jul. 2002; pp. 20-21.;;Method of Evaluation of the Functional State Regulatory Body of Biological Object; Russia Patent Application No. RU 2103911, published Nov. 8, 1993 to Baevsky et al.;;Mori, T., et al.; “Noise-Induced Entrainment and Stochastic Resonance in Human Brain Waves” Physical Review Letters vol. 88, No. 21 (2002); pp. 218101-1-218101-4.;;Mormann, F., “Seizure prediction: the long and winding road,” Brain 130 (2007), 314-333.;;Mousavi et al., Effects of Selected Aerobic Exercises on the Depression and Concentrations of Plasma Serotonin in the Depressed Female, Research Gate, Jan. 2012.;;Neurosigma, “Trigeminal Nerve Stimulation (TNS),” found at: http://www.neurosigma.com/tns.html.;;Nouri, M.D.; “Epilepsy and the Autonomic Nervous System” emedicine (updated May 5, 2006); pp. 1-14; http://www.emedicine.com/neuro/topic658.htm.;;O'Donovan, Cormac A. et al., “Computerized Seizure Detection Based on Heart Rate Changes,” abstract of AES Proceedings, Epilepsia, vol. 36, Suppl. 4, 1995, p. 7.;;O'Regan, M.E., et al.; “Abnormalities in Cardiac and Respiratory Function Observed During Seizures in Childhood” Developmental Medicine & Child Neurlogy, vol. 47 (2005) pp. 4-9.;;Osorio, Ivan et al, “An introduction to contingent (Closed-Loop) Brain Electrical Stimulation For Seizure Blockage, to Ultra-Short-Term Clinical Trials, and to Multidimensional Statistical Analysis of Therapeutic Efficacy,” Journal of Clinical Neurophysioloqv, vol. 18, No. 6, pp. 533-544, 2001.;;Osorio, Ivan et al., “Automated Seizure Abatement in Humans Using Electrical Stimulation,” Annals of Neurology, vol. 57, No. 2, pp. 258-268, 2005.;;Pathwardhan, R.V., et al., Control of Refractory status epilepticus precipitated by anticonvulasnt withdrawal using left vagal nerve stimulation: a case report, Surgical Neurology 64 (2005) 170-73.;;Poddubnaya, E.P., “Complex Estimation of Adaptation Abilities of the Organism in Children Using the Indices of Responsiveness of the Cardiovascular System and Characteristics of EEG” Neurophysiology vol. 38, No. 1 (2006); pp. 63-74.;;PR Newswire, “NeuroSigma at the 2011 American Epilepsy Society Annual Meeting and Introduce External Trigeminal Nerve Stimulation-the USB Port to le Brain,” Nov. 29, 2011, found at: http://www.prnewswire.com/ news-releases/neurosigma-to-exhibit-at-the-2011-american-epilepsy-society-annual-meeting.;;Robinson, Stephen E et al., “Heart Rate Variability Changes As Predictor of Response to Vagal Nerve Stimulation Therapy for Epilepsy,” abstract of AES Proceedinqs,Epilepsia, vol. 40, Suppl. 7, 1999, p. 147.;;Rugg-Gunn, F.J., et al.; “Cardiac Arrhythmias in Focal Epilepsy: a Prospective Long-Term Study” www.thelancet.com vol. 364 (2004) pp. 2212-2219.;;Sajadieh, A., et al.; “Increased Heart Rate and Reduced Heart-Rte Variability are Associated with Subclinical Inflammation in Middle-Aged and Elderly Subjects with no. Apparent Heart Disease” European Heart Journal vol. 25, (2004); pp. 363-370.;;Sandercock et al., Effect of Exercise on Heart Rate Variability: inferences from Meta-Analysis, Med Sci Sports Exerc., p. 433-439,2005.;;Schernthaner, C., et al.; “Autonomic Epilepsy—The Influence of Epileptic Discharges on Heart Rate and Rhythm” The Middle European Journal of Medicine vol. 111, No. 10 (1999) pp. 392-401.;;Sunderam, Sridhar et al., “Vagal and Sciatic Nerve Stimulation Have Complex, Time-Dependent Effects on Chemically-Induced Seizures: A Controlled Study,” Brain Research, vol. 918, pp. 60-66, 2001.;;Terry et al.; The Implantable Neurocybernetic Prosthesis System, Pacing and Clinical Electrophysiology, vol. 14, No. 1 (Jan. 1991), pp. 86-93.;;Tubbs, R.S., et al.; “Left-Sided Vagus Nerve Stimulation Decreases Intracranial Pressure Without Resultant Bradycardia in the Pig: A Potential Therapeutic Modality for Humans” Child's Nervous System Original Paper; Springer-Verlag 2004.;;Umetani, M.D., et al.; “Twenty-Four Hour Time Domain Heart Rate Variability and Heart Rate: Relations to Age and Gender Over Nince Decades” JACC vol. 31, No. 3; (Mar. 1998); pp. 593-601.;;Bachman, D.,S. et al.; “Effects of Vagal Volleys and Serotonin on Units of Cingulate Cortex in Monkeys,” Brain Research , vol. 130 (1977). pp. 253-269.;;Vonck, K., et al. “The Mechanism of Action of Vagus Nerve Stimulation for Refractory Epilepsy the Current Status”, Journal of Neurophysiology, vol. 18 No. 5 (2001), pp. 394-401.;;Weil, Sabine et al, “Heart Hate Increase in Otherwise Subclnical seizures is Different in Temporal Versus Extratemporal Seizure Onset: Support for Temporal Lobe Automatic Influence,” Epileptic Disord., vol. 7, No. 3, Sep. 2005, pp. 199-204.;;Wikipedia, “Photoplethysmogram,” found at: http://en.wikipedia.org/wiki/Photoplethysmogram.;;Woodbury, et al., “Vagal Stimulation Reduces the Severity of Maximal Electroshock Seizures in Intact Rats. Use ofa Cuff Electrode for Stimulating and Recording”; Pacing and Clinical Electrophysiology, vol. 14 (Jan. 1991), pp. 94-107.;;Zabara, J. “Inhibition of Experimental Seizures in Canines by Repetivie Vagal Stimulation” Epilepsia vol. 33, No. 6 (1992); pp. 1005-1012.;;Zabara, J., et al.; “Neural Control of Circulation /” The Physiologist, vol. 28 No. 4 (1985); 1 page.;;Zabara, J., et al.; “Neuroinhibition in the Regulation of Emesis” Space Life Sciences, vol. 3 (1972) pp. 282-292.;;Zabara, J.; “Neuroinhibition ofXylaine Induced Emesis” Pharmacology & Toxicology, vol. 63 (1988) pp. 70-74.;;Zijlmans, Maeike et al., “Heart Rate Changes and ECG Abnormalities During Epileptic Seizures: Prevalence and Definition of an Objective Clinical Sign,” Epilepsia, vol. 43, No. 8, 2002, oas. 847-854.",ACTIVE
83,US,A1,US 2019/0192856 A1,085-926-432-381-525,2019-06-27,2019,US 201916288238 A,2019-02-28,US 201916288238 A;;US 201313746478 A,2013-01-22,METHODS AND SYSTEMS TO DIAGNOSE DEPRESSION,"A method includes receiving sensor data at a processor from sensors of an external medical device. The sensor data corresponds to at least a first body parameter value for a patient and a second body parameter value for the patient. The method includes determining a first depression-indicative value based on the first body parameter value, a second depression-indicative value based on the second body parameter value, a depression detection value as a function of a first weight applied to the first depression-indicative value and a second weight applied to the second depression-indicative value, and a depression state based at least in part on a comparison of the depression detection value to one or more threshold values.",LIVANOVA USA INC,LIAO WANGCAI,,https://lens.org/085-926-432-381-525,Patent Application,yes,1,0,7,085-926-432-381-525;;183-930-199-757-737;;183-843-259-992-865;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,7,085-926-432-381-525;;183-843-259-992-865;;183-930-199-757-737;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,0,A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61N1/36096;;A61B5/4836;;A61B5/24;;A61N1/36096;;A61B5/4836;;A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61B5/24,A61N1/36;;A61B5/00;;A61B5/16;;A61N1/05;;G16H20/70;;G16H50/20,,0,0,,,,ACTIVE
84,US,B2,US 10220211 B2,183-930-199-757-737,2019-03-05,2019,US 201313746478 A,2013-01-22,US 201313746478 A,2013-01-22,Methods and systems to diagnose depression,"A method includes receiving sensor data at a processor from sensors of an external medical device. The sensor data corresponds to at least a first body parameter value for a patient and a second body parameter value for the patient. The method includes determining a first depression-indicative value based on the first body parameter value, a second depression-indicative value based on the second body parameter value, a depression detection value as a function of a first weight applied to the first depression-indicative value and a second weight applied to the second depression-indicative value, and a depression state based at least in part on a comparison of the depression detection value to one or more threshold values.",LIVANOVA USA INC,LIAO WANGCAI,LIVANOVA USA INC (2013-01-22),https://lens.org/183-930-199-757-737,Granted Patent,yes,598,5,7,085-926-432-381-525;;183-930-199-757-737;;183-843-259-992-865;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,7,085-926-432-381-525;;183-843-259-992-865;;183-930-199-757-737;;147-392-582-829-739;;010-269-063-908-10X;;055-458-164-846-820;;077-970-841-848-569,US,0,A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61N1/36096;;A61B5/4836;;A61B5/24;;A61N1/36096;;A61B5/4836;;A61N1/0529;;A61B5/01;;A61B5/0205;;A61B5/165;;G16H50/20;;G16H20/70;;A61B5/24,A61N1/36;;A61B5/00;;A61B5/01;;A61B5/0205;;A61B5/04;;A61B5/16;;A61N1/05,,66,51,013-620-213-165-976;;032-676-139-657-586;;033-503-915-578-321;;054-868-494-791-055;;019-411-892-837-769;;052-630-116-618-842;;115-741-015-188-295;;037-772-810-641-647;;145-702-660-075-441;;054-630-468-158-977;;018-561-710-123-368;;022-966-379-058-403;;048-642-493-280-14X;;046-397-703-096-430;;002-403-074-135-442;;019-308-872-975-51X;;112-897-527-124-30X;;005-812-068-829-241;;032-751-441-147-285;;046-621-728-923-715;;056-177-900-384-501;;098-586-850-446-33X;;066-328-676-515-762;;018-202-351-494-006;;097-426-806-139-480;;072-028-517-836-043;;091-962-532-331-31X;;103-040-249-541-832;;016-207-089-756-778;;050-957-455-833-565;;011-498-617-423-119;;019-773-125-379-283;;014-724-861-390-592;;015-820-060-894-869;;038-128-501-814-320;;112-318-944-745-749;;003-290-790-587-579;;026-435-299-569-935;;047-345-017-295-263;;139-831-627-763-342;;023-093-432-161-773;;035-904-149-105-698;;025-424-076-138-599;;079-757-926-093-134;;030-501-930-582-312;;013-993-295-891-841;;088-853-742-205-302;;024-644-707-340-274;;015-943-288-841-720;;029-700-863-111-313;;046-503-391-804-165,15741842;;10.1249/01.mss.0000155388.39002.9d;;10.1111/j.1528-1167.2006.00594.x;;16886985;;10.1016/0006-8993(77)90274-8;;406970;;10.1023/a:1014866501535;;17446414;;10.1152/japplphysiol.00137.2007;;11974997;;10.1007/978-3-7091-6105-0_21;;11709644;;10.1097/00004691-200109000-00003;;10839541;;10.1038/35013070;;15109218;;10.1113/expphysiol.2003.002654;;17565508;;10.1142/s0129065707000993;;9774527;;10.1006/nlme.1998.3863;;16828317;;10.1016/j.seizure.2006.03.005;;10.1046/j.1528-1157.2001.0420081007.x;;11554886;;10.1016/s0006-3223(99)00308-x;;10686263;;10.1212/wnl.59.6_suppl_4.s3;;12270962;;10.1016/0006-8993(77)90275-x;;195672;;10.1109/tbme.2003.821013;;15000380;;12769431;;10.1109/tbme.2003.810705;;9684488;;10.1016/j.seizure.2007.11.004;;18096413;;11709649;;10.1097/00004691-200109000-00008;;9178333;;10.1097/00006842-199705000-00004;;10.1046/j.1528-1157.2003.34702.x;;12614390;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;19047522;;10.1001/archpsyc.65.12.1358;;2226362;;10.1111/j.1528-1157.1990.tb05844.x;;10.1088/2058-7058/15/7/27;;10.1103/physrevlett.88.218101;;12059504;;17008335;;10.1093/brain/awl241;;10.1017/s0012162205000022;;15686283;;16051017;;10.1016/j.surneu.2004.11.026;;10.1007/s11062-006-0027-9;;10.1016/s0140-6736(04)17594-6;;15610808;;10.1016/j.ehj.2003.12.003;;15033247;;10413832;;1705341;;10.1111/j.1540-8159.1991.tb04052.x;;10.1007/s00381-004-0947-x;;15083332;;10.1016/s0735-1097(97)00554-8;;9502641;;11709643;;10.1097/00004691-200109000-00002;;10.1111/j.1540-8159.1991.tb04053.x;;1705342;;2903494;;10.1111/j.1600-0773.1988.tb00913.x;;10.1111/j.1528-1157.1992.tb01751.x;;1464256;;10.1007/bf00928176;;4338867;;10.1097/00004691-200111000-00003;;11779966;;15668970;;10.1002/ana.20377;;11684042;;10.1016/s0006-8993(01)02928-6;;16162428;;10.1016/j.clinph.2003.12.016;;15066542;;10.1046/j.1528-1157.2002.37801.x;;12181003;;10.1016/s0273-1177(98)80014-8;;11541400,"Sandercock et al., Effect of Exercise on Heart Rate Variability: inferences from Meta-Analysis, Med Sci Sports Exerc., p. 433-439, 2005.;;Mousavi et al., Effects of Selected Aerobic Exercises on the Depression and Concentrations of Plasma Serotonin in the Depressed Female, Research Gate, Jan. 2012.;;clinicaltrials.gov, “Exploring Biomarkers for Depression,” found at: http://clinicaltrials.gov/ct2/show/NCT01424111.;;Wikipedia, “Photoplethysmogram,” found at: http://en.wikipedia.org/wiki/Photoplethysmogram.;;Apmkorea, “Leading PhotoPlethysmoGraphy Sensor Technology, Transmissive SpO2 PPG Sensor,” found at: http://www.apmkr.com/spo2_oximeter_blood_sensor.htm.;;PR Newswire, “NeuroSigma at the 2011 American Epilepsy Society Annual Meeting and Introduce External Trigeminal Nerve Stimulation-the USB Port to to Brain,” Nov. 29, 2011, found at: http://www.prnewswire.com/news-releases/neurosigma-to-exhibit-at-the-2011-american-epilepsy-society-annual-meeting.;;Neurosigma, “Trigeminal Nerve Stimulation (TNS),” found at: http://www.neurosigma.com/tns.html.;;DeGiorgio et al., “Pilot Study of Trigeminal Nerve Stimulation (TNS) for Epilepsy: A Proof-of-Concept Trial,” Epilepsia, 47(7):1213-1215, 2006.;;Bachman, D.,S. et al.; “Effects of Vagal Volleys and Serotonin on Units of Cingulate Cortex in Monkeys;” Brain Research , vol. 130 (1977). pp. 253-269.;;Baevskii, R.M. “Analysis of Heart Rate Variability in Space Medicine;” Human Physiology, vol. 28, No. 2, (2002); pp. 202-213.;;Baevsky, R.M., et al.; “Autonomic Cardiovascular and Respiratory Control During Prolonged Spaceflights Aboard the International Space Station;” J. Applied Physiological, vol. 103, (2007) pp. 156-161.;;Boon, P., et al.; “Vagus Nerve Stimulation for Epilepsy, Clinical Efficacy of Programmed and Magnet Stimulation;” (2001); pp. 93-98.;;Boon, Paul, et al.; “Programmed and Magnet-Induced Vagus Nerve Stimulation for Refractory Epilepsy;”Journal of Clinical Neurophysiology vol. 18 No. 5; (2001); pp. 402-407.;;Borovikova, L.V., et al.; “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin;” Letters to Nature; vol. 405; (May 2000); pp. 458-462.;;Brack, Kieran E., et al.; “Interaction Between Direct Sympathetic and Vagus Nerve Stimulation on Heart Rate in the Isolated Rabbit Heart;” Experimental Physiology vol. 89, No. 1; pp. 128-139, 2004.;;Chakravarthy, N., et al.; “Controlling Synchronization in a Neuron-Level Population Model;” International Journal of Neural Systems, vol. 17, No. 2 (2007) pp. 123-138.;;Clark, K.B., et al.; “Posttraining Electrical Stimulation of Vagal Afferents with Concomitant Vagal Efferent Inactivation Enhances Memory Storage Processes in the Rat;” Neurobiology of Learning and Memory, vol. 70, 364-373 (1998) Art. No. NL983863.;;Elmpt, W.J.C., et al.; “A Model of Heart Rate Changes to Detect Seizures in Severe Epilepsy” Seizure vol. 15, (2006) pp. 366-375.;;Frei, M.G., et al.; “Left Vagus Nerve Stimulation with the Neurocybernetic Prosthesis Has Complex Effects on Heart Rate and on Its Variability in Humans:” Epilepsia, vol. 42, No. 8 (2001); pp. 1007-1016.;;George, M.S., et al.; “Vagus Nerve Stimulation: A New Tool for Brain Research and Therapy;”Society of Biological Psychiatry vol. 47 (2000) pp. 287-295.;;“Heart Rate Variability—Standards of Measurement, Physiological Interpretation, and Clinical Use” Circulation—Electrophysiology vol. 93, No. 5; http://circ.ahajournals.org/cgi/content-nw/full/93/5/1043/F3, printed on Sep. 10, 2013.;;Henry, Thomas R.; “Therapeutic Mechanisms of Vague Name Stimulation;”. Neurology, vol. 59 (Supp 4) (Sep. 2002), pp. S3-S14.;;Hallowitz et al., “Effects of Vagal Volleys on Units of Intralaminar and Juxtalaminar Thalamic Nuclei in Monkeys;” Brain Research, vol. 130 (1977), pp. 271-286.;;Iasemidis; L.D., et al.; “Dynamical Resetting of the Human Brain at Epilepctic Seizures: Application of Nonlinear Dynamics and Global Optimization Techniques;” IEEE Transactions on Biomedical Engineering, vol. 51, No. 3 (Mar. 2004); pp. 493-506.;;Iasemidis; L.D., et al.; “Spatiotemporal Transition to Epileptic Seizures: A Nonlinear Dynamical Analysis of Scalp and Intracranial EEG Recordings;” Spatiotemporal Models in Biological and Artificial Systems; F.L. Silva et al. (Eds.) IOS Press, 1997; pp. 81-88.;;Iasemidis, L.D.; “Epileptic Seizure Prediction and Control” IEEE Transactions on Biomedical Engineering, vol. 50, No. 5 (May 2003); pp. 549-558.;;Kautzner, J., et al.; “Utility of Short-Term Heart Rate Variability for Prediction of Sudden Cardiac Death After Acute Myocardial Infarction” Acta Univ. Palacki. Olomuc., Fac. Med., vol. 141 (1998) pp. 69-73.;;Koenig, S.A., et al.; “Vagus Nerve Stimulation Improves Severely Impaired Heart Rate Variability in a Patient with Lennox-Gastaut-Syndrome” Seizure (2007) Article in Press—YSEIZ-1305; pp. 1-4.;;Koo, B., “EEG Changes With Vagus Nerve Stimulation” Journal of Clinical Neurophysiology, vol. 18 No. 5 (Sep. 2001); pp. 434-441.;;Krittayaphong, M.D., et al.; “Heart Rate Variability in Patients with Coronary Artery Disease: Differences in Patients with Higher and Lower Depression Scores” Psychosomatic Medicine vol. 59 (1997) pp. 231-235.;;Leutmezer, F., et al.; “Electrocardiographic Changes at the Onset of Epileptic Seizures;” Epilepsia, vol. 44, No. 3; (2003); pp. 348-354.;;Lewis, M.E., et al.; “Vagus Nerve Stimulation Decreases Left Ventricular Contractility in Vivo in the Human and Pig Heart” The Journal of Physiology vol. 534, No. 2, (2001) pp. 547-552.;;Li, M., et al.; “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats;” Circulation (Jan. 2004) pp. 120-124.;;Licht, C.M.M.; Association Between Major Depressive Disorder and Heart Rate Variability in the Netherlands Study of Depression and Anxiety (NESDA); Arch. Gen Psychiatry, vol. 65, No. 12 (Dec. 2008); pp. 1358-1367.;;Lockard et al., “Feasibility and Safety of Vagal Stimulation in Monkey Model;” Epilepsia, vol. 31 (Supp. 2) (1990), pp. S20-S26.;;McClintock, P., “Can Noise Actually Boost Brain Power” Physics World Jul. 2002; pp. 20-21.;;Mori, T., et al.; “Noise-Induced Entrainment and Stochastic Resonance in Human Brain Waves” Physical Review Letters vol. 88, No. 21 (2002); pp. 218101-1-218101-4.;;Mormann, F., “Seizure prediction: the long and winding road,” Brain 130 (2007), 314-333.;;Nouri, M.D.; “Epilepsy and the Autonomic Nervous System” emedicine (updated May 5, 2006); pp. 1-14; http://www.emedicine.com/neuro/topic658.htm.;;O'Regan, M.E., et al.; “Abnormalities in Cardiac and Respiratory Function Observed During Seizures in Childhood” Developmental Medicine & Child Neurlogy, vol. 47 (2005) pp. 4-9.;;Pathwardhan, R.V., et al., Control of Refractory status epilepticus precipitated by anticonvulasnt withdrawal using left vagal nerve stimulation: a case report, Surgical Neurology 64 (2005) 170-73.;;Poddubnaya, E.P., “Complex Estimation of Adaptation Abilities of the Organism in Children Using the Indices of Responsiveness of the Cardiovascular System and Characteristics of EEG” Neurophysiology vol. 38, No. 1 (2006); pp. 63-74.;;Rugg-Gunn, F.J., et al.; “Cardiac Arrhythmias in Focal Epilepsy: a Prospective Long-Term Study” www.thelancet.com vol. 364 (2004) pp. 2212-2219.;;Sajadieh, A., et al.; “Increased Heart Rate and Reduced Heart-Rte Variability are Associated with Subclinical Inflammation in Middle-Aged and Elderly Subjects with No Apparent Heart Disease” European Heart Journal vol. 25, (2004); pp. 363-370.;;Schernthaner, C., et al.; “Autonomic Epilepsy—The Influence of Epileptic Discharges on Heart Rate and Rhythm” The Middle European Journal of Medicine vol. 111, No. 10 (1999) pp. 392-401.;;Terry et al.; “The Implantable Neurocybernetic Prosthesis System”, Pacing and Clinical Electrophysiology, vol. 14, No. 1 (Jan. 1991), pp. 86-93.;;Tubbs, R.S., et al.; “Left-Sided Vagus Nerve Stimulation Decreases Intracranial Pressure Without Resultant Bradycardia in the Pig: A Potential Therapeutic Modality for Humans” Child's Nervous System Original Paper; Springer-Verlag 2004.;;Umetani, M.D., et al.; “Twenty-Four Hour Time Domain Heart Rate Variability and Heart Rate: Relations to Age and Gender Over Nince Decades”JACC vol. 31, No. 3; (Mar. 1998); pp. 593-601.;;Vonck, K., et al. “The Mechanism of Action of Vagus Nerve Stimulation for Refractory Epilepsy—The Current Status”, Journal of Neurophysiology, vol. 18 No. 5 (2001), pp. 394-401.;;Woodbury, et al., “Vagal Stimulation Reduces the Severity of Maximal Electroshock Seizures in Intact Rats. Use of a Cuff Electrode for Stimulating and Recording”; Pacing and Clinical Electrophysiology, vol. 14 (Jan. 1991), pp. 94-107.;;Zabara, J.; “Neuroinhibition of Xylaine Induced Emesis” Pharmacology & Toxicology, vol. 63 (1988) pp. 70-74.;;Zabara, J. “Inhibition of Experimental Seizures in Canines by Repetivie Vagal Stimulation” Epilepsia vol. 33, No. 6 (1992); pp. 1005-1012.;;Zabara, J., et al.; “Neural Control of Circulation I” The Physiologist, vol. 28 No. 4 (1985); 1 page.;;Zabara, J., et al.; “Neuroinhibition in the Regulation of Emesis” Space Life Sciences, vol. 3 (1972) pp. 282-292.;;Osorio, Ivan et al., “An Introduction to Contingent (Closed-Loop) Brain Electrical Stimulation for Seizure Blockage, To Ultra-Short-Term Clinical Trials, And to Multidimensional Statistical Analysis of Therapeutic Efficacy,” Journal of Clinical Neurophysiology, vol. 18, No. 6, pp. 533-544, 2001.;;Osorio, Ivan et al., “Automated Seizure Abatement In Humans Using Electrical Stimulation,” Annals Of Neurology, vol. 57, No. 2, pp. 258-268, 2005.;;Sunderam, Sridhar et al., “Vagal and Sciatic Nerve Stimulation Have Complex, Time-Dependent Effects On Chemically-Induced Seizures: A Controlled Study,” Brain Research, vol. 918, pp. 60-66, 2001.;;Weil, Sabine et al, “Heart Rate Increase In Otherwise Subclinical Seizures Is Different In Temporal Versus Extratemporal Seizure Onset: Support For Temporal Lobe Automatic Influence,” Epileptic Disord., vol. 7, No. 3, Sep. 2005, pp. 199-204.;;Digenarro, Giancarlo et al., “Ictal Heart Rate Increase Precedes EEG Discharge in Drug-Resistant Mesial Temporal Lobe Seizures,” Clinical Neurophysiology, No. 115, 2004, pp. 1169-1177.;;Zijlmans, Maeike et al., “Heart Rate Changes And ECG Abnormalities During Epileptic Seizures: Prevalence and Definition Of An Objective Clinical Sign,” Epilepsia, vol. 43, No. 8, 2002, pp. 847-854.;;O'Donovan, Cormac A. et al., “Computerized Seizure Detection Based On Heart Rate Changes,” abstract of AES Proceedings, Epilepsia, vol. 36, Suppl. 4, 1995, p. 7.;;Robinson, Stephen E et al., “Heart Rate Variability Changes As Predictor Of Response To Vagal Nerve Stimulation Therapy For Epilepsy,” abstract of AES Proceedings,Epilepsia, vol. 40, Suppl. 7, 1999, p. 147.;;Long, Teresa J. et al., “Effectiveness Of Heart Rate Seizure Detection Compared To EEG In An Epilepsy MoitoringUnit (EMU),” abstract of AES Proceedings, Epilepsia, vol. 40, Suppl. 7, 1999, p. 174.;;Method of Evaluation of the Functional State Regulatory Body of Biological Object; Russia Patent Application No. RU 2103911, published Nov. 8, 1993 to Baevsky et al.;;Method of Evaluation of the Functional State Regulatory Body of Biological Object; Russia Patent Application No. RU 2103911, published Nov. 8, 1993 to Baevsky et al. Machine Translation.;;Baevsky, R.M. et al., “Regulation Of Autonomic Nervous System In Space and Magnetic Storms”, Adv. Space Res., vol. 22, No. 2., pp. 227-234; 1998.",ACTIVE
85,US,B2,US 10898714 B2,145-158-920-258-759,2021-01-26,2021,US 201615285337 A,2016-10-04,US 201615285337 A;;US 201562237078 P,2015-10-05,Stimulation suspension in response to patient discomfort or state,"Systems and methods are provided for delivering neurostimulation therapies to patients. Stimulation from an implantable medical device (IMD) may be suspended in response to detecting a patient discomfort event, such as a cough, throat irritation, or voice alteration. The suspension period may be based on at least one of a severity level of the patient discomfort event and a patient physical state, such as being asleep or lying down. Detection of a patient discomfort event may be calibrated.",CYBERONICS INC;;LIVANOVA USA INC,LIBBUS IMAD;;STUBBS SCOTT R;;KENKNIGHT BRUCE H,LIVANOVA USA INC (2015-10-06),https://lens.org/145-158-920-258-759,Granted Patent,yes,13,7,7,145-158-920-258-759;;168-183-432-485-134;;110-378-002-453-162;;117-514-853-968-824;;130-767-094-738-433;;181-238-050-927-079;;012-260-058-023-245,WO;;EP;;US,7,145-158-920-258-759;;168-183-432-485-134;;110-378-002-453-162;;117-514-853-968-824;;181-238-050-927-079;;130-767-094-738-433;;012-260-058-023-245,WO;;EP;;US,0,A61B5/0823;;A61N1/36167;;A61B5/1135;;A61N1/36053;;A61N1/36114;;A61N1/36132;;A61N1/3614;;A61B5/086;;A61B5/0823;;A61N1/36167;;A61B5/1135;;A61N1/3614;;A61B5/086;;A61N1/36053;;A61N1/36114;;A61N1/36132;;A61N1/36139,A61N1/36;;A61B5/08;;A61B5/113,,5,3,167-840-581-033-386;;022-878-788-729-829;;114-554-829-110-585,10.1093/eurheartj/ehq391;;21030409;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1161/circheartfailure.109.873968;;19919995,"International Search Report and Written opinion for PCT Patent Application No. PCT/US2016/055366, dated Mar. 10, 2017, 21 pages.;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;Hellyer, et al., “Autonomic Nerve Activity and Blood Pressure in Ambulatory Dogs,” Heart Rhythm, vol. 11(2), Feb. 2014, pp. 307-313.;;Zhang et al., Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model, Circulation Heart Fail 2009, vol. 2, Sep. 22, 2009, pp. 692-699.;;First Report on Examination for EP Application No. 16781647.9 dated Aug. 13, 2020, 5 pages.",ACTIVE
86,US,B2,US 10220217 B2,060-014-288-242-969,2019-03-05,2019,US 201615222591 A,2016-07-28,US 201615222591 A;;US 201213434240 A;;US 201161507992 P;;US 201213433907 A;;US 201213434119 A,2011-07-14,Powering of an implantable medical therapy delivery device using far field radiative powering at multiple frequencies,A particular implantable device may include one or more antennas configured to receive a first far field radiative signal and a second far field radiative signal. The one or more antennas may be configured to receive the first far field radiative signal in a first frequency band and to receive the second far field radiative signal in a second frequency band. The implantable device may include a voltage rectifier configured to rectify the received first far field radiative signal and the received second far field radiative signal to provide a rectified voltage signal. The implantable device may further include a charge storage element operative to receive the rectified voltage signal and to store charge responsive to the rectified voltage signal. The implantable device may also include a therapy delivery unit powered by the charge storage element. The therapy delivery unit may be operative to deliver a therapy to a patient.,LIVANOVA USA INC,CHOW ERIC Y;;ROWELL JONATHAN D,LIVANOVA USA INC (2012-03-26),https://lens.org/060-014-288-242-969,Granted Patent,yes,48,1,8,080-774-921-092-642;;017-341-918-961-28X;;086-848-440-260-294;;026-058-550-379-277;;060-014-288-242-969;;029-617-034-994-764;;144-931-230-159-517;;021-885-174-850-48X,US,33,128-948-672-418-265;;026-058-550-379-277;;042-771-851-374-684;;029-617-034-994-764;;195-098-984-927-554;;021-885-174-850-48X;;180-804-269-442-073;;108-365-439-579-740;;080-774-921-092-642;;017-341-918-961-28X;;028-965-547-491-710;;086-848-440-260-294;;199-835-636-739-429;;060-014-288-242-969;;195-210-398-909-764;;058-144-722-381-747;;148-475-242-654-418;;144-931-230-159-517;;078-997-154-124-610;;198-292-555-739-801;;023-627-613-572-225;;061-025-857-463-201;;063-578-240-530-681;;096-099-637-917-47X;;072-121-457-323-364;;046-339-685-643-211;;079-427-311-527-213;;113-455-919-242-426;;177-121-504-109-828;;120-189-758-298-430;;002-567-851-747-242;;026-453-599-657-047;;046-910-745-744-867,ES;;WO;;EP;;AU;;CA;;JP;;US,0,A61N1/3787;;A61N1/0556;;A61N1/3605;;A61N1/37223;;A61N1/3787;;A61N1/0551;;A61N1/0556;;A61N1/3605;;A61N1/37211;;A61N1/37223,A61N1/372;;A61N1/05;;A61N1/36;;A61N1/378,,68,48,081-051-816-397-185;;030-111-234-793-091;;014-506-970-152-125;;068-877-675-089-145;;058-544-367-423-473;;030-910-999-870-248;;011-994-359-502-14X;;027-425-138-766-441;;061-901-980-147-017;;030-809-302-556-536;;002-931-812-171-795;;087-231-758-485-561;;094-878-614-812-640;;048-906-223-119-272;;079-035-736-222-842;;023-301-610-176-411;;006-919-923-496-043;;142-382-211-584-663;;085-929-984-757-336;;148-024-698-698-344;;068-541-154-284-86X;;037-767-298-613-615;;142-401-383-484-74X;;010-411-063-187-44X;;021-336-502-752-853;;120-309-964-669-515;;127-817-632-406-052;;040-202-734-681-885;;144-025-843-763-579;;012-602-551-180-102;;074-914-949-037-869;;018-529-304-095-365;;067-621-069-925-283;;068-406-437-640-105;;138-790-704-818-761;;070-553-485-527-205;;002-810-620-027-333;;009-736-966-079-896;;020-957-788-288-261;;030-504-850-729-509;;087-063-586-747-835;;108-307-828-992-410;;180-171-706-442-024;;008-433-559-336-870;;018-236-436-916-269;;030-908-648-005-33X;;024-803-109-344-211;;027-035-712-970-356,10.1109/lawp.2005.850798;;23851518;;10.1109/tbcas.2007.893180;;10.1109/tmtt.1984.1132833;;10.1109/jsen.2006.870158;;10.1109/tap.2006.889823;;10.1109/lawp.2007.914115;;10.1109/tbcas.2010.2081364;;23850751;;10.1109/tbme.2010.2041058;;20172781;;10.1109/iembs.2007.4353867;;10.1109/mwsym.2009.5165947;;10.1109/tmtt.2008.2007338;;10.1109/mwsym.2008.4633303;;10.1109/isscc.2010.5433933;;10.1109/iembs.2010.5627324;;21096710;;19807844;;10.1111/j.1540-8183.2009.00483.x;;10.1109/tap.2011.2144551;;10.1109/tcsi.2005.854294;;10.1109/tcsi.2009.2034891;;10.1049/el:20081794;;10.1063/1.1771078;;18238340;;10.1109/51.57877;;10.21236/ada303903;;10.1088/0031-9155/41/11/001;;8938024;;8938025;;10.1088/0031-9155/41/11/002;;10.1088/0031-9155/41/11/003;;8938026;;10.1109/tmtt.2004.823585;;10.1016/s0042-6989(03)00457-7;;13129543;;9525427;;10.1109/aps.2007.4396616;;10.1109/tmtt.2008.919373;;10.1109/tap.2006.883982;;10.1109/tap.2009.2029376;;10.1016/s0039-6257(02)00311-9;;12161210;;15307446;;10.1023/b:bmmd.0000013367.30870.4e;;10.1109/lawp.2010.2046999;;10.1109/tap.2010.2096386;;10.1109/lawp.2011.2109030;;10.1109/tpel.2008.921167;;10.1109/tmtt.2006.871362;;10.1161/circulationaha.107.702191;;18056531;;10.1109/tap.2011.2109676;;10.1109/tmtt.2004.831976;;10.1109/tap.2008.929525;;10.1109/tap.2009.2036279;;10.1016/j.ajo.2007.01.027;;17362868;;10.1109/tmtt.2005.860509;;10.1109/proc.1980.11611;;10.1109/tap.2007.913165,"“Part 15—Radio Frequency Devices (47 CFR 15), Title 47 of the Code of Federal Regulations,” Federal Communications Commission, current as of Dec. 22, 2011, found at: http://www.ecfr.gov/cgi-bin/text-idx?node=47:1.0.1.1.16.;;“SOLX, Inc.,” found at: http://www.solx.com/, 2011, printed on Aug. 14, 2014.;;Akkermans, J.A.G. et al., “Analytical models for low-power rectenna design,” Antennas and Wireless Propagation Letters, IEEE , vol. 4, No., pp. 187-190, 2005, doi: 10.1109/LAWP.2005.850798, found at: http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arn umber=1435362&isnumber=30362.;;Baker, M.W. et al., “Feedback Analysis and Design of RF Power Links for Low-Power Bionic Systems,” Biomedical Circuits and Systems, IEEE Transactions on , vol. 1, No. 1, pp. 28-38, Mar. 2007, doi 10.1109/TBCAS.2007.893180, found at: http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=4156129&isn umber=4156127.;;Bowditch, N., The American Practice Navigator, National Imagery and Mapping Agency, Bethesda Maryland, 2002, 1 page.;;Brown, W.C., “The History of Power Transmission by Radio Waves,” Microwave Theory and Techniques, IEEE Transactions on, vol. 32, pp. 1230-1242, 1984.;;Chaimanonart, N. et al., “Remote RF powering system for wireless MEMS strain sensors,” Sensors Journal, IEEE, vol. 6, No. 2, pp. 484-489, Apr. 2006, doi: 10.1109/JSEN.2006.870158, found at: http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=1608093&isnumber=33774.;;Chen, Z.N. et al., “Small Printed Ultrawideband Antenna With Reduced Ground Plane Effect,” Antennas and Propagation, IEEE Transactions on, vol. 55, pp. 383-388, 2007.;;Cheng, S. et al., “Printed Slot Planar Inverted Cone Antenna for Ultrawideband Applications,” Antennas and Wireless Propagation Letters, IEEE, vol. 7, pp. 18-21, 2008.;;Chow, E. et al., “Evaluation of Cardiovascular Stents as Antennas for Implantable Wireless Applications,” Microwave Theory and Techniques, IEEE Transactions on, vol. 57, pp. 2523-2532, 2009.;;Chow, E. Y. et al., “A Miniature-Implantable RF-Wireless Active Glaucoma Intraocular Pressure Monitor,” Biomedical Circuits and Systems, IEEE Transactions on, vol. 4, pp. 340-349, 2010.;;Chow, E. Y. et al., “Fully Wireless Implantable Cardiovascular Pressure Monitor Integrated with a Medical Stent,” Biomedical Engineering, IEEE Transactions on, vol. 57, pp. 1487-1496, 2010.;;Chow, E. Y. et al., “High Data-Rate 6.7 GHz Wireless ASIC Transmitter for Neural Prostheses,” in Engineering in Medicine and Biology Society, 2007, EMBS 2007, 29th Annual International Conference of the IEEE, 2007, pp. 6580-6583.;;Chow, E. Y. et al., “High frequency transcutaneous transmission using stents configured as a dipole radiator for cardiovascular implantable devices,” in Microwave Symposium Digest, 2009, MTT '09, IEEE MTT-S International, 2009, pp. 1317-1320.;;Chow, E. Y. et al., “Implantable Wireless Telemetry Boards for in Vivo Transocular Transmission,” Microwave Theory and Techniques, IEEE Transactions on, vol. 56, pp. 3200-3208, 2008.;;Chow, E. Y. et al., “Miniature antenna for RF telemetry through ocular tissue,” in Microwave Symposium Digest, 2008 IEEE MTT-S International, 2008, pp. 1309-1312.;;Chow, E. Y. et al., “Mixed-signal integrated circuits for self-contained sub-cubic millimeter biomedical implants,” in Solid-State Circuits Conference Digest of Technical Papers (ISSCC), 2010 IEEE International, 2011, pp. 236-237.;;Chow, E. Y. et al., “Sub-cubic millimeter intraocular pressure monitoring implant to enable genetic studies on pressure-induced neurodegeneration,” in Engineering in Medicine and Biology Society (EMBC), 2010 Annual International Conference of the IEEE, 2010, pp. 6429-6432.;;Chow, E. Y. et al., “Toward an Implantable Wireless Cardiac Monitoring Platform Integrated with an FDA-Approved Cardiovascular Stent,” Journal of Interventional Cardioloav, vol. 22, pp. 479-487, 2009.;;Chow, E.Y. et al., “Wireless Powering and the Study of RF Propagation Through Ocular Tissue for Development of Implantable Sensors,” Antennas and Propagation, IEEE Transactions on, vol. 59, pp. 2379-2387, 2011.;;Curty, Jari-Pascal et al., A Model for-Power Rectifier Analysis and Design, IEEE Transactions on Circuits and Systems—I: Regular Papers, vol. 52, No. 12, Dec. 2005, pp. 2771-2779.;;Dolgov, A.; et al., “Power Management System for Online Low Power RF Energy Harvesting Optimization,” Circuits and Systems I: Regular Papers, IEEE Transactions on , vol. 57, No. 7, pp. 1802-1811, Jul. 2010; doi: 10.1109/TCSI.2009.2034891; found at: http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&a rnumber=5395599&isn umber=5512812.;;Douyere, A. et al., “High efficiency microwave rectenna circuit: modelling and design,” Electronics Letters , vol. 44, No. 24, pp. 1409-1410, Nov. 20, 2008, doi: 10.1049/el:20081794 URL: http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&a rnumber=4689488&isn umber=46894 70.;;Everhart, E. et al., The Cockcroft Walton Voltage Multiplying Circuit Rev. Sci. Instrum. 25, 394 (1954), found at: http://rsi.aio.ora/resource/1 /rsinak/v25/i4/o394 s1?isAuthorized=no.;;Extended European Search Report for EP Application No. 15189806.1, dated Feb. 10, 2016, 5 pages.;;Fischell, R.E., “The retrospectroscope—the invention of the rechargeable cardiac pacemaker: vignette #9,” Engineering in Medicine and Biologv Magazine, IEEE, vol. 9, pp. 77-78, 1990.;;Gabriel, C. et al., “Compilation of the dielectric properties of body tissues at RF and microwave frequencies,” Report N.AUOE-TR-1996-0037, Occupational and environmental health directorate, Radiofrequency Radiation Division, Brooks Air Force Base, Texas (USA), 1996.;;Gabriel, C. et al., “The dielectric properties of biological tissues: I. Literature survey.” vol. 41, 1996, p. 2231.;;Gabriel, S. et al., “The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz.” vol. 41, 1996, p. 2251.;;Gabriel, S. et al., “The dielectric properties of biological tissues: III. Parametric models for the dielectric spectrum of tissues.” vol. 41, 1996, p. 2271.;;Hagerty, J.A. et al., “Recycling ambient microwave energy with broad-band rectenna arrays,” Microwave Theory and Techniques, IEEE Transactions on , vol. 52, No. 3, pp. 1014-1024, Mar. 2004, doi: 10.1109/TMTT.2004.823585 found at: http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arn umber=1273745&isn umber=28503.;;Humayun, M.S., et al., “Visual perception in a blind subject with a chronic microelectronic retinal prosthesis,” Vision Research, vol. 43, pp. 2573-2581, 2003.;;ICNIRP, “Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz),” Health Phys., vol. 74, pp. 494-522, 1998.;;International Application No. PCT/US2014/035309; PCT Search Report & Written Opinion dated Jul. 23, 2014, 12 pages.;;International Search Report & Written Opinion for PCT Application No. PCT/US2014/035309, dated Jul. 23, 2014, 11 pages.;;International Search Report and Written Opinion for PCT Application No. PCT/US2012/032009, dated Jun. 13, 2012, 13 pages.;;Joshi, R. K. et al., “Printed wideband variable strip width loop antenna,” in Antennas and Propagation Society International Symposium, 2007 IEEE, 2007, pp. 4793-4796.;;Karacolak, T. et al., “Design of a Dual-Band Implantable Antenna and Development of Skin Mimicking Gels for Continuous Glucose Monitoring,” Microwave Theory and Techniques, IEEE Transactions on, vol. 56, pp. 1001-1008, 2008.;;Knapp, J.P., “ANSYS Inc. Request for Waiver of 47 C.F.R. § 1.1307(b)(2) of Commission Rules, DA 11-192,” Federal Communications Commission, 2011.;;Lin, Yi-Cheng. et al., “Compact Ultrawideband Rectangular Aperture Antenna and Band-Notched Designs,” Antennas and Propagation, IEEE Transactions on, vol. 54, pp. 3075-3081, 2006.;;Ling, Ching-Wei et al., “A Simple Printed Ultrawideband Antenna With a Quasi-Transmission Line Section,” Antennas and Propagation, IEEE Transactions on, vol. 57, pp. 3333-3336, 2009.;;Margalit, E., et al., “Retinal Prosthesis for the Blind,” Survey of Ophthalmologv, vol. 47, pp. 335-356, 2002.;;Means, D. L. et al., “Evaluating Compliance with FCC Guidelines for Human Exposure to Radiofrequency Electromagnetic Fields,” OET Bulletin 65 (Edition 97-01) Supplement C (Edition 01-01), Federal Communications Commission Office of Engineering & Technology, 2001.;;Najafi, N. et al., “Initial Animal Studies of a Wireless, Batteryless, MEMS Implant for Cardiovascular Applications ” Biomedical Microdevices, vol. 6, pp. 61-65, 2004.;;Nazli, H. et al., “An Improved Design of Planar Elliptical Dipole Antenna for UWB Applications,” Antennas and Wireless Propagation Letters, IEEE, vol. 9, pp. 264-267, 2010.;;Ojaroudi, M. et al., “Small Square Monopole Antenna With Enhanced Bandwidth by Using Inverted T-Shaped Slot and Conductor-Backed Plane,” Antennas and Propagation, IEEE Transactions on, vol. 59, pp. 670-674, Feb. 2011.;;Oraizi, H. et al., “Miniaturized UWB Monopole Microstrip Antenna Design by the Combination of Giusepe Peano and Sierpinski Carpet Fractals,” Antennas and Wireless Propagation Letters, IEEE, vol. 10, pp. 67-70, 2011.;;Paing, T. et al., “Resistor Emulation Approach to Low-Power RF Energy Harvesting,” Power Electronics, IEEE Transactions on , vol. 23, No. 3, pp. 1494-1501, May 2008 doi: 10.1109/TPEL.2008.921167, found at: http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=4492966&isnumber=4509502.;;Ren, Yu-Jiun et al., “5.8-GHz circularly polarized dual-diode rectenna and rectenna array for microwave power transmission,” Microwave Theory and Techniques, IEEE Transactions on , vol. 54, No. 4, pp. 1495-1502, Jun. 2006; doi: 10.1109/TMTT.2006.871362; found at: http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=1618568&isnumber=33917.;;Ritzema, J. et al., “Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients,” Circulation, vol. 116, pp. 2952-2959, 2007.;;Ryu, K. S. et al., “UWB Dielectric Resonator Antenna Having Consistent Omnidirectional Pattern and Low Cross-Polarization Characteristics,” Antennas and Propagation, IEEE Transactions on, vol. 59, pp. 1403-1408, Apr. 2011.;;Soontornpipit, P. et al., “Design of implantable microstrip antenna for communication with medical implants,” Microwave Theory and Techniques, IEEE Transactions on, vol. 52, pp. 1944-1951, 2004.;;Sze, Jia-Yi et al., “Design of Band-Notched Ultrawideband Square Aperture Antenna With a Hat-Shaped Back-Patch,” Antennas and Propagation, IEEE Transactions on, vol. 56, pp. 3311-3314, 2008.;;Thomas, K. G., et al., “A Simple Ultrawideband Planar Rectangular Printed Antenna With Band Dispensation,” Antennas and Propagation, IEEE Transactions on, vol. 58, pp. 27-34, Jan. 2010.;;Yanai, D., et al., “Visual Performance Using a Retinal Prosthesis in Three Subjects With Retinitis Pigmentosa,” American Journal of Ophthalmology, vol. 143, pp. 820-827.e2, 2007.;;Yazdanboost, K. Y. et al., “Ultra wideband L-loop antenna,” in Ultra-Wideband, 2005. ICU 2005. 2005 IEEE International Conference on, 2005, pp. 201-205.;;Zbitou, J.; et al. , “Hybrid rectenna and monolithic integrated zero-bias microwave rectifier,” Microwave Theory and Techniques, IEEE Transactions on , vol. 54, No. 1, pp. 147-152, Jan. 2006 doi: 10.1109/TMTT.2005.860509, found at: URL: http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=1573807&isn umber=33279.;;Balanis, C. A., Advanced Engineering Electromagnetics, New York: Wiley, 1989, pp. 39-98, and 123-258.;;Chow, E. Y. et al., “Chapter 9: Wireless Powering and Propagation of Radio Frequencies through Tissue,” in Wireless Power Transfer, J. Agbinya, Ed., Aalborg, Denmark: River Publishers, Jul. 2012, pp. 301-336.;;Glaser, P., “Satellite solar power station and microwave transmission to earth,” Journal of Microwave Power, vol. 5, 1970. 15 pages.;;Ogden, C. L., et al., “Mean Body Weight, Height, and Body Mass Index, United States 1960-2002,” Centers for Disease Control and Prevention, vol. 347, 2004. 19 pages.;;PCT Search Report and Written Opinion for International Application No. PCT/US2013/047113, dated Nov. 4, 2013, 9 pages.;;Ramo, S. et al., Fields and Waves in Communication Electronics, 3rd ed.: John Wiley & Sons, Inc., 1994, pp. 274-313, 584-668, 667-733.;;Sun, X. et al., “Design of Several Key Circuits of UHF Passive RFID Tag,” China Integrated Circuit, vol. 16, 2007 (Institute of Microelectronics of Tsinghua University), found at: hUQ://en.cnki.com.cn/Article_en/CJFDTOTAL-JCDI200701009.htm. 7 pages.;;Tesla, Nikola, Colorado Springs Notes 1899-1900, found at: http://www.scribd.com/doc/41567714/Nikola-Tesla-Colorado-Springs-Notes-1899-1900. 431 pages.;;Zhang, Jin-Ping. et al., “Microstrip-Fed Semi-Elliptical Dipole Antennas for Ultrawideband Communications,” Antennas and Propagation, IEEE Transactions on, vol. 56, pp. 241-244, 2008.;;Office Action on Canadian Patent Application No. 2841406 dated Jun. 30, 2016. 5 pages.;;Office Action on European Patent Application No. 14726295.0 dated Jun. 26, 2017. 3 pages.",ACTIVE
87,US,B2,US 11612749 B2,064-123-267-437-474,2023-03-28,2023,US 201716090088 A,2017-03-31,US 201716090088 A;;US 201662317352 P;;US 201662318156 P;;US 2017/0025476 W,2016-04-01,Vagus nerve stimulation patient selection,"A method for assessing a patient's suitability for receiving a vagus nerve stimulation therapy includes receiving a criterion regarding the patient's suitability for receiving a vagus nerve stimulation therapy; controlling a stimulation device to provide stimulation to a vagus nerve of the patient; receiving, from a sensor, response data indicative of a physiological response of the patient to the stimulation of the vagus nerve; and determining the patient's suitability for receiving the vagus nerve stimulation therapy based on the criterion and the physiological response of the patient to the stimulation.",LIVANOVA USA INC,LIBBUS IMAD;;KENKNIGHT BRUCE H;;HENRY CHRISTINE,LIVANOVA USA INC (2021-03-04),https://lens.org/064-123-267-437-474,Granted Patent,yes,68,1,17,049-585-831-245-32X;;161-983-854-429-678;;172-573-469-687-870;;171-290-434-643-775;;146-104-110-095-989;;123-479-051-040-895;;089-100-685-398-08X;;018-098-815-580-627;;197-763-732-677-034;;064-123-267-437-474;;148-128-553-937-89X;;096-855-815-787-665;;136-271-349-381-78X;;172-922-370-754-685;;025-588-534-327-698;;178-193-330-882-448;;122-796-702-055-250,WO;;EP;;CN;;AU;;IL;;CA;;BR;;JP;;US,17,049-585-831-245-32X;;161-983-854-429-678;;172-573-469-687-870;;171-290-434-643-775;;146-104-110-095-989;;123-479-051-040-895;;089-100-685-398-08X;;018-098-815-580-627;;197-763-732-677-034;;148-128-553-937-89X;;064-123-267-437-474;;096-855-815-787-665;;136-271-349-381-78X;;172-922-370-754-685;;025-588-534-327-698;;178-193-330-882-448;;122-796-702-055-250,WO;;EP;;CN;;AU;;IL;;CA;;BR;;JP;;US,0,A61N1/36139;;A61B5/02405;;A61B5/4035;;A61B5/4836;;A61N1/0551;;A61N1/36031;;A61N1/36053;;A61N1/36114;;A61N1/36139;;A61B5/02405;;A61B5/4035;;A61B5/4836;;A61N1/0551;;A61N1/36031;;A61N1/36053;;A61N1/36114;;A61N1/36135;;A61N1/0556;;A61N1/056;;A61N1/36036;;A61N1/36114;;A61N1/37247,A61N1/36;;A61N1/05;;A61N1/372,,86,65,032-866-407-559-809;;070-932-745-660-601;;046-083-313-471-125;;104-293-010-941-895;;039-030-006-142-935;;034-525-821-785-841;;044-269-005-304-213;;054-395-837-726-670;;039-901-094-183-892;;068-634-089-247-298;;099-282-270-804-659;;124-802-088-972-905;;060-827-473-176-252;;100-664-305-434-393;;005-034-497-676-695;;059-080-640-017-462;;077-560-289-321-963;;079-466-401-615-008;;083-150-852-398-237;;001-699-109-596-476;;047-972-384-206-560;;019-142-341-224-189;;061-524-064-119-239;;037-855-856-766-385;;015-543-168-983-211;;082-285-368-594-481;;004-047-264-547-688;;065-498-207-644-778;;009-987-742-560-222;;017-109-720-372-440;;151-730-325-588-165;;057-045-029-312-938;;057-013-838-517-312;;057-249-935-874-400;;058-850-333-321-095;;030-651-611-742-159;;007-867-465-117-329;;056-128-938-479-513;;036-171-672-477-331;;087-667-730-347-885;;057-640-147-676-43X;;098-626-946-880-02X;;007-913-269-795-434;;041-511-766-086-293;;132-111-371-422-535;;021-283-877-224-313;;073-783-306-508-950;;024-352-160-730-353;;087-363-815-660-659;;053-076-182-439-544;;133-788-372-383-874;;078-324-851-719-12X;;004-791-294-770-173;;083-999-790-804-879;;005-283-049-992-691;;048-791-714-991-391;;027-915-374-638-937;;003-214-267-647-78X;;132-545-606-197-706;;017-979-921-338-395;;017-723-592-502-748;;054-187-595-061-074;;036-934-303-829-453;;018-910-007-794-517;;004-034-683-339-856,25443696;;10.1016/j.jacc.2014.07.979;;pmc4254424;;10.1016/j.rmed.2015.07.012;;26231928;;16054475;;10.1016/j.amjcard.2005.03.093;;23553674;;10.1002/jcp.24373;;21097480;;10.1093/europace/euq408;;16714188;;10.1016/s0140-6736(06)68735-7;;20820912;;10.1007/s10741-010-9190-6;;10.1016/s0002-9149(02)02380-9;;12088774;;10.2298/vsp1410925b;;25518271;;11342756;;10.1023/a:1011485609838;;6472388;;10.1056/nejm198409273111310;;24793667;;10.1016/j.amjcard.2014.03.050;;10.1080/ac.70.4.3096896;;26455251;;10.1016/s0140-6736(15)60341-5;;26312848;;18479331;;10.1111/j.1540-8167.2008.01190.x;;pmc2756798;;pmc6655544;;9853191;;24658981;;7006851;;10.1161/01.cir.63.3.645;;9412538;;10.1016/s0002-9149(97)00844-8;;10193717;;10.1016/s0735-1097(99)00021-2;;10.1161/circresaha.114.302589;;24855204;;pmc1768543;;15486114;;10.1136/hrt.2003.026146;;10681488;;10.1053/euhj.1999.1875;;10.1111/j.1751-7133.2008.tb00016.x;;10.1016/j.jacc.2016.03.525;;27058909;;8665972;;10.1093/oxfordjournals.eurheartj.a061053;;15618038;;10.1093/eurheartj/ehi067;;10768902;;pmc1760828;;10.1136/heart.83.5.531;;10.1007/s12350-008-9008-2;;19152136;;3812275;;10.1016/0002-9149(87)90795-8;;20031856;;10.1161/circoutcomes.108.831529;;9482439;;10.1016/s0140-6736(97)11144-8;;10.1016/j.jacc.2008.09.034;;19130988;;10.1161/01.cir.0000047275.25795.17;;12566367;;10.1016/j.jacc.2008.01.038;;18452777;;17909120;;10.1161/hypertensionaha.107.094649;;pmc3843360;;23989716;;10.1161/circresaha.113.300308;;10.1136/hrt.2002.002998;;pmc1768050;;14729802;;pmc483717;;8011405;;10.1136/hrt.71.5.422;;26417677;;10.1002/ejhf.328;;22536936;;pmc3400715;;10.1111/j.1751-7133.2011.00282.x;;17540210;;10.1016/j.ahj.2007.02.038;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/0735-1097(92)90167-l;;1351488;;24699011;;10.2459/jcm.0000000000000028;;10.1093/eurheartj/ehs041;;22507981;;9202356;;10.1016/s0002-9149(97)00215-4;;25424143;;10.1714/1694.18512;;10.1016/s0022-2828(85)80130-9;;3894676;;21080025;;10.1007/s10286-010-0089-z;;25210049;;10.1161/circgenetics.113.000384;;14966771;;10.1016/s1071-9164(03)00583-9;;10.1093/eurheartj/eht436;;24174128;;10.1007/978-3-662-45074-1;;10.1111/jce.12280;;24118293;;pmc3432262;;22730411;;10.1161/circep.112.970541;;10.1016/j.jacc.2009.05.015;;19874988;;9118512;;10.1161/01.cir.95.6.1449;;18242558;;10.1016/j.hrthm.2007.10.021;;17184514;;10.1111/j.1440-1681.2006.04523.x;;17434976;;pmc2084464;;10.1152/ajpheart.00147.2007;;10.1161/01.cir.69.6.1079;;6713612;;10.1161/hypertensionaha.109.134023;;19620513;;pmc5368481;;25592094;;10.5152/akd.2014.5710;;26011593;;10.1002/ejhf.299,"Ahmad, Tariq, et al. “Clinical implications of chronic heart failure phenotypes defined by cluster analysis.” Journal of the American College of Cardiology 64.17 (2014): 1765-1774.;;Alter, Peter, et al. “Airflow limitation in COPD is associated with increased left ventricular wall stress in coincident heart failure.” Respiratory medicine 109.9 (2015): 1131-1137.;;Anastasiou-Nana, Maria I., et al. “Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.” The American Journal of Cardiology 96.3 (2005): 427-431.;;Babick, Andrea, et al. “Reversal of cardiac dysfunction and subcellular alterations by metoprolol in heart failure due to myocardial infarction.” Journal of cellular physiology 228.10 (2013): 2063-2070.;;Battipaglia, Irma, et al. “Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators.” Europace 12.12 (2010): 1725-1731.;;Bauer, Axel, et al. “Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study.” The lancet 367.9523 (2006): 1674-1681.;;Bibevski, Steve, et al. “Evidence for impaired vagus nerve activity in heart failure.” Heart failure reviews 16.2 (2011): 129-135.;;Bilchick, Kenneth C., et al. “Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure).” The American Journal of Cardiology 90.1 (2002): 24-28.;;BioControl Medical. (2015). INOVATE-HF study closure [Press release]. Retrieved from http://www.biocontrol-medical.com/press_item.php?ID=29. 1 page.;;BioControl Medical. INcrease Of VAgal TonE in CHF (INOVATE-HF)—A Randomized Study to Establish the Safety and Efficacy of CardioFit® for the Treatment of Subjects With Heart Failure and Left Ventricular Dysfunction. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). (2011) [last updated Dec. 11, 2015] [cited Mar. 29, 2016]. Available from: https://clinicaltrials.gov/ct2/show/NCT01303718 NLM Identifier: NCT01303718. 4 pages.;;Boscokovic, Aneta, et al. “Prognostic value of heart rate variability in post-infarction patients.” Vojnosanitetski pregled 71.10 (2014): 925-930.;;Boveda, Serge, et al. “Prognostic value of heart rate variability in time domain analysis in congestive heart failure.” Journal of interventional cardiac electrophysiology 5.2 (2001): 181-187.;;Bristow, Michael R. “The adrenergic nervous system in heart failure.” (1984): 850-851.;;Brunet-Bernard, Anne, et al. “Combined score using clinical, electrocardiographic, and echocardiographic parameters to predict left ventricular remodeling in patients having had cardiac resynchronization therapy six months earlier.” The American journal of cardiology 113.12 (2014): 2045-2051.;;Canbay, Alper, et al. “Procalcitonin: a marker of heart failure.” Acta cardiologica 70.4 (2015): 473-478.;;Cao, Thong Huy, et al. “Identification of novel biomarkers in plasma for prediction of treatment response in patients with heart failure.” The Lancet 385 (2015): S26. 1 page.;;Cha, Yong-Mei, et al. “Cardiac resynchronization therapy upregulates cardiac autonomic control.” Journal of Cardiovascular Electrophysiology 19.10 (2008): 1045-1052.;;Colucci, Wilson S. “The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure.” Clinical cardiology 21.S1 (1998): 20-24.;;Davoodi, Gholamreza, et al. “Evaluation of In-Hospital NT-proBNP Changes in Heart Failure Patients to Identify the Six-Month Clinical Response Following Cardiac Resynchronization Therapy.” Acta Medica Iranica 52.1 (2014): 15-23. 9 pages.;;Dzau, Victor J., et al. “Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.” Circulation 63.3 (1981): 645-651.;;Esler, Murray, et al. “Adrenergic nervous system in heart failure.” The American journal of cardiology 80.11 (1997): 7L-14L.;;Fauchier, Laurent, et al. “Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy.” Journal of the American College of Cardiology 33.5 (1999): 1203-1207.;;Florea, Viorel G., et al. “The autonomic nervous system and heart failure.” Circulation research 114.11 (2014): 1815-1826.;;Frenneaux, M. P. “Autonomic changes in patients with heart failure and in post-myocardial infarction patients.” Heart 90.11 (2004): 1248-1255.;;Galinier, M., et al. “Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure.” European heart journal 21.6 (2000): 475-482.;;Germany, Robin. “The Use of Device-Based Diagnostics to Manage Patients With Heart Failure.” Congestive Heart Failure 14.s2 (2008): 19-24.;;Gold, Michael R. et al., “The Effect of Vagal Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial” [PowerPoint], Late-Breaking Clinical Trials: Deep Dive II, Session 415-08, ACC.16 Scientific Session, American College of Cardiology, Apr. 4, 2016, Chicago, IL. 12 pages.;;Gold, Michael R. “The Effect of Vagal Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial” [Transcript], Late-Breaking Clinical Trials: Deep Dive II, Session 415-08, ACC.16 Scientific Session, American College of Cardiology, Apr. 4, 2016, Chicago, IL. 2 pages.;;Gold, Michael R. et al., “The Effect of Vagal Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial” [Abstract], Late-Breaking Clinical Trials, Session 412-12, ACC.16 Scientific Session, American College of Cardiology, Apr. 4, 2016, Chicago, IL. 1 page.;;Gold, Michael R. et al., “The Effect of Vagal Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial” [PowerPoint], Late-Breaking Clinical Trials, Session 412-12, ACC.16 Scientific Session, American College of Cardiology, Apr. 4, 2016, Chicago, IL. 18 pages.;;Gold, Michael R. et al., “The Effect of Vagal Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial” [Transcript], Late-Breaking Clinical Trials, Session 412-12, ACC.16 Scientific Session, American College of Cardiology, Apr. 4, 2016, Chicago, IL. 3 pages.;;Gold, Michael R., et al. “Vagus nerve stimulation for the treatment of heart failure: The INOVATE-HF trial.” Journal of the American College of Cardiology 68.2 (2016): 149-158.;;Guzzetti, S., et al. “Sympathetic predominance followed by functional denervation in the progression of chronic heart failure.” European heart journal 16.8 (1995): 1100-1107.;;Guzzetti, Stefano, et al. “Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure.” European Heart Journal 26.4 (2005): 357-362.;;Hoffmann, J., et al. “Heart rate variability and baroreflex sensitivity in idiopathic dilated cardiomyopathy.” Heart 83.5 (2000): 531-536.;;International Search Report and Written Opinion for International Application No. PCT/US2017/25476 dated Aug. 24, 2017, 19 pages.;;Jacobson, Arnold F., et al. “123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials.” Journal of nuclear cardiology 16.1 (2009): 113-121.;;Kaul, Sanjay, Armstrong, Paul W., et al. “Panel Discussion re: The Effect of Vagal Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial” [Transcript], Late-Breaking Clinical Trials: Deep Dive II, Session 415-10, ACC.16 Scientific Session, American College of Cardiology, Apr. 4, 2016, Chicago, IL. 3 pages.;;Kleiger, Robert E., et al. “Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.” The American journal of cardiology 59.4 (1987): 256-262.;;Kuch et al. “Extent of the Decrease of 28-Day Case Fatality of Hospitalized Patients With Acute Myocardial Infarction Over 22 Years. Epidemiological Versus Clinical View: The MONICA/KORA Augsburg Infarction Registry”. Circ Cardiovasc Qual Outcomes. 2009;2:313-319. 7 pages.;;La Rovere, Maria Teresa, et al. “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction.” The Lancet 351.9101 (1998): 478-484.;;La Rovere, Maria Teresa, et al. “Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era.” Journal of the American College of Cardiology 53.2 (2009): 193-199.;;La Rovere, Maria Teresa, et al. “Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients.” Circulation 107.4 (2013): 565-570.;;Lahiri, Marc K., et al. “Assessment of autonomic function in cardiovascular disease.” Journal of the American College of Cardiology 51.18 (2008): 1725-1733.;;Lambert, Elisabeth, et al. “Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension.” Hypertension 50.5 (2007): 862-868.;;Liang, Chang-seng, et al. “Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial β-adrenergic receptor sensitivity in the ferret.” Circulation 102.1 (2000): 96-103.;;Lymperopoulos, Anastasios, “The adrenergic nervous system in heart failure.” Circulation research 113.6 (2013): 739-753.;;Moore, R., et al. “Altered short term heart rate variability with spinal cord stimulation in chronic refractory angina: evidence for the presence of procedure related cardiac sympathetic blockade.” Heart 90.2 (2004): 211-212.;;Mortara, A., et al. “Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation.” British heart journal 71.5 (1994): 422-430.;;Mortara, Andrea, et al. “Baroreceptor activation therapy: The importance of targeting the right patient: who needs to be treated?” European journal of heart failure 17.10 (2015): 1000-1002.;;Murad, Khalil, et al. “Exercise Training Improves Heart Rate Variability in Older Patients With Heart Failure: A Randomized, Controlled, Single-Blinded Trial.” Congestive Heart Failure 18.4 (2012): 192-197.;;Myers, Jonathan, et al. “Effects of exercise training on heart rate recovery in patients with chronic heart failure.” American Heart Journal 153.6 (2007): 1056-1063.;;Nolan, James, et al. “Prospective study of heart rate variability and mortality in chronic heart failure.” Circulation 98.15 (1998): 1510-1516.;;Packer, Milton. “The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure.” Journal of the American College of Cardiology 20.1 (1992): 248-254.;;Padeletti, Luigi, et al. “Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure.” Journal of Cardiovascular Medicine 15.4 (2014): 295-300.;;Paratt, Gianfranco, et al. “The human sympathetic nervous system: its relevance in hypertension and heart failure.” European heart journal (2012): 33 (9): 1058-1066.;;Pepper, Gregory S., et al. “Sympathetic activation in heart failure and its treatment with β-blockade.” Archives of Internal Medicine 159.3 (1999): 225-234.;;Pinto, Fausto J., Walsh, Mary N., et al. “Panel Discussion re: The Effect of Vagal Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial” [Transcript], Late-Breaking Clinical Trials, Session 412-13, ACC.16 Scientific Session, American College of Cardiology, Apr. 4, 2016, Chicago, IL. 3 pages.;;Ponikowski, Piotr, et al. “Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.” The American journal of cardiology 79.12 (1997): 1645-1650.;;Proclemer, A., et al. “The pacemaker and implantable cardioverter-defibrillator registry of the Italian Association Arrhythmology Cardiac Pacing and cardiac pacing-annual report 2013.” Giornale italiano di cardiologia (2006) 15.11 (2014): 638-650.;;Rona, G. “Catecholamine cardiotoxicity.” J Mol Cell Cardiol, 17 (1985): 291-306.;;Rydlewska, Agnieszka, et al. “Changes in autonomic balance in patients with decompensated chronic heart failure.” Clinical Autonomic Research 21.1 (2011): 47-54.;;Schmitz, Boris, et al. “Identification of genetic markers for treatment success in heart failure patients: Insight from cardiac resynchronization therapy.” Circulation: Cardiovascular Genetics (2014): CIRCGENETICS-113.;;Selig, Steve E., et al. “Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength, endurance, heart rate variability, and forearm blood flow.” Journal of Cardiac Failure 10.1 (2004): 21-30.;;Singh, Jagmeet P., et al. “Non-pharmacological modulation of the autonomic tone to treat heart failure.” European heart journal 35.2 (2014): 77-85.;;Slart, Riemer H.J.A, Elsinga, Philip H., Tio, Rene A., & Schwaiger, Markus (Ed.). (2015). Autonomic innervation of the heart: Role of molecular imaging. Germany: Springer. 4 pages.;;Ten Sande, Judith N., et al. “Value of serial heart rate variability measurement for prediction of appropriate ICD discharge in patients with heart failure.” Journal of cardiovascular electrophysiology 25.1 (2014): 60-65.;;Tereshchenko, Larisa G., et al. “Predictive Value of Beat-to-Beat QT Variability Index across the Continuum of Left Ventricular Dysfunction: Competing Risks of Non-Cardiac or Cardiovascular Death, and Sudden or Non-Sudden Cardiac Death.” Circulation. Arrhythmia and Electrophysiology 5.4 (2012): 719-727.;;Triposkiadis, Filippos, et al. “The sympathetic nervous system in heart failure: Physiology, pathophysiology, and clinical implications.” Journal of the American College of Cardiology 54.19 (2009): 1747-1762.;;Van De Borne, Philippe, et al. “Absence of low-frequency variability of sympathetic nerve activity in severe heart failure.” Circulation 95.6 (1997): 1449-1454.;;Vanoli, Emilio, et al. “Prediction of unexpected sudden death among healthy dogs by a novel marker of autonomic neural activity.” Heart Rhythm 5.2 (2008): 300-305.;;Watson, A. M. D., et al. “Mechanisms of sympathetic activation in heart failure.” Clinical and experimental pharmacology and physiology 33.12 (2006): 1269-1274.;;Watson, A. M. D, et al. “Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex.” American Journal of Physiology-Heart and Circulatory Physiology 293.1 (2007): H798-H804.;;Wilson, John R., et al. “Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.” Circulation 69.6 (1984): 1079-1087.;;Wustmann, Kerstin, et al. “Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension.” Hypertension 54.3 (2009): 530-536.;;Yaylali, Yt, et al. “The effects of baseline heart rate recovery normality and exercise training protocol on heart rate recovery in patients with heart failure.” The Anatolian Journal of Cardiology 15.9 (2015): 727-734.;;Zile, Michael R., et al. “Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.” European journal of heart failure 17.10 (2015): 1066-1074.;;Zipes, Douglas P. “'Deep Dive' Critique of The Effect of Vagal Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial” [PowerPoint], Late-Breaking Clinical Trials: Deep Dive II, Session 415-09, ACC.16 Scientific Session, American College of Cardiology, Apr. 4, 2016, Chicago, IL. 11 pages.;;Zipes, Douglas P. “'Deep Dive' Critique of The Effect of Vagal Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial” [Transcript], Late-Breaking Clinical Trials: Deep Dive II, Session 415-09, ACC.16 Scientific Session, American College of Cardiology, Apr. 4, 2016, Chicago, IL. 2 pages.;;Extended European search report on EP 17776820.7 dated Nov. 28, 2019. 5 pages.;;Office Action issued in JP Application No. 2019-502535 dated Feb. 10, 2021.;;Examination Report issued on Australian application No. 2017240755 dated Oct. 14, 2021.;;Office Action issued on Israeli application No. 262009 dated Sep. 5, 2021.;;Office Action issued in CN 2017800326629 dated Jan. 24, 2022.;;Office Action issued in JP 2019-502535 dated Dec. 16, 2021.;;CN Office Action with Search Report on CN Appl. Ser. No. 201780032662.9 dated Sep. 30, 2022 (21 pages).",ACTIVE
88,US,A1,US 2019/0344082 A1,048-221-496-779-610,2019-11-14,2019,US 201916422588 A,2019-05-24,US 201916422588 A;;US 201715600519 A;;US 201615230023 A;;US 201414224922 A,2014-03-25,NEUROSTIMULATION IN A NEURAL FULCRUM ZONE FOR THE TREATMENT OF CHRONIC CARDIAC DYSFUNCTION,"Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone corresponds to a combination of stimulation parameters at which autonomic engagement is achieved, while the tachycardia-inducing stimulation effects are offset by the bradycardia-inducing effects, thereby minimizing side effects such as significant heart rate changes while providing a therapeutic level of stimulation.",LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,KENKNIGHT BRUCE H;;ARDELL JEFFREY L;;LIBBUS IMAD;;AMURTHUR BADRI,EAST TENNESSEE STATE UNIVERSITY (2015-02-05);;LIVANOVA USA INC (2014-03-26),https://lens.org/048-221-496-779-610,Patent Application,yes,0,0,10,041-155-035-657-891;;167-525-921-748-75X;;039-973-530-342-718;;145-193-365-685-455;;147-722-091-954-665;;149-428-563-452-07X;;048-221-496-779-610;;078-221-536-829-239;;129-906-186-458-473;;183-521-051-255-573,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/3615;;A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/3615,A61N1/36,,0,0,,,,ACTIVE
89,US,B2,US 11077304 B2,145-193-365-685-455,2021-08-03,2021,US 201916422588 A,2019-05-24,US 201916422588 A;;US 201715600519 A;;US 201615230023 A;;US 201414224922 A,2014-03-25,Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction,"Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone corresponds to a combination of stimulation parameters at which autonomic engagement is achieved, while the tachycardia-inducing stimulation effects are offset by the bradycardia-inducing effects, thereby minimizing side effects such as significant heart rate changes while providing a therapeutic level of stimulation.",LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,KENKNIGHT BRUCE H;;ARDELL JEFFREY L;;LIBBUS IMAD;;AMURTHUR BADRI,EAST TENNESSEE STATE UNIVERSITY (2015-02-05);;LIVANOVA USA INC (2014-03-26),https://lens.org/145-193-365-685-455,Granted Patent,yes,266,3,10,041-155-035-657-891;;167-525-921-748-75X;;039-973-530-342-718;;145-193-365-685-455;;147-722-091-954-665;;149-428-563-452-07X;;048-221-496-779-610;;078-221-536-829-239;;129-906-186-458-473;;183-521-051-255-573,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/3615;;A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/3615,A61N1/36,,255,220,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;029-374-303-889-599;;137-877-214-221-749;;039-372-831-731-510;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;4434368;;10.1093/cvr/8.5.647;;17281904;;10.1109/iembs.2005.1616135;;10.1161/hypertensionaha.107.095216;;17846349;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of ADInstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958¬2963 (1999).;;Bilgutay, et al., “Vagal Tuning a new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y—immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859¬866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223¬231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425¬438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306¬311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-9 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-9A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the Accord Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages.;;Ridker, et al., “Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First cardiovascular Events,” New England Journal of Medicine, vol. 347, No. 20, pp. 1557-1566 (Nov. 14, 2002). et al.",ACTIVE
90,US,A1,US 2022/0016429 A1,149-428-563-452-07X,2022-01-20,2022,US 202117390481 A,2021-07-30,US 202117390481 A;;US 201916422588 A;;US 201715600519 A;;US 201615230023 A;;US 201414224922 A,2014-03-25,NEUROSTIMULATION IN A NEURAL FULCRUM ZONE FOR THE TREATMENT OF CHRONIC CARDIAC DYSFUNCTION,"Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone corresponds to a combination of stimulation parameters at which autonomic engagement is achieved, while the tachycardia-inducing stimulation effects are offset by the bradycardia-inducing effects, thereby minimizing side effects such as significant heart rate changes while providing a therapeutic level of stimulation.",LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,KENKNIGHT BRUCE H;;ARDELL JEFFREY L;;LIBBUS IMAD;;AMURTHUR BADRI,EAST TENNESSEE STATE UNIVERSITY (2015-02-05);;LIVANOVA USA INC (2014-03-26),https://lens.org/149-428-563-452-07X,Patent Application,yes,5,0,10,041-155-035-657-891;;167-525-921-748-75X;;039-973-530-342-718;;145-193-365-685-455;;147-722-091-954-665;;149-428-563-452-07X;;048-221-496-779-610;;078-221-536-829-239;;129-906-186-458-473;;183-521-051-255-573,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/3615;;A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/3615,A61N1/36,,0,0,,,,ACTIVE
91,US,B2,US 11738199 B2,041-155-035-657-891,2023-08-29,2023,US 202117390481 A,2021-07-30,US 202117390481 A;;US 201916422588 A;;US 201715600519 A;;US 201615230023 A;;US 201414224922 A,2014-03-25,Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction,"Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone corresponds to a combination of stimulation parameters at which autonomic engagement is achieved, while the tachycardia-inducing stimulation effects are offset by the bradycardia-inducing effects, thereby minimizing side effects such as significant heart rate changes while providing a therapeutic level of stimulation.",LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,KENKNIGHT BRUCE H;;ARDELL JEFFREY L;;LIBBUS IMAD;;AMURTHUR BADRI,EAST TENNESSEE STATE UNIVERSITY (2015-02-05);;LIVANOVA USA INC (2014-03-26),https://lens.org/041-155-035-657-891,Granted Patent,yes,268,0,10,041-155-035-657-891;;167-525-921-748-75X;;039-973-530-342-718;;145-193-365-685-455;;147-722-091-954-665;;149-428-563-452-07X;;048-221-496-779-610;;078-221-536-829-239;;129-906-186-458-473;;183-521-051-255-573,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/3615;;A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/3615,A61N1/36,,257,220,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of ADInstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal ofthe American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958¬2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration In Human Subjects and Verification In a Paced Canine Model Of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285¬2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrioventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control ofthe Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859¬866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source ofthe vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223¬231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425¬438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Baroreflex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306¬311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition ofthe Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages.;;Ridker, et al., “Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First cardiovascular Events,” New England Journal of Medicine, vol. 347, No. 20, pp. 1557-1566 (Nov. 14, 2002). et al.",ACTIVE
92,US,B2,US 10300284 B2,039-973-530-342-718,2019-05-28,2019,US 201715600519 A,2017-05-19,US 201715600519 A;;US 201615230023 A;;US 201414224922 A,2014-03-25,Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction,"Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone corresponds to a combination of stimulation parameters at which autonomic engagement is achieved, while the tachycardia-inducing stimulation effects are offset by the bradycardia-inducing effects, thereby minimizing side effects such as significant heart rate changes while providing a therapeutic level of stimulation.",LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,KENKNIGHT BRUCE H;;ARDELL JEFFREY L;;LIBBUS IMAD;;AMURTHUR BADRI,EAST TENNESSEE STATE UNIVERSITY (2015-02-05);;LIVANOVA USA INC (2014-03-26),https://lens.org/039-973-530-342-718,Granted Patent,yes,263,5,10,041-155-035-657-891;;167-525-921-748-75X;;039-973-530-342-718;;145-193-365-685-455;;147-722-091-954-665;;149-428-563-452-07X;;048-221-496-779-610;;078-221-536-829-239;;129-906-186-458-473;;183-521-051-255-573,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/3615;;A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/3615,A61N1/36,,247,217,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;U.S. Appl. No. 13/314,119, filed Dec. 7, 2011, Libbus et al.;;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at www.boddunan.com/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning a new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 2 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirecl.com/science/article/pii/SOO1448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(1), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of IMPROVE HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrioventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Health Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y- immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: noninvasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1459-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425¬438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation protects cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Gire J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky, et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation, Journal of the American Heart Association, 118, pp. 863-871 (2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/068541, International Preliminary Report on Patentability dated May 21, 2015, 9 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, et al., “Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First cardiovascular Events,” New England Journal of Medicine, vol. 347, No. 20, pp. 1557-1566 (Nov. 14, 2002).;;Ridker, et al., “C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women,” The New England Journal of Medicine, vol. 342, No. 12, pp. 836-841 (Mar. 23, 2000).;;Ridker, et al., “Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels,” Circulation, Journal of the American Heart Association, 98, pp. 839-844 (1998).;;Roger, et al., “Heart Disease and Stroke Statistics-2011 Update: A Report from the American Heart Association,” Circulation, Journal of the American Heart Association. Available at http://circ.ahajournals.org/content/123/4/e18 (2010).;;Romanovsky, et al., “The vagus nerve in the thermoregulatory response to systemic inflammation,” Am. J. Physiol., 273, pp. R407-R413 (1997).;;Rossi, et al., “Epicardial ganglionated plexus stimulation decreases postoperative inflammatory response in humans,” Heart Rhythm, vol. 9, No. 6, pp. 943-950 (Jun. 2012). et al.",ACTIVE
93,US,A1,US 2019/0126045 A1,186-963-412-118-804,2019-05-02,2019,US 201816234097 A,2018-12-27,US 201816234097 A;;US 201715805062 A;;US 201615267922 A;;US 201514861390 A;;US 201414271714 A,2014-05-07,RESPONSIVE NEUROSTIMULATION FOR THE TREATMENT OF CHRONIC CARDIAC DYSFUNCTION,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for monitoring the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time and a control system for adjusting stimulation parameters to maintain stimulation in the neural fulcrum zone based on detected changes in the physiological response to stimulation.,LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;ARDELL JEFFREY L,EAST TENNESSEE STATE UNIVERSITY (2015-02-09);;LIVANOVA USA INC (2014-05-14),https://lens.org/186-963-412-118-804,Patent Application,yes,0,4,13,052-128-932-596-510;;027-553-391-126-727;;102-729-056-642-518;;136-732-681-890-622;;162-606-386-904-88X;;149-114-957-379-715;;179-674-065-929-48X;;114-984-202-256-476;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;035-596-150-775-996,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36135;;A61N1/36114;;A61N1/36135;;A61N1/36139;;A61N1/37217;;A61N1/37264;;A61N1/36114;;A61N1/36053;;A61N1/3615,A61N1/36;;A61N1/372,,0,0,,,,ACTIVE
94,US,A1,US 2025/0065122 A1,052-128-932-596-510,2025-02-27,2025,US 202418947702 A,2024-11-14,US 202418947702 A;;US 202217716807 A;;US 201816234097 A;;US 201715805062 A;;US 201615267922 A;;US 201514861390 A;;US 201414271714 A,2014-05-07,RESPONSIVE NEUROSTIMULATION FOR THE TREATMENT OF CHRONIC CARDIAC DYSFUNCTION,"A method may include delivering stimulation to a nerve of a patient using a first set of stimulation parameters. The method may further include detecting a first heart rate change within a range between a baseline heart rate and a predefined threshold. The method may further include, subsequent to detecting the first heart rate change, detecting a second heart rate change that is outside of the range between the baseline heart rate and the predefined threshold. The method may further include delivering stimulation to the nerve of the patient using a second set of stimulation parameters based on the second heart rate change being outside of the range between the baseline heart rate and the predefined threshold.",LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;ARDELL JEFFREY L,EAST TENNESSEE STATE UNIVERSITY (2015-02-09);;LIVANOVA USA INC (2014-05-14),https://lens.org/052-128-932-596-510,Patent Application,yes,0,0,13,052-128-932-596-510;;027-553-391-126-727;;102-729-056-642-518;;136-732-681-890-622;;162-606-386-904-88X;;149-114-957-379-715;;179-674-065-929-48X;;114-984-202-256-476;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;035-596-150-775-996,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36135;;A61N1/36114;;A61N1/36135;;A61N1/36139;;A61N1/37217;;A61N1/37264;;A61N1/36114;;A61N1/36053;;A61N1/3615,A61N1/36;;A61N1/372,,0,0,,,,PENDING
95,US,A1,US 2019/0168001 A1,105-175-749-602-727,2019-06-06,2019,US 201916265765 A,2019-02-01,US 201916265765 A;;US 201715783941 A;;US 201615236039 A;;US 201414262289 A,2014-04-25,NEUROSTIMULATION AND RECORDING OF PHYSIOLOGICAL RESPONSE FOR THE TREATMENT OF CHRONIC CARDIAC DYSFUNCTION,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for recording the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time.,LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;ARDELL JEFFREY L,,https://lens.org/105-175-749-602-727,Patent Application,yes,0,0,8,115-576-988-379-198;;003-901-966-642-878;;004-784-617-407-278;;092-756-443-136-175;;004-731-030-938-951;;032-406-458-040-997;;195-578-662-071-610;;105-175-749-602-727,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/36146;;A61N1/36157;;A61N1/36171;;A61N1/3627;;A61N1/36139;;A61N1/0551;;A61N1/36053;;A61N1/36114;;A61N1/36146;;A61N1/36157;;A61N1/36171;;A61N1/3627,A61N1/36;;A61N1/05,,0,0,,,,ACTIVE
96,US,B2,US 11298543 B2,025-728-063-031-373,2022-04-12,2022,US 201816234097 A,2018-12-27,US 201816234097 A;;US 201715805062 A;;US 201615267922 A;;US 201514861390 A;;US 201414271714 A,2014-05-07,Responsive neurostimulation for the treatment of chronic cardiac dysfunction,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for monitoring the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time and a control system for adjusting stimulation parameters to maintain stimulation in the neural fulcrum zone based on detected changes in the physiological response to stimulation.,LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;ARDELL JEFFREY L,EAST TENNESSEE STATE UNIVERSITY (2015-02-09);;LIVANOVA USA INC (2014-05-14),https://lens.org/025-728-063-031-373,Granted Patent,yes,266,0,13,052-128-932-596-510;;027-553-391-126-727;;102-729-056-642-518;;136-732-681-890-622;;162-606-386-904-88X;;149-114-957-379-715;;179-674-065-929-48X;;114-984-202-256-476;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;035-596-150-775-996,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36135;;A61N1/36114;;A61N1/36135;;A61N1/36139;;A61N1/37217;;A61N1/37264;;A61N1/36114;;A61N1/36053;;A61N1/3615,A61N1/36;;A61N1/372,,257,220,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 9 9, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285¬2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Health Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859¬866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223¬231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425¬438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLoS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., p. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306¬311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages.;;Ridker, et al., “Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First cardiovascular Events,” New England Journal of Medicine, vol. 347, No. 20, pp. 1557-1566 (Nov. 14, 2002). et al.",ACTIVE
97,US,B2,US 10967184 B2,003-901-966-642-878,2021-04-06,2021,US 201916265765 A,2019-02-01,US 201916265765 A;;US 201715783941 A;;US 201615236039 A;;US 201414262289 A,2014-04-25,Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for recording the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time.,LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;ARDELL JEFFREY L,,https://lens.org/003-901-966-642-878,Granted Patent,yes,264,0,8,115-576-988-379-198;;003-901-966-642-878;;004-784-617-407-278;;092-756-443-136-175;;004-731-030-938-951;;032-406-458-040-997;;195-578-662-071-610;;105-175-749-602-727,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/36146;;A61N1/36157;;A61N1/36171;;A61N1/3627;;A61N1/36139;;A61N1/0551;;A61N1/36053;;A61N1/36114;;A61N1/36146;;A61N1/36157;;A61N1/36171;;A61N1/3627,A61N1/36;;A61N1/05;;A61N1/362,,255,220,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb., 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning a new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” SLEEP, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of IMPROVE HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y- immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL—Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages.;;Ridker, et al., “Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First cardiovascular Events,” New England Journal of Medicine, vol. 347, No. 20, pp. 1557-1566 (Nov. 14, 2002). et al.",ACTIVE
98,US,A1,US 2022/0226657 A1,149-114-957-379-715,2022-07-21,2022,US 202217716807 A,2022-04-08,US 202217716807 A;;US 201816234097 A;;US 201715805062 A;;US 201615267922 A;;US 201514861390 A;;US 201414271714 A,2014-05-07,RESPONSIVE NEUROSTIMULATION FOR THE TREATMENT OF CHRONIC CARDIAC DYSFUNCTION,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for monitoring the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time and a control system for adjusting stimulation parameters to maintain stimulation in the neural fulcrum zone based on detected changes in the physiological response to stimulation.,LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;ARDELL JEFFREY L,EAST TENNESSEE STATE UNIVERSITY (2015-02-09);;LIVANOVA USA INC (2014-05-14),https://lens.org/149-114-957-379-715,Patent Application,yes,0,0,13,052-128-932-596-510;;027-553-391-126-727;;102-729-056-642-518;;136-732-681-890-622;;162-606-386-904-88X;;149-114-957-379-715;;179-674-065-929-48X;;114-984-202-256-476;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;035-596-150-775-996,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36135;;A61N1/36114;;A61N1/36135;;A61N1/36139;;A61N1/37217;;A61N1/37264;;A61N1/36114;;A61N1/36053;;A61N1/3615,A61N1/36;;A61N1/372,,0,0,,,,ACTIVE
99,US,B2,US 10463859 B2,153-946-771-244-747,2019-11-05,2019,US 201715585742 A,2017-05-03,US 201715585742 A;;US 201414255276 A,2014-04-17,Fine resolution identification of a neural fulcrum for the treatment of chronic cardiac dysfunction,"Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone may be identified by monitoring a patient's response to incrementally increased intensity settings at a first frequency. If the incremental intensity increases do not result in the identification of the neural fulcrum zone, the frequency may be changed to provide finer resolution identification of the neural fulcrum zone.",LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,KENKNIGHT BRUCE H;;LIBBUS IMAD;;AMURTHUR BADRI;;ARDELL JEFFREY L,EAST TENNESSEE STATE UNIVERSITY (2015-02-05);;LIVANOVA USA INC (2014-04-29),https://lens.org/153-946-771-244-747,Granted Patent,yes,263,0,4,153-946-771-244-747;;154-919-726-579-735;;075-719-756-152-652;;004-460-936-750-873,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/36157;;A61N1/36171;;A61N1/3627;;A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/36157;;A61N1/36171;;A61N1/3627,A61N1/36;;A61N1/362,,256,220,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510;;101-879-262-785-509,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349;;14504253;;10.1161/01.cir.0000093381.57779.67,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at www.boddunan.com/education/20-medicine-a-surgery/12730-nerver-fiber- types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning a new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 2 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirecl.com/science/article/pii/SOO1448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of IMPROVE HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Health Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y—immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Gire J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky, et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation, Journal of the American Heart Association, 118, pp. 863-871 (2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, International Preliminary Report on Patentability dated May 21, 2015, 9 pages.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, et al., “Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First cardiovascular Events,” New England Journal of Medicine, vol. 347, No. 20, pp. 1557-1566 (Nov. 14, 2002). et al.",ACTIVE
100,US,B2,US 12157008 B2,114-984-202-256-476,2024-12-03,2024,US 202217716807 A,2022-04-08,US 202217716807 A;;US 201816234097 A;;US 201715805062 A;;US 201615267922 A;;US 201514861390 A;;US 201414271714 A,2014-05-07,Responsive neurostimulation for the treatment of chronic cardiac dysfunction,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. The implanted stimulation device includes a physiological sensor for monitoring the patient's response to the neurostimulation therapy on an ambulatory basis over extended periods of time and a control system for adjusting stimulation parameters to maintain stimulation in the neural fulcrum zone based on detected changes in the physiological response to stimulation.,LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;ARDELL JEFFREY L,EAST TENNESSEE STATE UNIVERSITY (2015-02-09);;LIVANOVA USA INC (2014-05-14),https://lens.org/114-984-202-256-476,Granted Patent,yes,269,0,13,052-128-932-596-510;;027-553-391-126-727;;102-729-056-642-518;;136-732-681-890-622;;162-606-386-904-88X;;149-114-957-379-715;;179-674-065-929-48X;;114-984-202-256-476;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;035-596-150-775-996,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36135;;A61N1/36114;;A61N1/36135;;A61N1/36139;;A61N1/37217;;A61N1/37264;;A61N1/36114;;A61N1/36053;;A61N1/3615,A61N1/36;;A61N1/372,,257,219,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-245-320-055-579;;061-418-436-648-248;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;10733371;;10.1056/nejm200003233421202;;12432042;;10.1056/nejmoa021993;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;A.M. Gillis, MD, FHRS President, “HeartRhythm Celebrates 10 Years,” The President's Page, Editorial Commentary, Heart Rhythm Society, 2013 (1 page).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at ww.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning a new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;EP Office Action issued in EP Appl. Ser. No. 15712014.8 dated Apr. 8, 2021 (5 pages).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859-866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;International Search Report and Written Opinion on PCT Appl. Ser. No. PCT/US2015/020116 dated Jul. 6, 2015 (12 pages).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-κB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Oirc J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure Pathophysiology and Potential Implications for Therapy,” Circulation, Journal of the American Heart Association, 2008, vol. 118 (pp. 863-871).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages. et al.",ACTIVE
101,US,B2,US 10974050 B2,130-955-238-671-919,2021-04-13,2021,US 201816009099 A,2018-06-14,US 201816009099 A;;US 201414521044 A;;US 201361897425 P,2013-10-30,Implantable neurostimulator-implemented method utilizing multi-modal stimulation parameters,"Multi-modal stimulation therapy may be utilized in which two or more stimulation therapies having different stimulation parameters may be delivered to a single patient. This can preferentially stimulate different nerve fiber types and drive different functional responses in the target organs. The stimulation parameters that may vary between the different stimulation therapies include, for example, pulse frequency, pulse width, pulse amplitude, and duty cycle.",LIVANOVA USA INC;;EAST TENNESSEE STATE UNIV,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;ARDELL JEFFREY L;;ORDWAY GREGORY A,,https://lens.org/130-955-238-671-919,Granted Patent,yes,245,0,4,104-726-375-413-180;;130-955-238-671-919;;051-205-619-805-11X;;006-408-280-650-822,US,4,104-726-375-413-180;;130-955-238-671-919;;006-408-280-650-822;;051-205-619-805-11X,US,0,A61N1/36114;;A61N1/0556;;A61N1/36053;;A61N1/36139;;A61N1/3615;;A61N1/36171;;A61N1/36114;;A61N1/0556;;A61N1/36053;;A61N1/36139;;A61N1/3615;;A61N1/36171,A61N1/36;;A61N1/05,,254,218,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;117-723-850-131-683;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10.1016/j.cardfail.2011.06.184;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews Cardiology, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Clinical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al., “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, JA, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at www.boddunan/education/20-medicine-a-surgery/12730-nerver-fiber-types-and-function.html (2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958-2963 (1999).;;Bilgutay, et al., “Vagal Tuning. A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration in Human Subjects and Verification in a Paced Canine Model of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 208-221 (2013).;;Borggrefe, “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www. sciencedirect.com/science/article/pii/S001448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: Recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari, et al., “Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure,” European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285-2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-851 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Circ Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Circ Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 88, pp. 320-337 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul lntegr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Heath Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnoea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. R859-R866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythm, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. R818-R826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integrative Comp Physiol, 287, pp. R1468-R1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Crit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1459-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-κB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vasc Biol, 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, et al., “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223-231 (2009).;;Katz, et al., “Disease of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses ischemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425-438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Circulation, Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92-93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Atrami (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li, et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Circ Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Circ. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Baroreflex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306-311 (2004).;;Lu, et al., “Vagal nerve stimulation protects cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement), p. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Circ J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement), pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation: Journal of the American Heart Association, vol. 118, iss. 8, pp. 863-871 (Aug. 2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 32-36 (2013).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-29A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Ricco, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Circulation, Journal of the American Heart Association, 108, pp. e81-e85 Sep. 2003. 6 pages.;;Ridker, et al., “Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First cardiovascular Events,” New England Journal of Medicine, vol. 347, No. 20, pp. 1557-1566 (Nov. 14, 2002). et al.",ACTIVE
102,US,B2,US 10426961 B2,177-090-509-015-119,2019-10-01,2019,US 201815958985 A,2018-04-20,US 201815958985 A;;US 201414262270 A,2014-04-25,Dynamic stimulation adjustment for identification of a neural fulcrum,Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A computer-implemented control system is operated to automatically identify a neural fulcrum zone based on a monitored patient physiological response. Ongoing neurostimulation therapy is delivered within the neural fulcrum zone.,CYBERONICS INC;;EAST TENNESSEE STATE UNIV;;LIVANOVA USA INC,LIBBUS IMAD;;AMURTHUR BADRI;;KENKNIGHT BRUCE H;;ARDELL JEFFREY L,EAST TENNESSEE STATE UNIVERSITY (2015-02-05);;LIVANOVA USA INC (2014-05-02),https://lens.org/177-090-509-015-119,Granted Patent,yes,262,0,4,123-795-948-914-459;;055-889-597-036-174;;083-765-260-860-986;;177-090-509-015-119,US,43,180-754-229-163-827;;003-901-966-642-878;;004-784-617-407-278;;027-553-391-126-727;;136-732-681-890-622;;048-221-496-779-610;;092-756-443-136-175;;149-428-563-452-07X;;032-406-458-040-997;;055-889-597-036-174;;179-674-065-929-48X;;167-525-921-748-75X;;114-984-202-256-476;;154-919-726-579-735;;143-786-056-734-672;;153-946-771-244-747;;078-221-536-829-239;;129-906-186-458-473;;105-175-749-602-727;;052-128-932-596-510;;075-719-756-152-652;;083-765-260-860-986;;102-729-056-642-518;;195-578-662-071-610;;162-606-386-904-88X;;102-450-554-706-184;;004-731-030-938-951;;004-460-936-750-873;;149-114-957-379-715;;123-153-499-533-217;;115-576-988-379-198;;039-973-530-342-718;;147-722-091-954-665;;145-193-365-685-455;;123-795-948-914-459;;177-090-509-015-119;;106-826-595-904-652;;116-317-775-548-47X;;186-963-412-118-804;;025-728-063-031-373;;041-155-035-657-891;;035-596-150-775-996;;183-521-051-255-573,WO;;EP;;US,0,A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/36146;;A61N1/36157;;A61N1/36171;;A61N1/3627;;A61N1/36139;;A61N1/36053;;A61N1/36114;;A61N1/36146;;A61N1/36157;;A61N1/36171;;A61N1/3627,A61N1/36;;A61N1/362,,256,221,114-554-829-110-585;;010-771-256-952-768;;032-651-635-310-054;;045-663-358-458-949;;018-746-592-512-370;;071-480-142-550-915;;011-000-452-662-224;;062-946-481-680-189;;023-758-433-381-78X;;016-271-478-252-895;;014-895-845-534-599;;007-090-741-081-845;;088-558-598-747-147;;050-875-309-620-458;;000-373-317-870-584;;064-115-714-342-814;;022-511-942-426-578;;005-977-968-019-135;;055-276-033-728-245;;035-562-540-595-960;;021-489-363-733-923;;037-026-585-324-99X;;055-583-617-761-09X;;044-269-005-304-213;;005-719-696-014-979;;035-983-938-270-993;;034-634-786-058-907;;134-165-267-906-894;;018-763-445-154-66X;;037-772-810-641-647;;029-440-702-255-959;;063-392-003-240-589;;072-743-323-465-46X;;054-267-325-105-209;;038-690-204-104-398;;048-178-639-864-783;;032-819-077-066-566;;063-214-772-498-945;;052-319-443-744-334;;022-175-984-861-965;;056-381-879-809-736;;071-104-501-676-116;;058-468-964-079-461;;005-786-849-507-660;;016-365-034-442-695;;167-840-581-033-386;;006-364-753-745-425;;109-382-545-944-378;;011-058-654-863-86X;;027-248-277-529-791;;090-003-169-378-657;;001-079-163-297-867;;058-346-179-472-545;;170-178-223-543-049;;026-298-036-152-208;;083-305-737-806-892;;084-345-542-488-073;;126-869-965-355-888;;124-265-940-219-855;;097-970-178-838-254;;028-048-637-544-881;;000-883-607-878-760;;034-639-118-583-768;;052-197-839-648-004;;001-188-702-508-460;;024-420-695-635-178;;108-483-863-597-400;;006-586-475-063-312;;011-102-706-549-430;;012-455-867-118-72X;;020-614-206-510-236;;016-506-080-216-062;;031-211-168-215-609;;022-878-788-729-829;;020-066-944-224-405;;017-995-012-641-768;;005-838-627-602-664;;106-586-523-830-674;;021-932-155-708-946;;034-377-880-564-588;;025-462-739-531-752;;106-931-623-348-337;;003-051-203-957-187;;120-548-013-050-352;;002-361-344-391-233;;135-710-624-136-259;;010-444-310-506-585;;129-485-851-138-785;;007-558-589-937-880;;075-682-975-788-953;;050-279-251-510-668;;036-013-307-360-932;;031-769-628-668-610;;015-302-711-454-235;;023-429-775-342-708;;093-169-392-951-769;;126-424-186-638-051;;001-331-402-098-497;;048-640-156-075-277;;047-041-374-562-531;;057-045-029-312-938;;035-744-239-809-146;;049-780-792-131-883;;018-202-351-494-006;;097-426-806-139-480;;044-535-726-535-539;;005-338-401-818-541;;020-264-676-376-863;;131-082-682-819-47X;;025-714-969-244-511;;011-610-415-265-260;;000-137-047-426-541;;024-157-475-918-517;;019-389-025-191-21X;;036-543-972-746-606;;017-422-233-958-736;;177-906-347-538-812;;043-332-392-421-614;;032-537-664-441-871;;026-545-006-627-693;;033-935-550-039-120;;074-778-636-843-081;;006-661-620-350-180;;028-386-020-190-421;;076-097-163-611-035;;071-967-705-882-564;;060-776-884-829-45X;;020-221-769-312-543;;007-913-269-795-434;;063-726-504-986-52X;;044-786-130-906-649;;088-026-329-479-861;;036-296-977-870-547;;068-311-222-642-945;;069-980-150-836-074;;067-146-932-103-361;;051-771-325-739-678;;042-354-262-372-181;;137-998-326-960-571;;053-527-255-172-060;;097-901-563-588-723;;058-973-264-742-469;;010-266-346-759-702;;076-274-887-196-476;;042-071-123-770-358;;103-548-864-668-322;;010-810-798-256-440;;101-879-262-785-509;;061-418-436-648-248;;061-245-320-055-579;;089-129-609-419-589;;070-972-987-296-642;;044-739-191-371-295;;008-116-731-440-807;;078-375-088-800-038;;001-385-377-272-601;;052-374-111-868-631;;034-419-831-492-517;;077-827-167-745-610;;117-723-850-131-683;;063-595-193-133-468;;132-288-490-639-204;;003-971-084-334-375;;087-953-796-174-603;;099-614-699-289-248;;017-603-466-885-382;;006-176-884-239-305;;100-979-440-868-430;;054-362-910-657-616;;003-971-372-447-956;;051-782-858-038-376;;062-394-660-305-162;;018-659-466-367-840;;073-400-454-872-745;;154-074-007-186-079;;004-742-342-565-553;;040-822-851-784-450;;118-242-174-504-921;;110-079-407-616-812;;077-006-809-865-326;;024-708-544-916-004;;121-944-052-032-342;;016-388-117-054-841;;004-811-708-971-908;;082-076-757-532-662;;060-077-304-479-615;;051-951-105-499-172;;078-727-438-173-625;;013-382-462-024-794;;084-014-455-783-609;;132-528-183-975-232;;129-174-417-393-005;;028-453-987-423-907;;003-879-950-539-499;;001-379-308-988-015;;004-588-720-447-560;;075-954-298-097-253;;005-996-539-746-733;;033-179-918-312-56X;;011-823-943-897-092;;005-399-667-042-719;;041-741-063-760-708;;080-443-952-477-477;;033-799-020-874-475;;053-093-006-080-282;;015-565-391-687-631;;147-491-105-204-203;;005-917-924-394-000;;092-535-877-651-765;;066-640-143-791-840;;026-601-420-987-09X;;088-631-813-629-089;;157-962-292-799-484;;113-577-581-319-507;;038-926-068-890-600;;000-054-409-661-079;;119-943-265-017-174;;095-877-137-038-788;;137-877-214-221-749;;029-374-303-889-599;;039-372-831-731-510,10.1161/circheartfailure.109.873968;;19919995;;pmc3753073;;23229137;;10.1038/nrcardio.2012.178;;15313946;;10.1161/01.cir.0000139841.42454.78;;10.1113/jphysiol.1957.sp005703;;pmc1358921;;13398974;;10.1373/clinchem.2004.036004;;15205370;;10.1046/j.1365-201x.2001.00812.x;;11437735;;16129801;;10.1161/circulationaha.104.508465;;10.1088/1741-2560/8/3/034004;;21543838;;3021001;;10.1152/ajpheart.1986.251.4.h764;;15271675;;10.1152/ajpregu.00183.2004;;10.1016/s0008-6363(98)00252-1;;10325952;;17455544;;10.3949/ccjm.74.suppl_1.s48;;1171567;;10.1159/000144411;;1147004;;10.1152/ajplegacy.1975.228.1.141;;10.1113/expphysiol.2007.041178;;17981929;;10.1007/bf00389602;;3826653;;16026115;;10.1080/07853890510007232;;10.2337/dc12-s011;;22187469;;pmc3632172;;20379081;;10.1292/jvms.09-0425;;10.1084/jem.20011714;;pmc2193742;;11901203;;11189015;;10.1016/s1566-0702(00)00215-0;;982212;;10.1161/01.cir.99.7.855;;10027805;;20820912;;10.1007/s10741-010-9190-6;;10.1161/01.cir.99.22.2958;;10359742;;5663136;;10.1016/s0022-5223(19)42875-4;;10.1016/0735-1097(91)90602-6;;1856414;;pmc1909508;;8799581;;10.1111/j.1476-5381.1996.tb15505.x;;23360102;;10.1111/nmo.12076;;10839541;;10.1038/35013070;;pmc3677978;;22678767;;10.1007/s10741-012-9314-2;;10.1111/j.1525-1403.2006.00062.x;;22151709;;18075042;;10.1109/tbme.2007.908310;;10.1016/0002-9149(91)90447-s;;1987725;;10.1016/j.expneurol.2010.09.011;;20851118;;pmc4322860;;20577901;;10.1007/s10741-010-9174-6;;pmc3688069;;10.1001/jama.2011.1474;;22009099;;9741520;;10.1016/s0735-1097(98)00305-2;;10.1001/jama.2009.888;;pmc2765917;;19549974;;10.1161/01.cir.0000068339.04731.4d;;12743004;;10.1007/s10741-010-9182-6;;20623184;;10491351;;10.1042/cs19990035;;10.1042/cs0970503;;17143074;;10.1097/yco.0b013e3280117733;;21526047;;pmc3082733;;10.4330/wjc.v3.i4.105;;10.1093/europace/eul024;;16635994;;10.1093/eurheartj/ehq391;;21030409;;18068036;;10.1016/j.jacc.2007.08.043;;19964772;;10.1109/iembs.2009.5334414;;10.1007/s10741-010-9216-0;;21165697;;10.1038/ni1229;;16025117;;10.1007/s10741-010-9195-1;;20924667;;10.1016/s0165-1838(98)00048-4;;9686913;;12829433;;10.1152/ajpheart.01051.2002;;10.1093/sleep/22.8.1067;;10617167;;3661734;;10.1152/ajpheart.1987.253.4.h863;;13192020;;pmc1244678;;pmc6931990;;10.1111/j.1542-474x.2005.00065.x;;16255755;;10.4067/s0717-95022010000100007;;10.1007/bf00569652;;3736685;;23130115;;10.1161/jaha.111.000018;;pmc3487312;;pmc1182941;;10.1113/jphysiol.1986.sp016289;;2886656;;10336524;;7853189;;8867095;;10.1016/0165-1838(95)00104-2;;9406117;;10.1016/s0165-1838(97)00071-4;;22088304;;10.1152/ajpregu.00535.2011;;pmc3289548;;10807470;;10.1016/s0735-1097(00)00582-9;;10.1152/japplphysiol.00616.2003;;14978001;;14978003;;10.1152/japplphysiol.00621.2003;;10.1016/s0140-6736(84)90062-x;;10.1152/ajpregu.90306.2008;;pmc2685292;;18832084;;pmc2739792;;10.1152/ajpregu.00245.2009;;19605763;;10.1007/s10741-010-9222-2;;21191650;;pmc3918428;;10.1016/j.hrthm.2013.11.022;;24275433;;10.1152/ajpregu.00426.2010;;21289238;;13425014;;10.1002/ar.1091270306;;10.1152/ajpregu.00251.2004;;15297264;;pmc2118357;;10.1084/jem.20052362;;16785311;;17901837;;10.1097/01.ccm.0000288102.15975.ba;;10.1097/00003246-200712000-00014;;pmc1728758;;10.1136/hrt.80.1.71;;9764064;;10.1161/01.cir.90.3.1459;;8087953;;10.1111/j.1540-8167.2010.01915.x;;20958828;;10.1016/0165-1838(82)90037-6;;7086068;;10938017;;10.1161/01.atv.20.8.1953;;10.1161/01.cir.72.3.585;;4017210;;19324966;;10.1161/circulationaha.109.192065;;19324967;;14978002;;10.1152/japplphysiol.00620.2003;;19674111;;10.1111/j.1742-4658.2009.07208.x;;7815369;;10.1159/000006913;;10545675;;10.1016/j.jtcvs.2008.08.020;;19154929;;10.1136/hrt.24.3.257;;pmc1017881;;14454369;;10.1111/apha.12055;;23279751;;16125731;;10.1016/j.lfs.2005.05.087;;10.1007/s00429-005-0462-1;;15887046;;21154273;;10.1016/0002-9149(75)90866-8;;1146697;;239801;;10.1161/01.cir.52.4.578;;23189120;;10.1371/journal.pone.0042799;;pmc3506552;;10.1161/01.cir.103.16.2072;;11319197;;9482439;;10.1016/s0140-6736(97)11144-8;;pmc1768862;;10.1136/hrt.2003.025254;;15831662;;10.1161/01.cir.103.10.1428;;11245648;;11454971;;10.1111/j.1469-7793.2001.00547.x;;pmc2278718;;14662714;;10.1161/01.cir.0000105721.71640.da;;10.1007/s10741-010-9184-4;;20658318;;10.1161/circep.109.868331;;19948505;;10.1161/hc0902.104353;;11877368;;10.1152/ajpheart.1997.273.2.h805;;9277498;;23357542;;10.1016/j.hrthm.2013.01.030;;10.1161/01.hyp.0000111837.73693.9b;;14707159;;pmc3822819;;10.1111/jcmm.12049;;23577721;;10.1152/ajpregu.00768.2001;;12376395;;10.1016/j.ejheart.2004.07.004;;15762009;;12456484;;10.1161/01.res.0000043825.01705.1b;;12500970;;10.1146/annurev.physiol.65.092101.142249;;15944935;;10.14670/hh-20.851;;10.1016/s0735-1097(83)80350-7;;6630790;;9748580;;10.1016/s0006-8993(98)00613-1;;7407841;;10.1007/bf00234756;;10.1016/j.jneumeth.2004.10.020;;15661300;;9396441;;10.1161/01.cir.96.10.3450;;12622441;;10.1536/jhj.44.91;;10.1016/s0014-2999(99)00845-6;;10666509;;10.1046/j.1540-8167.2002.00896.x;;12380928;;10.1161/circep.111.965434;;22157521;;pmc3296063;;10.1253/circj.69.493;;15791049;;5925156;;10.1161/01.res.19.3.576;;10.1161/01.cir.98.15.1510;;9769304;;10.1016/j.jacc.2007.03.045;;17659201;;9633928;;10.1161/01.atv.18.6.894;;20635563;;18711023;;10.1161/circulationaha.107.760405;;23246597;;10.1016/j.hrthm.2012.12.015;;pmc3758134;;22987542;;10.1109/tnsre.2012.2214058;;10.1056/nejm200105313442201;;11386263;;16549778;;10.1073/pnas.0600506103;;pmc1405626;;10.1042/bst0341037;;17073745;;10.1016/b978-0-12-374248-3.00019-7;;10.1161/01.cir.97.14.1362;;9577947;;10.1016/0735-1097(93)90458-d;;8376693;;2337494;;pmc1024436;;10.1136/hrt.63.4.228;;10.1152/ajplegacy.1974.227.2.444;;4854069;;2872849;;10.1067/mhj.2001.113078;;11231442;;8910234;;10.1113/jphysiol.1996.sp021703;;pmc1160895;;10.2337/dc09-1278;;pmc2858202;;20427682;;14504253;;10.1161/01.cir.0000093381.57779.67;;12432042;;10.1056/nejmoa021993;;10733371;;10.1056/nejm200003233421202;;9738637;;10.1161/01.cir.98.9.839;;pmc4418670;;21160056;;10.1161/cir.0b013e3182009701;;10.1152/ajpregu.1997.273.1.r407;;9249579;;10.1016/j.hrthm.2012.01.025;;22306617;;pmc1510440;;10.1111/j.1476-5381.1994.tb17102.x;;7858851;;19763129;;10.1038/hr.2009.140;;10.1111/j.1528-1157.1990.tb05843.x;;2226360;;21128115;;pmc3784341;;10.1007/s10741-010-9209-z;;21097604;;10.1161/circheartfailure.110.955013;;pmc3048958;;10.1016/j.cardfail.2011.06.184;;10626084;;10.1002/clc.4960221211;;pmc6655929;;23403057;;10.1016/j.hrthm.2013.02.003;;10644585;;10.1152/ajpheart.2000.278.1.h67;;1634664;;10.1016/0735-1097(92)90094-4;;10.1253/circj.cj-10-1019;;21127379;;10.1097/hco.0b013e3283413961;;21099680;;22962285;;10.1136/heartjnl-2012-302291;;19880077;;10.1016/j.hrthm.2009.08.012;;10.1161/01.cir.78.4.969;;3168199;;10.1016/0002-9149(76)90420-3;;1274864;;10.1016/j.ejheart.2008.07.016;;18760668;;10.1007/s10741-010-9179-1;;20577900;;8891862;;10.1016/s1071-9164(96)80047-9;;10.1111/j.1540-8167.2011.02070.x;;21489033;;10.1056/nejm199309303291401;;8366922;;1592409;;10.1109/10.126616;;pmc3101282;;10.1161/circulationaha.111.018028;;21555706;;10.1016/j.hrthm.2013.01.029;;23357541;;pmc3671581;;22035201;;pmc3331905;;10.1111/j.1540-8167.2011.02204.x;;9351439;;10.1161/01.res.81.5.664;;10070480;;10.1016/s0008-6363(98)00244-2;;10.1016/j.eplepsyres.2008.08.003;;18801642;;10.1046/j.1540-8167.2003.02441.x;;12776861;;16387796;;10.1124/mol.105.020701;;19088220;;10.1242/jeb.024042;;10.1016/j.biopsycho.2005.11.013;;17182165;;8032660;;10.1111/j.1476-5381.1994.tb13025.x;;pmc1910295;;17873422;;10.1088/1741-2560/4/3/005;;10.1093/cvr/cvm092;;18065771;;10.1016/j.hrthm.2010.03.043;;20381645;;10.1212/01.wnl.0000138499.87068.c0;;15452317;;363413;;pmc1637264;;10.1289/ehp.7826151;;10.1161/01.res.68.5.1471;;2019002;;10.1161/01.cir.0000057810.48709.f6;;12654604;;14047639;;10.1161/01.res.13.2.132;;pmc2729712;;18955667;;10.1161/circulationaha.108.784215;;21920259;;10.1016/j.jacc.2011.06.029;;pmc4111570;;pmc3530117;;22966163;;10.1113/jphysiol.2012.241943;;10.1038/nature01339;;12508119;;11458681;;10.1111/j.1749-6632.2001.tb03680.x;;10625148;;10.1114/1.229;;10.1177/0269881108089820;;18562428;;17245469;;pmc1764546;;10.1016/0024-3205(95)02047-m;;7658909;;10.1016/j.autneu.2009.04.005;;pmc2751833;;19442588;;10.1152/ajpheart.1985.249.4.h703;;4051008;;15131554;;10.1016/j.ahj.2003.11.021;;16819581;;10.1007/s10741-006-9196-2;;23370017;;10.1088/1741-2560/10/2/026003;;22254997;;10.1109/iembs.2011.6090848;;22214613;;10.1016/j.hrthm.2011.12.023;;10.1016/j.hrthm.2012.11.019;;23183191;;10.1002/ar.1092390109;;8037379;;2490832;;10.1161/01.hyp.13.5_suppl.i74;;20559719;;10.1007/s10741-010-9178-2;;19243685;;10.1179/174313208x355486;;19187919;;10.1016/j.hrthm.2008.10.043;;22913453;;10.1111/j.1540-8167.2012.02405.x;;17281904;;10.1109/iembs.2005.1616135;;4434368;;10.1093/cvr/8.5.647;;10.1161/hypertensionaha.107.095216;;17846349,"US 8,315,702 B2, 11/2012, Chavan et al. (withdrawn);;Zhang, et al., “Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model,” Journal of the American Heart Association, Circ Heart Fail, 2, pp. 692-699 (2009).;;Abraham, et al., “Devices in the management of advanced, chronic heart failure,” Nature Reviews, vol. 10, pp. 98-110 (Feb. 2013) (Published online Dec. 11, 2012).;;Adamson, et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device,” Circulation, Journal of the American Heart Association, 110, pp. 2389-2394 (2004).;;Agostoni, et al., “Functional and Histological Studies of the Vagus Nerve and its Branches to the Heart, Lungs and Abdominal Viscera in the Cat,” J. Physiol. 135, pp. 182-205 (1957).;;Ajani, et al., “Prevalence of High C-Reactive Protein in Persons with Serum Lipid Concentrations within Recommended Values,” Chemical Chemistry, 50:9, pp. 1618-1622 (2004).;;Akiyama, et al., “Effects of right and left vagal stimulation on left ventricular acetylcholine levels in the cat,” Acta Physiol Scand, 172, pp. 11-16 (2001).;;Anand, et al., “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan,” Circulation, Journal of the American Heart Association, 112, pp. 1428-1434 (2005).;;Anholt, et al., “Recruitment and blocking properties of the CardioFit stimulation lead,” Journal of Neural Engineering, 8, pp. 1-6, (2011).;;Ardell, et al.; “Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart,” Am. J. Physiol. 251 (Heart Circ. Physiol. 20), pp. H764-H773 (1986).;;Armour, “Cardiac neuronal hierarchy in health and disease,” Am J Physiol Regul Integr Comp Physiol, 287, pp. R262-R271 (2004).;;Armour, “Myocardial ischaemia and the cardiac nervous system,” Cardiovascular Research, 41, pp. 41-54 (1999).;;Armour, “The little brain on the heart,” Cleveland Clinic Journal of Medicine, vol. 74, supp. 1, pp. S48-S51 (Feb. 2007).;;Armour, et al., “Functional anatomy of canine cardiac nerves,” Acta anat., 91, pp. 510-528 (1975).;;Armour, et al., “Localized myocardial responses to stimulation of small cardiac branches of the vagus,” American Journal of Physiology, vol. 228, No. 1 pp. 141-148 (Jan. 1975).;;Armour, Ja, “Potential clinical relevance of the ‘little brain’ on the mammalian heart,” Experimental Physiology, vol. 1 93, No. 2, pp. 165-176 (Feb. 2008). Online Publication Date: Nov. 2, 2007. Available at: http://ep.physoc.org/content/93/2/165.long.;;Asala, et al., “An electron microscope study of vagus nerve composition in the ferret,” Anat Embryol, 175, pp. 247-253 (1986).;;Aukrust, et al., “Inflammatory and anti-inflammatory cytokines in chronic heart failure: Potential therapeutic implications,” Annals of Medicine, 37, pp. 74-85 (2005).;;Author Unknown, “Nerve fiber—Types and Function,” www.boddunan.com Available at www.boddunan.com/education/20-medicine-a-surgery/12730-nerver-fiber- types-and-function.html (Apr. 19, 2010).;;Author Unknown, American Diabetes Association, “Standards of Medical Care in Diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11-S63 (Jan. 2012).;;Author Unknown, Staff of Adinstruments, “Principles of Nerve Stimulation,” Application Note, ADInstruments (Apr. 2002).;;Bae, et al., “Gliosis in the Amygdala Following Myocardial Infarction in the Rat,” J Vet Med Sci, 72(8), pp. 1041-1045 (2010).;;Bernik, et al., “Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway,” J. Exp. Med, vol. 195, No. 6, pp. 781-788 (Mar. 18, 2002).;;Berthoud, et al., “Functional and chemical anatomy of the afferent vagal system,” Autonomic Neuroscience: Basic and Clinical, 85, pp. 1-17 (2000).;;Bhagat, et al., “Differential Effect of Right and Left Vagal Stimulation on Right and Left Circumflex Coronary Arteries,” S A Medical Journal, 50, pp. 1591-1594 (1976).;;Biasucci, et al., “Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability,” Circulation, Journal of the American Heart Association, 99, pp. 855-860 (1999).;;Bibevski, et al., “Evidence for impaired vagus nerve activity in heart failure,” Heart Fail Rev, 16, pp. 129-135 (2011).;;Bibevski, et al., “Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure,” Circulation, Journal of the American Heart Association, 99, pp. 2958¬2963 (1999).;;Bilgutay, et al., “Vagal Tuning A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure,” Journal of Thoracic and Cardiovascular Surgery, vol. 56, No. 1, pp. 71-82 (Jul. 1968).;;Binkley, et al., “Parasympathetic Withdrawal Is an Integral Component of Autonomic Imbalance in Congestive Heart Failure: Demonstration In Human Subjects and Verification In a Paced Canine Model Of Ventricular Failure,” JACC, vol. 18, No. 2, pp. 464-472 (Aug. 1991).;;Bois, et al., “Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells,” Abstract, British Journal of Pharmacology, 118(4):1051-7 (1996).;;Bonaz, et al., “Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway,” Neurogastroenterology & Motility, pp. 1-14 (2013).;;Borggrefe, et al., “Vagal Stimulation Devices,” ESC Congress 2010 (2010).;;Borovilkova, et al., “Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin,” Nature, vol. 405, pp. 458-462 (May 25, 2000).;;Brack, et al., “Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties in vagus nerve stimulation on malignant arrhythmias in heart failure,” Heart Fail Rev (Published online Jun. 8, 2012).;;Bronzino, “Biomedical Engineering Fundamentals,” CRC Press, Chapter 30, pp. 30-10-30-15 (Apr. 2006).;;Buschman, et al., “Heart Rate Control Via Vagus Nerve Stimulation,” Neuromodulation, vol. 9, No. 3, pp. 214-220 (2006).;;Butterwick, et al., “Tissue Damage by Pulsed Electrical Stimulation,” IEEE Transactions on Biomedical Engineering, vol. 54, No. 12, pp. 2261-2267 (Dec. 2007).;;Calkins, et al., “Comparison of Responses to Isoproterenol and Epinephrine During Head-Up Tilt in Suspected Vasodepressor Syncope,” The American Journal of Cardiology, vol. 67 pp. 207-209 (Jan. 15, 1991).;;Castoro et al., “Excitation properties of the right cervical vagus nerve in adult dogs,” Experimental Neurology, vol. 2 227, iss. 1, pp. 62-68 (Jan. 2011). Online Publication Date: Sep. 17, 2010. Available at: http://www.sciencedirecl.com/science/article/pii/SOO1448861000347X.;;Chapleau, et al., “Methods of assessing vagus nerve activity and reflexes,” Heart Fail Rev, 16, pp. 109-127 (2011).;;Chen, et al., “National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008,” JAMA, vol. 306, No. 15 (Oct. 19, 2011).;;Chen, et al., “Role of Atrial Electrophysiology and Autonomic Nervous System in Patients with Supraventricular Tachycardia and Paroxysmal Artrial Fibrillation,” J Am Coll Cardiol, vol. 32, No. 3, pp. 732-738 (Sep. 1998).;;Cheng, et al., “Long-term Outcomes in Individuals with Prolonged PR Interval or First-Degree Atrioventricular Block,” JAMA, vol. 301, No. 24 pp. 2571-2577 (Jun. 24, 2009).;;Chiou, et al., “Effects of Continuous Enhanced Vagal Tone and Dual Atrioventricular Node and Accessory Pathways,” Circulation, Journal of the American Heart Association, 107, pp. 2583-2588 (2003).;;Cohen, et al., “Histopathology of the stimulated Vagus nerve: Primum non nocere,” Heart Fail Rev, 16, pp. 163-169 (2011).;;Colombo, et al., “Comparison between spectral analysis and the phenylephrine methods for the assessment of baroreflex sensitivity in chronic heart failure,” Clinical Science, 97, pp. 503-513 (1999).;;Cryan, et al., “Animal models and mood disorders: recent developments,” Current Opinion in Psychiatry, 20, pp. 1-7 (2007).;;Das, “Vagal nerve stimulation in prevention and management of coronary heart disease,” World J. Cardiol, 3(4), pp. 105-110 (Apr. 26, 2011).;;De Castro, et al., “Parasympathetic-mediated atrial fibrillation during tilt test associated with increased baroreflex sensitivity,” The European Society of Cardiology, Europace, 8, pp. 349-351 (2006).;;De Ferrari et al., Chronic Vagus Nerve Stimulation: A New and Promising Therapeutic Approach for Chronic Heart Failure, European Heart Journal, vol. 32, Oct. 28, 2010, pp. 847-855.;;De Ferrari, et al., “Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients with Preserved Left Ventricular Function,” Journal of the American College of Cardiology, vol. 50, No. 24, pp. 2285¬2290 (2007).;;De Ferrari, et al., “Chronic Vagal Stimulation in Patients with Congestive Heart Failure,” 31st Annual International Conference of the IEE EMBS (2009).;;De Ferrari, et al., “Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions,” Heart Fail Rev, 16, pp. 195-203 (2011) (Published Online Dec. 17, 2010).;;De Jonge, et al., “Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway,” Nature Immunology, vol. 6, No. 8, pp. 844-852 (Aug. 2005).;;Desai, et al., “Pharmacologic modulation of parasympathetic activity in heart failure,” Heart Fail Rev, 16, pp. 179-193 (Published online: Oct. 6, 2010) (2011).;;Dickerson, et al., “Parasympathetic neurons in the cranial medial ventricular fat pad on the dog heart selectively decrease ventricular contractility,” Journal of the Autonomic Nervous System, 70, pp. 129-141 (1998).;;Dunlap, et al., “Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity,” Am J Physiol Heart Gire Physiol, 285, pp. H1632-H1640 (Jun. 26, 2003).;;Elsenbruch, et al., “Heart Rate Variability During Waking and Sleep in Healthy Males and Females,” Sleep, vol. 22, No. 8, pp. 1067-1071 (1999).;;Euler, et al., “Acetylcholine release by a stimulus train lowers atrial fibrillation threshold,” Am. J Physiol. 253 (Heart Gire. Physiol, 22), pp. H863-H868 (1987).;;Evans, et al., “Histological and functional studies on the fibre composition of the vagus nerve of the rabbit,” Journal of Anatomy, 130, pp. 139-151 (1954).;;Fallen, “Vagal Afferent Stimulation as a Cardioprotective Strategy? Introducing the Concept,” A.N.E., vol. 10, No. 4 (Oct. 2005).;;Fan, et al., “Transvenous vagus nerve stimulation: A potential heart failure therapy is feasible in humans,” JACC, vol. 55, issue 10A, pp. E152-E153 (2010).;;Fazan, et al., “Diabetic Peripheral Neuropathies: A Morphometric Overview,” Int. J. Morphol, 28(I), pp. 51-64 (2010).;;Feinauer, et al., “Ouabain enhances release of acetylcholine in the heart evoked by unilateral vagal stimulation,” Arch Pharmacol, 333, pp. 7-12 (1986).;;Fonarow, et al., “Incremental Reduction in Risk of Death Associated with Use of Guideline-Recommended Therapies in Patients with Heart Failure: A Nested Case-Control Analysis of Improve HF,” J Am Heart Assoc, 1, pp. 16-26 (2012).;;Ford, et al., “The effects of electrical stimulation of myelinated and non-myelinated vagal fibres on heart rate in the rabbit,” J. Physiol. 380, pp. 341-347 (1986).;;Furukawa, et al., “Effects of Verapamil, Zatebradine, and E-4031 on the Pacemaker Location and Rate in Response to Sympathetic Stimulation in Dog Hearts,” The Journal of Pharmacology and Experimental Therapeutics, vol. 289, No. 3, pp. 1334-1342 (1999).;;Furukawa, et al., “Selective inhibition by zatebradine and discrete parasympathetic stimulation of the positive chronotropic response to sympathetic stimulation in anesthetized dogs,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(2):744-9 (1995).;;Gatti, et al., “Can neurons in the nucleus ambiguous selectively regulate cardiac rate and atrio-ventricular conduction?” Journal of the Autonomic Nervous System, 57, pp. 123-127 (1996).;;Gatti, et al., “Vagal control of left ventricular contractility is selectively mediated by a cranioventricular intracardiac ganglion in the cat,” Journal of the Autonomic Nervous System, 66, pp. 138-144 (1997).;;Gibbons, et al., “Neuromodulation targets intrinsic cardiac neurons to attenuate neuronally mediated atrial arrhythmias,” Am J Physiol Regul Integr Comp Physiol 302: R357-R364 (2012) (First published Nov. 16, 2011).;;Gottdiener, et al., “Predictors of Congestive Heart Failure in the Elderly: The Cardiovascular Health Study,” Journal of the American College of Cardiology, vol. 35, No. 6, pp. 1628-1637 (2000).;;Gray, et al., “Parasympathetic control of the Heart. II. A novel interganglionic intrinsic cardiac circuit mediates neural control of heart rate,” J. Appl Physiol, 96, pp. 2273-2278 (2004).;;Gray, et al., “Parasympathetic control of the Heart. III. Neuropeptide Y-immunoreactive nerve terminals synapse on three populations of negative chronotropic vagal preganglionic neurons,” J. Appl Physiol, 96, pp. 2279-2287 (2004).;;Grill, “Chapter 14—Principles of Electric Field Generation for Stimulation of the Central Nervous System,” Neuromodulation, Academic Press (2009).;;Guilleminault, et al., “Cyclical Variation of the Heart Rate in Sleep Apnea Syndrome,” The Lancet, pp. 126-131 (Jan. 21, 1984).;;Hardwick, et al., “Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexus,” Am J Physiol Regulatory Integrative Comp Physiol, 295, pp. 1926-1933 (2008).;;Hardwick, et al., “Remodeling of the guinea pig intrinsic cardiac plexus with chronic pressure overload,” Am J Physiol Regulatory Integrative Comp Physiol, 297, pp. 859¬866 (2009).;;Hauptman, et al., “The vagus nerve and autonomic imbalance in heart failure: past, present, and future,” Heart Fail Rev, 16, pp. 97-99 (2011).;;Hellyer, et al., “Autonomic nerve activity and blood pressure in ambulatory dogs,” Heart Rhythym, vol. 11(2), pp. 307-313 (Feb. 2014).;;Hirooka, et al., “Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension,” Am J Physiol Regulatory Integration Comp Physiol, 300, pp. 818-826 (2011).;;Hoffman, et al., “Vagus Nerve Components,” Anat Rec, 127, pp. 551-568 (1957).;;Hu, et al., “Role of sympathetic nervous system in myocardial ischemia injury: Beneficial or deleterious?” Letters to the Editor, Elsevier Ireland Ltd. (Mar. 27, 2012).;;Hua, et al., “Left vagal stimulation induces dynorphin release and suppresses substance P release from the rat thoracic spinal cord during cardiac ischemia,” Am J Physiol Regulatory Integration Comp Physiol, 287, pp. 1468-1477 (2004).;;Huston, et al., “Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis,” J. Exp. Med, vol. 203, No. 7 pp. 1623-1628 (Jun. 19, 2006).;;Huston, et al., “Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis,” Grit Care Med, vol. 35, No. 12, pp. 2762-2768 (2007).;;Ingemansson, et al., “Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation,” Heart, 80, pp. 71-76 (1998).;;Ito, et al., “Efferent sympathetic and vagal innervation of the canine right ventricle,” Circulation, Journal of the American Heart Association, vol. 90, pp. 1469-1468 (1994).;;Jacques, et al., “Spinal Cord Stimulation Causes Potentiation of Right Vagus Nerve Effects on Atrial Chronotropic Function and Repolarization in Canines,” Journal of Cardiovascular Electrophysiology, vol. 22, No. 4, pp. 440-447 (Apr. 2011).;;Jaenisch, et al., “Respiratory muscle training improves baroreceptor sensitivity, decrease sympathetic tonus and increase vagal effect in rats with heart failure,” European Heart Journal, 32 (Abstract Supplement, pp. 976 (2011).;;Jammes, et al., “Afferent and efferent components of the bronchial vagal branches in cats,” Journal of the Autonomic Nervous System, 5, pp. 165-176 (1982).;;Janabi, et al., “Oxidized LDL-Induced NF-kB Activation and Subsequent Expression of Proinflammatory Genes are Defective in Monocyte-Derived Macrophages from CD36-Deficient Patients,” Arterioscler Thromb Vase Biol., 20:1953-1960 (2000).;;Janse, et al., “Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs,” Circulation, Journal of the American Heart Association, 72, pp. 585-595 (1985).;;Jessup; et al., “2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults,” Circulation, Journal of the American Heart Association, vol. 119, pp. 1977-2016 (2009).;;Johnson, et al., “Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles,” J Appl Physiol, 96, pp. 2265-2272 (2004).;;Kakinuma, et al., “Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium,” FEBS Journal, 276, pp. 5111-5125 (2009).;;Kalman, “Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart,” Abstract, Journal of Pharmacology & Experimental Therapeutics, 272(1):85-93 (1995).;;Kaneko, et al., “C-Reactive Protein in Dilated Cardiomyopathy,” Cardiology, 91, pp. 215-219 (1999).;;Katare, et al., “Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of bradycardiac effect,” The Journal of Thoracic and Cardiovascular Surgery, vol. 137, No. 1, pp. 223¬231 (2009).;;Katz, et al., “Diseases of the heart in the Works of Hippocrates,” Br Heart J, 24, pp. 257-264 (1962).;;Kawada, et al., “High-frequency dominant depression of peripheral vagal control of heart rate in rats with chronic heart failure,” Acta Physiol 207, 494-502 (2013).;;Kawada, et al., “Vagal stimulation suppresses isschemia-induced myocardial interstitial norepinephrine release,” Life Sciences, 78, pp. 882-887 (2006).;;Kawashima, “The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution,” Anat Embryol, 209, pp. 425¬438 (2005).;;Klein et al., “Vagus nerve stimulation: A new approach to reduce heart failure,” Cardiology Journal, vol. 17, iss. 6, pp. 638-643 (2010).;;Kliks, et al., “Influence of Sympathetic Tone on Ventricular Fibrillation Threshold During Experimental Coronary Occlusion,” The American Journal of Cardiology, vol. 36, pp. 45-49 (Jul. 1975).;;Kolman, et al., “The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions,” Journal of the American Heart Association, 52, pp. 578-585 (1975).;;Kong, et al., “Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction,” PLOS One, vol. 7, issue 11 (Nov. 2012).;;Koopman, et al., “Pilot study of stimulation of the cholinergic anti-inflammatory pathway with an implantable vagus nerve stimulation device in patients with rheumatoid arthritis,” Abstract (2012).;;Kulbertus, et al., ed., “Neurocardiology,” Futura Publishing Co., pp. 13 (“Anatomy of the Cardiac Efferent Innvervation”); 61-63 (“Autonomic Neural Control”); 87, 89, 92¬93 (“Sympathetic-Parasympathetic Interactions”); 183, 187 (“Parasympathetic Nervous System”); 104 (1988).;;La Rovere, et al., “Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials,” Circulation, Journal of the American Heart Association, 103, pp. 2072-2077 (2001).;;La Rovere, et al., “Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators,” Lancet, 351(9101), pp. 478-484 (Feb. 14, 1998).;;Lane, et al., “Prediction and Prevention of Sudden Cardiac Death in Heart Failure,” Heart, 91, pp. 674-680 (2005).;;Lechat, et al., “Heart rate and Cardiac Rhythm Relationships with Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial,” Circulation, Journal of American Heart Association, 103, pp. 1428-1433 (2001).;;Lewis, et al., “Vagus nerve stimulation decreases left ventricular contractility in vivo in the human and pig heart,” Journal of Physiology, 534, pp. 547-552 (2001).;;Li et al., “Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats,” Circulation: Journal of the American Heart Association, vol. 109, iss. 1, pp. 120-124 (Jan. 2004). Online publication date: Dec. 8, 2003.;;Li, et al., “Early vagal stimulation markedly prevented cardiac dysfunction in rats after acute myocardial infarction in addition to suppressing arrhythmic death,” European Heart Journal, 32 (Abstract Supplement), pp. 297-298 (2011).;;Li, et al., “Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation,” Heart Fail Rev, 16, pp. 137-145 (2011).;;Li, et al., “Low-Level Vagosympathetic Stimulation. A Paradox and Potential New Modality for the Treatment of Focal Atrial Fibrillation,” Gire Arrhythm Electrophysiol, Journal of American Heart Association, 2, pp. 645-651 (2009).;;Li, et al., “Restoration of vagal tone by donepezil, on top of losartan treatment, markedly suppresses ventricular dysfunction and improves long-term survival in chronic heart failure rats,” European Heart Journal, 32 (Abstract Supplement), pp. 642 (2011).;;Libby, et al., “Inflammation and Atherosclerosis,” Circulation, Journal of the American Heart Association, 105, pp. 1135-1143 (2002).;;Liu, et al., “Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity,” Am. J. Physiol. 273 (Heart Gire. Physiol. 42), pp. H805-H816 (1997).;;Lo, et al., “Paradoxical long-term proarrhythmic effects after ablating the ‘head station’ ganglionated plexi of the vagal innervation to the heart,” Heart Rhythm, vol. 10, No. 5, pp. 751-757 (May 2013).;;Lohmeier, et al., “Prolonged Activation of the Barorelfex Produces Sustained Hypotension,” Hypertension, Journal of the American Heart Association, 43, pp. 306¬311 (2004).;;Lu, et al., “Vagal nerve stimulation produces cardiac injury by attenuating mitochondrial dysfunction in a murine burn injury model,” J. Cell. Mol. Med., vol. 17, No. 5, pp. 664-671 (2013).;;Ma, et al., “Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice,” Am J Physiol Regulatory Integration Comp Physiol, 283, pp. 1033-1040 (2002).;;Maj, et al., “P5775: Autonomic imbalance and circulating androgens and estrogens in men with systolic heart failure,” European Heart Journal, 32 (Abstract Supplement), pp. 1090 (2011).;;Malkin, et al., “Life-saving or life-prolonging? Interpreting trial data and survival curves for patients with congestive heart failure,” The European Journal of Heart Failure, 7, pp. 143-148 (2005).;;Mann, “Chapter 12—Peripheral Nerves,” The Nervous System in Action, michaeldmann.net/mannl2.html, (Jul. 2011).;;Mann, “Inflammatory Mediators and the Failing Heart. Past, Present, and the Foreseeable Future,” Circ Res., 91, pp. 988-998 (2002).;;Mann, “Stress-Activated Cytokines and the Heart: From Adaptation to Maladaptation,” Annu. Rev. Physiol., 65, pp. 81-101 (2003).;;Martin-Portugues, et al., “Histopathologic features of the vagus nerve after electrical stimulation in swine,” Histol Histopathol, 20, pp. 851-856 (2005).;;Martins, et al., “Distribution of Local Repolarization Changes Produced by Efferent Vagal Stimulation in the Canine Ventricles,” JACC, vol. 2, No. 6, pp. 1191-1199 (Dec. 1983).;;Massari, et al., “Neural control of left ventricular contractility in the dog heart: synaptic interactions of negative inotropic vagal preganglionic neurons in the nucleus ambiguus and tyrosine hydroxylase immunoreactive terminals,” Brain Research, 802, pp. 205-220 (1998).;;May, et al., “P564: Long-term prediction of all-cause mortality in diabetic autonomic neuropathy: simple function tests or 24-hour heart rate variability (HRV)?” European Heart Journal, 32 (Abstract Supplement, pp. 64 (2011).;;Mei, et al., “The Composition of the Vagus Nerve of the Cat,” Cell Tissue Res., 209, pp. 423-431 (1980).;;Merrill, et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols,” Journal of Neuroscience Methods, 141, pp. 171-198 (2005).;;Mortara, et al., “Arterial Baroreflex Modulation of Heart Rate in Chronic Heart Failure,” Circulation, Journal of the American Heart Association, vol. 96, No. 10, pp. 3450-3458 (Nov. 18, 1997).;;Murakawa, et al., “Effect of Cervical Vagal Nerve Stimulation on Defibrillation Energy,” Jpn Heart J, 44, pp. 91-100 (Jan. 2003).;;Naito, “Effects of zatebradine and propranolol on canine ischemia and reperfusion-induced arrhythmias,” European Journal of Pharmacology, 388, pp. 171-176 (2000).;;Nakajima, et al., “Autonomic Control of the Location and Rate of the Cardiac Pacemaker in the Sinoatrial Fat Pad of Parasympathetically Denervated Dog Hearts,” Journal of Cardiovascular Electrophysiology, vol. 13, No. 9 pp. 896-901 (Sep. 2002).;;Nearing, et al., “Crescendo in Depolarization and Repolarization Heterogeneity Heralds Development of Ventricular Tachycardia in Hospitalized Patients with Decompensated Heart Failure,” Circulation Arrhythmia and Electrophysiology, Journal of the American Heart Association, 5, pp. 84-90 (2012).;;Nihei, et al., “Decreased Vagal Control Over Heart Rate in Rats with Right-Sided Congestive Heart Failure—Downregulation of Neuronal Nitric Oxide Synthase,” Gire J, 69, pp. 493-499 (2005).;;Ninomiya, “Direct Evidence of Nonuniform Distribution of Vagal Effects on Dog Atria,” Circulation Research, vol. XIX, pp. 576-583 (Sep. 1966).;;Nolan, et al., “Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart),” Circulation, Journal of the American Heart Association, 98, pp. 1510-1516 (1998).;;Non-Final Office Action dated Mar. 20, 2015 in U.S. Appl. No. 14/271,714, filed May 7, 2014.;;Ochoa, et al., “P2497: Effects of insulin resistance on resting heart rate, baroreflex sensitivity and indices of autonomic cardiovascular modulation in individuals with high blood pressure levels,” European Heart Journal, 32 (Abstract Supplement, pp. 431-432 (2011).;;Ogawa, et al., “Left Stellate Ganglion and Vagal Nerve Activity and Cardiac Arrhythmias in Ambulatory Dogs with Pacing-Induced Congestive Heart Failure,” Journal of the American College of Cardiology, vol. 50, No. 4, pp. 335-444 (2007).;;Okada, et al., “Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells,” Arterioscler Thromb Vase Biol., 18, pp. 894-901 (1998).;;Oliveira, et al., “Effects of vagal stimulation on induction and termination of atrial fibrillation in an in vivo rabbit heart model,” Rev Port Cardiol, 29(03), pp. 375-389 (2010).;;Olshansky, et al., “Parasympathetic Nervous System and Heart Failure: Pathophysiology and Potential Implications for Therapy,” Circulation, Journal of the American Heart Association, 118, pp. 863-871 (2008).;;Onkka, et al., “Sympathetic nerve fibers and ganglia in canine cervical vagus nerves: Localization and quantitation,” Heart Rhythm, vol. 10, No. 4, pp. 585-591 (Apr. 2013).;;Ordelman, et al., “Selectivity for Specific Cardiovascular Effects of Vagal Nerve Stimulation with a Multi-Contact Electrode Cuff,” IEEE, pp. 1-6 (2011).;;Packer, et al., “Effect of Carvedilol on Survival in Severe Chronic Heart Failure,” The New England Journal of Medicine, vol. 344, No. 22, pp. 1651-1658 (May 31, 2001).;;Pavlov, et al., “Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia,” PNAS, vol. 103, No. 13, pp. 5219-5223 (Mar. 28, 2006).;;Pavlov, et al., “Controlling inflammation: the cholinergic anti-inflammatory pathway,” Biochemical Society Transactions, vol. 34, part 6, pp. 1037-1040 (2006).;;PCT Application No. PCT/US2012/068205, Search Report and Written Opinion dated Feb. 8, 2013, 15 pages.;;PCT Application No. PCT/US2012/068211, Search Report and Written Opinion dated Jun. 13, 2013.;;PCT Application No. PCT/US2012/068213, Search Report and Written Opinion dated Mar. 15, 2013, 11 pages.;;PCT Application No. PCT/US2012/068223, Search Report and Written Opinion dated Apr. 3, 2013, 11 pages.;;PCT Application No. PCT/US2013/021964, Search Report and Written Opinion dated Jul. 25, 2013, 9 pages.;;PCT Application No. PCT/US2013/050390, Search Report and Written Opinion dated Nov. 5, 2013.;;PCT Application No. PCT/US2013/068541, Search Report and Written Opinion dated Jan. 7, 2014.;;PCT Application No. PCT/US2014/024827, Search Report and Written Opinion dated Nov. 11, 2014, 18 pages.;;PCT Application No. PCT/US2015/020116, Search Report and Written Opinion dated Jul. 6, 2015, 12 pages.;;Peckham, et al., “Chapter 18—Implantable Neural Stimulators,” Neuromodulation, Academic Press (2009).;;Pina, et al., “The Predictive Value of Biomarkers in Heart Failure,” Medscape Education Cardiology, Available at http://www.medscape.org/viewarticle/765328 (CME Released: Jun. 15, 2012).;;Pitzalis, et al., “Comparison Between Noninvasive Indices of Baroreceptor Sensitivity and the Phenylephrine Method in Post-Myocardial Infarction Patients,” Circulation, Journal of the American Heart Association, 97, pp. 1362-1367 (1998).;;Poole-Wilson, “Relation of Pathophysiologic Mechanisms to Outcome in Heart Failure,” JACC, vol. 22, No. 4 (supplement A), pp. 22A-9A (Oct. 1993).;;Pye, et al., “Study of serum C-reactive protein concentration in cardiac failure,” Br Heart J, 63, pp. 228-230 (1990).;;Rademacher, et al., “P5878: Multidimensional halter-based analysis of cardiac autonomic regulation predicts early AF recurrence after electrical cardioversion,” European Heart Journal, 32 (Abstract Supplement), pp. 1116-1117 (2011).;;Randall, et al., “Regional vagosympathetic control of the heart,” American Journal of Physiology, vol. 227, No. 2, pp. 444-452 (1974).;;Randall, et al., “Selective Vagal Innervation of the Heart,” Annals of Clinical and Laboratory Science, vol. 16, No. 3, pp. 198-208 (1986).;;Raymond, et al., “Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction,” American Heart Journal, vol. 141, No. 3, pp. 435-438 (Mar. 2001).;;Rhee, et al., “Effects of suprathreshold vagal stimulation on stellate ganglion nerve activity in ambulatory dogs,” 33rd Annual Scientific Sessions, Heart Rhythm, Presentation Abstract (2012).;;Riccio, et al., “Interganglionic segregation of distinct vagal afferent fibre phenotypes in guinea-pig airways,” Journal of Physiology, 495.2, pp. 521-530 (1996).;;Riddle, et al., “Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the Accord Trial,” Diabetes Care, vol. 33, No. 5, pp. 983-990 (May 2010).;;Ridker, C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke, Journal of the American Heart Association, 108, pp. e81-e85 (2003).;;Ridker, et al., “Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First cardiovascular Events,” New England Journal of Medicine, vol. 347, No. 20, pp. 1557-1566 (Nov. 14, 2002). et al.",ACTIVE
